data_2lnv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lnv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.472 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.8 Cg_exo . . . . . 0 CA--C 1.532 0.404 0 N-CA-C 111.711 -0.15 . . . . 0.0 111.711 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.537 ' OG ' ' HB2' ' A' ' 152' ' ' GLU . 52.7 m 54.16 -99.58 0.09 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.514 0.326 . . . . 0.0 111.077 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.559 HG22 HD23 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -139.2 -42.3 0.46 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -176.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.872 ' H ' HD23 ' A' ' 154' ' ' LEU . 50.9 tp 60.38 109.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.496 0.665 . . . . 0.0 111.934 -174.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.546 ' O ' ' HB3' ' A' ' 156' ' ' LEU . 2.9 p-10 -174.55 -157.88 0.08 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.7 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER 44.37 -175.41 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 176.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.2 t -127.31 111.8 14.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.219 163.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.945 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -82.43 72.82 9.49 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.563 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -34.3 -42.62 0.14 Allowed 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 178.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.442 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 157.78 150.71 5.81 Favored Glycine 0 CA--C 1.484 -1.903 0 C-N-CA 119.16 -1.495 . . . . 0.0 112.676 171.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.746 HG21 HG22 ' A' ' 138' ' ' ILE . 19.0 m -104.13 160.44 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 122.432 1.111 . . . . 0.0 110.69 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.828 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 23.4 mmt -119.34 89.41 3.12 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 112.89 -1.959 . . . . 0.0 107.698 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.82 132.91 55.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.85 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 108' ' ' ARG . . . -117.34 90.85 0.52 Allowed Glycine 0 CA--C 1.496 -1.142 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.252 -173.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' A' ' 107' ' ' SER . 31.0 t0 73.86 -53.33 0.69 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -172.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.771 ' O ' ' HB3' ' A' ' 109' ' ' SER . 38.6 t70 179.24 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.45 -1.704 . . . . 0.0 106.935 170.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.536 ' CB ' HG23 ' A' ' 124' ' ' VAL . 9.9 p-10 -90.37 -9.74 46.54 Favored 'General case' 0 C--N 1.334 -0.103 0 O-C-N 124.248 0.968 . . . . 0.0 109.885 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.698 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 24.9 m -69.02 11.39 0.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.771 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.698 ' HG3' ' O ' ' A' ' 107' ' ' SER . 30.2 mtt85 178.59 -79.87 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -171.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.994 ' HB2' HD13 ' A' ' 138' ' ' ILE . 13.2 p 48.51 110.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 174.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.828 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 3.9 mm -94.41 134.25 32.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.76 174.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.918 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -124.06 108.42 12.33 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.745 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.669 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 13.8 mm -94.55 92.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.945 HG23 ' HA ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER -105.87 143.16 17.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.047 -174.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.835 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 31.4 t -103.61 126.36 50.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.703 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 129' ' ' PRO . 26.3 tptp -118.55 98.77 6.41 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 52.3 26.77 4.25 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -166.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.835 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 3.4 t-20 79.01 39.72 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.851 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 12.6 pt-20 -111.94 92.47 4.04 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.965 0.888 . . . . 0.0 108.934 161.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.652 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 63.0 mt-30 -66.4 126.63 29.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.585 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.669 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.5 m-85 -118.8 161.65 19.78 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.543 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.0 p -102.98 99.16 9.04 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 122.086 0.946 . . . . 0.0 110.922 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.593 ' HB2' ' HB1' ' A' ' 111' ' ' ALA . 22.8 mmt180 -107.74 -159.24 0.68 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.531 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.617 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . 165.33 179.94 39.43 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.857 -174.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.536 HG23 ' CB ' ' A' ' 106' ' ' ASP . 25.4 t -52.53 121.83 2.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 114.183 -1.009 . . . . 0.0 109.924 168.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.809 ' HA ' ' HE3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 78.52 21.55 0.78 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.546 1.165 . . . . 0.0 109.747 178.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 123' ' ' GLY . 3.6 mm-40 -117.06 158.93 23.33 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.96 -1.927 . . . . 0.0 106.42 167.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.855 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 40.1 mt-10 -113.22 148.91 34.54 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 118.17 0.441 . . . . 0.0 110.38 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.515 HG22 ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -58.74 147.77 70.32 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.755 -177.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.742 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 6.0 Cg_exo -58.79 130.95 39.32 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.811 2.341 . . . . 0.0 112.188 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.52 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 94.99 -63.5 1.48 Allowed Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 116.086 -0.507 . . . . 0.0 112.765 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.403 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 14.6 m-85 -109.31 148.07 31.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.15 49.83 0.58 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -175.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.717 ' HB3' HD21 ' A' ' 145' ' ' LEU . . . -84.58 97.56 9.66 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.855 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . 5.7 tptm -79.8 123.04 27.36 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-O 121.324 0.583 . . . . 0.0 111.373 -171.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.574 HG12 HG13 ' A' ' 143' ' ' VAL . 71.2 mt -75.68 93.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.58 HG21 ' HG3' ' A' ' 134' ' ' LYS . 2.1 t -87.97 -10.53 10.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.557 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.2 OUTLIER -157.08 117.35 3.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.984 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.994 HD13 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -87.45 131.42 35.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.139 178.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.558 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 13.1 mmt180 -141.45 151.15 60.11 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 141' ' ' ASP . 84.5 Cg_exo -19.41 -77.68 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 125.261 3.974 . . . . 0.0 114.767 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.534 ' HA ' HD23 ' A' ' 97' ' ' LEU . 4.4 p-10 -125.05 36.86 4.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.467 1.127 . . . . 0.0 109.034 168.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.805 ' HD2' HG11 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -131.45 138.15 48.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.006 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.723 HG22 HD22 ' A' ' 97' ' ' LEU . 3.2 t -144.74 121.71 4.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 122.044 0.925 . . . . 0.0 112.131 -176.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.775 HG23 HG21 ' A' ' 153' ' ' VAL . 37.4 t -79.21 102.18 5.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.852 HD12 HD22 ' A' ' 154' ' ' LEU . 1.8 pp -120.12 152.0 38.25 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.103 0.954 . . . . 0.0 113.294 -169.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 4.0 tp60 -100.23 102.86 14.26 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.716 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.548 ' HD2' ' HB1' ' A' ' 133' ' ' ALA . 0.4 OUTLIER -136.78 135.16 37.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.15 -1.386 . . . . 0.0 107.529 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.409 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.7 mp0 70.39 32.19 2.83 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.673 0.389 . . . . 0.0 111.274 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.84 1.96 87.84 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.027 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.732 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 20.1 tpp180 -130.31 143.49 50.81 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.704 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 34.6 p90 -119.84 108.94 14.98 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 122.278 1.037 . . . . 0.0 108.523 175.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.732 ' HG2' ' HG3' ' A' ' 150' ' ' ARG . 51.1 mm-40 -125.79 -170.41 2.18 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.646 -173.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.805 HG11 ' HD2' ' A' ' 142' ' ' ARG . 2.9 t -102.25 101.84 12.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.843 0.83 . . . . 0.0 109.985 -169.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.872 HD23 ' H ' ' A' ' 93' ' ' LEU . 4.7 tp -112.23 118.19 34.63 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.54 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.433 ' HA3' ' NH1' ' A' ' 142' ' ' ARG . . . -102.96 58.27 0.56 Allowed Glycine 0 C--N 1.308 -0.98 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.553 169.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.81 HD13 HD11 ' A' ' 97' ' ' LEU . 2.3 mt -37.67 104.74 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.687 0 O-C-N 124.52 0.777 . . . . 0.0 110.214 174.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 91.2 t80 . . . . . 0 C--N 1.329 -0.312 0 O-C-N 121.524 -0.735 . . . . 0.0 109.544 -178.117 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.738 ' HG2' ' HB3' ' A' ' 152' ' ' GLU . 73.4 Cg_endo . . . . . 0 CA--C 1.532 0.39 0 CA-C-O 119.554 -0.269 . . . . 0.0 111.675 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.832 ' HB3' ' HG ' ' A' ' 154' ' ' LEU . 22.8 t 53.21 -101.8 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 117.878 0.308 . . . . 0.0 110.677 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.741 HG21 HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -127.94 -34.67 2.13 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.475 0.58 . . . . 0.0 112.46 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.641 ' H ' HD13 ' A' ' 154' ' ' LEU . 47.2 tp 59.68 107.48 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.335 0.588 . . . . 0.0 111.993 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 156' ' ' LEU . 2.4 p-10 -176.54 -157.05 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.75 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.4 OUTLIER 55.23 174.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 173.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.1 t -126.67 117.31 22.48 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.749 163.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.745 HD23 HG21 ' A' ' 113' ' ' ILE . 11.5 mt -77.23 125.51 29.44 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.606 HG22 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -91.53 -33.8 15.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.21 154.43 6.17 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.088 162.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.576 HG22 HG12 ' A' ' 138' ' ' ILE . 3.4 m -104.17 146.8 11.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 122.303 1.049 . . . . 0.0 110.799 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.607 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 65.6 mtt -105.75 91.58 3.81 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.176 -1.829 . . . . 0.0 108.782 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.31 129.59 42.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.55 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.572 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -114.6 94.85 0.7 Allowed Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 1.3 m-20 73.92 -53.81 0.69 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -169.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.764 ' O ' ' HB3' ' A' ' 109' ' ' SER . 25.8 t70 178.95 -90.01 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.692 -1.594 . . . . 0.0 107.466 168.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.759 ' HB2' HG23 ' A' ' 124' ' ' VAL . 13.3 p-10 -91.11 -38.85 12.5 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.16 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.447 ' C ' ' HD2' ' A' ' 108' ' ' ARG . 2.7 m -49.3 -55.89 11.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.195 -172.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.531 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 5.3 mmm180 -120.48 34.77 5.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.134 0.493 . . . . 0.0 109.902 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.764 ' HB3' ' O ' ' A' ' 105' ' ' ASP . 19.1 p -76.35 141.87 41.38 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -168.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 10.2 mm -120.94 84.16 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 121.87 0.843 . . . . 0.0 111.273 -176.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.594 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -74.2 102.63 4.35 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.26 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 3.2 mm -87.04 96.19 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.745 HG21 HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -103.29 144.58 13.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.689 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.803 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 31.2 t -105.31 120.28 41.17 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.568 ' HE3' ' HA3' ' A' ' 130' ' ' GLY . 23.9 tptp -123.45 110.41 15.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -174.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.07 17.29 7.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -168.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.803 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 2.8 t-20 73.98 35.53 0.78 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.913 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -104.82 101.33 10.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 164.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.606 ' NE2' HG22 ' A' ' 98' ' ' THR . 36.3 mt-30 -67.2 120.99 14.68 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.34 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 5.7 t80 -120.21 143.41 48.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.819 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.3 p -87.14 95.42 9.95 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.396 1.093 . . . . 0.0 111.119 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.481 ' HD3' ' HB3' ' A' ' 126' ' ' GLU . 13.6 mmt180 -103.57 -157.48 0.61 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.569 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.711 ' HA2' HD12 ' A' ' 138' ' ' ILE . . . 162.28 -174.64 38.73 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 119.87 -1.157 . . . . 0.0 112.17 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.759 HG23 ' HB2' ' A' ' 106' ' ' ASP . 2.1 t -56.62 122.72 6.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.134 -1.033 . . . . 0.0 109.639 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.53 ' HA ' ' CE ' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 75.29 35.16 0.59 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.969 1.366 . . . . 0.0 108.223 176.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.481 ' HB3' ' HD3' ' A' ' 122' ' ' ARG . 4.8 mm-40 -133.8 144.88 49.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 111.985 -2.37 . . . . 0.0 106.81 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.566 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 34.7 mt-10 -103.34 132.56 49.5 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.196 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.599 HG23 HG13 ' A' ' 113' ' ' ILE . 0.4 OUTLIER -61.15 140.1 94.31 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.071 -176.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.701 ' O ' HD22 ' A' ' 95' ' ' LEU . 23.8 Cg_exo -64.77 142.67 77.39 Favored 'Trans proline' 0 C--O 1.223 -0.227 0 C-N-CA 123.094 2.529 . . . . 0.0 112.442 -167.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.568 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 97.06 -43.21 2.05 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.567 ' HB3' ' CE1' ' A' ' 147' ' ' TYR . 62.1 m-85 -114.11 170.13 8.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -96.43 46.44 1.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 170.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.676 ' HB2' HD21 ' A' ' 145' ' ' LEU . . . -85.81 97.52 10.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.566 ' CA ' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -81.81 104.61 12.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.715 -169.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 123' ' ' GLY . 70.8 mt -52.3 94.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.83 0.824 . . . . 0.0 110.106 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.482 ' H ' ' HA ' ' A' ' 145' ' ' LEU . 3.4 m -83.38 -3.78 7.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.517 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.796 ' HB3' ' HB ' ' A' ' 144' ' ' VAL . 3.6 t -168.71 117.4 0.7 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.905 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.711 HD12 ' HA2' ' A' ' 123' ' ' GLY . 7.1 tt -97.2 135.88 29.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.735 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.717 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 17.1 mmt180 -141.44 157.5 65.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -18.94 -82.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.013 1 C-N-CA 125.579 4.186 . . . . 0.0 115.05 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.455 ' C ' HD12 ' A' ' 97' ' ' LEU . 7.7 p-10 -133.21 40.19 3.21 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 123.471 1.605 . . . . 0.0 107.438 167.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.717 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -126.57 139.2 53.38 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 111.642 -2.526 . . . . 0.0 107.154 169.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.546 ' N ' ' HD3' ' A' ' 142' ' ' ARG . 1.1 t -137.07 160.33 36.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.133 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.936 HG22 HG11 ' A' ' 153' ' ' VAL . 13.9 t -120.33 117.16 52.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 165.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.855 HD13 HD12 ' A' ' 154' ' ' LEU . 2.2 pp -132.5 162.49 31.08 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.765 0.793 . . . . 0.0 111.956 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 4.2 tp60 -109.97 108.91 19.33 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.65 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.568 ' HD2' ' NE2' ' A' ' 148' ' ' GLN . 76.9 t80 -135.86 141.32 44.61 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.577 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.568 ' NE2' ' HD2' ' A' ' 147' ' ' TYR . 0.0 OUTLIER 59.11 22.38 10.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 169.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 98.6 -1.39 58.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.57 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.425 ' HG2' ' HG2' ' A' ' 148' ' ' GLN . 13.2 ptp180 -130.19 137.62 50.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.372 0.586 . . . . 0.0 111.875 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.605 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 16.5 p90 -114.7 108.22 16.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.391 1.091 . . . . 0.0 108.477 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.738 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 52.6 mt-10 -139.45 -170.42 2.9 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.443 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.936 HG11 HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -96.34 99.65 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 122.006 0.908 . . . . 0.0 110.208 -168.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.855 HD12 HD13 ' A' ' 145' ' ' LEU . 0.4 OUTLIER -101.99 106.82 17.79 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.704 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -98.98 53.11 1.08 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 173.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.75 HD22 ' HB2' ' A' ' 95' ' ' LEU . 3.9 mt -32.36 115.22 0.17 Allowed 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.907 1.004 . . . . 0.0 110.69 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.4 p90 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -172.168 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.848 ' HG2' ' HB3' ' A' ' 152' ' ' GLU . 6.3 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 CA-C-O 119.773 -0.178 . . . . 0.0 112.118 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.527 ' HB2' HD13 ' A' ' 154' ' ' LEU . 70.5 m 56.83 -86.63 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.614 0.765 . . . . 0.0 112.179 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.566 HG21 HD22 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -160.97 -44.67 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.831 -0.543 . . . . 0.0 112.381 -176.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.824 ' H ' HD22 ' A' ' 154' ' ' LEU . 6.5 tt 51.54 112.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.773 ' H ' HD23 ' A' ' 156' ' ' LEU . 2.3 p-10 -167.48 -56.81 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.814 HD12 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -54.71 176.34 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 122.95 0.5 . . . . 0.0 111.154 176.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.481 ' HB3' ' OG ' ' A' ' 114' ' ' SER . 1.5 t -117.59 109.93 17.29 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.292 170.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.726 ' HA ' HG22 ' A' ' 113' ' ' ILE . 1.9 mp -73.23 115.95 13.19 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 170.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.425 HG23 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -82.83 -35.7 26.14 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -176.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.51 169.83 31.55 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.745 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.713 HG23 ' HA ' ' A' ' 111' ' ' ALA . 2.3 t -130.11 126.55 62.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.904 0.859 . . . . 0.0 110.889 -175.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.861 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 64.8 mtt -92.0 89.98 7.21 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.583 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.11 121.52 14.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.731 -175.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -114.04 100.37 1.03 Allowed Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -172.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.575 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 10.5 t70 74.4 -64.67 0.38 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -170.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 109' ' ' SER . 7.0 m-20 -169.37 -91.52 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.942 -1.935 . . . . 0.0 106.519 169.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.509 ' HA ' HG21 ' A' ' 124' ' ' VAL . 12.5 p-10 -91.87 -30.75 15.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.665 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 t -60.07 -57.18 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.459 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 4.4 mmm180 -111.58 28.9 8.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.367 0.603 . . . . 0.0 110.067 -170.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.66 ' HB2' ' CD1' ' A' ' 138' ' ' ILE . 22.5 p -73.02 135.8 44.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.685 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.861 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 6.4 mm -120.39 89.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.393 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.895 ' HB3' HD12 ' A' ' 113' ' ' ILE . . . -78.64 100.95 7.22 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.921 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.5 mm -86.3 93.18 3.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.895 HD12 ' HB3' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -106.86 159.93 6.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.235 -176.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.481 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 26.4 p -125.82 135.48 52.02 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-O 121.308 0.575 . . . . 0.0 109.54 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.814 ' HD3' HD12 ' A' ' 95' ' ' LEU . 24.9 tptp -119.21 108.39 14.59 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 59.25 20.43 8.54 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -167.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.445 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.1 t-20 79.74 37.19 0.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 113.435 -1.711 . . . . 0.0 111.666 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.615 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 16.6 pt-20 -107.4 101.77 11.1 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.963 0.887 . . . . 0.0 109.626 166.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.686 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 2.8 mt-30 -67.24 135.89 54.11 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -142.81 146.15 33.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.737 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -88.07 103.11 15.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.924 0.869 . . . . 0.0 111.552 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.475 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 21.9 mmt180 -107.42 -159.62 0.7 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.682 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.524 ' N ' ' HG3' ' A' ' 126' ' ' GLU . . . 174.94 173.64 40.93 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -175.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.517 HG23 ' OG ' ' A' ' 109' ' ' SER . 16.7 t -49.39 132.59 7.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 165.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.579 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 72.29 19.55 4.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.459 1.123 . . . . 0.0 109.574 175.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 123' ' ' GLY . 0.4 OUTLIER -120.64 158.04 28.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.145 -1.843 . . . . 0.0 106.347 167.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 41.6 mt-10 -104.2 156.89 17.52 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 118.435 0.561 . . . . 0.0 110.116 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.656 HG21 HD22 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -66.4 145.2 98.95 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.553 178.345 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.76 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 21.7 Cg_exo -52.98 130.69 39.1 Favored 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 122.847 2.364 . . . . 0.0 112.009 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.522 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 96.6 -59.06 1.29 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.633 176.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.452 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 27.0 m-85 -113.63 153.66 28.51 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 121.434 -0.106 . . . . 0.0 111.036 -174.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -74.81 44.76 0.23 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.712 ' HB1' HD23 ' A' ' 145' ' ' LEU . . . -83.06 90.4 7.03 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 170.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.703 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -80.49 120.83 24.99 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.472 -170.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.631 HG22 HG13 ' A' ' 143' ' ' VAL . 74.4 mt -68.62 94.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.412 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.702 HG21 ' HE2' ' A' ' 134' ' ' LYS . 1.5 t -88.59 -3.77 9.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.732 0.777 . . . . 0.0 108.965 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.47 ' HB3' HG21 ' A' ' 144' ' ' VAL . 1.7 t -162.38 115.32 1.71 Allowed 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.492 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.827 HD12 ' HB1' ' A' ' 111' ' ' ALA . 3.5 tt -88.98 132.93 32.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.069 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 7.4 mmt180 -141.89 159.23 60.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.438 ' HB2' ' H ' ' A' ' 141' ' ' ASP . 72.1 Cg_exo -22.63 -78.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 125.093 3.862 . . . . 0.0 114.474 177.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.456 ' HA ' HD22 ' A' ' 97' ' ' LEU . 9.5 p-10 -128.33 39.53 3.81 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.398 1.094 . . . . 0.0 108.715 169.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 1.9 tpp180 -136.93 143.35 42.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.73 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 135' ' ' ILE . 4.8 t -148.41 119.33 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.83 -176.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 1.092 HG23 HG11 ' A' ' 153' ' ' VAL . 7.1 t -79.04 65.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.712 HD23 ' HB1' ' A' ' 133' ' ' ALA . 1.9 pp -82.63 167.92 17.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.022 -175.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -112.57 124.39 52.43 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.577 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.592 ' HD2' ' HB2' ' A' ' 133' ' ' ALA . 0.3 OUTLIER -145.27 140.04 27.53 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.467 ' N ' ' HD1' ' A' ' 147' ' ' TYR . 2.2 mp0 67.91 28.94 6.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.966 0.412 . . . . 0.0 109.942 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.15 8.43 87.44 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.605 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 0.3 OUTLIER -132.61 139.78 47.93 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 117.247 0.523 . . . . 0.0 110.905 -173.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.689 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 13.3 p90 -118.94 111.96 19.01 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.106 0.955 . . . . 0.0 109.392 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.848 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 34.6 mt-10 -134.94 -175.9 4.06 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.161 -177.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 1.092 HG11 HG23 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -96.24 99.27 8.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 119.676 -0.809 . . . . 0.0 110.233 -165.17 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.824 HD22 ' H ' ' A' ' 93' ' ' LEU . 6.0 tp -103.66 119.55 39.14 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.384 -0.825 . . . . 0.0 113.163 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -104.29 54.86 0.62 Allowed Glycine 0 C--N 1.304 -1.204 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 168.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.773 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.5 mt -36.51 107.25 0.06 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.39 0.7 . . . . 0.0 110.101 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 19.7 t80 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.746 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.741 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.6 Cg_exo . . . . . 0 CA--C 1.534 0.496 0 N-CA-C 111.005 -0.421 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.846 ' HB2' ' HB2' ' A' ' 152' ' ' GLU . 9.1 t 51.23 -137.98 1.11 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.211 0.205 . . . . 0.0 111.121 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.441 ' HB ' ' CD2' ' A' ' 147' ' ' TYR . 4.9 t -95.53 -37.85 10.69 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.587 ' N ' HD22 ' A' ' 154' ' ' LEU . 31.7 tp 49.59 68.47 0.73 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.781 ' H ' HD23 ' A' ' 156' ' ' LEU . 5.3 t30 -174.04 100.59 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.846 ' HB2' HD21 ' A' ' 156' ' ' LEU . 0.0 OUTLIER 164.44 -167.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 175.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.682 ' HB2' ' HG ' ' A' ' 114' ' ' SER . 49.9 m -132.01 103.75 6.45 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.606 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.966 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -83.25 74.14 10.05 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -37.72 -46.67 0.92 Allowed 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 140' ' ' PRO . . . 161.54 152.47 6.67 Favored Glycine 0 CA--C 1.486 -1.775 0 C-N-CA 119.121 -1.514 . . . . 0.0 112.358 172.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.603 HG11 ' HA ' ' A' ' 111' ' ' ALA . 4.7 m -104.59 143.21 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 121.659 0.743 . . . . 0.0 110.021 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.863 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 87.1 mmm -90.86 86.33 6.27 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.83 ' HA ' ' HG ' ' A' ' 109' ' ' SER . . . -65.61 119.69 11.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.945 -176.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -114.7 102.45 1.17 Allowed Glycine 0 CA--C 1.498 -1.022 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -171.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 2.6 m-20 72.22 -69.41 0.19 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -172.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -149.72 -111.89 0.06 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.092 170.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.506 ' OD2' HG13 ' A' ' 124' ' ' VAL . 5.8 m-20 -90.59 -13.13 35.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.739 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.3 t -64.44 -58.03 7.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.534 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -109.91 29.67 7.41 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.401 -173.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.83 ' HG ' ' HA ' ' A' ' 102' ' ' ALA . 2.6 t -85.52 141.65 29.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.247 0.546 . . . . 0.0 111.763 -170.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.863 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 10.7 mm -122.21 87.93 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.422 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.832 ' HB3' HD12 ' A' ' 113' ' ' ILE . . . -69.09 98.61 1.01 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.483 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.542 HG23 ' HG2' ' A' ' 119' ' ' GLN . 13.6 mm -87.33 90.03 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.966 HG23 ' HA ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -101.79 132.84 46.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.759 -179.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.682 ' HG ' ' HB2' ' A' ' 96' ' ' SER . 2.7 p -99.41 135.21 41.16 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.04 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.8 ' CD ' HD22 ' A' ' 95' ' ' LEU . 24.3 tptp -122.69 110.87 16.04 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 61.71 21.51 12.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -166.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 77.39 33.69 0.4 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.677 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 114' ' ' SER . 81.3 tt0 -101.6 96.78 7.34 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 170.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.542 ' HG2' HG23 ' A' ' 112' ' ' ILE . 3.8 mt-30 -67.5 108.62 2.9 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 5.2 t80 -110.13 141.99 42.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.927 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.9 p -90.19 95.12 10.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.807 0.813 . . . . 0.0 112.177 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.894 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 18.8 mmt180 -91.96 -160.07 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.492 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.65 ' N ' ' HG3' ' A' ' 126' ' ' GLU . . . 163.8 105.62 0.19 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.582 -168.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.765 ' O ' ' HB2' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -9.5 117.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 125.408 1.299 . . . . 0.0 113.23 -177.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.765 ' HB2' ' O ' ' A' ' 124' ' ' VAL . 0.9 OUTLIER 88.59 27.48 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 124.999 1.437 . . . . 0.0 108.428 -167.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.894 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 5.1 mm-40 -124.75 147.49 48.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 112.833 -1.985 . . . . 0.0 107.891 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.555 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 50.9 mt-10 -105.41 140.25 38.81 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.571 HG22 ' CD1' ' A' ' 156' ' ' LEU . 0.5 OUTLIER -57.18 154.77 19.59 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.23 -176.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.07 119.24 6.2 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.883 2.389 . . . . 0.0 112.279 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.556 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 99.21 -52.1 1.1 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.328 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.539 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 21.3 m-85 -104.34 132.57 50.44 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -79.27 52.57 1.35 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.571 1.078 . . . . 0.0 110.962 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.684 ' HB1' HD23 ' A' ' 145' ' ' LEU . . . -84.78 101.72 12.47 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.59 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -81.39 107.9 14.55 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.015 -171.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.1 mt -55.91 94.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 O-C-N 123.806 0.691 . . . . 0.0 109.834 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 151' ' ' TYR . 0.2 OUTLIER -88.19 -4.2 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.621 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -164.65 118.32 1.33 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.767 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.731 ' HB ' HG22 ' A' ' 124' ' ' VAL . 7.2 tt -92.88 128.79 44.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.552 0.691 . . . . 0.0 111.727 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.797 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 16.9 mmt180 -142.06 160.17 56.29 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.602 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 7.3 Cg_exo -25.49 -85.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 1 C-N-CA 126.14 4.56 . . . . 0.0 114.98 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.5 ' HA ' HD23 ' A' ' 97' ' ' LEU . 1.9 p30 -123.78 14.05 9.3 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.036 0.922 . . . . 0.0 109.08 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.797 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -115.25 142.72 46.3 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.704 169.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.618 HG23 HD22 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -137.89 170.48 17.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.851 177.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.774 HG21 HG12 ' A' ' 153' ' ' VAL . 40.7 t -122.1 97.98 5.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.684 HD23 ' HB1' ' A' ' 133' ' ' ALA . 1.2 pp -120.34 158.59 26.8 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.039 0.923 . . . . 0.0 112.847 -170.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 4.6 tp60 -106.64 103.04 12.39 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.555 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.584 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 52.9 t80 -128.22 144.42 51.12 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.613 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 0.0 OUTLIER 59.38 29.31 18.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 171.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.436 ' N ' HE22 ' A' ' 146' ' ' GLN . . . 83.24 5.24 89.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.133 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.614 ' HG2' ' HG2' ' A' ' 152' ' ' GLU . 66.5 ttt180 -133.32 138.47 46.39 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 117.071 0.435 . . . . 0.0 110.803 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 6.4 p90 -116.75 112.33 21.02 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.547 1.165 . . . . 0.0 108.812 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.846 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 76.5 mm-40 -128.87 -169.79 2.15 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.384 -174.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.774 HG12 HG21 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -98.64 100.4 10.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.081 0.944 . . . . 0.0 108.475 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.65 HD13 ' HG ' ' A' ' 156' ' ' LEU . 0.3 OUTLIER -119.38 106.3 12.14 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.701 -172.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.47 ' CA ' ' HA ' ' A' ' 142' ' ' ARG . . . -106.46 70.49 0.22 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.846 HD21 ' HB2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -37.06 124.14 0.91 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.604 0.762 . . . . 0.0 110.447 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.2 t80 . . . . . 0 C--N 1.331 -0.23 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -161.859 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.504 ' O ' HD11 ' A' ' 154' ' ' LEU . 2.8 Cg_exo . . . . . 0 CA--C 1.531 0.35 0 N-CA-C 111.364 -0.283 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.478 ' HB2' HD11 ' A' ' 154' ' ' LEU . 58.5 m 56.38 -83.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.895 0.478 . . . . 0.0 112.006 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.606 ' HB ' HE22 ' A' ' 148' ' ' GLN . 1.6 t -161.07 -41.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.544 -0.722 . . . . 0.0 112.336 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.781 ' H ' HD21 ' A' ' 154' ' ' LEU . 48.8 tp 56.2 99.77 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.744 ' H ' HD21 ' A' ' 156' ' ' LEU . 3.1 p-10 -160.07 -61.09 0.06 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.863 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -57.28 -178.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.415 0.626 . . . . 0.0 111.75 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.451 ' HB3' ' OG ' ' A' ' 114' ' ' SER . 9.6 t -117.28 119.85 36.43 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.621 170.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.933 HD21 HG23 ' A' ' 113' ' ' ILE . 53.4 mt -76.74 131.34 38.68 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 165.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.27 -32.48 15.01 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 175.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.898 ' HA2' ' HB3' ' A' ' 141' ' ' ASP . . . 154.71 168.19 17.67 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.97 161.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.7 HG12 HG22 ' A' ' 138' ' ' ILE . 2.7 t -114.4 132.01 64.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.781 0.801 . . . . 0.0 110.91 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.81 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 67.1 mtt -104.17 87.41 2.75 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.21 177.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.81 46.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.4 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.725 ' H ' ' HA ' ' A' ' 109' ' ' SER . . . -106.62 88.14 0.54 Allowed Glycine 0 CA--C 1.496 -1.156 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 25.1 t70 74.85 -54.65 0.66 Allowed 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -169.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.696 ' O ' ' HB3' ' A' ' 109' ' ' SER . 12.7 t70 -178.97 -124.07 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.902 -1.499 . . . . 0.0 106.994 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.681 ' HA ' HG22 ' A' ' 124' ' ' VAL . 2.3 p-10 -80.9 -6.59 58.85 Favored 'General case' 0 CA--C 1.522 -0.101 0 O-C-N 124.184 0.928 . . . . 0.0 109.939 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.1 t -60.46 -42.5 96.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.164 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.477 ' C ' ' HG ' ' A' ' 109' ' ' SER . 78.7 mtp180 -126.2 -65.61 0.97 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.421 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.725 ' HA ' ' H ' ' A' ' 103' ' ' GLY . 13.7 p 53.58 127.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 174.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.81 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 3.6 mm -116.9 129.92 72.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.329 174.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.873 ' HB3' HD12 ' A' ' 113' ' ' ILE . . . -120.69 98.42 6.01 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.802 0.335 . . . . 0.0 111.653 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.43 HG13 ' HE3' ' A' ' 101' ' ' MET . 5.5 mm -80.33 94.54 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.933 HG23 HD21 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -105.82 142.62 18.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.718 177.224 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 84.5 p -113.66 129.18 56.61 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.846 0.832 . . . . 0.0 109.353 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.863 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.6 tptp -124.81 101.46 7.1 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -171.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 55.07 22.16 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -164.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 78.24 40.67 0.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.697 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 15.5 pt-20 -108.71 90.75 3.39 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.276 1.036 . . . . 0.0 108.292 161.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 34.9 mt-30 -67.22 124.19 22.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.524 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -128.69 147.98 50.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.993 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -97.3 105.12 17.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.616 0.722 . . . . 0.0 111.532 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.935 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 28.1 mmt180 -95.2 -163.05 1.0 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.316 176.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.59 ' O ' ' HG2' ' A' ' 126' ' ' GLU . . . 164.74 110.88 0.24 Allowed Glycine 0 C--O 1.216 -1.001 0 C-N-CA 119.738 -1.22 . . . . 0.0 114.088 -171.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.681 HG22 ' HA ' ' A' ' 106' ' ' ASP . 28.1 t 4.85 115.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.152 1.381 . . . . 0.0 114.452 -175.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.705 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 80.8 35.48 0.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.313 -175.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.935 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 13.1 mm-40 -127.31 150.72 49.45 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.781 170.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 2.3 mp0 -101.39 150.84 22.6 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 118.571 0.623 . . . . 0.0 109.861 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.633 HG21 HG21 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -62.35 151.72 81.56 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.493 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.502 ' O ' HD11 ' A' ' 95' ' ' LEU . 3.6 Cg_exo -62.94 127.52 20.62 Favored 'Trans proline' 0 C--N 1.332 -0.292 0 C-N-CA 122.953 2.435 . . . . 0.0 112.37 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.589 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 100.48 -64.1 0.59 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.353 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.499 ' HE2' HD13 ' A' ' 95' ' ' LEU . 4.3 m-85 -110.73 140.56 45.01 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -78.87 56.37 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.538 0.608 . . . . 0.0 111.831 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.698 ' HB3' HD23 ' A' ' 145' ' ' LEU . . . -79.88 96.97 6.51 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.705 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.5 OUTLIER -81.13 115.91 20.79 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.256 0.551 . . . . 0.0 110.911 -169.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.51 HG22 HG13 ' A' ' 138' ' ' ILE . 74.7 mt -67.47 94.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.401 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.574 HG23 ' HE2' ' A' ' 134' ' ' LYS . 1.3 t -86.62 -6.57 10.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.713 ' CB ' ' HB ' ' A' ' 144' ' ' VAL . 4.1 t -157.15 117.12 3.46 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.125 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.805 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -91.55 125.99 44.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.991 0.9 . . . . 0.0 111.238 176.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.586 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 13.5 mmt85 -142.11 148.96 50.48 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.647 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.29 81.2 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.628 2.218 . . . . 0.0 113.67 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.898 ' HB3' ' HA2' ' A' ' 99' ' ' GLY 0.279 2.9 p30 75.62 27.0 1.05 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.868 1.667 . . . . 0.0 110.17 170.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.696 ' HD2' ' N ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -139.72 151.32 45.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 112.255 -2.248 . . . . 0.0 106.204 157.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.696 ' N ' ' HD2' ' A' ' 142' ' ' ARG . 7.2 t -141.21 164.89 19.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-O 121.526 0.679 . . . . 0.0 111.395 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.713 ' HB ' ' CB ' ' A' ' 137' ' ' SER . 59.1 t -122.12 100.45 8.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.699 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 2.0 pp -122.56 156.56 33.94 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 122.21 1.005 . . . . 0.0 113.223 -168.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.451 HE22 ' N ' ' A' ' 149' ' ' GLY . 2.2 tp60 -103.46 104.58 14.68 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 112.533 -2.121 . . . . 0.0 108.581 -174.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.5 ' CD2' HG21 ' A' ' 92' ' ' THR . 0.4 OUTLIER -136.54 135.5 38.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.711 175.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.606 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.8 mp0 67.93 34.34 4.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.46 175.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.451 ' N ' HE22 ' A' ' 146' ' ' GLN . . . 70.55 12.81 70.56 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.729 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.461 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 29.2 ttp180 -130.95 137.43 49.28 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.792 -0.24 . . . . 0.0 110.362 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 22.3 p90 -118.58 108.8 15.4 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.704 1.24 . . . . 0.0 109.313 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.1 mm-40 -129.02 -170.72 2.32 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.483 -1.69 . . . . 0.0 109.179 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.685 HG22 HG23 ' A' ' 144' ' ' VAL . 3.5 t -97.17 105.54 17.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.184 0.516 . . . . 0.0 109.903 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.781 HD21 ' H ' ' A' ' 93' ' ' LEU . 6.1 tp -108.17 121.2 44.36 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.488 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -108.14 59.26 0.37 Allowed Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 167.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.744 HD21 ' H ' ' A' ' 94' ' ' ASN . 1.5 mt -36.46 109.73 0.1 Allowed 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.269 0.629 . . . . 0.0 109.521 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.4 t80 . . . . . 0 C--N 1.329 -0.299 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -172.269 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 CA--C 1.534 0.493 0 N-CA-C 114.718 1.007 . . . . 0.0 114.718 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.646 ' HB3' HD22 ' A' ' 154' ' ' LEU . 46.5 t -61.63 -76.43 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.13 0.423 . . . . 0.0 111.624 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.826 ' HB ' HE22 ' A' ' 148' ' ' GLN . 2.7 t -127.7 -45.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.777 ' H ' HD11 ' A' ' 154' ' ' LEU . 45.6 tp 59.06 86.07 0.09 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.308 0.575 . . . . 0.0 111.889 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.701 ' ND2' ' H ' ' A' ' 95' ' ' LEU . 9.5 t30 -160.42 -149.5 0.19 Allowed 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.955 ' HB2' HD21 ' A' ' 156' ' ' LEU . 0.5 OUTLIER 51.71 177.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 172.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.8 m -137.23 115.55 11.81 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.221 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.874 HD21 HG21 ' A' ' 113' ' ' ILE . 12.0 mt -74.97 143.16 43.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 174.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -33.2 10.84 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 147.05 154.22 6.14 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 162.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.663 HG13 ' HA ' ' A' ' 111' ' ' ALA . 13.6 m -103.69 144.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 122.654 1.216 . . . . 0.0 112.011 -173.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.724 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 65.3 mmm -97.73 89.5 4.65 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.374 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.793 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -64.74 134.64 54.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.788 0.327 . . . . 0.0 110.857 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -125.27 89.3 0.38 Allowed Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 28.9 t70 71.32 -57.81 0.59 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -166.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.621 ' O ' ' HB2' ' A' ' 109' ' ' SER . 20.8 t70 -173.88 -87.24 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.263 -1.789 . . . . 0.0 107.846 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.666 ' HA ' ' CG2' ' A' ' 124' ' ' VAL . 5.6 t70 -91.5 -46.6 7.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.492 -175.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.9 t -55.13 -40.64 70.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.41 -167.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -130.26 26.7 5.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.552 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.793 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 7.8 t -92.03 140.79 29.3 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.007 -172.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.724 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 8.0 mm -117.66 91.28 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.611 -174.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.814 ' HB1' HD13 ' A' ' 138' ' ' ILE . . . -72.75 96.8 2.09 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.267 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 4.5 mm -79.84 93.71 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.874 HG21 HD21 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -101.86 154.12 5.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.87 175.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 14.5 p -121.09 126.13 49.02 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.709 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 24.5 tptp -117.24 105.21 11.96 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -171.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 58.43 24.7 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -163.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 15.3 t-20 68.9 40.25 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 112.002 -2.363 . . . . 0.0 112.161 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.709 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 12.4 pt-20 -102.26 103.09 13.55 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 162.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 4.8 mt-30 -68.17 131.48 45.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.489 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 7.9 t80 -135.96 144.3 45.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.448 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.6 p -88.9 94.78 10.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 122.057 0.932 . . . . 0.0 111.22 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.487 ' CB ' ' HB2' ' A' ' 111' ' ' ALA . 16.0 mmt180 -98.56 -159.53 0.74 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.049 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 126' ' ' GLU . . . 178.9 161.74 27.1 Favored Glycine 0 N--CA 1.408 -3.205 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.884 HG22 ' HB ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -57.12 128.04 17.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 165.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.676 ' HB2' ' O ' ' A' ' 124' ' ' VAL . 0.9 OUTLIER 81.14 28.58 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.482 1.134 . . . . 0.0 109.057 -176.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 123' ' ' GLY . 1.2 mm-40 -132.65 153.29 51.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 112.596 -2.093 . . . . 0.0 107.664 170.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.563 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 41.4 mt-10 -104.83 145.61 30.15 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.456 HG23 HD11 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -62.65 153.87 76.5 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.486 -174.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.612 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 23.7 Cg_exo -66.37 126.92 16.41 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.569 2.18 . . . . 0.0 111.787 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.65 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 103.91 -57.89 0.53 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.06 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 147' ' ' TYR . 34.1 m-85 -111.92 149.62 31.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.957 -0.121 . . . . 0.0 110.743 -176.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.407 HD21 ' HA ' ' A' ' 132' ' ' ASN . 10.9 m120 -75.97 53.77 0.79 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.089 0.471 . . . . 0.0 111.778 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.661 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -90.24 95.69 10.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.656 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.563 ' CA ' ' HG2' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -82.14 107.29 14.72 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.017 0.437 . . . . 0.0 110.846 -171.151 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.654 HG12 HG12 ' A' ' 143' ' ' VAL . 64.8 mt -54.07 94.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.357 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 144' ' ' VAL . 3.9 m -97.35 8.27 7.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.948 0.88 . . . . 0.0 108.815 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.751 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 5.7 m -165.41 114.81 1.04 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.079 176.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.884 ' HB ' HG22 ' A' ' 124' ' ' VAL . 1.1 tt -98.45 127.99 50.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.401 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 5.2 mmt180 -143.73 150.3 49.79 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -14.55 -74.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 1 C-N-CA 125.708 4.272 . . . . 0.0 114.974 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.445 ' C ' HD13 ' A' ' 97' ' ' LEU . 7.8 p-10 -138.98 47.73 1.91 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.247 1.022 . . . . 0.0 109.475 168.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.787 ' HD3' HG13 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -143.81 139.37 29.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.154 165.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.654 HG12 HG12 ' A' ' 135' ' ' ILE . 10.4 t -135.02 118.19 23.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.071 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.861 HG23 HG21 ' A' ' 153' ' ' VAL . 9.2 t -80.48 62.23 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.136 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.661 HD22 ' HB1' ' A' ' 133' ' ' ALA . 1.7 pp -79.83 166.78 21.36 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -171.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 2.1 tp60 -108.83 104.87 14.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 111.662 -2.517 . . . . 0.0 108.41 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 131' ' ' TYR . 1.0 OUTLIER -139.3 133.48 31.27 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.458 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.826 HE22 ' HB ' ' A' ' 92' ' ' THR . 3.1 mt-30 70.39 32.83 2.66 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.471 0.482 . . . . 0.0 110.859 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.58 3.78 79.29 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.409 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 2.3 tpm_? -125.02 153.53 42.69 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.614 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 2.7 p90 -134.77 106.64 7.01 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.355 1.074 . . . . 0.0 108.229 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 81.0 mm-40 -134.62 -176.24 4.15 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.46 -169.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.861 HG21 HG23 ' A' ' 144' ' ' VAL . 26.2 t -93.67 100.2 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.014 0.912 . . . . 0.0 108.724 -170.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.777 HD11 ' H ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -106.87 102.91 12.24 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 114.22 -1.354 . . . . 0.0 111.363 -175.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 142' ' ' ARG . . . -100.99 57.13 0.72 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.572 175.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.955 HD21 ' HB2' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -37.23 109.82 0.11 Allowed 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.385 0.697 . . . . 0.0 109.624 171.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 33.9 p90 . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 112.04 -164.892 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.518 ' HB2' ' H ' ' A' ' 91' ' ' SER . 4.0 Cg_exo . . . . . 0 N--CA 1.461 -0.395 0 CA-C-O 119.243 -0.399 . . . . 0.0 111.518 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.776 ' HB2' HD12 ' A' ' 154' ' ' LEU . 22.1 m 54.74 -79.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.863 HG23 ' HD2' ' A' ' 147' ' ' TYR . 0.1 OUTLIER -163.72 -44.56 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.124 -0.36 . . . . 0.0 111.216 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.915 ' H ' HD22 ' A' ' 154' ' ' LEU . 1.0 OUTLIER 52.48 99.78 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.046 0.451 . . . . 0.0 111.434 -177.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.801 ' H ' HD23 ' A' ' 156' ' ' LEU . 0.1 OUTLIER -157.63 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.002 -172.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.871 HD22 ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -56.77 174.65 0.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.374 179.152 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.4 t -121.58 118.98 30.59 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.557 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.547 ' HA ' HG22 ' A' ' 113' ' ' ILE . 6.0 mp -79.02 124.36 28.19 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.72 -29.85 22.1 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.01 173.64 30.92 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 169.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.764 HG21 ' HA ' ' A' ' 111' ' ' ALA . 2.4 t -129.75 126.84 63.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.558 0.694 . . . . 0.0 110.397 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.855 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -89.42 89.38 7.84 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.047 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.712 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -65.91 132.24 48.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.224 -174.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 108' ' ' ARG . . . -117.47 92.16 0.55 Allowed Glycine 0 CA--C 1.5 -0.868 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 -173.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.5 t0 69.53 -59.55 0.49 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.935 0.874 . . . . 0.0 108.784 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -156.83 -146.81 0.17 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.313 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.6 ' CA ' HG21 ' A' ' 124' ' ' VAL . 7.2 m-20 -56.53 -33.34 65.98 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.49 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.8 t -46.84 -56.3 6.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.425 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 22.7 mtp180 -119.49 30.49 7.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.611 -167.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.712 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 8.4 t -86.96 145.64 26.44 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.733 0.777 . . . . 0.0 112.133 -172.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.855 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 12.6 mm -114.3 92.5 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.404 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.877 ' HB3' HD11 ' A' ' 113' ' ' ILE . . . -73.86 101.46 3.77 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.399 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 28.8 mm -86.47 93.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.877 HD11 ' HB3' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -104.5 150.08 7.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.647 -177.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 64.6 p -116.05 130.56 56.87 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.133 0.492 . . . . 0.0 109.724 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.871 ' HA ' HD22 ' A' ' 95' ' ' LEU . 19.0 tptp -110.43 102.48 11.1 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 59.89 27.13 16.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.3 t-20 81.21 33.25 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 112.453 -2.158 . . . . 0.0 110.854 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -106.12 97.39 7.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.657 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.7 mt-30 -66.61 135.89 54.79 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.594 -176.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 15.6 t80 -144.86 149.54 35.52 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.367 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.547 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 6.4 m -88.57 101.6 14.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.608 0.718 . . . . 0.0 111.169 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.423 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 18.0 mmt180 -104.94 -160.13 0.74 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.828 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.488 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . -179.31 169.47 40.66 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.115 -1.04 . . . . 0.0 111.461 -176.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 1.017 HG23 ' HB ' ' A' ' 138' ' ' ILE . 5.7 t -45.32 129.9 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 114.223 -0.988 . . . . 0.0 110.456 162.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.728 ' HA ' ' HD2' ' A' ' 134' ' ' LYS . 0.0 OUTLIER 69.09 14.75 8.76 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 124.749 1.281 . . . . 0.0 110.428 176.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -105.81 164.48 11.9 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 167.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.807 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 33.1 mt-10 -114.12 151.13 33.07 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 119.142 0.883 . . . . 0.0 110.018 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.659 HG21 HG23 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -59.13 143.42 84.54 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.048 0.451 . . . . 0.0 110.416 -176.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.626 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.1 Cg_exo -73.06 94.16 0.81 Allowed 'Trans proline' 0 C--O 1.222 -0.309 0 C-N-CA 123.244 2.63 . . . . 0.0 112.467 -170.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.452 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 132.76 -48.73 0.95 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.533 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 10.4 m-85 -112.65 137.7 50.53 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -73.91 46.75 0.24 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.897 0.772 . . . . 0.0 112.993 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.708 ' HB3' HD22 ' A' ' 145' ' ' LEU . . . -82.56 99.17 9.36 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 171.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.807 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -80.65 125.79 30.45 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-O 120.849 0.357 . . . . 0.0 110.939 -171.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.5 mt -77.23 89.93 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.578 HG21 ' HG3' ' A' ' 134' ' ' LYS . 1.3 t -85.11 -3.97 8.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 122.044 0.926 . . . . 0.0 108.641 -175.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.512 ' HB3' HG22 ' A' ' 144' ' ' VAL . 1.7 t -160.59 117.36 2.38 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.434 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 1.017 ' HB ' HG23 ' A' ' 124' ' ' VAL . 3.6 tt -94.92 133.51 35.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.495 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.582 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 17.0 mmt180 -141.79 162.85 44.21 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 170.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 141' ' ' ASP . 89.0 Cg_exo -25.22 -84.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.75 3.633 . . . . 0.0 114.635 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.436 ' H ' ' HB2' ' A' ' 140' ' ' PRO . 5.1 p-10 -116.64 29.81 7.71 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.154 0.978 . . . . 0.0 108.61 169.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 6.1 tpp85 -127.97 141.91 51.39 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.03 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 144' ' ' VAL . 4.3 t -145.61 168.55 7.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.706 -175.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.95 HG21 HG22 ' A' ' 153' ' ' VAL . 19.5 t -129.84 62.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.771 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 1.5 pp -82.38 155.27 24.79 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -165.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.468 HE22 ' N ' ' A' ' 150' ' ' ARG . 11.4 tp60 -99.91 104.42 16.06 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 111.937 -2.392 . . . . 0.0 108.586 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.863 ' HD2' HG23 ' A' ' 92' ' ' THR . 0.6 OUTLIER -141.83 132.95 26.21 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.835 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.8 mt-30 67.59 28.18 7.55 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.405 0.44 . . . . 0.0 110.774 175.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.32 -2.91 85.41 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 119.809 -1.186 . . . . 0.0 112.698 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.468 ' N ' HE22 ' A' ' 146' ' ' GLN . 28.5 ptt180 -126.26 145.51 50.38 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.576 -0.367 . . . . 0.0 111.242 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.771 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 6.4 p90 -122.76 109.96 14.87 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 171.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.438 ' HB2' ' OG ' ' A' ' 91' ' ' SER . 36.7 mt-10 -127.33 -175.47 3.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.95 HG22 HG21 ' A' ' 144' ' ' VAL . 6.0 p -95.99 98.72 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-O 122.835 1.302 . . . . 0.0 110.155 -165.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.915 HD22 ' H ' ' A' ' 93' ' ' LEU . 10.0 tp -106.81 116.22 31.55 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.36 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.571 ' O ' ' HD2' ' A' ' 157' ' ' TYR . . . -99.57 61.06 0.75 Allowed Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.952 167.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.801 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.7 mt -36.38 111.61 0.15 Allowed 'General case' 0 N--CA 1.485 1.306 0 O-C-N 124.325 0.662 . . . . 0.0 109.748 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.571 ' HD2' ' O ' ' A' ' 155' ' ' GLY . 51.3 p90 . . . . . 0 C--O 1.234 0.248 0 CA-C-N 118.19 0.45 . . . . 0.0 110.45 -172.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.63 ' O ' HD21 ' A' ' 154' ' ' LEU . 33.6 Cg_exo . . . . . 0 CA--C 1.536 0.597 0 CA-C-O 119.556 -0.269 . . . . 0.0 111.99 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.636 ' HB2' ' HG ' ' A' ' 154' ' ' LEU . 60.0 m 53.46 -83.03 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.54 0.336 . . . . 0.0 110.992 -170.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.965 ' HB ' HE22 ' A' ' 148' ' ' GLN . 0.0 OUTLIER -156.04 -49.51 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 119.491 -0.29 . . . . 0.0 111.037 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.626 HD11 ' HA ' ' A' ' 156' ' ' LEU . 46.0 tp 54.17 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.504 0.502 . . . . 0.0 111.663 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.744 ' H ' HD21 ' A' ' 156' ' ' LEU . 5.8 t30 -162.5 -60.21 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.024 0.44 . . . . 0.0 111.669 -175.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.84 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -56.34 175.96 0.1 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.124 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.7 t -114.98 108.5 16.79 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.028 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.833 ' HA ' HG22 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -73.22 117.33 14.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 171.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.629 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -91.18 -34.53 14.98 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -173.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.557 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 158.51 141.17 3.08 Favored Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.783 171.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.587 HG22 HG22 ' A' ' 138' ' ' ILE . 12.1 m -102.39 147.85 8.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.77 0.795 . . . . 0.0 109.689 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.847 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 67.5 mtt -104.03 90.69 3.68 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.024 176.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.59 120.95 9.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.777 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -110.98 97.96 1.01 Allowed Glycine 0 CA--C 1.492 -1.367 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -174.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 3.6 m-20 73.42 -66.03 0.33 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -173.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.558 ' O ' ' HB3' ' A' ' 109' ' ' SER . 8.3 m-20 -162.29 -102.64 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.692 -1.594 . . . . 0.0 107.594 167.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.68 ' HB2' HG22 ' A' ' 124' ' ' VAL . 6.5 p-10 -91.73 -20.2 21.8 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.35 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.439 ' C ' ' HD3' ' A' ' 108' ' ' ARG . 14.5 m -61.87 -47.01 86.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.077 -174.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.439 ' HD3' ' C ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -123.79 19.89 9.35 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.053 -168.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.724 ' HB2' HD13 ' A' ' 138' ' ' ILE . 2.8 p -66.77 147.29 53.45 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.324 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.847 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 5.5 mm -126.94 84.74 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-O 121.783 0.802 . . . . 0.0 110.862 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.93 ' HB3' HD11 ' A' ' 113' ' ' ILE . . . -72.93 96.92 2.18 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.404 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.72 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 9.9 mm -81.86 94.35 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.93 HD11 ' HB3' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -105.29 140.43 23.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.666 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.834 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 29.9 t -99.69 129.31 45.81 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.865 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.84 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.9 tptp -128.79 106.06 8.66 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.7 t70 62.52 18.57 10.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -169.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.834 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 2.6 t-20 76.22 38.54 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.535 -175.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.51 ' HG2' ' CE1' ' A' ' 120' ' ' PHE . 31.1 tt0 -113.13 93.6 4.49 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.161 167.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.629 ' NE2' HG21 ' A' ' 98' ' ' THR . 74.2 mt-30 -66.83 129.72 40.8 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.886 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.72 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 50.6 m-85 -119.88 150.34 40.63 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.306 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.5 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 6.2 m -94.23 99.16 11.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.712 0.768 . . . . 0.0 109.844 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.691 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 64.9 mmt-85 -89.61 -161.86 0.82 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.822 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.665 ' N ' ' HG2' ' A' ' 126' ' ' GLU . . . 161.11 95.59 0.11 Allowed Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.007 -1.092 . . . . 0.0 112.894 -163.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.68 HG22 ' HB2' ' A' ' 106' ' ' ASP . 2.2 t 4.55 123.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 126.563 1.978 . . . . 0.0 114.976 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.681 ' HA ' ' CE ' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 78.21 34.42 0.29 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.664 -177.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.665 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 0.8 OUTLIER -124.04 167.08 14.67 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 112.669 -2.059 . . . . 0.0 107.844 168.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 1.9 mp0 -112.1 146.31 38.22 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.525 HG21 HD23 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -61.66 153.72 69.52 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.485 ' O ' HD11 ' A' ' 95' ' ' LEU . 24.4 Cg_exo -66.04 127.84 18.45 Favored 'Trans proline' 0 C--N 1.333 -0.287 0 C-N-CA 122.424 2.083 . . . . 0.0 112.442 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.556 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 100.66 -59.78 0.67 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.209 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.596 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 10.9 m-85 -109.68 140.75 43.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.025 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -74.94 49.89 0.44 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.659 0.663 . . . . 0.0 111.789 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.715 ' HB3' HD22 ' A' ' 145' ' ' LEU . . . -80.64 96.68 6.94 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.75 ' HD2' ' C ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -80.49 108.96 14.55 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 121.044 0.45 . . . . 0.0 110.989 -168.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.633 HG12 HG12 ' A' ' 143' ' ' VAL . 50.5 mt -60.81 95.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.93 177.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.713 HG22 ' HZ2' ' A' ' 134' ' ' LYS . 0.5 OUTLIER -84.15 -8.63 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.081 179.09 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.656 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 39.4 m -157.49 116.18 3.22 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.435 -174.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.724 HD13 ' HB2' ' A' ' 109' ' ' SER . 3.9 mt -92.61 127.91 44.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.598 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.596 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 28.0 mmt180 -141.2 151.62 62.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 173.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.41 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 78.0 Cg_exo -18.57 -75.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 1 C-N-CA 125.519 4.146 . . . . 0.0 114.776 -178.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.485 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -129.21 39.47 3.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.412 1.101 . . . . 0.0 108.797 168.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 8.2 tpp85 -136.06 143.56 44.73 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.835 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.813 HG23 HD21 ' A' ' 97' ' ' LEU . 3.4 t -141.67 169.25 14.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.534 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.838 HG23 HG13 ' A' ' 153' ' ' VAL . 18.3 t -133.58 61.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.848 HD13 HD11 ' A' ' 154' ' ' LEU . 1.9 pp -82.64 162.47 21.86 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -167.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 1.8 tp60 -105.73 105.49 15.56 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 112.556 -2.111 . . . . 0.0 108.232 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.606 ' HD2' HG23 ' A' ' 92' ' ' THR . 0.7 OUTLIER -141.21 136.78 32.08 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.753 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.965 HE22 ' HB ' ' A' ' 92' ' ' THR . 11.8 mt-30 68.29 28.67 6.23 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.534 0.521 . . . . 0.0 110.998 173.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.35 3.25 78.79 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.71 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 20.4 ttt180 -133.31 144.69 49.84 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.78 -0.247 . . . . 0.0 111.065 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.681 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 11.0 p90 -115.88 107.84 15.53 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.438 1.113 . . . . 0.0 107.999 171.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.852 ' HG3' ' H ' ' A' ' 153' ' ' VAL . 10.2 tp10 -130.79 -173.18 3.01 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.546 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.852 ' H ' ' HG3' ' A' ' 152' ' ' GLU . 0.9 OUTLIER -95.28 100.06 10.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.676 0.75 . . . . 0.0 111.015 -167.058 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.848 HD11 HD13 ' A' ' 145' ' ' LEU . 1.2 mt -101.35 109.44 21.29 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.672 176.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.44 ' O ' ' HD2' ' A' ' 157' ' ' TYR . . . -99.85 52.19 1.03 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.744 HD21 ' H ' ' A' ' 94' ' ' ASN . 2.4 mt -35.77 117.68 0.45 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.673 0.866 . . . . 0.0 109.659 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.44 ' HD2' ' O ' ' A' ' 155' ' ' GLY . 45.6 p90 . . . . . 0 C--N 1.321 -0.661 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.696 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.9 Cg_exo . . . . . 0 CA--C 1.531 0.347 0 N-CA-C 111.854 -0.095 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.568 ' OG ' ' HB2' ' A' ' 152' ' ' GLU . 0.0 OUTLIER 47.91 -100.23 0.06 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.261 0.624 . . . . 0.0 112.049 -174.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.567 ' H ' HD13 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -138.45 -37.19 0.56 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.024 0.829 . . . . 0.0 112.541 -178.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.607 ' H ' ' CD1' ' A' ' 154' ' ' LEU . 1.3 tm? 66.57 -4.11 0.78 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.506 ' N ' HD23 ' A' ' 156' ' ' LEU . 4.0 t30 -103.96 97.61 7.57 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.623 -0.673 . . . . 0.0 112.572 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.72 ' HB2' HD21 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -179.97 179.01 0.57 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 177.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.56 ' H ' HD12 ' A' ' 95' ' ' LEU . 24.4 t -123.29 101.04 7.15 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 119.442 1.019 . . . . 0.0 110.345 173.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.878 ' HA ' HG21 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -81.23 75.46 8.19 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.133 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.701 HG23 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -40.31 -47.57 2.52 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 174.22 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 140' ' ' PRO . . . 160.33 153.45 6.94 Favored Glycine 0 CA--C 1.488 -1.595 0 C-N-CA 118.317 -1.897 . . . . 0.0 113.431 173.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.623 HG23 HG21 ' A' ' 138' ' ' ILE . 8.0 m -103.92 142.72 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-O 121.565 0.698 . . . . 0.0 109.64 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.823 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -98.48 87.42 3.84 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.819 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -56.18 135.21 53.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.878 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 105' ' ' ASP . . . -123.14 92.69 0.47 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.815 -176.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 t70 71.28 -40.57 0.48 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.239 1.015 . . . . 0.0 110.118 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.565 ' H ' ' C ' ' A' ' 103' ' ' GLY . 4.3 t70 -178.88 -141.02 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.723 ' CB ' HG21 ' A' ' 124' ' ' VAL . 20.8 m-20 -67.07 -29.61 69.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.3 0.571 . . . . 0.0 109.605 167.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.5 t -52.86 -57.46 10.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.937 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.407 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 5.2 mmm180 -114.29 26.52 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.122 -173.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.819 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 1.6 t -76.47 152.29 36.19 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.781 0.324 . . . . 0.0 111.217 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.823 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 15.4 mm -123.69 85.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 122.059 0.933 . . . . 0.0 110.833 -176.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.929 ' HB2' HD13 ' A' ' 113' ' ' ILE . . . -70.85 99.52 1.76 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.95 -176.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 7.8 mm -88.29 91.72 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.929 HD13 ' HB2' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -100.8 137.74 27.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.904 -177.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.43 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 4.2 m -95.22 122.47 37.94 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.754 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HE3' ' HA3' ' A' ' 130' ' ' GLY . 25.0 tptp -117.07 97.42 5.92 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 58.88 23.58 11.52 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -164.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 114' ' ' SER . 1.5 t30 75.98 38.8 0.33 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.912 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -99.26 92.88 5.65 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 161.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.701 ' NE2' HG23 ' A' ' 98' ' ' THR . 61.6 mt-30 -68.54 105.37 2.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.028 -173.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 6.7 t80 -106.67 133.82 50.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.863 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.6 p -85.31 98.89 10.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.307 1.051 . . . . 0.0 111.431 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.847 ' HB3' ' OE2' ' A' ' 126' ' ' GLU . 14.5 mmt180 -89.45 -161.89 0.82 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.392 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.595 ' N ' ' HG2' ' A' ' 126' ' ' GLU . . . 158.93 94.13 0.1 OUTLIER Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.586 -165.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.723 HG21 ' CB ' ' A' ' 106' ' ' ASP . 21.5 t 7.74 120.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.478 1.911 . . . . 0.0 115.71 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.707 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 83.04 40.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 123.05 1.405 . . . . 0.0 109.165 -178.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.847 ' OE2' ' HB3' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -135.83 158.26 44.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 111.917 -2.401 . . . . 0.0 108.115 171.245 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.638 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 52.9 mt-10 -105.49 142.75 34.7 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.223 0.535 . . . . 0.0 110.981 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.483 HG21 ' HD2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -56.65 143.51 68.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.723 -174.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.483 ' HD2' HG21 ' A' ' 128' ' ' VAL . 2.2 Cg_endo -57.22 116.91 3.55 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.761 2.307 . . . . 0.0 112.924 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.49 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 113.98 -63.05 0.31 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.524 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.442 ' HD2' HD22 ' A' ' 95' ' ' LEU . 18.2 m-85 -107.79 147.36 30.95 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -78.58 58.37 2.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.983 0.81 . . . . 0.0 111.674 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.703 ' HB2' HD23 ' A' ' 145' ' ' LEU . . . -91.9 97.71 11.14 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.244 175.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.707 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER -80.23 106.92 12.61 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 120.69 0.281 . . . . 0.0 110.653 -171.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.735 ' HB ' ' OE1' ' A' ' 126' ' ' GLU . 75.6 mt -56.5 96.33 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 122.097 0.951 . . . . 0.0 110.174 176.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.662 HG21 ' HA ' ' A' ' 145' ' ' LEU . 1.6 t -88.09 -2.74 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.379 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.538 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -165.89 117.61 1.07 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.332 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.648 HD13 ' HB3' ' A' ' 109' ' ' SER . 1.9 mt -92.79 125.13 45.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.043 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 8.4 mmt180 -129.9 153.21 80.91 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.541 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 32.4 Cg_exo -22.82 -68.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 1 C-N-CA 125.388 4.059 . . . . 0.0 114.605 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.497 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -137.31 39.07 2.49 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.642 1.21 . . . . 0.0 109.111 172.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.545 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 2.3 tpp85 -142.05 142.81 32.89 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.208 -1.814 . . . . 0.0 108.393 176.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 135' ' ' ILE . 2.1 t -139.87 166.91 19.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.499 0.666 . . . . 0.0 110.996 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.604 HG22 HG11 ' A' ' 153' ' ' VAL . 40.9 t -130.04 95.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.874 HD13 HD12 ' A' ' 154' ' ' LEU . 2.6 pp -121.12 158.4 28.02 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -164.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.7 OUTLIER -92.27 110.41 21.8 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.168 -1.833 . . . . 0.0 109.468 -176.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.495 ' CD2' HG21 ' A' ' 92' ' ' THR . 0.5 OUTLIER -151.14 133.38 15.33 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 74.14 34.83 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.65 0.593 . . . . 0.0 110.423 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.0 13.74 82.89 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.794 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.568 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 32.5 ptt180 -142.59 170.47 15.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 26.1 p90 -136.03 111.08 8.88 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.314 1.054 . . . . 0.0 108.409 171.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.696 ' HG3' ' HB2' ' A' ' 90' ' ' PRO . 76.7 mm-40 -119.76 -170.19 1.91 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.126 -173.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.604 HG11 HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -103.03 107.13 21.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.637 0.732 . . . . 0.0 110.407 -172.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.874 HD12 HD13 ' A' ' 145' ' ' LEU . 1.4 mt -113.44 114.16 26.18 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.47 -175.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.469 ' O ' ' HD1' ' A' ' 157' ' ' TYR . . . -110.11 50.84 0.74 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 168.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.781 HD22 HD11 ' A' ' 154' ' ' LEU . 0.5 OUTLIER -36.04 113.25 0.21 Allowed 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.803 0.943 . . . . 0.0 109.608 178.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.469 ' HD1' ' O ' ' A' ' 155' ' ' GLY . 51.3 p90 . . . . . 0 N--CA 1.45 -0.448 0 O-C-N 121.75 -0.594 . . . . 0.0 109.784 -172.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.664 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 9.1 Cg_exo . . . . . 0 CA--C 1.538 0.687 0 N-CA-C 115.434 1.282 . . . . 0.0 115.434 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.488 ' HB2' HD12 ' A' ' 154' ' ' LEU . 67.9 m -56.0 -71.29 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.502 0.592 . . . . 0.0 111.142 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.713 ' H ' HD11 ' A' ' 154' ' ' LEU . 1.7 t -160.36 -48.45 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.991 ' H ' HD23 ' A' ' 154' ' ' LEU . 53.8 tp 60.99 118.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.678 ' H ' HD22 ' A' ' 156' ' ' LEU . 4.5 t30 -176.54 -63.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.834 0.35 . . . . 0.0 111.901 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -55.64 169.31 0.34 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.798 -178.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.5 m -114.55 110.74 20.28 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.713 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.67 ' HA ' HG22 ' A' ' 113' ' ' ILE . 3.3 mp -76.21 123.06 25.27 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 114' ' ' SER . 0.2 OUTLIER -87.58 -36.54 17.48 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -175.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.543 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 159.49 146.75 4.66 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.654 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.689 HG23 ' HA ' ' A' ' 111' ' ' ALA . 5.2 t -103.97 131.05 53.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.054 0.454 . . . . 0.0 110.689 -174.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.845 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -97.46 88.02 4.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.809 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -67.95 126.74 30.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -174.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -128.52 110.48 1.13 Allowed Glycine 0 CA--C 1.5 -0.871 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.93 -171.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 23.9 t70 70.11 -65.18 0.33 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.698 ' O ' ' HB2' ' A' ' 109' ' ' SER . 20.2 t70 -167.72 -91.34 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.26 161.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.569 ' HA ' HG21 ' A' ' 124' ' ' VAL . 6.1 p-10 -91.97 -21.21 20.67 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.812 0.695 . . . . 0.0 111.078 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.417 ' HB2' ' HG2' ' A' ' 108' ' ' ARG . 3.9 m -60.03 -38.0 81.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.385 -172.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.417 ' HG2' ' HB2' ' A' ' 107' ' ' SER . 0.1 OUTLIER -141.94 32.44 1.58 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.674 -172.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.809 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 1.5 t -85.99 135.84 33.49 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.034 0.445 . . . . 0.0 110.24 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.845 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 13.0 mm -116.91 88.49 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.341 -173.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.901 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -73.88 98.06 2.91 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.47 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.543 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 17.1 mm -82.87 94.73 3.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.901 HD12 ' HB2' ' A' ' 111' ' ' ALA . 0.3 OUTLIER -106.28 148.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.644 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.523 ' HB3' ' OG1' ' A' ' 98' ' ' THR . 1.3 p -118.37 132.71 56.26 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.473 0.654 . . . . 0.0 109.611 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.79 ' HA ' HD21 ' A' ' 95' ' ' LEU . 17.8 tptm -108.68 100.65 9.87 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.2 t70 52.92 33.32 14.28 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -165.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.2 t-20 79.85 29.81 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 112.537 -2.119 . . . . 0.0 111.393 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.7 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 8.6 tp10 -96.88 92.77 6.28 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 170.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.626 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 29.3 mt-30 -73.85 132.58 42.68 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -138.29 152.29 48.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.58 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.2 p -95.39 105.79 17.79 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.316 0.579 . . . . 0.0 111.503 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 1.041 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 30.1 mmt180 -96.83 -163.75 1.08 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.805 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.629 ' N ' ' HG3' ' A' ' 126' ' ' GLU . . . 173.05 93.41 0.09 OUTLIER Glycine 0 C--O 1.222 -0.596 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.456 -164.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.922 HG22 ' HB ' ' A' ' 138' ' ' ILE . 1.3 t 4.64 45.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 127.426 2.29 . . . . 0.0 115.84 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.511 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 166.96 39.3 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -174.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 1.041 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 11.4 mm-40 -144.58 135.05 24.52 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 111.777 -2.465 . . . . 0.0 108.071 -170.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 58.4 mt-10 -91.84 142.62 27.38 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.724 HG21 HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -60.0 152.12 62.08 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.15 -177.283 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.632 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 24.0 Cg_exo -66.23 129.44 21.64 Favored 'Trans proline' 0 C--N 1.329 -0.454 0 C-N-CA 122.667 2.245 . . . . 0.0 111.46 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.424 ' HA3' ' CE ' ' A' ' 115' ' ' LYS . . . 93.82 -38.31 3.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.942 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -124.67 133.18 53.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.607 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -76.92 52.98 0.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.399 0.619 . . . . 0.0 111.084 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.63 ' HB1' HD21 ' A' ' 145' ' ' LEU . . . -93.22 99.01 11.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 172.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 1.4 tmmm? -81.09 121.92 26.7 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-O 121.005 0.431 . . . . 0.0 110.827 -170.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.695 HG12 HG13 ' A' ' 143' ' ' VAL . 95.4 mt -67.14 94.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.607 HG23 ' HE2' ' A' ' 134' ' ' LYS . 2.8 t -86.58 -9.88 11.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.499 ' CB ' ' HB ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -158.12 116.8 3.11 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.982 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.922 ' HB ' HG22 ' A' ' 124' ' ' VAL . 0.2 OUTLIER -86.64 133.51 29.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.064 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.667 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 19.2 mmt180 -141.88 154.56 65.59 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 172.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.4 ' O ' ' N ' ' A' ' 100' ' ' VAL . 52.6 Cg_exo -22.79 -78.19 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 125.138 3.892 . . . . 0.0 114.777 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.491 ' HA ' HD21 ' A' ' 97' ' ' LEU . 3.4 p-10 -127.43 39.85 3.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.494 1.14 . . . . 0.0 109.086 168.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.667 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 7.1 tpp85 -134.95 139.98 45.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.689 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.695 HG13 HG12 ' A' ' 135' ' ' ILE . 3.5 t -143.59 123.38 8.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.747 0.784 . . . . 0.0 112.429 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.891 HG22 HG13 ' A' ' 153' ' ' VAL . 22.0 t -80.55 101.66 5.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 169.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.962 HD11 HD22 ' A' ' 154' ' ' LEU . 1.1 pp -122.77 158.41 30.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -168.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -95.27 103.1 14.95 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.449 -175.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.562 ' HD1' ' N ' ' A' ' 148' ' ' GLN . 0.3 OUTLIER -139.93 135.62 33.01 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.562 ' N ' ' HD1' ' A' ' 147' ' ' TYR . 1.9 mp0 72.96 31.94 1.43 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.635 0.584 . . . . 0.0 110.57 173.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.04 16.49 74.94 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.062 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.764 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 6.0 tpp180 -132.28 157.13 45.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.79 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 25.4 p90 -134.67 107.11 7.29 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.764 ' HG2' ' HG3' ' A' ' 150' ' ' ARG . 43.1 mm-40 -124.03 -171.69 2.38 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.523 -174.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.891 HG13 HG22 ' A' ' 144' ' ' VAL . 3.1 m -100.4 99.95 9.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.838 0.828 . . . . 0.0 110.489 -172.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.991 HD23 ' H ' ' A' ' 93' ' ' LEU . 3.5 tp -107.27 109.75 21.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.854 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 142' ' ' ARG . . . -97.11 53.51 1.36 Allowed Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.312 172.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.678 HD22 ' H ' ' A' ' 94' ' ' ASN . 2.2 mt -37.09 115.49 0.39 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.447 0.734 . . . . 0.0 109.358 176.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 53.4 p90 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 118.533 0.606 . . . . 0.0 109.946 -175.816 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.7 p -114.33 -18.09 11.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.098 0.475 . . . . 0.0 110.859 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -88.47 -11.44 45.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.967 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 54.8 ttp -119.06 111.18 17.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.727 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.0 tt -98.11 104.43 16.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -96.13 -74.7 0.55 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.138 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.4 mmt 55.99 72.56 0.48 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.714 0.634 . . . . 0.0 110.565 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.34 45.92 1.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.931 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.09 -115.89 4.11 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.51 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -175.94 -35.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.135 0.493 . . . . 0.0 109.907 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -154.67 163.03 40.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.459 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.33 81.99 3.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.405 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.03 -33.72 72.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.888 0.375 . . . . 0.0 111.312 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.583 ' HA ' ' HB2' ' A' ' 86' ' ' SER . 20.0 m -68.54 -16.23 63.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.436 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -60.56 -34.4 74.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.935 0.398 . . . . 0.0 110.424 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.6 ttt -102.03 7.79 41.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.413 0.625 . . . . 0.0 110.26 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.583 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 8.0 t -80.78 81.76 6.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.522 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -98.16 -15.42 19.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.287 0.565 . . . . 0.0 109.747 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.2 118.23 57.43 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.427 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.11 110.13 0.96 Allowed 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.858 2.372 . . . . 0.0 112.745 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.472 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.8 Cg_exo -77.16 -137.29 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.505 2.803 . . . . 0.0 111.711 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.537 ' OG ' ' HB2' ' A' ' 152' ' ' GLU . 52.7 m 54.16 -99.58 0.09 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.514 0.326 . . . . 0.0 111.077 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.559 HG22 HD23 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -139.2 -42.3 0.46 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -176.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.872 ' H ' HD23 ' A' ' 154' ' ' LEU . 50.9 tp 60.38 109.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.496 0.665 . . . . 0.0 111.934 -174.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.546 ' O ' ' HB3' ' A' ' 156' ' ' LEU . 2.9 p-10 -174.55 -157.88 0.08 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.7 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER 44.37 -175.41 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 176.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 10.2 t -127.31 111.8 14.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.219 163.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.945 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -82.43 72.82 9.49 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.563 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -34.3 -42.62 0.14 Allowed 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 178.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.442 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 157.78 150.71 5.81 Favored Glycine 0 CA--C 1.484 -1.903 0 C-N-CA 119.16 -1.495 . . . . 0.0 112.676 171.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.746 HG21 HG22 ' A' ' 138' ' ' ILE . 19.0 m -104.13 160.44 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 122.432 1.111 . . . . 0.0 110.69 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.828 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 23.4 mmt -119.34 89.41 3.12 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 112.89 -1.959 . . . . 0.0 107.698 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.82 132.91 55.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.85 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 108' ' ' ARG . . . -117.34 90.85 0.52 Allowed Glycine 0 CA--C 1.496 -1.142 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.252 -173.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' A' ' 107' ' ' SER . 31.0 t0 73.86 -53.33 0.69 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -172.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.771 ' O ' ' HB3' ' A' ' 109' ' ' SER . 38.6 t70 179.24 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.45 -1.704 . . . . 0.0 106.935 170.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.536 ' CB ' HG23 ' A' ' 124' ' ' VAL . 9.9 p-10 -90.37 -9.74 46.54 Favored 'General case' 0 C--N 1.334 -0.103 0 O-C-N 124.248 0.968 . . . . 0.0 109.885 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.698 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 24.9 m -69.02 11.39 0.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.771 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.698 ' HG3' ' O ' ' A' ' 107' ' ' SER . 30.2 mtt85 178.59 -79.87 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -171.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.994 ' HB2' HD13 ' A' ' 138' ' ' ILE . 13.2 p 48.51 110.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 174.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.828 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 3.9 mm -94.41 134.25 32.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.76 174.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.918 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -124.06 108.42 12.33 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.745 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.669 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 13.8 mm -94.55 92.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.945 HG23 ' HA ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER -105.87 143.16 17.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.047 -174.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.835 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 31.4 t -103.61 126.36 50.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.703 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.742 ' HB2' ' HB2' ' A' ' 129' ' ' PRO . 26.3 tptp -118.55 98.77 6.41 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.856 ' HA ' ' HB2' ' A' ' 161' ' ' ASP . 3.6 m-20 52.3 26.77 4.25 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -166.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.835 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 3.4 t-20 79.01 39.72 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.851 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 12.6 pt-20 -111.94 92.47 4.04 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.965 0.888 . . . . 0.0 108.934 161.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.652 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 63.0 mt-30 -66.4 126.63 29.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.585 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.669 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.5 m-85 -118.8 161.65 19.78 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.543 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.0 p -102.98 99.16 9.04 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 122.086 0.946 . . . . 0.0 110.922 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.593 ' HB2' ' HB1' ' A' ' 111' ' ' ALA . 22.8 mmt180 -107.74 -159.24 0.68 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.531 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.617 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . 165.33 179.94 39.43 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.857 -174.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.536 HG23 ' CB ' ' A' ' 106' ' ' ASP . 25.4 t -52.53 121.83 2.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 114.183 -1.009 . . . . 0.0 109.924 168.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.809 ' HA ' ' HE3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 78.52 21.55 0.78 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.546 1.165 . . . . 0.0 109.747 178.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 123' ' ' GLY . 3.6 mm-40 -117.06 158.93 23.33 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.96 -1.927 . . . . 0.0 106.42 167.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.855 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 40.1 mt-10 -113.22 148.91 34.54 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 118.17 0.441 . . . . 0.0 110.38 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.515 HG22 ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -58.74 147.77 70.32 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.755 -177.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.742 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 6.0 Cg_exo -58.79 130.95 39.32 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.811 2.341 . . . . 0.0 112.188 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.52 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 94.99 -63.5 1.48 Allowed Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 116.086 -0.507 . . . . 0.0 112.765 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.403 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 14.6 m-85 -109.31 148.07 31.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.15 49.83 0.58 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -175.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.717 ' HB3' HD21 ' A' ' 145' ' ' LEU . . . -84.58 97.56 9.66 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.855 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . 5.7 tptm -79.8 123.04 27.36 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-O 121.324 0.583 . . . . 0.0 111.373 -171.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.574 HG12 HG13 ' A' ' 143' ' ' VAL . 71.2 mt -75.68 93.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.58 HG21 ' HG3' ' A' ' 134' ' ' LYS . 2.1 t -87.97 -10.53 10.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.557 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.2 OUTLIER -157.08 117.35 3.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.984 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.994 HD13 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -87.45 131.42 35.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.139 178.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.558 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 13.1 mmt180 -141.45 151.15 60.11 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 141' ' ' ASP . 84.5 Cg_exo -19.41 -77.68 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 125.261 3.974 . . . . 0.0 114.767 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.534 ' HA ' HD23 ' A' ' 97' ' ' LEU . 4.4 p-10 -125.05 36.86 4.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.467 1.127 . . . . 0.0 109.034 168.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.805 ' HD2' HG11 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -131.45 138.15 48.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.006 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.723 HG22 HD22 ' A' ' 97' ' ' LEU . 3.2 t -144.74 121.71 4.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 122.044 0.925 . . . . 0.0 112.131 -176.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.775 HG23 HG21 ' A' ' 153' ' ' VAL . 37.4 t -79.21 102.18 5.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.852 HD12 HD22 ' A' ' 154' ' ' LEU . 1.8 pp -120.12 152.0 38.25 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.103 0.954 . . . . 0.0 113.294 -169.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 4.0 tp60 -100.23 102.86 14.26 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.716 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.548 ' HD2' ' HB1' ' A' ' 133' ' ' ALA . 0.4 OUTLIER -136.78 135.16 37.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.15 -1.386 . . . . 0.0 107.529 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.409 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.7 mp0 70.39 32.19 2.83 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.673 0.389 . . . . 0.0 111.274 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.84 1.96 87.84 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.027 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.732 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 20.1 tpp180 -130.31 143.49 50.81 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.704 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 34.6 p90 -119.84 108.94 14.98 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 122.278 1.037 . . . . 0.0 108.523 175.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.732 ' HG2' ' HG3' ' A' ' 150' ' ' ARG . 51.1 mm-40 -125.79 -170.41 2.18 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.646 -173.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.805 HG11 ' HD2' ' A' ' 142' ' ' ARG . 2.9 t -102.25 101.84 12.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.843 0.83 . . . . 0.0 109.985 -169.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.872 HD23 ' H ' ' A' ' 93' ' ' LEU . 4.7 tp -112.23 118.19 34.63 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.54 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.433 ' HA3' ' NH1' ' A' ' 142' ' ' ARG . . . -102.96 58.27 0.56 Allowed Glycine 0 C--N 1.308 -0.98 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.553 169.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.81 HD13 HD11 ' A' ' 97' ' ' LEU . 2.3 mt -37.67 104.74 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.687 0 O-C-N 124.52 0.777 . . . . 0.0 110.214 174.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -136.62 133.8 36.67 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.524 -0.735 . . . . 0.0 109.544 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 75.3 m -154.51 162.04 41.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.268 0.556 . . . . 0.0 111.059 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -132.75 -6.09 3.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -77.25 -17.37 58.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.127 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.856 ' HB2' ' HA ' ' A' ' 116' ' ' ASP . 14.9 p-10 -80.35 -43.91 20.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.723 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.548 ' HA ' ' HB2' ' A' ' 117' ' ' ASN . 20.2 m -71.11 -34.17 70.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.406 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -90.66 59.15 3.32 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.382 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 66.9 p -162.66 146.9 11.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -98.98 -9.58 23.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.516 0.674 . . . . 0.0 110.14 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.67 11.12 51.73 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.434 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.2 100.09 53.19 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.3 109.52 2.44 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.579 2.186 . . . . 0.0 111.757 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -162.4 -167.45 22.84 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.518 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.31 -43.61 7.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.909 0.385 . . . . 0.0 110.722 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -122.54 83.31 2.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.256 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.32 -35.26 22.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.898 175.027 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.1 p -100.95 35.29 2.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.306 0.574 . . . . 0.0 111.377 -176.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -92.49 97.63 10.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -68.35 134.48 50.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.491 0.662 . . . . 0.0 111.677 -174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 pp -104.02 17.49 24.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.896 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -68.29 139.29 55.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.8 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.574 ' HE1' ' OG ' ' A' ' 137' ' ' SER . 14.8 ptm -94.25 40.05 1.08 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.366 -174.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.46 -152.78 0.39 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.611 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.32 -27.65 24.74 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.985 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.492 ' HB3' ' HE2' ' A' ' 76' ' ' MET . . . 68.88 14.65 8.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.238 0.615 . . . . 0.0 110.643 -178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -163.18 27.1 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.54 -25.55 64.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.086 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.514 ' HA ' ' HB3' ' A' ' 87' ' ' ASN . . . -58.14 -36.43 72.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.331 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 m -77.14 -13.66 59.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.726 0.298 . . . . 0.0 111.297 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.563 ' HG2' ' HG3' ' A' ' 85' ' ' MET . 58.8 tt0 -85.64 -33.58 21.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 111.201 -175.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.563 ' HG3' ' HG2' ' A' ' 84' ' ' GLN . 65.3 mtt -146.13 -86.8 0.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.137 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.7 t -148.43 -55.06 0.2 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 82' ' ' ALA . 4.8 t-20 59.7 89.86 0.06 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.81 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -70.64 119.38 72.42 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HG2' HD21 ' A' ' 93' ' ' LEU . 14.7 Cg_endo -57.02 110.31 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.405 2.737 . . . . 0.0 113.138 -175.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.738 ' HG2' ' HB3' ' A' ' 152' ' ' GLU . 73.4 Cg_endo -78.03 -139.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.144 2.563 . . . . 0.0 111.675 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.832 ' HB3' ' HG ' ' A' ' 154' ' ' LEU . 22.8 t 53.21 -101.8 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 117.878 0.308 . . . . 0.0 110.677 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.741 HG21 HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -127.94 -34.67 2.13 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.475 0.58 . . . . 0.0 112.46 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.641 ' H ' HD13 ' A' ' 154' ' ' LEU . 47.2 tp 59.68 107.48 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.335 0.588 . . . . 0.0 111.993 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.48 ' HA ' HE21 ' A' ' 159' ' ' GLN . 2.4 p-10 -176.54 -157.05 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.75 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.4 OUTLIER 55.23 174.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 173.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.1 t -126.67 117.31 22.48 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.749 163.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.745 HD23 HG21 ' A' ' 113' ' ' ILE . 11.5 mt -77.23 125.51 29.44 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.606 HG22 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -91.53 -33.8 15.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.21 154.43 6.17 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.088 162.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.576 HG22 HG12 ' A' ' 138' ' ' ILE . 3.4 m -104.17 146.8 11.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 122.303 1.049 . . . . 0.0 110.799 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.607 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 65.6 mtt -105.75 91.58 3.81 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.176 -1.829 . . . . 0.0 108.782 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.31 129.59 42.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.55 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.572 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -114.6 94.85 0.7 Allowed Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 1.3 m-20 73.92 -53.81 0.69 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -169.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.764 ' O ' ' HB3' ' A' ' 109' ' ' SER . 25.8 t70 178.95 -90.01 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.692 -1.594 . . . . 0.0 107.466 168.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.759 ' HB2' HG23 ' A' ' 124' ' ' VAL . 13.3 p-10 -91.11 -38.85 12.5 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.16 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.447 ' C ' ' HD2' ' A' ' 108' ' ' ARG . 2.7 m -49.3 -55.89 11.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.195 -172.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.531 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 5.3 mmm180 -120.48 34.77 5.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.134 0.493 . . . . 0.0 109.902 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.764 ' HB3' ' O ' ' A' ' 105' ' ' ASP . 19.1 p -76.35 141.87 41.38 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -168.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 10.2 mm -120.94 84.16 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 121.87 0.843 . . . . 0.0 111.273 -176.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.594 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -74.2 102.63 4.35 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.26 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 3.2 mm -87.04 96.19 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.745 HG21 HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -103.29 144.58 13.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.689 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.803 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 31.2 t -105.31 120.28 41.17 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.568 ' HE3' ' HA3' ' A' ' 130' ' ' GLY . 23.9 tptp -123.45 110.41 15.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -174.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.07 17.29 7.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -168.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.803 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 2.8 t-20 73.98 35.53 0.78 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.913 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -104.82 101.33 10.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 164.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.606 ' NE2' HG22 ' A' ' 98' ' ' THR . 36.3 mt-30 -67.2 120.99 14.68 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.34 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 5.7 t80 -120.21 143.41 48.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.819 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.3 p -87.14 95.42 9.95 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.396 1.093 . . . . 0.0 111.119 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.481 ' HD3' ' HB3' ' A' ' 126' ' ' GLU . 13.6 mmt180 -103.57 -157.48 0.61 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.569 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.711 ' HA2' HD12 ' A' ' 138' ' ' ILE . . . 162.28 -174.64 38.73 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 119.87 -1.157 . . . . 0.0 112.17 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.759 HG23 ' HB2' ' A' ' 106' ' ' ASP . 2.1 t -56.62 122.72 6.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.134 -1.033 . . . . 0.0 109.639 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.53 ' HA ' ' CE ' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 75.29 35.16 0.59 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.969 1.366 . . . . 0.0 108.223 176.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.481 ' HB3' ' HD3' ' A' ' 122' ' ' ARG . 4.8 mm-40 -133.8 144.88 49.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 111.985 -2.37 . . . . 0.0 106.81 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.566 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 34.7 mt-10 -103.34 132.56 49.5 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.196 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.599 HG23 HG13 ' A' ' 113' ' ' ILE . 0.4 OUTLIER -61.15 140.1 94.31 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.071 -176.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.701 ' O ' HD22 ' A' ' 95' ' ' LEU . 23.8 Cg_exo -64.77 142.67 77.39 Favored 'Trans proline' 0 C--O 1.223 -0.227 0 C-N-CA 123.094 2.529 . . . . 0.0 112.442 -167.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.568 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 97.06 -43.21 2.05 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.567 ' HB3' ' CE1' ' A' ' 147' ' ' TYR . 62.1 m-85 -114.11 170.13 8.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -96.43 46.44 1.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 170.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.676 ' HB2' HD21 ' A' ' 145' ' ' LEU . . . -85.81 97.52 10.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.566 ' CA ' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -81.81 104.61 12.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.715 -169.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 123' ' ' GLY . 70.8 mt -52.3 94.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.83 0.824 . . . . 0.0 110.106 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.482 ' H ' ' HA ' ' A' ' 145' ' ' LEU . 3.4 m -83.38 -3.78 7.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.517 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.796 ' HB3' ' HB ' ' A' ' 144' ' ' VAL . 3.6 t -168.71 117.4 0.7 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.905 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.711 HD12 ' HA2' ' A' ' 123' ' ' GLY . 7.1 tt -97.2 135.88 29.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.735 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.717 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 17.1 mmt180 -141.44 157.5 65.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -18.94 -82.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.013 1 C-N-CA 125.579 4.186 . . . . 0.0 115.05 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.455 ' C ' HD12 ' A' ' 97' ' ' LEU . 7.7 p-10 -133.21 40.19 3.21 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 123.471 1.605 . . . . 0.0 107.438 167.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.717 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -126.57 139.2 53.38 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 111.642 -2.526 . . . . 0.0 107.154 169.028 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.546 ' N ' ' HD3' ' A' ' 142' ' ' ARG . 1.1 t -137.07 160.33 36.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.133 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.936 HG22 HG11 ' A' ' 153' ' ' VAL . 13.9 t -120.33 117.16 52.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 165.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.855 HD13 HD12 ' A' ' 154' ' ' LEU . 2.2 pp -132.5 162.49 31.08 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.765 0.793 . . . . 0.0 111.956 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 4.2 tp60 -109.97 108.91 19.33 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.65 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.568 ' HD2' ' NE2' ' A' ' 148' ' ' GLN . 76.9 t80 -135.86 141.32 44.61 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.577 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.568 ' NE2' ' HD2' ' A' ' 147' ' ' TYR . 0.0 OUTLIER 59.11 22.38 10.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 169.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 98.6 -1.39 58.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.57 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.425 ' HG2' ' HG2' ' A' ' 148' ' ' GLN . 13.2 ptp180 -130.19 137.62 50.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.372 0.586 . . . . 0.0 111.875 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.605 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 16.5 p90 -114.7 108.22 16.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.391 1.091 . . . . 0.0 108.477 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.738 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 52.6 mt-10 -139.45 -170.42 2.9 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.443 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.936 HG11 HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -96.34 99.65 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 122.006 0.908 . . . . 0.0 110.208 -168.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.855 HD12 HD13 ' A' ' 145' ' ' LEU . 0.4 OUTLIER -101.99 106.82 17.79 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.704 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -98.98 53.11 1.08 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 173.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.75 HD22 ' HB2' ' A' ' 95' ' ' LEU . 3.9 mt -32.36 115.22 0.17 Allowed 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.907 1.004 . . . . 0.0 110.69 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -133.59 160.85 36.26 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.3 m -48.37 104.51 0.06 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.48 HE21 ' HA ' ' A' ' 94' ' ' ASN . 13.7 pt20 -149.62 18.68 0.92 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.726 0.774 . . . . 0.0 109.395 172.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -147.65 -34.45 0.24 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -71.57 -36.03 70.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.997 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.2 t -144.32 146.8 32.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.092 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.25 118.26 2.92 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 38.6 m -128.16 173.82 9.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.937 0.368 . . . . 0.0 111.411 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -53.41 -51.34 62.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.033 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.91 12.3 14.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.061 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 84.4 t -115.76 115.69 41.3 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.96 145.88 28.75 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.977 2.452 . . . . 0.0 112.248 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -104.49 18.95 43.56 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.935 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.21 82.02 1.89 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.041 0.448 . . . . 0.0 110.395 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -120.17 -119.28 0.3 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.238 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 18.3 m -68.39 -19.66 24.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 166.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 . . . . . 0 C--O 1.248 1.02 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.451 170.932 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.2 m -128.53 89.58 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.344 0.592 . . . . 0.0 110.81 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -84.59 55.72 3.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.367 0.603 . . . . 0.0 110.173 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 71.5 mmm -82.75 68.82 9.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.036 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.03 -30.14 60.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.348 -175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -67.88 -14.05 62.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.537 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 52.1 mtm -136.99 54.11 1.87 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.439 . . . . 0.0 110.524 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.72 -1.85 58.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.44 63.98 2.15 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.945 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -119.66 111.65 18.32 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.931 -0.158 . . . . 0.0 110.844 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 3.3 mm? 58.51 28.92 17.65 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.729 0.643 . . . . 0.0 111.435 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 27.0 t70 150.93 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -170.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.56 ' H ' ' CG ' ' A' ' 81' ' ' ASP . . . -91.98 -61.81 1.55 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.2 t -100.94 -65.17 0.99 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.713 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -101.33 -71.71 0.7 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -163.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.442 ' CA ' ' HB2' ' A' ' 81' ' ' ASP . 24.5 ptm -169.04 -35.39 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.5 m -153.5 49.05 0.68 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.093 -0.379 . . . . 0.0 111.54 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.9 m120 47.48 48.36 16.77 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.404 0.44 . . . . 0.0 111.719 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.67 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 49.8 tp -73.96 126.55 89.28 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.7 -176.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -97.1 90.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.893 3.062 . . . . 0.0 112.272 173.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.848 ' HG2' ' HB3' ' A' ' 152' ' ' GLU . 6.3 Cg_endo -90.42 -138.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.685 2.923 . . . . 0.0 112.118 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.527 ' HB2' HD13 ' A' ' 154' ' ' LEU . 70.5 m 56.83 -86.63 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.614 0.765 . . . . 0.0 112.179 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.566 HG21 HD22 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -160.97 -44.67 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.831 -0.543 . . . . 0.0 112.381 -176.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.824 ' H ' HD22 ' A' ' 154' ' ' LEU . 6.5 tt 51.54 112.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.773 ' H ' HD23 ' A' ' 156' ' ' LEU . 2.3 p-10 -167.48 -56.81 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.814 HD12 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -54.71 176.34 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 122.95 0.5 . . . . 0.0 111.154 176.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.657 ' HB2' ' OG ' ' A' ' 158' ' ' SER . 1.5 t -117.59 109.93 17.29 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.292 170.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.726 ' HA ' HG22 ' A' ' 113' ' ' ILE . 1.9 mp -73.23 115.95 13.19 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 170.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.425 HG23 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -82.83 -35.7 26.14 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -176.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.51 169.83 31.55 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.745 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.713 HG23 ' HA ' ' A' ' 111' ' ' ALA . 2.3 t -130.11 126.55 62.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.904 0.859 . . . . 0.0 110.889 -175.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.861 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 64.8 mtt -92.0 89.98 7.21 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.583 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.11 121.52 14.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.731 -175.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.575 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -114.04 100.37 1.03 Allowed Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -172.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.575 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 10.5 t70 74.4 -64.67 0.38 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -170.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 109' ' ' SER . 7.0 m-20 -169.37 -91.52 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.942 -1.935 . . . . 0.0 106.519 169.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.509 ' HA ' HG21 ' A' ' 124' ' ' VAL . 12.5 p-10 -91.87 -30.75 15.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.665 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 t -60.07 -57.18 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.459 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 4.4 mmm180 -111.58 28.9 8.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.367 0.603 . . . . 0.0 110.067 -170.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.66 ' HB2' ' CD1' ' A' ' 138' ' ' ILE . 22.5 p -73.02 135.8 44.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.685 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.861 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 6.4 mm -120.39 89.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.393 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.895 ' HB3' HD12 ' A' ' 113' ' ' ILE . . . -78.64 100.95 7.22 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.921 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.5 mm -86.3 93.18 3.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.895 HD12 ' HB3' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -106.86 159.93 6.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.235 -176.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.481 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 26.4 p -125.82 135.48 52.02 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-O 121.308 0.575 . . . . 0.0 109.54 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.814 ' HD3' HD12 ' A' ' 95' ' ' LEU . 24.9 tptp -119.21 108.39 14.59 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 59.25 20.43 8.54 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -167.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.445 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.1 t-20 79.74 37.19 0.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 113.435 -1.711 . . . . 0.0 111.666 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.615 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 16.6 pt-20 -107.4 101.77 11.1 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.963 0.887 . . . . 0.0 109.626 166.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.686 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 2.8 mt-30 -67.24 135.89 54.11 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -142.81 146.15 33.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.737 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -88.07 103.11 15.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.924 0.869 . . . . 0.0 111.552 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.475 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 21.9 mmt180 -107.42 -159.62 0.7 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.682 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.524 ' N ' ' HG3' ' A' ' 126' ' ' GLU . . . 174.94 173.64 40.93 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -175.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.517 HG23 ' OG ' ' A' ' 109' ' ' SER . 16.7 t -49.39 132.59 7.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 165.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.579 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 72.29 19.55 4.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.459 1.123 . . . . 0.0 109.574 175.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.524 ' HG3' ' N ' ' A' ' 123' ' ' GLY . 0.4 OUTLIER -120.64 158.04 28.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.145 -1.843 . . . . 0.0 106.347 167.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 41.6 mt-10 -104.2 156.89 17.52 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 118.435 0.561 . . . . 0.0 110.116 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.656 HG21 HD22 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -66.4 145.2 98.95 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.553 178.345 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.76 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 21.7 Cg_exo -52.98 130.69 39.1 Favored 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 122.847 2.364 . . . . 0.0 112.009 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.522 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 96.6 -59.06 1.29 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.633 176.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.452 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 27.0 m-85 -113.63 153.66 28.51 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 121.434 -0.106 . . . . 0.0 111.036 -174.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -74.81 44.76 0.23 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.712 ' HB1' HD23 ' A' ' 145' ' ' LEU . . . -83.06 90.4 7.03 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 170.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.703 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -80.49 120.83 24.99 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.472 -170.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.631 HG22 HG13 ' A' ' 143' ' ' VAL . 74.4 mt -68.62 94.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.412 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.702 HG21 ' HE2' ' A' ' 134' ' ' LYS . 1.5 t -88.59 -3.77 9.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.732 0.777 . . . . 0.0 108.965 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.47 ' HB3' HG21 ' A' ' 144' ' ' VAL . 1.7 t -162.38 115.32 1.71 Allowed 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.492 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.827 HD12 ' HB1' ' A' ' 111' ' ' ALA . 3.5 tt -88.98 132.93 32.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.069 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 7.4 mmt180 -141.89 159.23 60.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.438 ' HB2' ' H ' ' A' ' 141' ' ' ASP . 72.1 Cg_exo -22.63 -78.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 125.093 3.862 . . . . 0.0 114.474 177.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.456 ' HA ' HD22 ' A' ' 97' ' ' LEU . 9.5 p-10 -128.33 39.53 3.81 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.398 1.094 . . . . 0.0 108.715 169.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 1.9 tpp180 -136.93 143.35 42.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.73 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.631 HG13 HG22 ' A' ' 135' ' ' ILE . 4.8 t -148.41 119.33 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.83 -176.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 1.092 HG23 HG11 ' A' ' 153' ' ' VAL . 7.1 t -79.04 65.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.712 HD23 ' HB1' ' A' ' 133' ' ' ALA . 1.9 pp -82.63 167.92 17.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.022 -175.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -112.57 124.39 52.43 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.577 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.592 ' HD2' ' HB2' ' A' ' 133' ' ' ALA . 0.3 OUTLIER -145.27 140.04 27.53 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.467 ' N ' ' HD1' ' A' ' 147' ' ' TYR . 2.2 mp0 67.91 28.94 6.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.966 0.412 . . . . 0.0 109.942 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.15 8.43 87.44 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.605 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 0.3 OUTLIER -132.61 139.78 47.93 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 117.247 0.523 . . . . 0.0 110.905 -173.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.689 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 13.3 p90 -118.94 111.96 19.01 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.106 0.955 . . . . 0.0 109.392 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.848 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 34.6 mt-10 -134.94 -175.9 4.06 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.161 -177.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 1.092 HG11 HG23 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -96.24 99.27 8.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 119.676 -0.809 . . . . 0.0 110.233 -165.17 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.824 HD22 ' H ' ' A' ' 93' ' ' LEU . 6.0 tp -103.66 119.55 39.14 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.384 -0.825 . . . . 0.0 113.163 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -104.29 54.86 0.62 Allowed Glycine 0 C--N 1.304 -1.204 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 168.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.773 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.5 mt -36.51 107.25 0.06 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.39 0.7 . . . . 0.0 110.101 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -134.24 121.7 21.7 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.657 ' OG ' ' HB2' ' A' ' 96' ' ' SER . 38.0 m -61.4 132.98 55.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.231 0.539 . . . . 0.0 111.399 -174.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -72.06 179.69 3.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.101 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -80.59 118.21 21.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.143 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -71.5 -18.93 62.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.516 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.8 p -82.29 -29.22 31.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.961 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -106.4 25.53 22.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.229 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.3 t -156.44 151.52 26.32 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.87 1.23 57.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.409 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 92.42 -21.26 39.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.942 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.24 130.72 23.71 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.73 109.19 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.312 2.008 . . . . 0.0 111.582 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 177.47 -178.28 48.33 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . 59.09 -158.59 0.31 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.911 0.418 . . . . 0.0 110.959 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 58.62 50.49 8.94 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.585 0.707 . . . . 0.0 110.496 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 20.6 t -91.02 -26.18 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 . . . . . 0 C--O 1.25 1.116 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.069 174.914 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.713 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 t -85.24 -1.35 56.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -86.66 -14.63 42.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 110.368 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 77.3 mtp -133.17 102.99 5.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.593 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.9 tp -72.2 105.64 4.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -94.01 117.09 29.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.221 0.534 . . . . 0.0 111.456 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -83.08 69.49 9.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.883 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.5 39.99 0.63 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.729 -176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.84 -171.78 41.8 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.019 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -163.73 -70.31 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.0 tp -124.39 93.51 3.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -103.54 131.17 50.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.161 -171.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.21 -12.8 61.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.734 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.6 m -64.4 -10.8 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.349 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -56.67 -40.8 76.16 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.058 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.798 ' HE2' ' HA ' ' A' ' 85' ' ' MET . 9.4 mmt 66.5 -163.54 0.23 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.625 0.578 . . . . 0.0 110.368 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.8 m 65.78 25.51 11.35 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.513 0.508 . . . . 0.0 111.334 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -92.41 69.13 5.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.768 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.632 ' HB3' ' HD3' ' A' ' 89' ' ' PRO . 8.8 tt -161.56 -56.5 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.305 -0.379 . . . . 0.0 111.786 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.632 ' HD3' ' HB3' ' A' ' 88' ' ' LEU . 45.8 Cg_exo -56.74 114.28 1.85 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.548 2.165 . . . . 0.0 113.728 -173.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.741 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.6 Cg_exo -78.45 -133.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.712 2.941 . . . . 0.0 111.005 174.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.846 ' HB2' ' HB2' ' A' ' 152' ' ' GLU . 9.1 t 51.23 -137.98 1.11 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.211 0.205 . . . . 0.0 111.121 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.441 ' HB ' ' CD2' ' A' ' 147' ' ' TYR . 4.9 t -95.53 -37.85 10.69 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.587 ' N ' HD22 ' A' ' 154' ' ' LEU . 31.7 tp 49.59 68.47 0.73 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.781 ' H ' HD23 ' A' ' 156' ' ' LEU . 5.3 t30 -174.04 100.59 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.846 ' HB2' HD21 ' A' ' 156' ' ' LEU . 0.0 OUTLIER 164.44 -167.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 175.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.682 ' HB2' ' HG ' ' A' ' 114' ' ' SER . 49.9 m -132.01 103.75 6.45 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.606 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.966 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -83.25 74.14 10.05 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -37.72 -46.67 0.92 Allowed 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 140' ' ' PRO . . . 161.54 152.47 6.67 Favored Glycine 0 CA--C 1.486 -1.775 0 C-N-CA 119.121 -1.514 . . . . 0.0 112.358 172.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.603 HG11 ' HA ' ' A' ' 111' ' ' ALA . 4.7 m -104.59 143.21 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 121.659 0.743 . . . . 0.0 110.021 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.863 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 87.1 mmm -90.86 86.33 6.27 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.83 ' HA ' ' HG ' ' A' ' 109' ' ' SER . . . -65.61 119.69 11.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.945 -176.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -114.7 102.45 1.17 Allowed Glycine 0 CA--C 1.498 -1.022 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -171.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 2.6 m-20 72.22 -69.41 0.19 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -172.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -149.72 -111.89 0.06 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.092 170.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.506 ' OD2' HG13 ' A' ' 124' ' ' VAL . 5.8 m-20 -90.59 -13.13 35.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.739 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.3 t -64.44 -58.03 7.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.534 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -109.91 29.67 7.41 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.401 -173.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.83 ' HG ' ' HA ' ' A' ' 102' ' ' ALA . 2.6 t -85.52 141.65 29.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.247 0.546 . . . . 0.0 111.763 -170.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.863 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 10.7 mm -122.21 87.93 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.422 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.832 ' HB3' HD12 ' A' ' 113' ' ' ILE . . . -69.09 98.61 1.01 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.483 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.542 HG23 ' HG2' ' A' ' 119' ' ' GLN . 13.6 mm -87.33 90.03 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.966 HG23 ' HA ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -101.79 132.84 46.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.759 -179.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.682 ' HG ' ' HB2' ' A' ' 96' ' ' SER . 2.7 p -99.41 135.21 41.16 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.04 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.8 ' CD ' HD22 ' A' ' 95' ' ' LEU . 24.3 tptp -122.69 110.87 16.04 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 61.71 21.51 12.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -166.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 77.39 33.69 0.4 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.677 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' A' ' 114' ' ' SER . 81.3 tt0 -101.6 96.78 7.34 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 170.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.542 ' HG2' HG23 ' A' ' 112' ' ' ILE . 3.8 mt-30 -67.5 108.62 2.9 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 5.2 t80 -110.13 141.99 42.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.927 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.9 p -90.19 95.12 10.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.807 0.813 . . . . 0.0 112.177 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.894 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 18.8 mmt180 -91.96 -160.07 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.492 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.65 ' N ' ' HG3' ' A' ' 126' ' ' GLU . . . 163.8 105.62 0.19 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.582 -168.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.765 ' O ' ' HB2' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -9.5 117.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 125.408 1.299 . . . . 0.0 113.23 -177.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.765 ' HB2' ' O ' ' A' ' 124' ' ' VAL . 0.9 OUTLIER 88.59 27.48 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 124.999 1.437 . . . . 0.0 108.428 -167.601 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.894 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 5.1 mm-40 -124.75 147.49 48.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 112.833 -1.985 . . . . 0.0 107.891 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.555 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 50.9 mt-10 -105.41 140.25 38.81 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.571 HG22 ' CD1' ' A' ' 156' ' ' LEU . 0.5 OUTLIER -57.18 154.77 19.59 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.23 -176.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.07 119.24 6.2 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.883 2.389 . . . . 0.0 112.279 -175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.556 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 99.21 -52.1 1.1 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.328 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.539 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 21.3 m-85 -104.34 132.57 50.44 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -79.27 52.57 1.35 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.571 1.078 . . . . 0.0 110.962 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.684 ' HB1' HD23 ' A' ' 145' ' ' LEU . . . -84.78 101.72 12.47 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.59 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -81.39 107.9 14.55 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.015 -171.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.1 mt -55.91 94.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 O-C-N 123.806 0.691 . . . . 0.0 109.834 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.521 HG22 ' HB2' ' A' ' 151' ' ' TYR . 0.2 OUTLIER -88.19 -4.2 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.621 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -164.65 118.32 1.33 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.767 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.731 ' HB ' HG22 ' A' ' 124' ' ' VAL . 7.2 tt -92.88 128.79 44.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.552 0.691 . . . . 0.0 111.727 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.797 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 16.9 mmt180 -142.06 160.17 56.29 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.602 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 7.3 Cg_exo -25.49 -85.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 1 C-N-CA 126.14 4.56 . . . . 0.0 114.98 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.5 ' HA ' HD23 ' A' ' 97' ' ' LEU . 1.9 p30 -123.78 14.05 9.3 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.036 0.922 . . . . 0.0 109.08 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.797 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -115.25 142.72 46.3 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.704 169.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.618 HG23 HD22 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -137.89 170.48 17.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.851 177.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.774 HG21 HG12 ' A' ' 153' ' ' VAL . 40.7 t -122.1 97.98 5.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.684 HD23 ' HB1' ' A' ' 133' ' ' ALA . 1.2 pp -120.34 158.59 26.8 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.039 0.923 . . . . 0.0 112.847 -170.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 4.6 tp60 -106.64 103.04 12.39 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.555 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.584 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 52.9 t80 -128.22 144.42 51.12 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.613 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.584 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 0.0 OUTLIER 59.38 29.31 18.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 171.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.436 ' N ' HE22 ' A' ' 146' ' ' GLN . . . 83.24 5.24 89.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.133 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.614 ' HG2' ' HG2' ' A' ' 152' ' ' GLU . 66.5 ttt180 -133.32 138.47 46.39 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 117.071 0.435 . . . . 0.0 110.803 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 6.4 p90 -116.75 112.33 21.02 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.547 1.165 . . . . 0.0 108.812 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.846 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 76.5 mm-40 -128.87 -169.79 2.15 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.384 -174.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.774 HG12 HG21 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -98.64 100.4 10.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.081 0.944 . . . . 0.0 108.475 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.65 HD13 ' HG ' ' A' ' 156' ' ' LEU . 0.3 OUTLIER -119.38 106.3 12.14 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.701 -172.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.47 ' CA ' ' HA ' ' A' ' 142' ' ' ARG . . . -106.46 70.49 0.22 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.846 HD21 ' HB2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -37.06 124.14 0.91 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.604 0.762 . . . . 0.0 110.447 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -132.35 145.89 51.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -161.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.1 m -85.99 139.75 30.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.522 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 66.08 -156.65 0.26 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.957 170.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 70.05 -65.47 0.31 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.503 0.721 . . . . 0.0 111.098 -177.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.61 -14.05 57.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.577 0.703 . . . . 0.0 109.985 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.3 t -129.26 141.3 51.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.694 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -161.69 173.44 38.06 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.927 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 9.3 t -124.99 33.3 5.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.643 0.735 . . . . 0.0 110.021 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -97.36 25.73 5.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.369 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.43 15.84 13.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.175 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.03 122.22 84.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.605 0.24 . . . . 0.0 110.432 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.24 111.25 2.21 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.999 2.466 . . . . 0.0 112.716 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -116.86 172.45 14.24 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -84.77 12.41 7.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.014 0.435 . . . . 0.0 111.521 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -143.5 79.97 1.65 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.1 m -69.1 -28.14 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.824 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.53 -0.747 . . . . 0.0 110.73 179.393 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 m -74.1 -48.84 26.95 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -89.34 100.44 13.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.163 0.506 . . . . 0.0 112.088 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 69.7 mtm -126.07 81.31 1.98 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.552 ' HA ' ' HE2' ' A' ' 76' ' ' MET . 2.7 pp -83.48 24.72 0.81 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.678 -171.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -66.31 -29.13 69.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.378 0.609 . . . . 0.0 109.902 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.679 ' HA ' ' HE1' ' A' ' 76' ' ' MET . 28.7 mmt 65.36 43.13 3.59 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.881 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.64 -15.53 48.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.404 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.62 -136.36 13.16 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 54.64 49.69 17.55 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.721 0.408 . . . . 0.0 111.611 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.22 -93.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.931 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -146.58 14.92 1.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.763 0.316 . . . . 0.0 110.517 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.45 -38.25 68.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.238 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 p -93.61 -38.32 11.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.811 0.339 . . . . 0.0 111.535 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -73.82 -30.47 62.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 -176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.5 mtt 70.99 122.09 0.03 OUTLIER 'General case' 0 C--O 1.231 0.129 0 O-C-N 124.045 0.84 . . . . 0.0 110.557 -176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.6 t -72.22 -20.13 61.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.108 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 67.5 -168.58 0.2 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.984 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 pp -123.91 156.27 65.82 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.402 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.86 107.93 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.415 2.743 . . . . 0.0 114.031 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.504 ' O ' HD11 ' A' ' 154' ' ' LEU . 2.8 Cg_exo -77.53 -132.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.617 2.878 . . . . 0.0 111.364 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.478 ' HB2' HD11 ' A' ' 154' ' ' LEU . 58.5 m 56.38 -83.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.895 0.478 . . . . 0.0 112.006 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.606 ' HB ' HE22 ' A' ' 148' ' ' GLN . 1.6 t -161.07 -41.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.544 -0.722 . . . . 0.0 112.336 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.781 ' H ' HD21 ' A' ' 154' ' ' LEU . 48.8 tp 56.2 99.77 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.744 ' H ' HD21 ' A' ' 156' ' ' LEU . 3.1 p-10 -160.07 -61.09 0.06 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.863 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -57.28 -178.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.415 0.626 . . . . 0.0 111.75 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.799 ' HB2' ' HB3' ' A' ' 158' ' ' SER . 9.6 t -117.28 119.85 36.43 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.621 170.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.933 HD21 HG23 ' A' ' 113' ' ' ILE . 53.4 mt -76.74 131.34 38.68 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 165.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.27 -32.48 15.01 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 175.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.898 ' HA2' ' HB3' ' A' ' 141' ' ' ASP . . . 154.71 168.19 17.67 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.97 161.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.7 HG12 HG22 ' A' ' 138' ' ' ILE . 2.7 t -114.4 132.01 64.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.781 0.801 . . . . 0.0 110.91 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.81 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 67.1 mtt -104.17 87.41 2.75 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.21 177.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.81 46.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.4 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.725 ' H ' ' HA ' ' A' ' 109' ' ' SER . . . -106.62 88.14 0.54 Allowed Glycine 0 CA--C 1.496 -1.156 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 25.1 t70 74.85 -54.65 0.66 Allowed 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -169.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.696 ' O ' ' HB3' ' A' ' 109' ' ' SER . 12.7 t70 -178.97 -124.07 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.902 -1.499 . . . . 0.0 106.994 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.681 ' HA ' HG22 ' A' ' 124' ' ' VAL . 2.3 p-10 -80.9 -6.59 58.85 Favored 'General case' 0 CA--C 1.522 -0.101 0 O-C-N 124.184 0.928 . . . . 0.0 109.939 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.1 t -60.46 -42.5 96.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.164 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.477 ' C ' ' HG ' ' A' ' 109' ' ' SER . 78.7 mtp180 -126.2 -65.61 0.97 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.421 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.725 ' HA ' ' H ' ' A' ' 103' ' ' GLY . 13.7 p 53.58 127.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 174.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.81 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 3.6 mm -116.9 129.92 72.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.329 174.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.873 ' HB3' HD12 ' A' ' 113' ' ' ILE . . . -120.69 98.42 6.01 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.802 0.335 . . . . 0.0 111.653 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.43 HG13 ' HE3' ' A' ' 101' ' ' MET . 5.5 mm -80.33 94.54 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.933 HG23 HD21 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -105.82 142.62 18.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.718 177.224 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 84.5 p -113.66 129.18 56.61 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.846 0.832 . . . . 0.0 109.353 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.863 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.6 tptp -124.81 101.46 7.1 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -171.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 55.07 22.16 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -164.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 78.24 40.67 0.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.697 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 15.5 pt-20 -108.71 90.75 3.39 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.276 1.036 . . . . 0.0 108.292 161.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 34.9 mt-30 -67.22 124.19 22.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.524 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -128.69 147.98 50.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.993 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -97.3 105.12 17.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.616 0.722 . . . . 0.0 111.532 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.935 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 28.1 mmt180 -95.2 -163.05 1.0 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.316 176.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.59 ' O ' ' HG2' ' A' ' 126' ' ' GLU . . . 164.74 110.88 0.24 Allowed Glycine 0 C--O 1.216 -1.001 0 C-N-CA 119.738 -1.22 . . . . 0.0 114.088 -171.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.681 HG22 ' HA ' ' A' ' 106' ' ' ASP . 28.1 t 4.85 115.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.152 1.381 . . . . 0.0 114.452 -175.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.705 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 80.8 35.48 0.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.313 -175.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.935 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 13.1 mm-40 -127.31 150.72 49.45 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.781 170.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 2.3 mp0 -101.39 150.84 22.6 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 118.571 0.623 . . . . 0.0 109.861 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.633 HG21 HG21 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -62.35 151.72 81.56 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.493 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.502 ' O ' HD11 ' A' ' 95' ' ' LEU . 3.6 Cg_exo -62.94 127.52 20.62 Favored 'Trans proline' 0 C--N 1.332 -0.292 0 C-N-CA 122.953 2.435 . . . . 0.0 112.37 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.589 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 100.48 -64.1 0.59 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.353 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.499 ' HE2' HD13 ' A' ' 95' ' ' LEU . 4.3 m-85 -110.73 140.56 45.01 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -78.87 56.37 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.538 0.608 . . . . 0.0 111.831 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.698 ' HB3' HD23 ' A' ' 145' ' ' LEU . . . -79.88 96.97 6.51 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.705 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.5 OUTLIER -81.13 115.91 20.79 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.256 0.551 . . . . 0.0 110.911 -169.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.51 HG22 HG13 ' A' ' 138' ' ' ILE . 74.7 mt -67.47 94.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.401 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.574 HG23 ' HE2' ' A' ' 134' ' ' LYS . 1.3 t -86.62 -6.57 10.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.713 ' CB ' ' HB ' ' A' ' 144' ' ' VAL . 4.1 t -157.15 117.12 3.46 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.125 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.805 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -91.55 125.99 44.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.991 0.9 . . . . 0.0 111.238 176.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.586 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 13.5 mmt85 -142.11 148.96 50.48 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.647 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.29 81.2 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.628 2.218 . . . . 0.0 113.67 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.898 ' HB3' ' HA2' ' A' ' 99' ' ' GLY 0.279 2.9 p30 75.62 27.0 1.05 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.868 1.667 . . . . 0.0 110.17 170.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.696 ' HD2' ' N ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -139.72 151.32 45.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 112.255 -2.248 . . . . 0.0 106.204 157.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.696 ' N ' ' HD2' ' A' ' 142' ' ' ARG . 7.2 t -141.21 164.89 19.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-O 121.526 0.679 . . . . 0.0 111.395 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.713 ' HB ' ' CB ' ' A' ' 137' ' ' SER . 59.1 t -122.12 100.45 8.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.699 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 2.0 pp -122.56 156.56 33.94 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 122.21 1.005 . . . . 0.0 113.223 -168.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.451 HE22 ' N ' ' A' ' 149' ' ' GLY . 2.2 tp60 -103.46 104.58 14.68 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 112.533 -2.121 . . . . 0.0 108.581 -174.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.5 ' CD2' HG21 ' A' ' 92' ' ' THR . 0.4 OUTLIER -136.54 135.5 38.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.711 175.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.606 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.8 mp0 67.93 34.34 4.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.46 175.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.451 ' N ' HE22 ' A' ' 146' ' ' GLN . . . 70.55 12.81 70.56 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.729 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.461 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 29.2 ttp180 -130.95 137.43 49.28 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.792 -0.24 . . . . 0.0 110.362 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 22.3 p90 -118.58 108.8 15.4 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.704 1.24 . . . . 0.0 109.313 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.1 mm-40 -129.02 -170.72 2.32 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.483 -1.69 . . . . 0.0 109.179 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.685 HG22 HG23 ' A' ' 144' ' ' VAL . 3.5 t -97.17 105.54 17.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.184 0.516 . . . . 0.0 109.903 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.781 HD21 ' H ' ' A' ' 93' ' ' LEU . 6.1 tp -108.17 121.2 44.36 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.488 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -108.14 59.26 0.37 Allowed Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 167.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.744 HD21 ' H ' ' A' ' 94' ' ' ASN . 1.5 mt -36.46 109.73 0.1 Allowed 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.269 0.629 . . . . 0.0 109.521 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -134.43 99.15 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -172.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.799 ' HB3' ' HB2' ' A' ' 96' ' ' SER . 8.6 t -115.35 142.27 46.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.085 0.469 . . . . 0.0 110.323 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.32 169.01 18.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.548 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.98 -76.63 0.59 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -109.52 -25.7 10.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.273 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.3 m 58.86 26.47 14.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.397 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.96 -62.1 4.25 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.998 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.3 m -148.33 104.49 3.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.969 0.414 . . . . 0.0 110.053 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -77.19 -21.93 53.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.105 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.96 -22.86 17.93 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.658 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.6 p -77.82 118.98 75.57 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.088 0.471 . . . . 0.0 110.246 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.28 130.75 5.53 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.519 2.146 . . . . 0.0 112.493 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -96.66 154.3 20.6 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.724 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.13 57.48 4.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.104 0.478 . . . . 0.0 110.877 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -84.39 93.36 8.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.938 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.98 135.23 60.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.657 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.973 -0.537 . . . . 0.0 110.333 177.259 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.6 m -83.62 95.52 8.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.23 0.538 . . . . 0.0 110.446 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -85.92 -47.95 9.17 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.433 ' HG2' ' HG ' ' A' ' 74' ' ' LEU . 27.1 ttt -174.49 127.35 0.33 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.96 175.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.433 ' HG ' ' HG2' ' A' ' 73' ' ' MET . 96.0 mt 69.91 115.37 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 O-C-N 124.069 0.856 . . . . 0.0 111.331 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -76.19 -2.3 30.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.309 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 47.1 ttm -57.77 -26.78 62.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.646 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.45 -20.39 65.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.074 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.94 80.2 0.7 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.95 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.11 97.47 7.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.9 0.381 . . . . 0.0 110.358 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.55 9.09 3.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.689 -173.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -104.05 -21.96 13.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.486 0.66 . . . . 0.0 109.647 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.86 3.36 51.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.505 0.669 . . . . 0.0 110.132 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.4 m -93.1 -26.84 17.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.568 -169.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -99.48 -42.1 7.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.585 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -152.38 134.03 14.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.057 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.5 t -174.41 171.39 3.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.509 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.6 m120 71.65 137.95 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.041 0.838 . . . . 0.0 112.923 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . 6.5 mp -125.24 123.44 25.24 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.675 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.767 ' HB3' HD23 ' A' ' 154' ' ' LEU . 53.8 Cg_exo -54.9 108.1 0.28 Allowed 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 123.583 2.855 . . . . 0.0 113.227 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 89' ' ' PRO . 2.7 Cg_exo -77.53 -31.74 3.23 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.667 2.911 . . . . 0.0 114.718 -172.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.646 ' HB3' HD22 ' A' ' 154' ' ' LEU . 46.5 t -61.63 -76.43 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.13 0.423 . . . . 0.0 111.624 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.826 ' HB ' HE22 ' A' ' 148' ' ' GLN . 2.7 t -127.7 -45.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.777 ' H ' HD11 ' A' ' 154' ' ' LEU . 45.6 tp 59.06 86.07 0.09 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.308 0.575 . . . . 0.0 111.889 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.701 ' ND2' ' H ' ' A' ' 95' ' ' LEU . 9.5 t30 -160.42 -149.5 0.19 Allowed 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.955 ' HB2' HD21 ' A' ' 156' ' ' LEU . 0.5 OUTLIER 51.71 177.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 172.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.422 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 40.8 m -137.23 115.55 11.81 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.221 166.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.874 HD21 HG21 ' A' ' 113' ' ' ILE . 12.0 mt -74.97 143.16 43.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 174.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -33.2 10.84 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 147.05 154.22 6.14 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 162.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.663 HG13 ' HA ' ' A' ' 111' ' ' ALA . 13.6 m -103.69 144.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 122.654 1.216 . . . . 0.0 112.011 -173.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.724 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 65.3 mmm -97.73 89.5 4.65 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.374 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.793 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -64.74 134.64 54.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.788 0.327 . . . . 0.0 110.857 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -125.27 89.3 0.38 Allowed Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 28.9 t70 71.32 -57.81 0.59 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -166.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.621 ' O ' ' HB2' ' A' ' 109' ' ' SER . 20.8 t70 -173.88 -87.24 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.263 -1.789 . . . . 0.0 107.846 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.666 ' HA ' ' CG2' ' A' ' 124' ' ' VAL . 5.6 t70 -91.5 -46.6 7.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.492 -175.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.9 t -55.13 -40.64 70.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.41 -167.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -130.26 26.7 5.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.552 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.793 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 7.8 t -92.03 140.79 29.3 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.007 -172.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.724 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 8.0 mm -117.66 91.28 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.611 -174.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.814 ' HB1' HD13 ' A' ' 138' ' ' ILE . . . -72.75 96.8 2.09 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.267 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 4.5 mm -79.84 93.71 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.874 HG21 HD21 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -101.86 154.12 5.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.87 175.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 14.5 p -121.09 126.13 49.02 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.709 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 24.5 tptp -117.24 105.21 11.96 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -171.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 58.43 24.7 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -163.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 15.3 t-20 68.9 40.25 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 112.002 -2.363 . . . . 0.0 112.161 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.709 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 12.4 pt-20 -102.26 103.09 13.55 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 162.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 4.8 mt-30 -68.17 131.48 45.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.489 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 7.9 t80 -135.96 144.3 45.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.448 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.6 p -88.9 94.78 10.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 122.057 0.932 . . . . 0.0 111.22 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.487 ' CB ' ' HB2' ' A' ' 111' ' ' ALA . 16.0 mmt180 -98.56 -159.53 0.74 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.049 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 126' ' ' GLU . . . 178.9 161.74 27.1 Favored Glycine 0 N--CA 1.408 -3.205 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.884 HG22 ' HB ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -57.12 128.04 17.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 165.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.676 ' HB2' ' O ' ' A' ' 124' ' ' VAL . 0.9 OUTLIER 81.14 28.58 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.482 1.134 . . . . 0.0 109.057 -176.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 123' ' ' GLY . 1.2 mm-40 -132.65 153.29 51.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 112.596 -2.093 . . . . 0.0 107.664 170.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.563 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 41.4 mt-10 -104.83 145.61 30.15 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.456 HG23 HD11 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -62.65 153.87 76.5 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.486 -174.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.612 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 23.7 Cg_exo -66.37 126.92 16.41 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.569 2.18 . . . . 0.0 111.787 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.65 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 103.91 -57.89 0.53 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.06 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 147' ' ' TYR . 34.1 m-85 -111.92 149.62 31.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.957 -0.121 . . . . 0.0 110.743 -176.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.407 HD21 ' HA ' ' A' ' 132' ' ' ASN . 10.9 m120 -75.97 53.77 0.79 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.089 0.471 . . . . 0.0 111.778 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.661 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -90.24 95.69 10.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.656 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.563 ' CA ' ' HG2' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -82.14 107.29 14.72 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.017 0.437 . . . . 0.0 110.846 -171.151 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.654 HG12 HG12 ' A' ' 143' ' ' VAL . 64.8 mt -54.07 94.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.357 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 144' ' ' VAL . 3.9 m -97.35 8.27 7.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.948 0.88 . . . . 0.0 108.815 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.751 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 5.7 m -165.41 114.81 1.04 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.079 176.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.884 ' HB ' HG22 ' A' ' 124' ' ' VAL . 1.1 tt -98.45 127.99 50.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.401 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 5.2 mmt180 -143.73 150.3 49.79 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -14.55 -74.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 1 C-N-CA 125.708 4.272 . . . . 0.0 114.974 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.445 ' C ' HD13 ' A' ' 97' ' ' LEU . 7.8 p-10 -138.98 47.73 1.91 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.247 1.022 . . . . 0.0 109.475 168.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.787 ' HD3' HG13 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -143.81 139.37 29.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.154 165.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.654 HG12 HG12 ' A' ' 135' ' ' ILE . 10.4 t -135.02 118.19 23.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.071 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.861 HG23 HG21 ' A' ' 153' ' ' VAL . 9.2 t -80.48 62.23 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.136 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.661 HD22 ' HB1' ' A' ' 133' ' ' ALA . 1.7 pp -79.83 166.78 21.36 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -171.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 2.1 tp60 -108.83 104.87 14.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 111.662 -2.517 . . . . 0.0 108.41 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 131' ' ' TYR . 1.0 OUTLIER -139.3 133.48 31.27 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.458 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.826 HE22 ' HB ' ' A' ' 92' ' ' THR . 3.1 mt-30 70.39 32.83 2.66 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.471 0.482 . . . . 0.0 110.859 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.58 3.78 79.29 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.409 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 2.3 tpm_? -125.02 153.53 42.69 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.614 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 2.7 p90 -134.77 106.64 7.01 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.355 1.074 . . . . 0.0 108.229 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 81.0 mm-40 -134.62 -176.24 4.15 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.46 -169.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.861 HG21 HG23 ' A' ' 144' ' ' VAL . 26.2 t -93.67 100.2 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.014 0.912 . . . . 0.0 108.724 -170.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.777 HD11 ' H ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -106.87 102.91 12.24 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 114.22 -1.354 . . . . 0.0 111.363 -175.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 142' ' ' ARG . . . -100.99 57.13 0.72 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.572 175.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.955 HD21 ' HB2' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -37.23 109.82 0.11 Allowed 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.385 0.697 . . . . 0.0 109.624 171.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -121.94 157.58 30.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 112.04 -164.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.422 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 18.1 m -86.22 106.78 17.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.354 175.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.599 ' HG3' ' HG3' ' A' ' 160' ' ' GLU . 9.7 pt20 -85.48 -57.1 3.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.133 -176.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.599 ' HG3' ' HG3' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -95.4 92.36 6.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.381 0.61 . . . . 0.0 111.108 177.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 162' ' ' SER . 4.2 p30 -89.91 18.22 5.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.377 177.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 169' ' ' GLY . 40.4 t 79.85 -29.98 0.13 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.222 1.009 . . . . 0.0 111.667 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.64 ' HA2' HG11 ' A' ' 167' ' ' VAL . . . 128.47 66.27 0.12 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.023 -1.084 . . . . 0.0 113.227 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.2 m -67.98 -40.09 83.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.937 0.399 . . . . 0.0 110.729 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -92.43 -12.46 32.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.02 0.438 . . . . 0.0 110.155 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 112.24 19.36 7.19 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.866 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.64 HG11 ' HA2' ' A' ' 163' ' ' GLY . 7.3 p -68.63 129.97 92.22 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.633 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.42 109.2 1.34 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.814 2.343 . . . . 0.0 112.378 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 162' ' ' SER . . . 166.16 57.39 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -116.83 -64.86 1.25 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.823 0.344 . . . . 0.0 111.221 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -82.47 -22.95 34.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.478 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.1 m -99.5 -38.2 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.854 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 . . . . . 0 C--O 1.249 1.036 0 O-C-N 123.951 0.782 . . . . 0.0 110.526 -177.148 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 p -69.33 136.48 51.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.858 0.361 . . . . 0.0 110.233 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -88.79 64.22 7.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.256 0.55 . . . . 0.0 110.285 -175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 22.5 ptp -79.45 -22.91 43.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.357 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.8 mt 64.2 -78.96 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.993 0.808 . . . . 0.0 111.013 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -173.45 110.57 0.18 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.036 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 96.3 mmm -74.87 99.04 3.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.023 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.6 -35.78 10.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.022 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.39 163.38 36.63 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.867 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.38 132.01 35.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -77.08 -28.52 54.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.524 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 84' ' ' GLN . 30.8 m-20 -84.63 56.98 4.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.35 0.595 . . . . 0.0 110.355 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.22 -31.59 71.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.442 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 t -84.24 -15.39 46.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.262 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.523 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 35.4 tt0 -83.0 -28.9 29.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.839 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 70.6 mtm 63.25 45.32 5.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.124 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -62.42 99.45 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.537 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -126.29 133.21 51.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.21 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.707 HD22 ' H ' ' A' ' 88' ' ' LEU . 2.6 pt? -104.49 147.51 34.51 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.25 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.71 113.49 3.55 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.66 2.24 . . . . 0.0 112.109 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.518 ' HB2' ' H ' ' A' ' 91' ' ' SER . 4.0 Cg_exo -75.84 -115.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.151 2.567 . . . . 0.0 111.518 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.776 ' HB2' HD12 ' A' ' 154' ' ' LEU . 22.1 m 54.74 -79.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.863 HG23 ' HD2' ' A' ' 147' ' ' TYR . 0.1 OUTLIER -163.72 -44.56 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.124 -0.36 . . . . 0.0 111.216 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.915 ' H ' HD22 ' A' ' 154' ' ' LEU . 1.0 OUTLIER 52.48 99.78 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.046 0.451 . . . . 0.0 111.434 -177.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.801 ' H ' HD23 ' A' ' 156' ' ' LEU . 0.1 OUTLIER -157.63 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.002 -172.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.871 HD22 ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -56.77 174.65 0.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.374 179.152 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 42.4 t -121.58 118.98 30.59 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.557 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.547 ' HA ' HG22 ' A' ' 113' ' ' ILE . 6.0 mp -79.02 124.36 28.19 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.72 -29.85 22.1 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.01 173.64 30.92 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 169.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.764 HG21 ' HA ' ' A' ' 111' ' ' ALA . 2.4 t -129.75 126.84 63.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.558 0.694 . . . . 0.0 110.397 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.855 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -89.42 89.38 7.84 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.047 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.712 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -65.91 132.24 48.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.224 -174.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 108' ' ' ARG . . . -117.47 92.16 0.55 Allowed Glycine 0 CA--C 1.5 -0.868 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 -173.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.5 t0 69.53 -59.55 0.49 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.935 0.874 . . . . 0.0 108.784 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -156.83 -146.81 0.17 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.313 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.6 ' CA ' HG21 ' A' ' 124' ' ' VAL . 7.2 m-20 -56.53 -33.34 65.98 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.49 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.8 t -46.84 -56.3 6.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.425 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 22.7 mtp180 -119.49 30.49 7.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.611 -167.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.712 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 8.4 t -86.96 145.64 26.44 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.733 0.777 . . . . 0.0 112.133 -172.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.855 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 12.6 mm -114.3 92.5 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.404 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.877 ' HB3' HD11 ' A' ' 113' ' ' ILE . . . -73.86 101.46 3.77 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.399 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 28.8 mm -86.47 93.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.877 HD11 ' HB3' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -104.5 150.08 7.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.647 -177.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 64.6 p -116.05 130.56 56.87 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.133 0.492 . . . . 0.0 109.724 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.871 ' HA ' HD22 ' A' ' 95' ' ' LEU . 19.0 tptp -110.43 102.48 11.1 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 59.89 27.13 16.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.438 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.3 t-20 81.21 33.25 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 112.453 -2.158 . . . . 0.0 110.854 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -106.12 97.39 7.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.657 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.7 mt-30 -66.61 135.89 54.79 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.594 -176.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 15.6 t80 -144.86 149.54 35.52 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.367 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.547 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 6.4 m -88.57 101.6 14.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.608 0.718 . . . . 0.0 111.169 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.423 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 18.0 mmt180 -104.94 -160.13 0.74 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.828 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.488 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . -179.31 169.47 40.66 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.115 -1.04 . . . . 0.0 111.461 -176.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 1.017 HG23 ' HB ' ' A' ' 138' ' ' ILE . 5.7 t -45.32 129.9 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 114.223 -0.988 . . . . 0.0 110.456 162.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.728 ' HA ' ' HD2' ' A' ' 134' ' ' LYS . 0.0 OUTLIER 69.09 14.75 8.76 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 124.749 1.281 . . . . 0.0 110.428 176.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -105.81 164.48 11.9 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 167.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.807 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 33.1 mt-10 -114.12 151.13 33.07 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 119.142 0.883 . . . . 0.0 110.018 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.659 HG21 HG23 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -59.13 143.42 84.54 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.048 0.451 . . . . 0.0 110.416 -176.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.626 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.1 Cg_exo -73.06 94.16 0.81 Allowed 'Trans proline' 0 C--O 1.222 -0.309 0 C-N-CA 123.244 2.63 . . . . 0.0 112.467 -170.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.452 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 132.76 -48.73 0.95 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.533 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 10.4 m-85 -112.65 137.7 50.53 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -73.91 46.75 0.24 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.897 0.772 . . . . 0.0 112.993 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.708 ' HB3' HD22 ' A' ' 145' ' ' LEU . . . -82.56 99.17 9.36 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 171.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.807 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -80.65 125.79 30.45 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-O 120.849 0.357 . . . . 0.0 110.939 -171.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.5 mt -77.23 89.93 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.578 HG21 ' HG3' ' A' ' 134' ' ' LYS . 1.3 t -85.11 -3.97 8.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 122.044 0.926 . . . . 0.0 108.641 -175.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.512 ' HB3' HG22 ' A' ' 144' ' ' VAL . 1.7 t -160.59 117.36 2.38 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.434 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 1.017 ' HB ' HG23 ' A' ' 124' ' ' VAL . 3.6 tt -94.92 133.51 35.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.495 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.582 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 17.0 mmt180 -141.79 162.85 44.21 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 170.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 141' ' ' ASP . 89.0 Cg_exo -25.22 -84.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.75 3.633 . . . . 0.0 114.635 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.436 ' H ' ' HB2' ' A' ' 140' ' ' PRO . 5.1 p-10 -116.64 29.81 7.71 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.154 0.978 . . . . 0.0 108.61 169.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 6.1 tpp85 -127.97 141.91 51.39 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.03 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 144' ' ' VAL . 4.3 t -145.61 168.55 7.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.706 -175.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.95 HG21 HG22 ' A' ' 153' ' ' VAL . 19.5 t -129.84 62.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.771 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 1.5 pp -82.38 155.27 24.79 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -165.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.468 HE22 ' N ' ' A' ' 150' ' ' ARG . 11.4 tp60 -99.91 104.42 16.06 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 111.937 -2.392 . . . . 0.0 108.586 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.863 ' HD2' HG23 ' A' ' 92' ' ' THR . 0.6 OUTLIER -141.83 132.95 26.21 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.835 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.8 mt-30 67.59 28.18 7.55 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.405 0.44 . . . . 0.0 110.774 175.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.32 -2.91 85.41 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 119.809 -1.186 . . . . 0.0 112.698 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.468 ' N ' HE22 ' A' ' 146' ' ' GLN . 28.5 ptt180 -126.26 145.51 50.38 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.576 -0.367 . . . . 0.0 111.242 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.771 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 6.4 p90 -122.76 109.96 14.87 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 171.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.438 ' HB2' ' OG ' ' A' ' 91' ' ' SER . 36.7 mt-10 -127.33 -175.47 3.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.95 HG22 HG21 ' A' ' 144' ' ' VAL . 6.0 p -95.99 98.72 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-O 122.835 1.302 . . . . 0.0 110.155 -165.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.915 HD22 ' H ' ' A' ' 93' ' ' LEU . 10.0 tp -106.81 116.22 31.55 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.36 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.571 ' O ' ' HD2' ' A' ' 157' ' ' TYR . . . -99.57 61.06 0.75 Allowed Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.952 167.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.801 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.7 mt -36.38 111.61 0.15 Allowed 'General case' 0 N--CA 1.485 1.306 0 O-C-N 124.325 0.662 . . . . 0.0 109.748 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.571 ' HD2' ' O ' ' A' ' 155' ' ' GLY . 51.3 p90 -134.09 149.07 51.09 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.19 0.45 . . . . 0.0 110.45 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 41.9 m -152.62 159.32 43.23 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 68.1 179.56 0.23 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.485 0.491 . . . . 0.0 111.262 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -126.06 112.62 16.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.543 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -74.25 -46.61 40.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.67 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.8 t 49.84 52.71 14.09 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.276 0.36 . . . . 0.0 111.175 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -169.05 -41.55 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.127 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.0 m -110.03 68.07 0.66 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.104 0.478 . . . . 0.0 110.964 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' A' ' 167' ' ' VAL . 8.6 p-10 -74.37 -53.49 9.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.651 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 58.54 34.18 74.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.433 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 165' ' ' ASP . 33.3 m -120.89 155.94 57.02 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.24 108.86 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.148 1.899 . . . . 0.0 111.435 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -78.39 123.41 6.26 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.049 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -94.26 77.27 3.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.375 0.607 . . . . 0.0 109.974 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -89.92 50.78 1.93 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.206 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.7 m -124.09 156.72 31.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.972 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.876 -179.288 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.849 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.9 m -84.27 74.35 10.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.815 0.34 . . . . 0.0 110.753 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 46.6 m170 58.46 56.71 4.2 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.805 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.42 51.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.691 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.9 tp -106.35 112.33 25.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.411 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 74.3 137.5 0.06 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.276 0.985 . . . . 0.0 112.617 171.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 42.4 tpp -75.4 -29.68 59.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.265 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.35 42.06 1.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.9 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.02 17.25 33.22 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.254 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.37 59.43 2.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.213 0.53 . . . . 0.0 110.587 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.558 ' HG ' ' H ' ' A' ' 81' ' ' ASP . 30.7 tp -153.66 176.06 12.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.337 -175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.558 ' H ' ' HG ' ' A' ' 80' ' ' LEU . 5.4 m-20 -64.8 -14.94 60.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.611 0.243 . . . . 0.0 111.583 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.92 -33.42 74.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.007 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.8 p -83.46 -19.26 36.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.655 0.264 . . . . 0.0 111.647 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -99.8 -51.28 3.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.258 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 70.1 mtm 47.97 34.39 4.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.189 0.518 . . . . 0.0 111.465 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 88' ' ' LEU . 75.1 m -166.71 160.45 14.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.559 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -84.6 36.92 0.62 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.674 0.749 . . . . 0.0 109.537 175.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.58 HD11 ' HD2' ' A' ' 89' ' ' PRO . 25.4 tp -88.02 130.1 47.65 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.722 -178.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.58 ' HD2' HD11 ' A' ' 88' ' ' LEU . 56.3 Cg_exo -40.52 114.81 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.087 3.191 . . . . 0.0 113.682 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.63 ' O ' HD21 ' A' ' 154' ' ' LEU . 33.6 Cg_exo -63.75 -134.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.438 2.759 . . . . 0.0 111.99 172.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.636 ' HB2' ' HG ' ' A' ' 154' ' ' LEU . 60.0 m 53.46 -83.03 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.54 0.336 . . . . 0.0 110.992 -170.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.965 ' HB ' HE22 ' A' ' 148' ' ' GLN . 0.0 OUTLIER -156.04 -49.51 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 119.491 -0.29 . . . . 0.0 111.037 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.626 HD11 ' HA ' ' A' ' 156' ' ' LEU . 46.0 tp 54.17 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.504 0.502 . . . . 0.0 111.663 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.744 ' H ' HD21 ' A' ' 156' ' ' LEU . 5.8 t30 -162.5 -60.21 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.024 0.44 . . . . 0.0 111.669 -175.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.84 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -56.34 175.96 0.1 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.124 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.788 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 21.7 t -114.98 108.5 16.79 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.028 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.833 ' HA ' HG22 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -73.22 117.33 14.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 171.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.629 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -91.18 -34.53 14.98 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -173.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.557 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 158.51 141.17 3.08 Favored Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.783 171.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.587 HG22 HG22 ' A' ' 138' ' ' ILE . 12.1 m -102.39 147.85 8.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.77 0.795 . . . . 0.0 109.689 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.847 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 67.5 mtt -104.03 90.69 3.68 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.024 176.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.59 120.95 9.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.777 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -110.98 97.96 1.01 Allowed Glycine 0 CA--C 1.492 -1.367 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -174.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 3.6 m-20 73.42 -66.03 0.33 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -173.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.558 ' O ' ' HB3' ' A' ' 109' ' ' SER . 8.3 m-20 -162.29 -102.64 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.692 -1.594 . . . . 0.0 107.594 167.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.68 ' HB2' HG22 ' A' ' 124' ' ' VAL . 6.5 p-10 -91.73 -20.2 21.8 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.35 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.439 ' C ' ' HD3' ' A' ' 108' ' ' ARG . 14.5 m -61.87 -47.01 86.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.077 -174.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.439 ' HD3' ' C ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -123.79 19.89 9.35 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.053 -168.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.724 ' HB2' HD13 ' A' ' 138' ' ' ILE . 2.8 p -66.77 147.29 53.45 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.324 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.847 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 5.5 mm -126.94 84.74 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-O 121.783 0.802 . . . . 0.0 110.862 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.93 ' HB3' HD11 ' A' ' 113' ' ' ILE . . . -72.93 96.92 2.18 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.404 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.72 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 9.9 mm -81.86 94.35 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.93 HD11 ' HB3' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -105.29 140.43 23.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.666 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.834 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 29.9 t -99.69 129.31 45.81 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.865 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.84 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.9 tptp -128.79 106.06 8.66 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.7 t70 62.52 18.57 10.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -169.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.834 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 2.6 t-20 76.22 38.54 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.535 -175.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.51 ' HG2' ' CE1' ' A' ' 120' ' ' PHE . 31.1 tt0 -113.13 93.6 4.49 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.161 167.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.629 ' NE2' HG21 ' A' ' 98' ' ' THR . 74.2 mt-30 -66.83 129.72 40.8 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.886 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.72 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 50.6 m-85 -119.88 150.34 40.63 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.306 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.5 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 6.2 m -94.23 99.16 11.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.712 0.768 . . . . 0.0 109.844 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.691 ' HB2' ' HB2' ' A' ' 111' ' ' ALA . 64.9 mmt-85 -89.61 -161.86 0.82 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.822 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.665 ' N ' ' HG2' ' A' ' 126' ' ' GLU . . . 161.11 95.59 0.11 Allowed Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.007 -1.092 . . . . 0.0 112.894 -163.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.68 HG22 ' HB2' ' A' ' 106' ' ' ASP . 2.2 t 4.55 123.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 126.563 1.978 . . . . 0.0 114.976 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.681 ' HA ' ' CE ' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 78.21 34.42 0.29 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.664 -177.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.665 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 0.8 OUTLIER -124.04 167.08 14.67 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 112.669 -2.059 . . . . 0.0 107.844 168.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 1.9 mp0 -112.1 146.31 38.22 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.525 HG21 HD23 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -61.66 153.72 69.52 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.485 ' O ' HD11 ' A' ' 95' ' ' LEU . 24.4 Cg_exo -66.04 127.84 18.45 Favored 'Trans proline' 0 C--N 1.333 -0.287 0 C-N-CA 122.424 2.083 . . . . 0.0 112.442 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.556 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 100.66 -59.78 0.67 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.209 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.596 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 10.9 m-85 -109.68 140.75 43.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.025 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -74.94 49.89 0.44 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.659 0.663 . . . . 0.0 111.789 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.715 ' HB3' HD22 ' A' ' 145' ' ' LEU . . . -80.64 96.68 6.94 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.75 ' HD2' ' C ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -80.49 108.96 14.55 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 121.044 0.45 . . . . 0.0 110.989 -168.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.633 HG12 HG12 ' A' ' 143' ' ' VAL . 50.5 mt -60.81 95.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.93 177.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.713 HG22 ' HZ2' ' A' ' 134' ' ' LYS . 0.5 OUTLIER -84.15 -8.63 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.081 179.09 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.656 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 39.4 m -157.49 116.18 3.22 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.435 -174.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.724 HD13 ' HB2' ' A' ' 109' ' ' SER . 3.9 mt -92.61 127.91 44.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.598 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.596 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 28.0 mmt180 -141.2 151.62 62.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 173.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.41 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 78.0 Cg_exo -18.57 -75.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 1 C-N-CA 125.519 4.146 . . . . 0.0 114.776 -178.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.485 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -129.21 39.47 3.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.412 1.101 . . . . 0.0 108.797 168.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 8.2 tpp85 -136.06 143.56 44.73 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.835 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.813 HG23 HD21 ' A' ' 97' ' ' LEU . 3.4 t -141.67 169.25 14.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.534 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.838 HG23 HG13 ' A' ' 153' ' ' VAL . 18.3 t -133.58 61.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.848 HD13 HD11 ' A' ' 154' ' ' LEU . 1.9 pp -82.64 162.47 21.86 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -167.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 1.8 tp60 -105.73 105.49 15.56 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 112.556 -2.111 . . . . 0.0 108.232 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.606 ' HD2' HG23 ' A' ' 92' ' ' THR . 0.7 OUTLIER -141.21 136.78 32.08 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.753 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.965 HE22 ' HB ' ' A' ' 92' ' ' THR . 11.8 mt-30 68.29 28.67 6.23 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.534 0.521 . . . . 0.0 110.998 173.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.35 3.25 78.79 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.71 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 20.4 ttt180 -133.31 144.69 49.84 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.78 -0.247 . . . . 0.0 111.065 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.681 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 11.0 p90 -115.88 107.84 15.53 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.438 1.113 . . . . 0.0 107.999 171.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.852 ' HG3' ' H ' ' A' ' 153' ' ' VAL . 10.2 tp10 -130.79 -173.18 3.01 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.546 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.852 ' H ' ' HG3' ' A' ' 152' ' ' GLU . 0.9 OUTLIER -95.28 100.06 10.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.676 0.75 . . . . 0.0 111.015 -167.058 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.848 HD11 HD13 ' A' ' 145' ' ' LEU . 1.2 mt -101.35 109.44 21.29 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.672 176.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.44 ' O ' ' HD2' ' A' ' 157' ' ' TYR . . . -99.85 52.19 1.03 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.744 HD21 ' H ' ' A' ' 94' ' ' ASN . 2.4 mt -35.77 117.68 0.45 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.673 0.866 . . . . 0.0 109.659 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.44 ' HD2' ' O ' ' A' ' 155' ' ' GLY . 45.6 p90 -135.84 153.08 51.61 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.788 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 2.3 t -99.61 168.33 10.02 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 173.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 68.79 -173.68 0.19 Allowed 'General case' 0 C--O 1.232 0.164 0 O-C-N 123.637 0.586 . . . . 0.0 110.221 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -99.05 124.87 44.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.44 ' C ' ' HG ' ' A' ' 162' ' ' SER . 8.5 p-10 -72.16 -65.9 0.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.283 -172.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.44 ' HG ' ' C ' ' A' ' 161' ' ' ASP . 47.2 p 46.13 49.33 12.51 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.216 0.607 . . . . 0.0 111.874 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.89 -163.79 10.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.625 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.3 m -112.49 135.8 52.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.055 0.455 . . . . 0.0 110.629 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -76.35 -27.99 56.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.229 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.32 3.64 27.46 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.885 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.445 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 66.6 t -86.03 112.0 42.29 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 167' ' ' VAL . 11.9 Cg_exo -70.53 110.94 2.84 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.071 2.514 . . . . 0.0 112.692 -176.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -86.27 -42.76 6.48 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . 57.96 -91.78 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.409 0.684 . . . . 0.0 111.607 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -81.76 69.09 8.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.84 0.352 . . . . 0.0 110.755 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.1 t -66.47 -38.16 81.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.564 ' HD3' ' C ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.822 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.176 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.844 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.4 m -84.22 123.36 30.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.706 0.288 . . . . 0.0 110.561 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -108.54 73.48 0.87 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 111.296 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 96.1 mmm -117.96 5.41 12.12 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.9 tp -77.5 75.11 4.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.109 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 54.42 65.28 1.55 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.076 175.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 19.8 ptm -84.0 78.4 9.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.418 0.628 . . . . 0.0 110.552 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.33 43.3 10.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.838 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.65 91.1 0.23 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.918 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 178.68 -36.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.588 0.355 . . . . 0.0 110.757 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.4 tp -64.33 96.5 0.16 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.435 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.5 t70 54.59 50.94 14.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.264 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -91.35 -64.39 1.13 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.298 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.434 ' HB3' HG13 ' A' ' 153' ' ' VAL . 14.9 m -88.99 -3.05 58.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.664 -176.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -76.15 -13.11 60.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.144 0.497 . . . . 0.0 110.255 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.1 mtt -78.26 -60.74 2.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.909 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.8 t 57.39 58.52 3.79 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.574 0.702 . . . . 0.0 109.84 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -99.32 -36.47 9.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.91 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.423 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 63.0 tp -139.2 108.65 7.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.02 107.89 1.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.294 2.663 . . . . 0.0 111.596 176.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.696 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.9 Cg_exo -77.7 -133.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.297 2.665 . . . . 0.0 111.854 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.568 ' OG ' ' HB2' ' A' ' 152' ' ' GLU . 0.0 OUTLIER 47.91 -100.23 0.06 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.261 0.624 . . . . 0.0 112.049 -174.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.567 ' H ' HD13 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -138.45 -37.19 0.56 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.024 0.829 . . . . 0.0 112.541 -178.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.607 ' H ' ' CD1' ' A' ' 154' ' ' LEU . 1.3 tm? 66.57 -4.11 0.78 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.506 ' N ' HD23 ' A' ' 156' ' ' LEU . 4.0 t30 -103.96 97.61 7.57 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.623 -0.673 . . . . 0.0 112.572 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.72 ' HB2' HD21 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -179.97 179.01 0.57 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 177.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.56 ' H ' HD12 ' A' ' 95' ' ' LEU . 24.4 t -123.29 101.04 7.15 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 119.442 1.019 . . . . 0.0 110.345 173.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.878 ' HA ' HG21 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -81.23 75.46 8.19 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.133 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.701 HG23 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -40.31 -47.57 2.52 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 174.22 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 140' ' ' PRO . . . 160.33 153.45 6.94 Favored Glycine 0 CA--C 1.488 -1.595 0 C-N-CA 118.317 -1.897 . . . . 0.0 113.431 173.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.623 HG23 HG21 ' A' ' 138' ' ' ILE . 8.0 m -103.92 142.72 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-O 121.565 0.698 . . . . 0.0 109.64 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.823 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -98.48 87.42 3.84 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.819 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -56.18 135.21 53.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.878 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 105' ' ' ASP . . . -123.14 92.69 0.47 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.815 -176.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 t70 71.28 -40.57 0.48 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.239 1.015 . . . . 0.0 110.118 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.565 ' H ' ' C ' ' A' ' 103' ' ' GLY . 4.3 t70 -178.88 -141.02 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.723 ' CB ' HG21 ' A' ' 124' ' ' VAL . 20.8 m-20 -67.07 -29.61 69.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.3 0.571 . . . . 0.0 109.605 167.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.5 t -52.86 -57.46 10.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.937 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.407 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 5.2 mmm180 -114.29 26.52 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.122 -173.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.819 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 1.6 t -76.47 152.29 36.19 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.781 0.324 . . . . 0.0 111.217 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.823 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 15.4 mm -123.69 85.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 122.059 0.933 . . . . 0.0 110.833 -176.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.929 ' HB2' HD13 ' A' ' 113' ' ' ILE . . . -70.85 99.52 1.76 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.95 -176.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 7.8 mm -88.29 91.72 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.929 HD13 ' HB2' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -100.8 137.74 27.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.904 -177.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.43 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 4.2 m -95.22 122.47 37.94 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.754 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HE3' ' HA3' ' A' ' 130' ' ' GLY . 25.0 tptp -117.07 97.42 5.92 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 58.88 23.58 11.52 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -164.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 114' ' ' SER . 1.5 t30 75.98 38.8 0.33 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.912 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -99.26 92.88 5.65 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 161.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.701 ' NE2' HG23 ' A' ' 98' ' ' THR . 61.6 mt-30 -68.54 105.37 2.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.028 -173.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 6.7 t80 -106.67 133.82 50.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.863 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.6 p -85.31 98.89 10.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.307 1.051 . . . . 0.0 111.431 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.847 ' HB3' ' OE2' ' A' ' 126' ' ' GLU . 14.5 mmt180 -89.45 -161.89 0.82 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.392 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.595 ' N ' ' HG2' ' A' ' 126' ' ' GLU . . . 158.93 94.13 0.1 OUTLIER Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.586 -165.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.723 HG21 ' CB ' ' A' ' 106' ' ' ASP . 21.5 t 7.74 120.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.478 1.911 . . . . 0.0 115.71 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.707 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 83.04 40.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 123.05 1.405 . . . . 0.0 109.165 -178.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.847 ' OE2' ' HB3' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -135.83 158.26 44.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 111.917 -2.401 . . . . 0.0 108.115 171.245 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.638 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 52.9 mt-10 -105.49 142.75 34.7 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.223 0.535 . . . . 0.0 110.981 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.483 HG21 ' HD2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -56.65 143.51 68.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.723 -174.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.483 ' HD2' HG21 ' A' ' 128' ' ' VAL . 2.2 Cg_endo -57.22 116.91 3.55 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.761 2.307 . . . . 0.0 112.924 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.49 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 113.98 -63.05 0.31 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.524 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.442 ' HD2' HD22 ' A' ' 95' ' ' LEU . 18.2 m-85 -107.79 147.36 30.95 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -78.58 58.37 2.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.983 0.81 . . . . 0.0 111.674 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.703 ' HB2' HD23 ' A' ' 145' ' ' LEU . . . -91.9 97.71 11.14 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.244 175.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.707 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER -80.23 106.92 12.61 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 120.69 0.281 . . . . 0.0 110.653 -171.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.735 ' HB ' ' OE1' ' A' ' 126' ' ' GLU . 75.6 mt -56.5 96.33 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 122.097 0.951 . . . . 0.0 110.174 176.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.662 HG21 ' HA ' ' A' ' 145' ' ' LEU . 1.6 t -88.09 -2.74 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.379 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.538 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -165.89 117.61 1.07 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.332 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.648 HD13 ' HB3' ' A' ' 109' ' ' SER . 1.9 mt -92.79 125.13 45.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.043 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 8.4 mmt180 -129.9 153.21 80.91 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.541 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 32.4 Cg_exo -22.82 -68.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 1 C-N-CA 125.388 4.059 . . . . 0.0 114.605 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.497 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -137.31 39.07 2.49 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.642 1.21 . . . . 0.0 109.111 172.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.545 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 2.3 tpp85 -142.05 142.81 32.89 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.208 -1.814 . . . . 0.0 108.393 176.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 135' ' ' ILE . 2.1 t -139.87 166.91 19.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.499 0.666 . . . . 0.0 110.996 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.604 HG22 HG11 ' A' ' 153' ' ' VAL . 40.9 t -130.04 95.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.874 HD13 HD12 ' A' ' 154' ' ' LEU . 2.6 pp -121.12 158.4 28.02 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -164.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.7 OUTLIER -92.27 110.41 21.8 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.168 -1.833 . . . . 0.0 109.468 -176.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.495 ' CD2' HG21 ' A' ' 92' ' ' THR . 0.5 OUTLIER -151.14 133.38 15.33 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.265 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 74.14 34.83 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.65 0.593 . . . . 0.0 110.423 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.0 13.74 82.89 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.794 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.568 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 32.5 ptt180 -142.59 170.47 15.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.658 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 26.1 p90 -136.03 111.08 8.88 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.314 1.054 . . . . 0.0 108.409 171.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.696 ' HG3' ' HB2' ' A' ' 90' ' ' PRO . 76.7 mm-40 -119.76 -170.19 1.91 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.126 -173.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.604 HG11 HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -103.03 107.13 21.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.637 0.732 . . . . 0.0 110.407 -172.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.874 HD12 HD13 ' A' ' 145' ' ' LEU . 1.4 mt -113.44 114.16 26.18 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.47 -175.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.469 ' O ' ' HD1' ' A' ' 157' ' ' TYR . . . -110.11 50.84 0.74 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 168.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.781 HD22 HD11 ' A' ' 154' ' ' LEU . 0.5 OUTLIER -36.04 113.25 0.21 Allowed 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.803 0.943 . . . . 0.0 109.608 178.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.469 ' HD1' ' O ' ' A' ' 155' ' ' GLY . 51.3 p90 -134.12 144.03 48.32 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.75 -0.594 . . . . 0.0 109.784 -172.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 96' ' ' SER . 23.2 t -152.45 107.79 3.28 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -97.9 -66.7 0.89 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.705 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -127.03 179.77 5.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.779 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.44 -68.53 0.61 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -176.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.7 t 49.77 40.65 20.74 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.977 0.417 . . . . 0.0 111.006 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.89 -49.39 7.09 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.055 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.6 t 69.82 -68.73 0.19 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.337 0.655 . . . . 0.0 111.269 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.49 -14.88 36.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.343 0.592 . . . . 0.0 110.351 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.41 -21.17 22.17 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.36 139.4 32.83 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.07 124.71 16.25 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.805 2.337 . . . . 0.0 111.818 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -92.08 38.52 3.17 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.415 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -88.37 43.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.206 0.527 . . . . 0.0 110.37 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -111.56 92.71 4.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.38 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 27.4 m -84.32 40.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.323 0.583 . . . . 0.0 111.571 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.608 -0.71 . . . . 0.0 109.872 -179.687 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.415 ' HB2' HD13 ' A' ' 74' ' ' LEU . 4.7 p -102.39 88.44 3.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.138 0.494 . . . . 0.0 110.646 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -113.42 -37.48 4.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.354 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.4 tpp -97.55 75.18 2.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.653 0.739 . . . . 0.0 110.779 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.415 HD13 ' HB2' ' A' ' 71' ' ' SER . 97.1 mt -113.54 11.66 18.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.32 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -89.17 8.21 31.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.45 -173.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.3 ttt -156.81 -81.62 0.07 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 47.02 74.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.029 0.831 . . . . 0.0 112.906 174.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.79 63.91 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.898 -1.144 . . . . 0.0 113.021 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -143.51 110.89 5.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.558 0.218 . . . . 0.0 110.983 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.2 mt 57.79 33.11 22.83 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.393 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.93 4.66 7.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.282 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 86' ' ' SER . . . -76.95 -30.04 55.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.046 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.1 m -69.92 -11.14 60.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.733 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -63.15 -64.16 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.553 -174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 37.3 tpp -120.85 -19.18 7.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.841 0.353 . . . . 0.0 111.446 -176.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 13.1 m -80.73 132.27 35.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.877 0.37 . . . . 0.0 110.481 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -116.31 -36.05 4.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.657 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.483 HD12 ' HD2' ' A' ' 89' ' ' PRO . 33.1 tp -74.87 124.78 89.77 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.921 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.797 ' HB3' HD13 ' A' ' 154' ' ' LEU . 76.3 Cg_exo -51.09 108.97 0.26 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.724 2.949 . . . . 0.0 112.796 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.664 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 9.1 Cg_exo -73.45 -33.87 6.44 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.856 3.038 . . . . 0.0 115.434 -169.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.488 ' HB2' HD12 ' A' ' 154' ' ' LEU . 67.9 m -56.0 -71.29 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.502 0.592 . . . . 0.0 111.142 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.713 ' H ' HD11 ' A' ' 154' ' ' LEU . 1.7 t -160.36 -48.45 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.991 ' H ' HD23 ' A' ' 154' ' ' LEU . 53.8 tp 60.99 118.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.678 ' H ' HD22 ' A' ' 156' ' ' LEU . 4.5 t30 -176.54 -63.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.834 0.35 . . . . 0.0 111.901 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -55.64 169.31 0.34 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.798 -178.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 158' ' ' SER . 16.5 m -114.55 110.74 20.28 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.713 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.67 ' HA ' HG22 ' A' ' 113' ' ' ILE . 3.3 mp -76.21 123.06 25.27 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 114' ' ' SER . 0.2 OUTLIER -87.58 -36.54 17.48 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -175.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.543 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 159.49 146.75 4.66 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.654 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.689 HG23 ' HA ' ' A' ' 111' ' ' ALA . 5.2 t -103.97 131.05 53.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.054 0.454 . . . . 0.0 110.689 -174.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.845 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -97.46 88.02 4.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.809 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -67.95 126.74 30.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -174.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -128.52 110.48 1.13 Allowed Glycine 0 CA--C 1.5 -0.871 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.93 -171.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 23.9 t70 70.11 -65.18 0.33 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.698 ' O ' ' HB2' ' A' ' 109' ' ' SER . 20.2 t70 -167.72 -91.34 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.26 161.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.569 ' HA ' HG21 ' A' ' 124' ' ' VAL . 6.1 p-10 -91.97 -21.21 20.67 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.812 0.695 . . . . 0.0 111.078 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.417 ' HB2' ' HG2' ' A' ' 108' ' ' ARG . 3.9 m -60.03 -38.0 81.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.385 -172.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.417 ' HG2' ' HB2' ' A' ' 107' ' ' SER . 0.1 OUTLIER -141.94 32.44 1.58 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.674 -172.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.809 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 1.5 t -85.99 135.84 33.49 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.034 0.445 . . . . 0.0 110.24 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.845 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 13.0 mm -116.91 88.49 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.341 -173.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.901 ' HB2' HD12 ' A' ' 113' ' ' ILE . . . -73.88 98.06 2.91 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.47 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.543 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 17.1 mm -82.87 94.73 3.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.901 HD12 ' HB2' ' A' ' 111' ' ' ALA . 0.3 OUTLIER -106.28 148.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.644 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.523 ' HB3' ' OG1' ' A' ' 98' ' ' THR . 1.3 p -118.37 132.71 56.26 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.473 0.654 . . . . 0.0 109.611 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.79 ' HA ' HD21 ' A' ' 95' ' ' LEU . 17.8 tptm -108.68 100.65 9.87 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.2 t70 52.92 33.32 14.28 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -165.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.2 t-20 79.85 29.81 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 112.537 -2.119 . . . . 0.0 111.393 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.7 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 8.6 tp10 -96.88 92.77 6.28 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 170.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.626 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 29.3 mt-30 -73.85 132.58 42.68 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -138.29 152.29 48.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.58 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.2 p -95.39 105.79 17.79 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.316 0.579 . . . . 0.0 111.503 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 1.041 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 30.1 mmt180 -96.83 -163.75 1.08 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.805 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.629 ' N ' ' HG3' ' A' ' 126' ' ' GLU . . . 173.05 93.41 0.09 OUTLIER Glycine 0 C--O 1.222 -0.596 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.456 -164.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.922 HG22 ' HB ' ' A' ' 138' ' ' ILE . 1.3 t 4.64 45.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 127.426 2.29 . . . . 0.0 115.84 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.511 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 166.96 39.3 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -174.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 1.041 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 11.4 mm-40 -144.58 135.05 24.52 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 111.777 -2.465 . . . . 0.0 108.071 -170.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 58.4 mt-10 -91.84 142.62 27.38 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.724 HG21 HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -60.0 152.12 62.08 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.15 -177.283 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.632 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 24.0 Cg_exo -66.23 129.44 21.64 Favored 'Trans proline' 0 C--N 1.329 -0.454 0 C-N-CA 122.667 2.245 . . . . 0.0 111.46 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.424 ' HA3' ' CE ' ' A' ' 115' ' ' LYS . . . 93.82 -38.31 3.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.942 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -124.67 133.18 53.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.607 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -76.92 52.98 0.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.399 0.619 . . . . 0.0 111.084 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.63 ' HB1' HD21 ' A' ' 145' ' ' LEU . . . -93.22 99.01 11.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 172.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 1.4 tmmm? -81.09 121.92 26.7 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-O 121.005 0.431 . . . . 0.0 110.827 -170.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.695 HG12 HG13 ' A' ' 143' ' ' VAL . 95.4 mt -67.14 94.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.607 HG23 ' HE2' ' A' ' 134' ' ' LYS . 2.8 t -86.58 -9.88 11.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.499 ' CB ' ' HB ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -158.12 116.8 3.11 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.982 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.922 ' HB ' HG22 ' A' ' 124' ' ' VAL . 0.2 OUTLIER -86.64 133.51 29.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.064 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.667 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 19.2 mmt180 -141.88 154.56 65.59 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 172.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.4 ' O ' ' N ' ' A' ' 100' ' ' VAL . 52.6 Cg_exo -22.79 -78.19 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 125.138 3.892 . . . . 0.0 114.777 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.491 ' HA ' HD21 ' A' ' 97' ' ' LEU . 3.4 p-10 -127.43 39.85 3.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.494 1.14 . . . . 0.0 109.086 168.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.667 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 7.1 tpp85 -134.95 139.98 45.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.689 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.695 HG13 HG12 ' A' ' 135' ' ' ILE . 3.5 t -143.59 123.38 8.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.747 0.784 . . . . 0.0 112.429 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.891 HG22 HG13 ' A' ' 153' ' ' VAL . 22.0 t -80.55 101.66 5.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 169.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.962 HD11 HD22 ' A' ' 154' ' ' LEU . 1.1 pp -122.77 158.41 30.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -168.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -95.27 103.1 14.95 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.449 -175.473 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.562 ' HD1' ' N ' ' A' ' 148' ' ' GLN . 0.3 OUTLIER -139.93 135.62 33.01 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.562 ' N ' ' HD1' ' A' ' 147' ' ' TYR . 1.9 mp0 72.96 31.94 1.43 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.635 0.584 . . . . 0.0 110.57 173.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.04 16.49 74.94 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.062 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.764 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 6.0 tpp180 -132.28 157.13 45.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.79 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 25.4 p90 -134.67 107.11 7.29 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.764 ' HG2' ' HG3' ' A' ' 150' ' ' ARG . 43.1 mm-40 -124.03 -171.69 2.38 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.523 -174.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.891 HG13 HG22 ' A' ' 144' ' ' VAL . 3.1 m -100.4 99.95 9.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.838 0.828 . . . . 0.0 110.489 -172.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.991 HD23 ' H ' ' A' ' 93' ' ' LEU . 3.5 tp -107.27 109.75 21.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.854 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 142' ' ' ARG . . . -97.11 53.51 1.36 Allowed Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.312 172.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.678 HD22 ' H ' ' A' ' 94' ' ' ASN . 2.2 mt -37.09 115.49 0.39 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.447 0.734 . . . . 0.0 109.358 176.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -133.21 160.7 36.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.533 0.606 . . . . 0.0 109.946 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.449 ' HA ' ' OG ' ' A' ' 96' ' ' SER . 19.9 m -53.33 123.61 12.41 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.349 0.406 . . . . 0.0 110.819 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.465 ' OE1' ' HA ' ' A' ' 162' ' ' SER . 11.9 pt20 -112.99 166.61 11.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 110.976 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -142.52 -36.57 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.475 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.75 -28.87 68.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.186 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.465 ' HA ' ' OE1' ' A' ' 159' ' ' GLN . 22.7 t 65.85 20.97 11.45 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.85 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.02 -3.25 87.56 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.586 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -91.03 -160.74 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.08 -12.31 61.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.107 0.479 . . . . 0.0 111.358 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.97 -2.95 27.15 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.268 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 p -92.99 127.97 45.3 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.37 109.52 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.669 2.246 . . . . 0.0 112.126 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 159.75 29.56 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.926 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.04 80.2 8.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.151 0.501 . . . . 0.0 110.209 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -83.4 -36.57 24.18 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 46.9 t -117.13 -60.71 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.421 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.715 -0.659 . . . . 0.0 109.67 178.097 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.492 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.8 Cg_exo . . . . . 0 CA--C 1.532 0.404 0 N-CA-C 111.711 -0.15 . . . . 0.0 111.711 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.545 ' OG ' ' HB2' ' A' ' 152' ' ' GLU . 52.7 m 54.16 -99.58 0.09 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.514 0.326 . . . . 0.0 111.077 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.583 HG23 HD21 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -139.2 -42.3 0.46 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -176.49 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.903 ' H ' HD21 ' A' ' 154' ' ' LEU . 50.9 tp 60.38 109.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.496 0.665 . . . . 0.0 111.934 -174.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.589 ' H ' HD23 ' A' ' 156' ' ' LEU . 2.9 p-10 -174.55 -157.88 0.08 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.748 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER 44.37 -175.41 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 176.259 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.2 t -127.31 111.8 14.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.219 163.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.93 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -82.43 72.82 9.49 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.412 HG21 ' OE1' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -34.3 -42.62 0.14 Allowed 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 178.588 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 157.78 150.71 5.81 Favored Glycine 0 CA--C 1.484 -1.903 0 C-N-CA 119.16 -1.495 . . . . 0.0 112.676 171.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.755 HG21 HG23 ' A' ' 138' ' ' ILE . 19.0 m -104.13 160.44 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 122.432 1.111 . . . . 0.0 110.69 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.842 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 23.4 mmt -119.34 89.41 3.12 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 112.89 -1.959 . . . . 0.0 107.698 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.82 132.91 55.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.85 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 108' ' ' ARG . . . -117.34 90.85 0.52 Allowed Glycine 0 CA--C 1.496 -1.142 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.252 -173.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 107' ' ' SER . 31.0 t0 73.86 -53.33 0.69 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -172.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.755 ' O ' ' HB3' ' A' ' 109' ' ' SER . 38.6 t70 179.24 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.45 -1.704 . . . . 0.0 106.935 170.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.713 ' HB2' HG11 ' A' ' 124' ' ' VAL . 9.9 p-10 -90.37 -9.74 46.54 Favored 'General case' 0 C--N 1.334 -0.103 0 O-C-N 124.248 0.968 . . . . 0.0 109.885 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.696 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 24.9 m -69.02 11.39 0.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.771 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.696 ' HG3' ' O ' ' A' ' 107' ' ' SER . 30.2 mtt85 178.59 -79.87 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -171.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.957 ' HB2' HD12 ' A' ' 138' ' ' ILE . 13.2 p 48.51 110.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 174.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.842 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 3.9 mm -94.41 134.25 32.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.76 174.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 1.032 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -124.06 108.42 12.33 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.745 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.654 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 13.8 mm -94.55 92.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 1.032 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.5 OUTLIER -105.87 143.16 17.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.047 -174.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.839 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 31.4 t -103.61 126.36 50.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.703 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.772 ' HB2' ' HB2' ' A' ' 129' ' ' PRO . 26.3 tptp -118.55 98.77 6.41 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 52.3 26.77 4.25 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -166.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.839 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 66.5 t30 79.01 39.72 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.851 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 12.6 pt-20 -111.94 92.47 4.04 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.965 0.888 . . . . 0.0 108.934 161.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.673 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 24.8 mt-30 -66.4 126.63 29.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.585 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.654 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.5 m-85 -118.8 161.65 19.78 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.543 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.0 p -102.98 99.16 9.04 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 122.086 0.946 . . . . 0.0 110.922 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.542 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 22.8 mmt180 -107.74 -159.24 0.68 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.531 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.619 ' HA2' ' CD1' ' A' ' 138' ' ' ILE . . . 165.33 179.94 39.43 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.857 -174.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.713 HG11 ' HB2' ' A' ' 106' ' ' ASP . 25.4 t -52.53 121.83 2.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 114.183 -1.009 . . . . 0.0 109.924 168.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.798 ' HA ' ' HE3' ' A' ' 134' ' ' LYS . 5.1 m-20 78.52 21.55 0.78 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.546 1.165 . . . . 0.0 109.747 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 123' ' ' GLY . 3.6 mm-40 -117.06 158.93 23.33 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.96 -1.927 . . . . 0.0 106.42 167.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.876 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 40.1 mt-10 -113.22 148.91 34.54 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 118.17 0.441 . . . . 0.0 110.38 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.757 HG22 ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -58.74 147.77 70.32 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.755 -177.58 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.772 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 6.0 Cg_exo -58.79 130.95 39.32 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.811 2.341 . . . . 0.0 112.188 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.542 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 94.99 -63.5 1.48 Allowed Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 116.086 -0.507 . . . . 0.0 112.765 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.42 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 14.6 m-85 -109.31 148.07 31.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -76.15 49.83 0.58 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.676 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -84.58 97.56 9.66 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.876 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . 5.7 tptm -79.8 123.04 27.36 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-O 121.324 0.583 . . . . 0.0 111.373 -171.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.621 HG12 HG11 ' A' ' 143' ' ' VAL . 71.2 mt -75.68 93.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.603 HG22 ' HG3' ' A' ' 134' ' ' LYS . 2.1 t -87.97 -10.53 10.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.585 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.2 OUTLIER -157.08 117.35 3.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.984 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.957 HD12 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -87.45 131.42 35.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.139 178.355 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 13.1 mmt180 -141.45 151.15 60.11 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -19.41 -77.68 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 125.261 3.974 . . . . 0.0 114.767 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.553 ' HA ' HD23 ' A' ' 97' ' ' LEU . 4.4 p-10 -125.05 36.86 4.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.467 1.127 . . . . 0.0 109.034 168.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.824 ' HD2' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -131.45 138.15 48.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.006 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.67 HG23 HD21 ' A' ' 97' ' ' LEU . 3.2 t -144.74 121.71 4.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 122.044 0.925 . . . . 0.0 112.131 -176.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.806 HG22 HG22 ' A' ' 153' ' ' VAL . 37.4 t -79.21 102.18 5.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.876 HD11 HD22 ' A' ' 154' ' ' LEU . 1.8 pp -120.12 152.0 38.25 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.103 0.954 . . . . 0.0 113.294 -169.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.565 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 1.4 tp-100 -100.23 102.86 14.26 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.716 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.504 ' HD2' ' HB2' ' A' ' 133' ' ' ALA . 0.4 OUTLIER -136.78 135.16 37.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.15 -1.386 . . . . 0.0 107.529 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.419 HE21 ' HB2' ' A' ' 148' ' ' GLN . 0.0 OUTLIER 70.39 32.19 2.83 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.673 0.389 . . . . 0.0 111.274 174.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.84 1.96 87.84 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.027 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.775 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 20.1 tpp180 -130.31 143.49 50.81 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 34.6 p90 -119.84 108.94 14.98 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 122.278 1.037 . . . . 0.0 108.523 175.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.775 ' HG2' ' HG3' ' A' ' 150' ' ' ARG . 51.1 mm-40 -125.79 -170.41 2.18 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.646 -173.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.824 HG13 ' HD2' ' A' ' 142' ' ' ARG . 2.9 t -102.25 101.84 12.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.843 0.83 . . . . 0.0 109.985 -169.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.903 HD21 ' H ' ' A' ' 93' ' ' LEU . 4.7 tp -112.23 118.19 34.63 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.54 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.448 ' HA3' ' NH1' ' A' ' 142' ' ' ARG . . . -102.96 58.27 0.56 Allowed Glycine 0 C--N 1.308 -0.98 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.553 169.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.836 HD12 HD13 ' A' ' 97' ' ' LEU . 2.3 mt -37.67 104.74 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.687 0 O-C-N 124.52 0.777 . . . . 0.0 110.214 174.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 91.2 t80 . . . . . 0 C--N 1.329 -0.312 0 O-C-N 121.524 -0.735 . . . . 0.0 109.544 -178.117 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.781 ' HG2' ' HB3' ' A' ' 152' ' ' GLU . 73.4 Cg_endo . . . . . 0 CA--C 1.532 0.39 0 CA-C-O 119.554 -0.269 . . . . 0.0 111.675 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.849 ' HB3' ' HG ' ' A' ' 154' ' ' LEU . 22.8 t 53.21 -101.8 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 117.878 0.308 . . . . 0.0 110.677 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.791 HG23 HD11 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -127.94 -34.67 2.13 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.475 0.58 . . . . 0.0 112.46 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.65 ' H ' HD11 ' A' ' 154' ' ' LEU . 47.2 tp 59.68 107.48 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.335 0.588 . . . . 0.0 111.993 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.463 ' H ' HD23 ' A' ' 156' ' ' LEU . 2.4 p-10 -176.54 -157.05 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.781 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.4 OUTLIER 55.23 174.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 173.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.1 t -126.67 117.31 22.48 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.749 163.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.749 HD23 HG23 ' A' ' 113' ' ' ILE . 11.5 mt -77.23 125.51 29.44 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.458 HG21 ' OE1' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -91.53 -33.8 15.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.21 154.43 6.17 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.088 162.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.633 ' HB ' HD11 ' A' ' 138' ' ' ILE . 3.4 m -104.17 146.8 11.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 122.303 1.049 . . . . 0.0 110.799 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.632 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 65.6 mtt -105.75 91.58 3.81 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.176 -1.829 . . . . 0.0 108.782 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.31 129.59 42.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.55 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -114.6 94.85 0.7 Allowed Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 1.3 m-20 73.92 -53.81 0.69 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -169.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.766 ' O ' ' HB3' ' A' ' 109' ' ' SER . 25.8 t70 178.95 -90.01 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.692 -1.594 . . . . 0.0 107.466 168.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.829 ' HB2' HG21 ' A' ' 124' ' ' VAL . 13.3 p-10 -91.11 -38.85 12.5 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.16 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.446 ' C ' ' HD2' ' A' ' 108' ' ' ARG . 2.7 m -49.3 -55.89 11.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.195 -172.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.537 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 5.3 mmm180 -120.48 34.77 5.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.134 0.493 . . . . 0.0 109.902 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.862 ' HB2' HD13 ' A' ' 138' ' ' ILE . 19.1 p -76.35 141.87 41.38 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -168.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 10.2 mm -120.94 84.16 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 121.87 0.843 . . . . 0.0 111.273 -176.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.651 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -74.2 102.63 4.35 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.26 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 3.2 mm -87.04 96.19 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.749 HG23 HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -103.29 144.58 13.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.689 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.796 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 31.2 t -105.31 120.28 41.17 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.6 ' HE3' ' HA3' ' A' ' 130' ' ' GLY . 23.9 tptp -123.45 110.41 15.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -174.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.07 17.29 7.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -168.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.796 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 2.8 t-20 73.98 35.53 0.78 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.913 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -104.82 101.33 10.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 164.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 15.6 mt-30 -67.2 120.99 14.68 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.34 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 5.7 t80 -120.21 143.41 48.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.819 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.3 p -87.14 95.42 9.95 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.396 1.093 . . . . 0.0 111.119 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.51 ' HD3' ' HB3' ' A' ' 126' ' ' GLU . 13.6 mmt180 -103.57 -157.48 0.61 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.569 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.883 ' HA2' HD12 ' A' ' 138' ' ' ILE . . . 162.28 -174.64 38.73 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 119.87 -1.157 . . . . 0.0 112.17 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 106' ' ' ASP . 2.1 t -56.62 122.72 6.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.134 -1.033 . . . . 0.0 109.639 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.505 ' HA ' ' CE ' ' A' ' 134' ' ' LYS . 7.7 m-20 75.29 35.16 0.59 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.969 1.366 . . . . 0.0 108.223 176.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HB3' ' HD3' ' A' ' 122' ' ' ARG . 4.8 mm-40 -133.8 144.88 49.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 111.985 -2.37 . . . . 0.0 106.81 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.571 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 34.7 mt-10 -103.34 132.56 49.5 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.196 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.628 HG21 HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -61.15 140.1 94.31 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.071 -176.271 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.709 ' O ' HD21 ' A' ' 95' ' ' LEU . 23.8 Cg_exo -64.77 142.67 77.39 Favored 'Trans proline' 0 C--O 1.223 -0.227 0 C-N-CA 123.094 2.529 . . . . 0.0 112.442 -167.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.6 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 97.06 -43.21 2.05 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.585 ' HB3' ' CE1' ' A' ' 147' ' ' TYR . 62.1 m-85 -114.11 170.13 8.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -96.43 46.44 1.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 170.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.688 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -85.81 97.52 10.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.571 ' CA ' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -81.81 104.61 12.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.715 -169.52 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 123' ' ' GLY . 70.8 mt -52.3 94.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.83 0.824 . . . . 0.0 110.106 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 145' ' ' LEU . 3.4 m -83.38 -3.78 7.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.517 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.827 ' HB3' ' HB ' ' A' ' 144' ' ' VAL . 3.6 t -168.71 117.4 0.7 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.905 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.883 HD12 ' HA2' ' A' ' 123' ' ' GLY . 7.1 tt -97.2 135.88 29.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.735 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.717 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 17.1 mmt180 -141.44 157.5 65.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 141' ' ' ASP . 60.2 Cg_exo -18.94 -82.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.013 1 C-N-CA 125.579 4.186 . . . . 0.0 115.05 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.465 ' C ' HD13 ' A' ' 97' ' ' LEU . 7.7 p-10 -133.21 40.19 3.21 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 123.471 1.605 . . . . 0.0 107.438 167.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.717 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -126.57 139.2 53.38 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 111.642 -2.526 . . . . 0.0 107.154 169.028 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.544 ' N ' ' HD3' ' A' ' 142' ' ' ARG . 1.1 t -137.07 160.33 36.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.133 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.954 HG22 HG12 ' A' ' 153' ' ' VAL . 13.9 t -120.33 117.16 52.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 165.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.843 HD11 HD12 ' A' ' 154' ' ' LEU . 2.2 pp -132.5 162.49 31.08 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.765 0.793 . . . . 0.0 111.956 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 1.7 tp-100 -109.97 108.91 19.33 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.65 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 131' ' ' TYR . 76.9 t80 -135.86 141.32 44.61 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.577 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.484 ' HB3' ' CD2' ' A' ' 147' ' ' TYR . 0.1 OUTLIER 59.11 22.38 10.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 169.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 98.6 -1.39 58.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.57 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.461 ' HG2' ' HG2' ' A' ' 148' ' ' GLN . 13.2 ptp180 -130.19 137.62 50.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.372 0.586 . . . . 0.0 111.875 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 16.5 p90 -114.7 108.22 16.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.391 1.091 . . . . 0.0 108.477 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.781 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 52.6 mt-10 -139.45 -170.42 2.9 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.443 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.954 HG12 HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -96.34 99.65 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 122.006 0.908 . . . . 0.0 110.208 -168.267 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.849 ' HG ' ' HB3' ' A' ' 91' ' ' SER . 0.4 OUTLIER -101.99 106.82 17.79 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.704 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -98.98 53.11 1.08 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 173.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.781 HD22 ' HB2' ' A' ' 95' ' ' LEU . 3.9 mt -32.36 115.22 0.17 Allowed 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.907 1.004 . . . . 0.0 110.69 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.4 p90 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -172.168 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.846 ' HG2' ' HB3' ' A' ' 152' ' ' GLU . 6.3 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 CA-C-O 119.773 -0.178 . . . . 0.0 112.118 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.635 ' HB2' HD13 ' A' ' 154' ' ' LEU . 70.5 m 56.83 -86.63 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.614 0.765 . . . . 0.0 112.179 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.577 HG23 HD21 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -160.97 -44.67 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.831 -0.543 . . . . 0.0 112.381 -176.331 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.945 ' H ' HD21 ' A' ' 154' ' ' LEU . 6.5 tt 51.54 112.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.708 ' H ' HD23 ' A' ' 156' ' ' LEU . 2.3 p-10 -167.48 -56.81 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.853 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -54.71 176.34 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 122.95 0.5 . . . . 0.0 111.154 176.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.492 ' HB3' ' OG ' ' A' ' 114' ' ' SER . 1.5 t -117.59 109.93 17.29 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.292 170.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.718 ' HA ' HG23 ' A' ' 113' ' ' ILE . 1.9 mp -73.23 115.95 13.19 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 170.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -35.7 26.14 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.51 169.83 31.55 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.745 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 111' ' ' ALA . 2.3 t -130.11 126.55 62.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.904 0.859 . . . . 0.0 110.889 -175.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.88 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 64.8 mtt -92.0 89.98 7.21 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.583 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.11 121.52 14.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.731 -175.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.579 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -114.04 100.37 1.03 Allowed Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -172.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.579 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 10.5 t70 74.4 -64.67 0.38 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -170.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 109' ' ' SER . 7.0 m-20 -169.37 -91.52 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.942 -1.935 . . . . 0.0 106.519 169.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.653 ' HA ' HG21 ' A' ' 124' ' ' VAL . 12.5 p-10 -91.87 -30.75 15.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.665 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 t -60.07 -57.18 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.464 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 4.4 mmm180 -111.58 28.9 8.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.367 0.603 . . . . 0.0 110.067 -170.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.809 ' HB2' HD13 ' A' ' 138' ' ' ILE . 22.5 p -73.02 135.8 44.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.685 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.88 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 6.4 mm -120.39 89.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.393 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.939 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -78.64 100.95 7.22 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.921 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.5 mm -86.3 93.18 3.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.939 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -106.86 159.93 6.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.235 -176.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 26.4 p -125.82 135.48 52.02 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-O 121.308 0.575 . . . . 0.0 109.54 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.9 tptp -119.21 108.39 14.59 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 59.25 20.43 8.54 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -167.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 66.7 t30 79.74 37.19 0.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 113.435 -1.711 . . . . 0.0 111.666 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 16.6 pt-20 -107.4 101.77 11.1 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.963 0.887 . . . . 0.0 109.626 166.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.709 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.2 mt-30 -67.24 135.89 54.11 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -142.81 146.15 33.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.737 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -88.07 103.11 15.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.924 0.869 . . . . 0.0 111.552 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.519 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 21.9 mmt180 -107.42 -159.62 0.7 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.682 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.691 ' HA2' HD12 ' A' ' 138' ' ' ILE . . . 174.94 173.64 40.93 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -175.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 106' ' ' ASP . 16.7 t -49.39 132.59 7.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 165.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.562 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 3.2 m-20 72.29 19.55 4.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.459 1.123 . . . . 0.0 109.574 175.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.519 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 0.4 OUTLIER -120.64 158.04 28.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.145 -1.843 . . . . 0.0 106.347 167.207 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.744 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 41.6 mt-10 -104.2 156.89 17.52 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 118.435 0.561 . . . . 0.0 110.116 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.742 HG22 ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -66.4 145.2 98.95 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.553 178.345 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.788 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 21.7 Cg_exo -52.98 130.69 39.1 Favored 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 122.847 2.364 . . . . 0.0 112.009 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.538 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 96.6 -59.06 1.29 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.633 176.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.468 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 27.0 m-85 -113.63 153.66 28.51 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 121.434 -0.106 . . . . 0.0 111.036 -174.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -74.81 44.76 0.23 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.673 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -83.06 90.4 7.03 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 170.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -80.49 120.83 24.99 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.472 -170.438 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.663 HG12 HG11 ' A' ' 143' ' ' VAL . 74.4 mt -68.62 94.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.412 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.742 HG22 ' HE2' ' A' ' 134' ' ' LYS . 1.5 t -88.59 -3.77 9.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.732 0.777 . . . . 0.0 108.965 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.474 ' HB3' HG23 ' A' ' 144' ' ' VAL . 1.7 t -162.38 115.32 1.71 Allowed 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.492 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.809 HD13 ' HB2' ' A' ' 109' ' ' SER . 3.5 tt -88.98 132.93 32.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.069 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 7.4 mmt180 -141.89 159.23 60.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -22.63 -78.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 125.093 3.862 . . . . 0.0 114.474 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.4 ' HA ' HD23 ' A' ' 97' ' ' LEU . 9.5 p-10 -128.33 39.53 3.81 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.398 1.094 . . . . 0.0 108.715 169.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.531 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 1.9 tpp180 -136.93 143.35 42.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.73 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.663 HG11 HG12 ' A' ' 135' ' ' ILE . 4.8 t -148.41 119.33 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.83 -176.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 1.076 HG22 HG13 ' A' ' 153' ' ' VAL . 7.1 t -79.04 65.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 1.9 pp -82.63 167.92 17.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.022 -175.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.619 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -112.57 124.39 52.43 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.577 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.559 ' HD2' ' HB2' ' A' ' 133' ' ' ALA . 0.3 OUTLIER -145.27 140.04 27.53 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.469 ' N ' ' HD1' ' A' ' 147' ' ' TYR . 0.0 OUTLIER 67.91 28.94 6.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.966 0.412 . . . . 0.0 109.942 176.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.15 8.43 87.44 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.605 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 0.3 OUTLIER -132.61 139.78 47.93 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 117.247 0.523 . . . . 0.0 110.905 -173.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.719 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 13.3 p90 -118.94 111.96 19.01 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.106 0.955 . . . . 0.0 109.392 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.846 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 34.6 mt-10 -134.94 -175.9 4.06 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.161 -177.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 1.076 HG13 HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -96.24 99.27 8.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 119.676 -0.809 . . . . 0.0 110.233 -165.17 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.945 HD21 ' H ' ' A' ' 93' ' ' LEU . 6.0 tp -103.66 119.55 39.14 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.384 -0.825 . . . . 0.0 113.163 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -104.29 54.86 0.62 Allowed Glycine 0 C--N 1.304 -1.204 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 168.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.708 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.5 mt -36.51 107.25 0.06 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.39 0.7 . . . . 0.0 110.101 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 19.7 t80 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.746 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.759 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.6 Cg_exo . . . . . 0 CA--C 1.534 0.496 0 N-CA-C 111.005 -0.421 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.869 ' HB2' ' HB2' ' A' ' 152' ' ' GLU . 9.1 t 51.23 -137.98 1.11 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.211 0.205 . . . . 0.0 111.121 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.443 ' HB ' ' CD2' ' A' ' 147' ' ' TYR . 4.9 t -95.53 -37.85 10.69 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.677 ' HA ' HD11 ' A' ' 154' ' ' LEU . 31.7 tp 49.59 68.47 0.73 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.862 ' H ' HD23 ' A' ' 156' ' ' LEU . 15.7 t-20 -174.04 100.59 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.894 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER 164.44 -167.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 175.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.508 ' HB2' ' OG ' ' A' ' 114' ' ' SER . 49.9 m -132.01 103.75 6.45 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.606 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.926 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -83.25 74.14 10.05 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -37.72 -46.67 0.92 Allowed 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 140' ' ' PRO . . . 161.54 152.47 6.67 Favored Glycine 0 CA--C 1.486 -1.775 0 C-N-CA 119.121 -1.514 . . . . 0.0 112.358 172.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 111' ' ' ALA . 4.7 m -104.59 143.21 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 121.659 0.743 . . . . 0.0 110.021 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.863 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 87.1 mmm -90.86 86.33 6.27 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.754 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -65.61 119.69 11.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.945 -176.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -114.7 102.45 1.17 Allowed Glycine 0 CA--C 1.498 -1.022 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -171.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 2.6 m-20 72.22 -69.41 0.19 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -172.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -149.72 -111.89 0.06 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.092 170.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.495 ' OD2' HG11 ' A' ' 124' ' ' VAL . 5.8 m-20 -90.59 -13.13 35.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.739 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.3 t -64.44 -58.03 7.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.534 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -109.91 29.67 7.41 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.401 -173.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.754 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 2.6 t -85.52 141.65 29.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.247 0.546 . . . . 0.0 111.763 -170.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.863 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 10.7 mm -122.21 87.93 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.422 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.897 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -69.09 98.61 1.01 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.483 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.552 HG22 ' HG2' ' A' ' 119' ' ' GLN . 13.6 mm -87.33 90.03 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -101.79 132.84 46.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.759 -179.059 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.508 ' OG ' ' HB2' ' A' ' 96' ' ' SER . 2.7 p -99.41 135.21 41.16 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.04 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.776 ' HA ' HD21 ' A' ' 95' ' ' LEU . 24.3 tptp -122.69 110.87 16.04 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 61.71 21.51 12.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -166.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.3 t30 77.39 33.69 0.4 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.677 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 114' ' ' SER . 81.3 tt0 -101.6 96.78 7.34 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 170.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.552 ' HG2' HG22 ' A' ' 112' ' ' ILE . 3.8 mt-30 -67.5 108.62 2.9 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 5.2 t80 -110.13 141.99 42.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.927 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.9 p -90.19 95.12 10.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.807 0.813 . . . . 0.0 112.177 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.941 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 18.8 mmt180 -91.96 -160.07 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.492 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.638 ' N ' ' HG3' ' A' ' 126' ' ' GLU . . . 163.8 105.62 0.19 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.582 -168.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.752 HG22 ' HB ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -9.5 117.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 125.408 1.299 . . . . 0.0 113.23 -177.092 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.736 ' HB2' ' O ' ' A' ' 124' ' ' VAL . 5.9 m-20 88.59 27.48 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 124.999 1.437 . . . . 0.0 108.428 -167.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.941 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 5.1 mm-40 -124.75 147.49 48.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 112.833 -1.985 . . . . 0.0 107.891 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.565 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 50.9 mt-10 -105.41 140.25 38.81 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 156' ' ' LEU . 0.5 OUTLIER -57.18 154.77 19.59 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.23 -176.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 128' ' ' VAL . 15.5 Cg_exo -70.07 119.24 6.2 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.883 2.389 . . . . 0.0 112.279 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.583 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 99.21 -52.1 1.1 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.328 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.548 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 21.3 m-85 -104.34 132.57 50.44 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -79.27 52.57 1.35 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.571 1.078 . . . . 0.0 110.962 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.793 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -84.78 101.72 12.47 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -81.39 107.9 14.55 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.015 -171.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.1 mt -55.91 94.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 O-C-N 123.806 0.691 . . . . 0.0 109.834 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 151' ' ' TYR . 0.2 OUTLIER -88.19 -4.2 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.656 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -164.65 118.32 1.33 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.767 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.752 ' HB ' HG22 ' A' ' 124' ' ' VAL . 7.2 tt -92.88 128.79 44.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.552 0.691 . . . . 0.0 111.727 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.804 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 16.9 mmt180 -142.06 160.17 56.29 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.61 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 7.3 Cg_exo -25.49 -85.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 1 C-N-CA 126.14 4.56 . . . . 0.0 114.98 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.603 ' HA ' HD23 ' A' ' 97' ' ' LEU . 1.9 p30 -123.78 14.05 9.3 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.036 0.922 . . . . 0.0 109.08 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.804 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -115.25 142.72 46.3 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.704 169.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.533 ' N ' ' HG2' ' A' ' 142' ' ' ARG . 0.9 OUTLIER -137.89 170.48 17.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.851 177.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.811 HG22 HG12 ' A' ' 153' ' ' VAL . 40.7 t -122.1 97.98 5.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.793 HD13 ' HB1' ' A' ' 133' ' ' ALA . 1.2 pp -120.34 158.59 26.8 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.039 0.923 . . . . 0.0 112.847 -170.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 1.9 tp-100 -106.64 103.04 12.39 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.555 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.572 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 52.9 t80 -128.22 144.42 51.12 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.613 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER 59.38 29.31 18.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 171.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.24 5.24 89.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.133 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.657 ' HG2' ' HG2' ' A' ' 152' ' ' GLU . 66.5 ttt180 -133.32 138.47 46.39 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 117.071 0.435 . . . . 0.0 110.803 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 6.4 p90 -116.75 112.33 21.02 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.547 1.165 . . . . 0.0 108.812 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.869 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 76.5 mm-40 -128.87 -169.79 2.15 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.384 -174.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.811 HG12 HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -98.64 100.4 10.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.081 0.944 . . . . 0.0 108.475 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.677 HD11 ' HA ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -119.38 106.3 12.14 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.701 -172.224 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 142' ' ' ARG . . . -106.46 70.49 0.22 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.894 HD22 ' HB2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -37.06 124.14 0.91 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.604 0.762 . . . . 0.0 110.447 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.2 t80 . . . . . 0 C--N 1.331 -0.23 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -161.859 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.54 ' O ' HD13 ' A' ' 154' ' ' LEU . 2.8 Cg_exo . . . . . 0 CA--C 1.531 0.35 0 N-CA-C 111.364 -0.283 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.518 ' HB2' HD13 ' A' ' 154' ' ' LEU . 58.5 m 56.38 -83.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.895 0.478 . . . . 0.0 112.006 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.683 ' HB ' HE22 ' A' ' 148' ' ' GLN . 1.6 t -161.07 -41.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.544 -0.722 . . . . 0.0 112.336 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.809 ' H ' HD21 ' A' ' 154' ' ' LEU . 48.8 tp 56.2 99.77 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.717 ' H ' HD23 ' A' ' 156' ' ' LEU . 3.1 p-10 -160.07 -61.09 0.06 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.842 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -57.28 -178.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.415 0.626 . . . . 0.0 111.75 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.434 ' HB3' ' OG ' ' A' ' 114' ' ' SER . 9.6 t -117.28 119.85 36.43 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.621 170.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.963 HD23 HG23 ' A' ' 113' ' ' ILE . 53.4 mt -76.74 131.34 38.68 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 165.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.459 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.2 OUTLIER -92.27 -32.48 15.01 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 175.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.934 ' HA2' ' HB3' ' A' ' 141' ' ' ASP . . . 154.71 168.19 17.67 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.97 161.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.718 HG11 HG23 ' A' ' 138' ' ' ILE . 2.7 t -114.4 132.01 64.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.781 0.801 . . . . 0.0 110.91 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.842 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 67.1 mtt -104.17 87.41 2.75 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.21 177.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.81 46.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.4 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.753 ' H ' ' HA ' ' A' ' 109' ' ' SER . . . -106.62 88.14 0.54 Allowed Glycine 0 CA--C 1.496 -1.156 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 25.1 t70 74.85 -54.65 0.66 Allowed 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -169.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.672 ' O ' ' HB3' ' A' ' 109' ' ' SER . 12.7 t70 -178.97 -124.07 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.902 -1.499 . . . . 0.0 106.994 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.74 ' HA ' HG21 ' A' ' 124' ' ' VAL . 2.3 p-10 -80.9 -6.59 58.85 Favored 'General case' 0 CA--C 1.522 -0.101 0 O-C-N 124.184 0.928 . . . . 0.0 109.939 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.1 t -60.46 -42.5 96.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.164 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 78.7 mtp180 -126.2 -65.61 0.97 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.421 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.753 ' HA ' ' H ' ' A' ' 103' ' ' GLY . 13.7 p 53.58 127.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 174.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.842 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 3.6 mm -116.9 129.92 72.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.329 174.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.927 ' HB2' HD11 ' A' ' 138' ' ' ILE . . . -120.69 98.42 6.01 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.802 0.335 . . . . 0.0 111.653 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.5 mm -80.33 94.54 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.963 HG23 HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -105.82 142.62 18.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.718 177.224 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.434 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 84.5 p -113.66 129.18 56.61 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.846 0.832 . . . . 0.0 109.353 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.842 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.6 tptp -124.81 101.46 7.1 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -171.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 55.07 22.16 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -164.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.8 t-20 78.24 40.67 0.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.697 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 15.5 pt-20 -108.71 90.75 3.39 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.276 1.036 . . . . 0.0 108.292 161.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 34.9 mt-30 -67.22 124.19 22.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.524 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -128.69 147.98 50.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.993 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -97.3 105.12 17.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.616 0.722 . . . . 0.0 111.532 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.982 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 28.1 mmt180 -95.2 -163.05 1.0 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.316 176.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.616 ' O ' ' HG2' ' A' ' 126' ' ' GLU . . . 164.74 110.88 0.24 Allowed Glycine 0 C--O 1.216 -1.001 0 C-N-CA 119.738 -1.22 . . . . 0.0 114.088 -171.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.74 HG21 ' HA ' ' A' ' 106' ' ' ASP . 28.1 t 4.85 115.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.152 1.381 . . . . 0.0 114.452 -175.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.705 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 4.7 m-20 80.8 35.48 0.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.313 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.982 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 13.1 mm-40 -127.31 150.72 49.45 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.781 170.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 2.3 mp0 -101.39 150.84 22.6 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 118.571 0.623 . . . . 0.0 109.861 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.619 HG22 HG21 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -62.35 151.72 81.56 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.493 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.565 ' HD2' HG22 ' A' ' 128' ' ' VAL . 3.6 Cg_exo -62.94 127.52 20.62 Favored 'Trans proline' 0 C--N 1.332 -0.292 0 C-N-CA 122.953 2.435 . . . . 0.0 112.37 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.62 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 100.48 -64.1 0.59 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.353 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.51 ' HE2' HD12 ' A' ' 95' ' ' LEU . 4.3 m-85 -110.73 140.56 45.01 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -78.87 56.37 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.538 0.608 . . . . 0.0 111.831 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.727 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -79.88 96.97 6.51 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.705 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.5 OUTLIER -81.13 115.91 20.79 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.256 0.551 . . . . 0.0 110.911 -169.394 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.58 HG21 HG13 ' A' ' 138' ' ' ILE . 74.7 mt -67.47 94.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.401 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.634 HG22 ' HE2' ' A' ' 134' ' ' LYS . 1.3 t -86.62 -6.57 10.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.723 ' CB ' ' HB ' ' A' ' 144' ' ' VAL . 4.1 t -157.15 117.12 3.46 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.125 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.927 HD11 ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -91.55 125.99 44.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.991 0.9 . . . . 0.0 111.238 176.34 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.6 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 13.5 mmt85 -142.11 148.96 50.48 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.647 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.29 81.2 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.628 2.218 . . . . 0.0 113.67 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.934 ' HB3' ' HA2' ' A' ' 99' ' ' GLY 0.279 2.9 p30 75.62 27.0 1.05 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.868 1.667 . . . . 0.0 110.17 170.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.703 ' HD2' ' N ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -139.72 151.32 45.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 112.255 -2.248 . . . . 0.0 106.204 157.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.703 ' N ' ' HD2' ' A' ' 142' ' ' ARG . 7.2 t -141.21 164.89 19.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-O 121.526 0.679 . . . . 0.0 111.395 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 153' ' ' VAL . 59.1 t -122.12 100.45 8.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.727 HD13 ' HB1' ' A' ' 133' ' ' ALA . 2.0 pp -122.56 156.56 33.94 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 122.21 1.005 . . . . 0.0 113.223 -168.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -103.46 104.58 14.68 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 112.533 -2.121 . . . . 0.0 108.581 -174.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.505 ' CD2' HG21 ' A' ' 92' ' ' THR . 0.4 OUTLIER -136.54 135.5 38.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.711 175.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.683 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.8 mp0 67.93 34.34 4.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.46 175.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.55 12.81 70.56 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.729 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.472 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 29.2 ttp180 -130.95 137.43 49.28 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.792 -0.24 . . . . 0.0 110.362 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.715 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 22.3 p90 -118.58 108.8 15.4 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.704 1.24 . . . . 0.0 109.313 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.1 mm-40 -129.02 -170.72 2.32 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.483 -1.69 . . . . 0.0 109.179 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 144' ' ' VAL . 3.5 t -97.17 105.54 17.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.184 0.516 . . . . 0.0 109.903 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.809 HD21 ' H ' ' A' ' 93' ' ' LEU . 6.1 tp -108.17 121.2 44.36 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.488 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -108.14 59.26 0.37 Allowed Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 167.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.717 HD23 ' H ' ' A' ' 94' ' ' ASN . 1.5 mt -36.46 109.73 0.1 Allowed 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.269 0.629 . . . . 0.0 109.521 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.4 t80 . . . . . 0 C--N 1.329 -0.299 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -172.269 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 CA--C 1.534 0.493 0 N-CA-C 114.718 1.007 . . . . 0.0 114.718 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.657 ' HB3' HD23 ' A' ' 154' ' ' LEU . 46.5 t -61.63 -76.43 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.13 0.423 . . . . 0.0 111.624 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.841 ' H ' HD21 ' A' ' 154' ' ' LEU . 2.7 t -127.7 -45.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.835 ' H ' HD11 ' A' ' 154' ' ' LEU . 45.6 tp 59.06 86.07 0.09 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.308 0.575 . . . . 0.0 111.889 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.681 ' H ' HD23 ' A' ' 156' ' ' LEU . 5.9 t-20 -160.42 -149.5 0.19 Allowed 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.027 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.5 OUTLIER 51.71 177.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 172.356 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.8 m -137.23 115.55 11.81 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.221 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.938 HD23 HG23 ' A' ' 113' ' ' ILE . 12.0 mt -74.97 143.16 43.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 174.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -33.2 10.84 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 147.05 154.22 6.14 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 162.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 111' ' ' ALA . 13.6 m -103.69 144.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 122.654 1.216 . . . . 0.0 112.011 -173.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.748 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 65.3 mmm -97.73 89.5 4.65 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.374 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.791 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -64.74 134.64 54.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.788 0.327 . . . . 0.0 110.857 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -125.27 89.3 0.38 Allowed Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 28.9 t70 71.32 -57.81 0.59 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -166.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.63 ' O ' ' HB2' ' A' ' 109' ' ' SER . 20.8 t70 -173.88 -87.24 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.263 -1.789 . . . . 0.0 107.846 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.889 ' HA ' HG21 ' A' ' 124' ' ' VAL . 5.6 t70 -91.5 -46.6 7.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.492 -175.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.9 t -55.13 -40.64 70.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.41 -167.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -130.26 26.7 5.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.552 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.791 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 7.8 t -92.03 140.79 29.3 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.007 -172.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.748 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 8.0 mm -117.66 91.28 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.611 -174.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.974 ' HB2' HD11 ' A' ' 138' ' ' ILE . . . -72.75 96.8 2.09 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.267 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 4.5 mm -79.84 93.71 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.938 HG23 HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -101.86 154.12 5.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.87 175.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.474 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 14.5 p -121.09 126.13 49.02 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.709 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 24.5 tptp -117.24 105.21 11.96 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -171.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 58.43 24.7 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -163.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 15.3 t-20 68.9 40.25 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 112.002 -2.363 . . . . 0.0 112.161 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.709 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 12.4 pt-20 -102.26 103.09 13.55 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 162.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 4.8 mt-30 -68.17 131.48 45.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.489 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 7.9 t80 -135.96 144.3 45.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.448 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.6 p -88.9 94.78 10.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 122.057 0.932 . . . . 0.0 111.22 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.494 ' CB ' ' HB3' ' A' ' 111' ' ' ALA . 16.0 mmt180 -98.56 -159.53 0.74 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.049 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 126' ' ' GLU . . . 178.9 161.74 27.1 Favored Glycine 0 N--CA 1.408 -3.205 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.995 HG22 ' HB ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -57.12 128.04 17.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 165.401 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.668 ' HB2' ' O ' ' A' ' 124' ' ' VAL . 5.5 m-20 81.14 28.58 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.482 1.134 . . . . 0.0 109.057 -176.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 123' ' ' GLY . 1.2 mm-40 -132.65 153.29 51.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 112.596 -2.093 . . . . 0.0 107.664 170.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 41.4 mt-10 -104.83 145.61 30.15 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.716 HG21 HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -62.65 153.87 76.5 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.486 -174.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.633 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 23.7 Cg_exo -66.37 126.92 16.41 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.569 2.18 . . . . 0.0 111.787 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.676 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 103.91 -57.89 0.53 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.06 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 147' ' ' TYR . 34.1 m-85 -111.92 149.62 31.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.957 -0.121 . . . . 0.0 110.743 -176.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -75.97 53.77 0.79 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.089 0.471 . . . . 0.0 111.778 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.643 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -90.24 95.69 10.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.656 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.652 ' HE2' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -82.14 107.29 14.72 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.017 0.437 . . . . 0.0 110.846 -171.151 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.72 HG12 HG11 ' A' ' 143' ' ' VAL . 64.8 mt -54.07 94.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.357 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 144' ' ' VAL . 3.9 m -97.35 8.27 7.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.948 0.88 . . . . 0.0 108.815 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.775 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 5.7 m -165.41 114.81 1.04 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.079 176.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.995 ' HB ' HG22 ' A' ' 124' ' ' VAL . 1.1 tt -98.45 127.99 50.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.401 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 5.2 mmt180 -143.73 150.3 49.79 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -14.55 -74.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 1 C-N-CA 125.708 4.272 . . . . 0.0 114.974 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.44 ' C ' HD13 ' A' ' 97' ' ' LEU . 7.8 p-10 -138.98 47.73 1.91 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.247 1.022 . . . . 0.0 109.475 168.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.821 ' HD3' HG13 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -143.81 139.37 29.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.154 165.278 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.72 HG11 HG12 ' A' ' 135' ' ' ILE . 10.4 t -135.02 118.19 23.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.071 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 153' ' ' VAL . 9.2 t -80.48 62.23 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.136 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.705 HD11 ' HG ' ' A' ' 154' ' ' LEU . 1.7 pp -79.83 166.78 21.36 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -171.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -108.83 104.87 14.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 111.662 -2.517 . . . . 0.0 108.41 -177.035 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 131' ' ' TYR . 1.0 OUTLIER -139.3 133.48 31.27 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.458 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.573 ' OE1' ' HB ' ' A' ' 92' ' ' THR . 0.7 OUTLIER 70.39 32.83 2.66 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.471 0.482 . . . . 0.0 110.859 175.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.58 3.78 79.29 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.409 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.53 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 2.3 tpm_? -125.02 153.53 42.69 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.655 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 2.7 p90 -134.77 106.64 7.01 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.355 1.074 . . . . 0.0 108.229 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 81.0 mm-40 -134.62 -176.24 4.15 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.46 -169.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 144' ' ' VAL . 26.2 t -93.67 100.2 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.014 0.912 . . . . 0.0 108.724 -170.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.841 HD21 ' H ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -106.87 102.91 12.24 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 114.22 -1.354 . . . . 0.0 111.363 -175.78 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 142' ' ' ARG . . . -100.99 57.13 0.72 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.572 175.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 1.027 HD22 ' HB2' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -37.23 109.82 0.11 Allowed 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.385 0.697 . . . . 0.0 109.624 171.298 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 33.9 p90 . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 112.04 -164.892 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.46 ' HB2' ' H ' ' A' ' 91' ' ' SER . 4.0 Cg_exo . . . . . 0 N--CA 1.461 -0.395 0 CA-C-O 119.243 -0.399 . . . . 0.0 111.518 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.797 ' HB2' HD13 ' A' ' 154' ' ' LEU . 22.1 m 54.74 -79.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.898 ' HB ' HE22 ' A' ' 148' ' ' GLN . 0.1 OUTLIER -163.72 -44.56 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.124 -0.36 . . . . 0.0 111.216 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.967 ' H ' HD21 ' A' ' 154' ' ' LEU . 1.0 OUTLIER 52.48 99.78 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.046 0.451 . . . . 0.0 111.434 -177.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.753 ' H ' HD23 ' A' ' 156' ' ' LEU . 40.1 t-20 -157.63 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.002 -172.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.868 HD21 ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -56.77 174.65 0.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.374 179.152 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.4 t -121.58 118.98 30.59 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.557 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.547 ' HA ' HG23 ' A' ' 113' ' ' ILE . 6.0 mp -79.02 124.36 28.19 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.72 -29.85 22.1 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.01 173.64 30.92 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 169.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.966 HG22 ' HA ' ' A' ' 111' ' ' ALA . 2.4 t -129.75 126.84 63.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.558 0.694 . . . . 0.0 110.397 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.878 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -89.42 89.38 7.84 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.047 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.695 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -65.91 132.24 48.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.224 -174.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 108' ' ' ARG . . . -117.47 92.16 0.55 Allowed Glycine 0 CA--C 1.5 -0.868 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 -173.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.5 t0 69.53 -59.55 0.49 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.935 0.874 . . . . 0.0 108.784 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -156.83 -146.81 0.17 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.313 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.67 ' HB3' HG21 ' A' ' 124' ' ' VAL . 7.2 m-20 -56.53 -33.34 65.98 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.49 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.8 t -46.84 -56.3 6.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.435 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 22.7 mtp180 -119.49 30.49 7.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.611 -167.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.695 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 8.4 t -86.96 145.64 26.44 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.733 0.777 . . . . 0.0 112.133 -172.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.878 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 12.6 mm -114.3 92.5 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.404 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.966 ' HA ' HG22 ' A' ' 100' ' ' VAL . . . -73.86 101.46 3.77 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.399 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 28.8 mm -86.47 93.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.901 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -104.5 150.08 7.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.647 -177.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 64.6 p -116.05 130.56 56.87 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.133 0.492 . . . . 0.0 109.724 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.868 ' HA ' HD21 ' A' ' 95' ' ' LEU . 19.0 tptp -110.43 102.48 11.1 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 59.89 27.13 16.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 66.8 t30 81.21 33.25 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 112.453 -2.158 . . . . 0.0 110.854 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -106.12 97.39 7.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.657 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -66.61 135.89 54.79 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.594 -176.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 15.6 t80 -144.86 149.54 35.52 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.367 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.543 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 6.4 m -88.57 101.6 14.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.608 0.718 . . . . 0.0 111.169 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 122' ' ' ARG . 18.0 mmt180 -104.94 -160.13 0.74 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.828 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.458 ' HA2' HD12 ' A' ' 138' ' ' ILE . . . -179.31 169.47 40.66 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.115 -1.04 . . . . 0.0 111.461 -176.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.845 HG23 ' HB ' ' A' ' 138' ' ' ILE . 5.7 t -45.32 129.9 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 114.223 -0.988 . . . . 0.0 110.456 162.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.686 ' HA ' ' HD2' ' A' ' 134' ' ' LYS . 0.0 OUTLIER 69.09 14.75 8.76 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 124.749 1.281 . . . . 0.0 110.428 176.204 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -105.81 164.48 11.9 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 167.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.836 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 33.1 mt-10 -114.12 151.13 33.07 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 119.142 0.883 . . . . 0.0 110.018 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.614 HG22 HG21 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -59.13 143.42 84.54 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.048 0.451 . . . . 0.0 110.416 -176.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.625 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.1 Cg_exo -73.06 94.16 0.81 Allowed 'Trans proline' 0 C--O 1.222 -0.309 0 C-N-CA 123.244 2.63 . . . . 0.0 112.467 -170.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.474 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 132.76 -48.73 0.95 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.532 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 10.4 m-85 -112.65 137.7 50.53 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -73.91 46.75 0.24 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.897 0.772 . . . . 0.0 112.993 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.68 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -82.56 99.17 9.36 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 171.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.836 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -80.65 125.79 30.45 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-O 120.849 0.357 . . . . 0.0 110.939 -171.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.5 mt -77.23 89.93 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.601 HG22 ' HG3' ' A' ' 134' ' ' LYS . 1.3 t -85.11 -3.97 8.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 122.044 0.926 . . . . 0.0 108.641 -175.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.496 ' HB3' HG23 ' A' ' 144' ' ' VAL . 1.7 t -160.59 117.36 2.38 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.434 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.938 HD11 ' HB2' ' A' ' 111' ' ' ALA . 3.6 tt -94.92 133.51 35.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.495 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.574 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 17.0 mmt180 -141.79 162.85 44.21 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 170.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 139' ' ' ARG . 89.0 Cg_exo -25.22 -84.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.75 3.633 . . . . 0.0 114.635 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -116.64 29.81 7.71 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.154 0.978 . . . . 0.0 108.61 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.574 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 6.1 tpp85 -127.97 141.91 51.39 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.03 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.453 HG23 HD21 ' A' ' 97' ' ' LEU . 4.3 t -145.61 168.55 7.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.706 -175.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.956 HG22 HG23 ' A' ' 153' ' ' VAL . 19.5 t -129.84 62.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.798 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 1.5 pp -82.38 155.27 24.79 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -165.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 134' ' ' LYS . 5.0 tp-100 -99.91 104.42 16.06 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 111.937 -2.392 . . . . 0.0 108.586 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.859 ' HD2' HG21 ' A' ' 92' ' ' THR . 0.6 OUTLIER -141.83 132.95 26.21 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.487 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.898 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.8 mt-30 67.59 28.18 7.55 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.405 0.44 . . . . 0.0 110.774 175.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.32 -2.91 85.41 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 119.809 -1.186 . . . . 0.0 112.698 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.401 ' HD2' ' OE2' ' A' ' 152' ' ' GLU . 28.5 ptt180 -126.26 145.51 50.38 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.576 -0.367 . . . . 0.0 111.242 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.798 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 6.4 p90 -122.76 109.96 14.87 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 171.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.455 ' OE2' ' HB2' ' A' ' 90' ' ' PRO . 36.7 mt-10 -127.33 -175.47 3.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.956 HG23 HG22 ' A' ' 144' ' ' VAL . 6.0 p -95.99 98.72 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-O 122.835 1.302 . . . . 0.0 110.155 -165.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.967 HD21 ' H ' ' A' ' 93' ' ' LEU . 10.0 tp -106.81 116.22 31.55 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.36 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.567 ' O ' ' HD2' ' A' ' 157' ' ' TYR . . . -99.57 61.06 0.75 Allowed Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.952 167.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.753 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.7 mt -36.38 111.61 0.15 Allowed 'General case' 0 N--CA 1.485 1.306 0 O-C-N 124.325 0.662 . . . . 0.0 109.748 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.567 ' HD2' ' O ' ' A' ' 155' ' ' GLY . 51.3 p90 . . . . . 0 C--O 1.234 0.248 0 CA-C-N 118.19 0.45 . . . . 0.0 110.45 -172.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.6 ' O ' HD21 ' A' ' 154' ' ' LEU . 33.6 Cg_exo . . . . . 0 CA--C 1.536 0.597 0 CA-C-O 119.556 -0.269 . . . . 0.0 111.99 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.671 ' HB2' ' HG ' ' A' ' 154' ' ' LEU . 60.0 m 53.46 -83.03 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.54 0.336 . . . . 0.0 110.992 -170.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.742 HG23 HD11 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -156.04 -49.51 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 119.491 -0.29 . . . . 0.0 111.037 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 156' ' ' LEU . 46.0 tp 54.17 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.504 0.502 . . . . 0.0 111.663 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.683 ' H ' HD23 ' A' ' 156' ' ' LEU . 26.5 t-20 -162.5 -60.21 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.024 0.44 . . . . 0.0 111.669 -175.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.847 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -56.34 175.96 0.1 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.124 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.7 t -114.98 108.5 16.79 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.028 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.836 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -73.22 117.33 14.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 171.341 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.491 HG21 ' OE1' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -91.18 -34.53 14.98 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -173.114 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 158.51 141.17 3.08 Favored Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.783 171.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.598 HG21 HG23 ' A' ' 138' ' ' ILE . 12.1 m -102.39 147.85 8.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.77 0.795 . . . . 0.0 109.689 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.866 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 67.5 mtt -104.03 90.69 3.68 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.024 176.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.59 120.95 9.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.777 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.598 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -110.98 97.96 1.01 Allowed Glycine 0 CA--C 1.492 -1.367 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -174.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.598 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 3.6 m-20 73.42 -66.03 0.33 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -173.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.539 ' O ' ' HB3' ' A' ' 109' ' ' SER . 8.3 m-20 -162.29 -102.64 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.692 -1.594 . . . . 0.0 107.594 167.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.693 ' HB2' HG21 ' A' ' 124' ' ' VAL . 6.5 p-10 -91.73 -20.2 21.8 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.35 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.45 ' C ' ' HD3' ' A' ' 108' ' ' ARG . 14.5 m -61.87 -47.01 86.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.077 -174.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.45 ' HD3' ' C ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -123.79 19.89 9.35 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.053 -168.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.66 ' HB2' HD12 ' A' ' 138' ' ' ILE . 2.8 p -66.77 147.29 53.45 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.324 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.866 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 5.5 mm -126.94 84.74 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-O 121.783 0.802 . . . . 0.0 110.862 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.865 ' HB3' ' HB2' ' A' ' 122' ' ' ARG . . . -72.93 96.92 2.18 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.404 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 9.9 mm -81.86 94.35 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.863 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -105.29 140.43 23.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.666 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.831 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 29.9 t -99.69 129.31 45.81 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.865 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.9 tptp -128.79 106.06 8.66 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.7 t70 62.52 18.57 10.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -169.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.831 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 64.8 t30 76.22 38.54 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.535 -175.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.506 ' HG2' ' CE1' ' A' ' 120' ' ' PHE . 31.1 tt0 -113.13 93.6 4.49 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.161 167.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 28.5 mt-30 -66.83 129.72 40.8 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.886 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.697 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 50.6 m-85 -119.88 150.34 40.63 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.306 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.499 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 6.2 m -94.23 99.16 11.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.712 0.768 . . . . 0.0 109.844 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.865 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 64.9 mmt-85 -89.61 -161.86 0.82 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.822 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.685 ' N ' ' HG2' ' A' ' 126' ' ' GLU . . . 161.11 95.59 0.11 Allowed Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.007 -1.092 . . . . 0.0 112.894 -163.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.693 HG21 ' HB2' ' A' ' 106' ' ' ASP . 2.2 t 4.55 123.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 126.563 1.978 . . . . 0.0 114.976 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.698 ' HA ' ' CE ' ' A' ' 134' ' ' LYS . 7.1 m-20 78.21 34.42 0.29 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.664 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.685 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 0.8 OUTLIER -124.04 167.08 14.67 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 112.669 -2.059 . . . . 0.0 107.844 168.874 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 1.9 mp0 -112.1 146.31 38.22 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.477 HG21 HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -61.66 153.72 69.52 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.479 ' O ' HD11 ' A' ' 95' ' ' LEU . 24.4 Cg_exo -66.04 127.84 18.45 Favored 'Trans proline' 0 C--N 1.333 -0.287 0 C-N-CA 122.424 2.083 . . . . 0.0 112.442 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.584 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 100.66 -59.78 0.67 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.209 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.622 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 10.9 m-85 -109.68 140.75 43.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.025 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -74.94 49.89 0.44 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.659 0.663 . . . . 0.0 111.789 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.705 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -80.64 96.68 6.94 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.752 ' HD2' ' C ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -80.49 108.96 14.55 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 121.044 0.45 . . . . 0.0 110.989 -168.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.652 HG12 HG11 ' A' ' 143' ' ' VAL . 50.5 mt -60.81 95.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.93 177.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.585 HG23 ' HA ' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -84.15 -8.63 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.081 179.09 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.683 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 39.4 m -157.49 116.18 3.22 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.435 -174.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.662 ' CD1' ' HB2' ' A' ' 111' ' ' ALA . 3.9 mt -92.61 127.91 44.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.598 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 28.0 mmt180 -141.2 151.62 62.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 173.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.411 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 78.0 Cg_exo -18.57 -75.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 1 C-N-CA 125.519 4.146 . . . . 0.0 114.776 -178.322 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.501 ' HA ' HD23 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -129.21 39.47 3.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.412 1.101 . . . . 0.0 108.797 168.093 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.593 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 8.2 tpp85 -136.06 143.56 44.73 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.835 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.729 HG23 HD21 ' A' ' 97' ' ' LEU . 3.4 t -141.67 169.25 14.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.534 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.85 HG22 HG12 ' A' ' 153' ' ' VAL . 18.3 t -133.58 61.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.786 HD11 HD12 ' A' ' 154' ' ' LEU . 1.9 pp -82.64 162.47 21.86 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -167.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.4 OUTLIER -105.73 105.49 15.56 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 112.556 -2.111 . . . . 0.0 108.232 -178.094 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.638 ' HD2' HG21 ' A' ' 92' ' ' THR . 0.7 OUTLIER -141.21 136.78 32.08 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.753 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.506 ' OE1' ' HB ' ' A' ' 92' ' ' THR . 4.7 mt-30 68.29 28.67 6.23 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.534 0.521 . . . . 0.0 110.998 173.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.35 3.25 78.79 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.71 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 20.4 ttt180 -133.31 144.69 49.84 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.78 -0.247 . . . . 0.0 111.065 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.709 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 11.0 p90 -115.88 107.84 15.53 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.438 1.113 . . . . 0.0 107.999 171.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.824 ' HG3' ' H ' ' A' ' 153' ' ' VAL . 10.2 tp10 -130.79 -173.18 3.01 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.546 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.85 HG12 HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -95.28 100.06 10.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.676 0.75 . . . . 0.0 111.015 -167.058 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.786 HD12 HD11 ' A' ' 145' ' ' LEU . 1.2 mt -101.35 109.44 21.29 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.672 176.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.437 ' O ' ' HD2' ' A' ' 157' ' ' TYR . . . -99.85 52.19 1.03 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.4 mt -35.77 117.68 0.45 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.673 0.866 . . . . 0.0 109.659 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.437 ' HD2' ' O ' ' A' ' 155' ' ' GLY . 45.6 p90 . . . . . 0 C--N 1.321 -0.661 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.718 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.9 Cg_exo . . . . . 0 CA--C 1.531 0.347 0 N-CA-C 111.854 -0.095 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.594 ' OG ' ' HB2' ' A' ' 152' ' ' GLU . 0.0 OUTLIER 47.91 -100.23 0.06 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.261 0.624 . . . . 0.0 112.049 -174.583 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.644 ' H ' HD11 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -138.45 -37.19 0.56 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.024 0.829 . . . . 0.0 112.541 -178.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.66 ' H ' ' CD1' ' A' ' 154' ' ' LEU . 1.3 tm? 66.57 -4.11 0.78 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.488 ' N ' HD23 ' A' ' 156' ' ' LEU . 4.0 t30 -103.96 97.61 7.57 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.623 -0.673 . . . . 0.0 112.572 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.746 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -179.97 179.01 0.57 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 177.704 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.537 ' H ' HD13 ' A' ' 95' ' ' LEU . 24.4 t -123.29 101.04 7.15 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 119.442 1.019 . . . . 0.0 110.345 173.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.894 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -81.23 75.46 8.19 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.133 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.586 HG21 ' OE1' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -40.31 -47.57 2.52 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 174.22 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 140' ' ' PRO . . . 160.33 153.45 6.94 Favored Glycine 0 CA--C 1.488 -1.595 0 C-N-CA 118.317 -1.897 . . . . 0.0 113.431 173.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.635 HG22 ' HA ' ' A' ' 140' ' ' PRO . 8.0 m -103.92 142.72 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-O 121.565 0.698 . . . . 0.0 109.64 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.846 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -98.48 87.42 3.84 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.81 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -56.18 135.21 53.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.878 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 105' ' ' ASP . . . -123.14 92.69 0.47 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.815 -176.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 t70 71.28 -40.57 0.48 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.239 1.015 . . . . 0.0 110.118 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 103' ' ' GLY . 4.3 t70 -178.88 -141.02 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.752 ' CB ' HG21 ' A' ' 124' ' ' VAL . 20.8 m-20 -67.07 -29.61 69.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.3 0.571 . . . . 0.0 109.605 167.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.5 t -52.86 -57.46 10.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.937 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.412 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 5.2 mmm180 -114.29 26.52 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.122 -173.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.81 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 1.6 t -76.47 152.29 36.19 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.781 0.324 . . . . 0.0 111.217 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.846 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 15.4 mm -123.69 85.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 122.059 0.933 . . . . 0.0 110.833 -176.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.883 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -70.85 99.52 1.76 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.95 -176.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 7.8 mm -88.29 91.72 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -100.8 137.74 27.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.904 -177.009 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 4.2 m -95.22 122.47 37.94 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.754 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.522 ' HE3' ' HA3' ' A' ' 130' ' ' GLY . 25.0 tptp -117.07 97.42 5.92 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 58.88 23.58 11.52 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -164.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 114' ' ' SER . 1.5 t30 75.98 38.8 0.33 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.912 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -99.26 92.88 5.65 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 161.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.586 ' OE1' HG21 ' A' ' 98' ' ' THR . 17.3 mt-30 -68.54 105.37 2.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.028 -173.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 6.7 t80 -106.67 133.82 50.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.863 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.6 p -85.31 98.89 10.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.307 1.051 . . . . 0.0 111.431 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.86 ' HB3' ' OE2' ' A' ' 126' ' ' GLU . 14.5 mmt180 -89.45 -161.89 0.82 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.392 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.588 ' N ' ' HG2' ' A' ' 126' ' ' GLU . . . 158.93 94.13 0.1 OUTLIER Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.586 -165.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.752 HG21 ' CB ' ' A' ' 106' ' ' ASP . 21.5 t 7.74 120.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.478 1.911 . . . . 0.0 115.71 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.676 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 5.4 m-20 83.04 40.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 123.05 1.405 . . . . 0.0 109.165 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.86 ' OE2' ' HB3' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -135.83 158.26 44.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 111.917 -2.401 . . . . 0.0 108.115 171.245 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 52.9 mt-10 -105.49 142.75 34.7 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.223 0.535 . . . . 0.0 110.981 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.836 HG22 ' HD2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -56.65 143.51 68.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.723 -174.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.836 ' HD2' HG22 ' A' ' 128' ' ' VAL . 2.2 Cg_endo -57.22 116.91 3.55 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.761 2.307 . . . . 0.0 112.924 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.522 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 113.98 -63.05 0.31 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.524 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.468 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 18.2 m-85 -107.79 147.36 30.95 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -78.58 58.37 2.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.983 0.81 . . . . 0.0 111.674 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.705 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -91.9 97.71 11.14 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.244 175.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.676 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER -80.23 106.92 12.61 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 120.69 0.281 . . . . 0.0 110.653 -171.652 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.744 ' HB ' ' OE1' ' A' ' 126' ' ' GLU . 75.6 mt -56.5 96.33 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 122.097 0.951 . . . . 0.0 110.174 176.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.715 HG23 ' HA ' ' A' ' 145' ' ' LEU . 1.6 t -88.09 -2.74 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.379 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -165.89 117.61 1.07 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.332 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.629 HG21 ' OG ' ' A' ' 109' ' ' SER . 1.9 mt -92.79 125.13 45.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.043 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 8.4 mmt180 -129.9 153.21 80.91 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.635 ' HA ' HG22 ' A' ' 100' ' ' VAL . 32.4 Cg_exo -22.82 -68.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 1 C-N-CA 125.388 4.059 . . . . 0.0 114.605 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.505 ' HA ' HD23 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -137.31 39.07 2.49 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.642 1.21 . . . . 0.0 109.111 172.585 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 2.3 tpp85 -142.05 142.81 32.89 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.208 -1.814 . . . . 0.0 108.393 176.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.61 HG11 HG12 ' A' ' 135' ' ' ILE . 2.1 t -139.87 166.91 19.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.499 0.666 . . . . 0.0 110.996 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 153' ' ' VAL . 40.9 t -130.04 95.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.878 HD11 HD12 ' A' ' 154' ' ' LEU . 2.6 pp -121.12 158.4 28.02 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -164.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.7 OUTLIER -92.27 110.41 21.8 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.168 -1.833 . . . . 0.0 109.468 -176.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.476 ' CD2' HG21 ' A' ' 92' ' ' THR . 0.5 OUTLIER -151.14 133.38 15.33 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.265 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 74.14 34.83 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.65 0.593 . . . . 0.0 110.423 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.0 13.74 82.89 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.794 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 32.5 ptt180 -142.59 170.47 15.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.689 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 26.1 p90 -136.03 111.08 8.88 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.314 1.054 . . . . 0.0 108.409 171.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.718 ' HG3' ' HB2' ' A' ' 90' ' ' PRO . 76.7 mm-40 -119.76 -170.19 1.91 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.126 -173.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.677 HG12 HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -103.03 107.13 21.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.637 0.732 . . . . 0.0 110.407 -172.26 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.878 HD12 HD11 ' A' ' 145' ' ' LEU . 1.4 mt -113.44 114.16 26.18 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.47 -175.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.468 ' O ' ' HD1' ' A' ' 157' ' ' TYR . . . -110.11 50.84 0.74 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 168.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.746 HD22 ' HB2' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -36.04 113.25 0.21 Allowed 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.803 0.943 . . . . 0.0 109.608 178.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.468 ' HD1' ' O ' ' A' ' 155' ' ' GLY . 51.3 p90 . . . . . 0 N--CA 1.45 -0.448 0 O-C-N 121.75 -0.594 . . . . 0.0 109.784 -172.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.668 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 9.1 Cg_exo . . . . . 0 CA--C 1.538 0.687 0 N-CA-C 115.434 1.282 . . . . 0.0 115.434 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.677 ' HB2' HD13 ' A' ' 154' ' ' LEU . 67.9 m -56.0 -71.29 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.502 0.592 . . . . 0.0 111.142 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.635 HG23 HD21 ' A' ' 154' ' ' LEU . 1.7 t -160.36 -48.45 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.046 ' H ' HD21 ' A' ' 154' ' ' LEU . 53.8 tp 60.99 118.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.581 ' H ' HD23 ' A' ' 156' ' ' LEU . 24.7 t-20 -176.54 -63.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.834 0.35 . . . . 0.0 111.901 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.835 HD21 ' HD2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -55.64 169.31 0.34 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.798 -178.329 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.5 m -114.55 110.74 20.28 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.713 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.694 ' HA ' HG23 ' A' ' 113' ' ' ILE . 3.3 mp -76.21 123.06 25.27 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 114' ' ' SER . 0.2 OUTLIER -87.58 -36.54 17.48 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -175.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.555 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 159.49 146.75 4.66 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.654 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.75 HG22 ' HA ' ' A' ' 111' ' ' ALA . 5.2 t -103.97 131.05 53.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.054 0.454 . . . . 0.0 110.689 -174.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.864 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -97.46 88.02 4.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.805 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -67.95 126.74 30.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -174.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -128.52 110.48 1.13 Allowed Glycine 0 CA--C 1.5 -0.871 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.93 -171.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 23.9 t70 70.11 -65.18 0.33 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.692 ' O ' ' HB2' ' A' ' 109' ' ' SER . 20.2 t70 -167.72 -91.34 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.26 161.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.767 ' HA ' HG21 ' A' ' 124' ' ' VAL . 6.1 p-10 -91.97 -21.21 20.67 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.812 0.695 . . . . 0.0 111.078 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.447 ' HB2' ' HG2' ' A' ' 108' ' ' ARG . 3.9 m -60.03 -38.0 81.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.385 -172.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 107' ' ' SER . 0.1 OUTLIER -141.94 32.44 1.58 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.674 -172.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.805 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 1.5 t -85.99 135.84 33.49 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.034 0.445 . . . . 0.0 110.24 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.864 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 13.0 mm -116.91 88.49 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.341 -173.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.959 ' HB2' HD11 ' A' ' 138' ' ' ILE . . . -73.88 98.06 2.91 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.47 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 17.1 mm -82.87 94.73 3.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.807 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.3 OUTLIER -106.28 148.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.644 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.526 ' HB3' ' OG1' ' A' ' 98' ' ' THR . 1.3 p -118.37 132.71 56.26 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.473 0.654 . . . . 0.0 109.611 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.835 ' HD2' HD21 ' A' ' 95' ' ' LEU . 17.8 tptm -108.68 100.65 9.87 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.2 t70 52.92 33.32 14.28 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -165.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 63.9 t30 79.85 29.81 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 112.537 -2.119 . . . . 0.0 111.393 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 8.6 tp10 -96.88 92.77 6.28 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 170.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 11.5 mt-30 -73.85 132.58 42.68 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -138.29 152.29 48.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.58 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.2 p -95.39 105.79 17.79 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.316 0.579 . . . . 0.0 111.503 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 1.093 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 30.1 mmt180 -96.83 -163.75 1.08 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.805 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.628 ' N ' ' HG3' ' A' ' 126' ' ' GLU . . . 173.05 93.41 0.09 OUTLIER Glycine 0 C--O 1.222 -0.596 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.456 -164.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 1.016 HG22 ' HB ' ' A' ' 138' ' ' ILE . 1.3 t 4.64 45.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 127.426 2.29 . . . . 0.0 115.84 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.48 ' C ' ' HD3' ' A' ' 134' ' ' LYS . 2.1 t30 166.96 39.3 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -174.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 1.093 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 11.4 mm-40 -144.58 135.05 24.52 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 111.777 -2.465 . . . . 0.0 108.071 -170.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 58.4 mt-10 -91.84 142.62 27.38 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.695 HG22 HG21 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -60.0 152.12 62.08 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.15 -177.283 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.659 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 24.0 Cg_exo -66.23 129.44 21.64 Favored 'Trans proline' 0 C--N 1.329 -0.454 0 C-N-CA 122.667 2.245 . . . . 0.0 111.46 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.448 ' HA3' ' CE ' ' A' ' 115' ' ' LYS . . . 93.82 -38.31 3.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.942 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.402 ' HB3' ' HE2' ' A' ' 147' ' ' TYR . 44.1 m-85 -124.67 133.18 53.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.607 -174.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -76.92 52.98 0.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.399 0.619 . . . . 0.0 111.084 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.678 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -93.22 99.01 11.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 172.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.754 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 1.4 tmmm? -81.09 121.92 26.7 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-O 121.005 0.431 . . . . 0.0 110.827 -170.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.796 HG12 HG11 ' A' ' 143' ' ' VAL . 95.4 mt -67.14 94.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.648 HG22 ' HE2' ' A' ' 134' ' ' LYS . 2.8 t -86.58 -9.88 11.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.508 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -158.12 116.8 3.11 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.982 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 1.016 ' HB ' HG22 ' A' ' 124' ' ' VAL . 0.2 OUTLIER -86.64 133.51 29.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.064 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.668 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 19.2 mmt180 -141.88 154.56 65.59 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 172.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 100' ' ' VAL . 52.6 Cg_exo -22.79 -78.19 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 125.138 3.892 . . . . 0.0 114.777 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.492 ' HA ' HD23 ' A' ' 97' ' ' LEU . 3.4 p-10 -127.43 39.85 3.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.494 1.14 . . . . 0.0 109.086 168.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.668 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 7.1 tpp85 -134.95 139.98 45.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.689 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.796 HG11 HG12 ' A' ' 135' ' ' ILE . 3.5 t -143.59 123.38 8.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.747 0.784 . . . . 0.0 112.429 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 HG12 ' A' ' 153' ' ' VAL . 22.0 t -80.55 101.66 5.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 169.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.969 HD11 HD22 ' A' ' 154' ' ' LEU . 1.1 pp -122.77 158.41 30.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -168.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -95.27 103.1 14.95 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.449 -175.473 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.563 ' HD1' ' N ' ' A' ' 148' ' ' GLN . 0.3 OUTLIER -139.93 135.62 33.01 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.563 ' N ' ' HD1' ' A' ' 147' ' ' TYR . 0.0 OUTLIER 72.96 31.94 1.43 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.635 0.584 . . . . 0.0 110.57 173.802 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.04 16.49 74.94 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.062 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.805 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 6.0 tpp180 -132.28 157.13 45.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.814 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 25.4 p90 -134.67 107.11 7.29 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.805 ' HG2' ' HG3' ' A' ' 150' ' ' ARG . 43.1 mm-40 -124.03 -171.69 2.38 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.523 -174.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.902 HG12 HG22 ' A' ' 144' ' ' VAL . 3.1 m -100.4 99.95 9.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.838 0.828 . . . . 0.0 110.489 -172.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 1.046 HD21 ' H ' ' A' ' 93' ' ' LEU . 3.5 tp -107.27 109.75 21.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.854 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 142' ' ' ARG . . . -97.11 53.51 1.36 Allowed Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.312 172.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.599 ' HA ' HD12 ' A' ' 93' ' ' LEU . 2.2 mt -37.09 115.49 0.39 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.447 0.734 . . . . 0.0 109.358 176.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 53.4 p90 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 118.533 0.606 . . . . 0.0 109.946 -175.816 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.7 p -114.33 -18.09 11.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.098 0.475 . . . . 0.0 110.859 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -88.47 -11.44 45.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.967 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 54.8 ttp -119.06 111.18 17.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.727 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.0 tt -98.11 104.43 16.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -96.13 -74.7 0.55 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.138 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.4 mmt 55.99 72.56 0.48 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.714 0.634 . . . . 0.0 110.565 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.34 45.92 1.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.931 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.09 -115.89 4.11 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.51 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -175.94 -35.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.135 0.493 . . . . 0.0 109.907 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -154.67 163.03 40.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.459 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.33 81.99 3.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.405 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.03 -33.72 72.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.888 0.375 . . . . 0.0 111.312 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.622 ' HA ' ' HB2' ' A' ' 86' ' ' SER . 20.0 m -68.54 -16.23 63.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.436 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -60.56 -34.4 74.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.935 0.398 . . . . 0.0 110.424 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.6 ttt -102.03 7.79 41.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.413 0.625 . . . . 0.0 110.26 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.622 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 8.0 t -80.78 81.76 6.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.522 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -98.16 -15.42 19.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.287 0.565 . . . . 0.0 109.747 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.2 118.23 57.43 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.427 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.11 110.13 0.96 Allowed 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.858 2.372 . . . . 0.0 112.745 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.492 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.8 Cg_exo -77.16 -137.29 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.505 2.803 . . . . 0.0 111.711 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.545 ' OG ' ' HB2' ' A' ' 152' ' ' GLU . 52.7 m 54.16 -99.58 0.09 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.514 0.326 . . . . 0.0 111.077 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.583 HG23 HD21 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -139.2 -42.3 0.46 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -176.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.903 ' H ' HD21 ' A' ' 154' ' ' LEU . 50.9 tp 60.38 109.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.496 0.665 . . . . 0.0 111.934 -174.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.589 ' H ' HD23 ' A' ' 156' ' ' LEU . 2.9 p-10 -174.55 -157.88 0.08 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.748 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER 44.37 -175.41 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 176.259 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 10.2 t -127.31 111.8 14.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.219 163.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.93 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -82.43 72.82 9.49 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.412 HG21 ' OE1' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -34.3 -42.62 0.14 Allowed 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 178.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 157.78 150.71 5.81 Favored Glycine 0 CA--C 1.484 -1.903 0 C-N-CA 119.16 -1.495 . . . . 0.0 112.676 171.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.755 HG21 HG23 ' A' ' 138' ' ' ILE . 19.0 m -104.13 160.44 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 122.432 1.111 . . . . 0.0 110.69 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.842 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 23.4 mmt -119.34 89.41 3.12 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 112.89 -1.959 . . . . 0.0 107.698 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.82 132.91 55.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.85 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 108' ' ' ARG . . . -117.34 90.85 0.52 Allowed Glycine 0 CA--C 1.496 -1.142 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.252 -173.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 107' ' ' SER . 31.0 t0 73.86 -53.33 0.69 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -172.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.755 ' O ' ' HB3' ' A' ' 109' ' ' SER . 38.6 t70 179.24 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.45 -1.704 . . . . 0.0 106.935 170.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.713 ' HB2' HG11 ' A' ' 124' ' ' VAL . 9.9 p-10 -90.37 -9.74 46.54 Favored 'General case' 0 C--N 1.334 -0.103 0 O-C-N 124.248 0.968 . . . . 0.0 109.885 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.696 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 24.9 m -69.02 11.39 0.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.771 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.696 ' HG3' ' O ' ' A' ' 107' ' ' SER . 30.2 mtt85 178.59 -79.87 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -171.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.957 ' HB2' HD12 ' A' ' 138' ' ' ILE . 13.2 p 48.51 110.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 174.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.842 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 3.9 mm -94.41 134.25 32.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.76 174.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 1.032 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -124.06 108.42 12.33 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.745 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.654 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 13.8 mm -94.55 92.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 1.032 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.5 OUTLIER -105.87 143.16 17.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.047 -174.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.839 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 31.4 t -103.61 126.36 50.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.703 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.772 ' HB2' ' HB2' ' A' ' 129' ' ' PRO . 26.3 tptp -118.55 98.77 6.41 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.836 ' HA ' ' HB2' ' A' ' 161' ' ' ASP . 3.6 m-20 52.3 26.77 4.25 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -166.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.839 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 66.5 t30 79.01 39.72 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.851 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 12.6 pt-20 -111.94 92.47 4.04 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.965 0.888 . . . . 0.0 108.934 161.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.673 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 24.8 mt-30 -66.4 126.63 29.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.585 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.654 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.5 m-85 -118.8 161.65 19.78 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.543 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.0 p -102.98 99.16 9.04 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 122.086 0.946 . . . . 0.0 110.922 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.542 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 22.8 mmt180 -107.74 -159.24 0.68 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.531 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.619 ' HA2' ' CD1' ' A' ' 138' ' ' ILE . . . 165.33 179.94 39.43 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.857 -174.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.713 HG11 ' HB2' ' A' ' 106' ' ' ASP . 25.4 t -52.53 121.83 2.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 114.183 -1.009 . . . . 0.0 109.924 168.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.798 ' HA ' ' HE3' ' A' ' 134' ' ' LYS . 5.1 m-20 78.52 21.55 0.78 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.546 1.165 . . . . 0.0 109.747 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 123' ' ' GLY . 3.6 mm-40 -117.06 158.93 23.33 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.96 -1.927 . . . . 0.0 106.42 167.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.876 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 40.1 mt-10 -113.22 148.91 34.54 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 118.17 0.441 . . . . 0.0 110.38 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.757 HG22 ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -58.74 147.77 70.32 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.755 -177.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.772 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 6.0 Cg_exo -58.79 130.95 39.32 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.811 2.341 . . . . 0.0 112.188 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.542 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 94.99 -63.5 1.48 Allowed Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 116.086 -0.507 . . . . 0.0 112.765 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.42 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 14.6 m-85 -109.31 148.07 31.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -76.15 49.83 0.58 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.676 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -84.58 97.56 9.66 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.876 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . 5.7 tptm -79.8 123.04 27.36 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-O 121.324 0.583 . . . . 0.0 111.373 -171.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.621 HG12 HG11 ' A' ' 143' ' ' VAL . 71.2 mt -75.68 93.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.603 HG22 ' HG3' ' A' ' 134' ' ' LYS . 2.1 t -87.97 -10.53 10.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.585 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.2 OUTLIER -157.08 117.35 3.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.984 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.957 HD12 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -87.45 131.42 35.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.139 178.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 13.1 mmt180 -141.45 151.15 60.11 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -19.41 -77.68 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 125.261 3.974 . . . . 0.0 114.767 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.553 ' HA ' HD23 ' A' ' 97' ' ' LEU . 4.4 p-10 -125.05 36.86 4.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.467 1.127 . . . . 0.0 109.034 168.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.824 ' HD2' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -131.45 138.15 48.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.006 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.67 HG23 HD21 ' A' ' 97' ' ' LEU . 3.2 t -144.74 121.71 4.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 122.044 0.925 . . . . 0.0 112.131 -176.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.806 HG22 HG22 ' A' ' 153' ' ' VAL . 37.4 t -79.21 102.18 5.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.876 HD11 HD22 ' A' ' 154' ' ' LEU . 1.8 pp -120.12 152.0 38.25 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.103 0.954 . . . . 0.0 113.294 -169.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.565 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 1.4 tp-100 -100.23 102.86 14.26 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.716 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.504 ' HD2' ' HB2' ' A' ' 133' ' ' ALA . 0.4 OUTLIER -136.78 135.16 37.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.15 -1.386 . . . . 0.0 107.529 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.419 HE21 ' HB2' ' A' ' 148' ' ' GLN . 0.0 OUTLIER 70.39 32.19 2.83 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.673 0.389 . . . . 0.0 111.274 174.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 79.84 1.96 87.84 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.027 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.775 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 20.1 tpp180 -130.31 143.49 50.81 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 34.6 p90 -119.84 108.94 14.98 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 122.278 1.037 . . . . 0.0 108.523 175.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.775 ' HG2' ' HG3' ' A' ' 150' ' ' ARG . 51.1 mm-40 -125.79 -170.41 2.18 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.646 -173.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.824 HG13 ' HD2' ' A' ' 142' ' ' ARG . 2.9 t -102.25 101.84 12.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.843 0.83 . . . . 0.0 109.985 -169.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.903 HD21 ' H ' ' A' ' 93' ' ' LEU . 4.7 tp -112.23 118.19 34.63 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.54 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.448 ' HA3' ' NH1' ' A' ' 142' ' ' ARG . . . -102.96 58.27 0.56 Allowed Glycine 0 C--N 1.308 -0.98 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.553 169.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.836 HD12 HD13 ' A' ' 97' ' ' LEU . 2.3 mt -37.67 104.74 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.687 0 O-C-N 124.52 0.777 . . . . 0.0 110.214 174.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -136.62 133.8 36.67 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.524 -0.735 . . . . 0.0 109.544 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 75.3 m -154.51 162.04 41.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.268 0.556 . . . . 0.0 111.059 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -132.75 -6.09 3.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -77.25 -17.37 58.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.127 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.836 ' HB2' ' HA ' ' A' ' 116' ' ' ASP . 14.9 p-10 -80.35 -43.91 20.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.723 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.553 ' HA ' ' HB2' ' A' ' 117' ' ' ASN . 20.2 m -71.11 -34.17 70.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.406 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -90.66 59.15 3.32 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.382 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 66.9 p -162.66 146.9 11.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -98.98 -9.58 23.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.516 0.674 . . . . 0.0 110.14 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.67 11.12 51.73 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.434 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.2 100.09 53.19 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.3 109.52 2.44 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.579 2.186 . . . . 0.0 111.757 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -162.4 -167.45 22.84 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.518 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.31 -43.61 7.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.909 0.385 . . . . 0.0 110.722 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -122.54 83.31 2.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.256 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.32 -35.26 22.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.898 175.027 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.1 p -100.95 35.29 2.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.306 0.574 . . . . 0.0 111.377 -176.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -92.49 97.63 10.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -68.35 134.48 50.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.491 0.662 . . . . 0.0 111.677 -174.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 pp -104.02 17.49 24.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.896 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -68.29 139.29 55.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.8 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 14.8 ptm -94.25 40.05 1.08 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.366 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.46 -152.78 0.39 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.611 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.32 -27.65 24.74 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.985 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 68.88 14.65 8.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.238 0.615 . . . . 0.0 110.643 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -163.18 27.1 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.54 -25.55 64.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.086 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 87' ' ' ASN . . . -58.14 -36.43 72.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.331 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 m -77.14 -13.66 59.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.726 0.298 . . . . 0.0 111.297 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.573 ' HG2' ' HG3' ' A' ' 85' ' ' MET . 58.8 tt0 -85.64 -33.58 21.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 111.201 -175.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.573 ' HG3' ' HG2' ' A' ' 84' ' ' GLN . 65.3 mtt -146.13 -86.8 0.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.137 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.7 t -148.43 -55.06 0.2 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 82' ' ' ALA . 4.8 t-20 59.7 89.86 0.06 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.81 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -70.64 119.38 72.42 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HG2' HD22 ' A' ' 93' ' ' LEU . 14.7 Cg_endo -57.02 110.31 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.405 2.737 . . . . 0.0 113.138 -175.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.781 ' HG2' ' HB3' ' A' ' 152' ' ' GLU . 73.4 Cg_endo -78.03 -139.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.144 2.563 . . . . 0.0 111.675 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.849 ' HB3' ' HG ' ' A' ' 154' ' ' LEU . 22.8 t 53.21 -101.8 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 117.878 0.308 . . . . 0.0 110.677 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.791 HG23 HD11 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -127.94 -34.67 2.13 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.475 0.58 . . . . 0.0 112.46 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.65 ' H ' HD11 ' A' ' 154' ' ' LEU . 47.2 tp 59.68 107.48 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.335 0.588 . . . . 0.0 111.993 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.463 ' H ' HD23 ' A' ' 156' ' ' LEU . 2.4 p-10 -176.54 -157.05 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.781 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.4 OUTLIER 55.23 174.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 173.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.1 t -126.67 117.31 22.48 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.749 163.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.749 HD23 HG23 ' A' ' 113' ' ' ILE . 11.5 mt -77.23 125.51 29.44 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.458 HG21 ' OE1' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -91.53 -33.8 15.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.21 154.43 6.17 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.088 162.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.633 ' HB ' HD11 ' A' ' 138' ' ' ILE . 3.4 m -104.17 146.8 11.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 122.303 1.049 . . . . 0.0 110.799 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.632 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 65.6 mtt -105.75 91.58 3.81 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.176 -1.829 . . . . 0.0 108.782 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.31 129.59 42.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.55 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -114.6 94.85 0.7 Allowed Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 1.3 m-20 73.92 -53.81 0.69 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -169.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.766 ' O ' ' HB3' ' A' ' 109' ' ' SER . 25.8 t70 178.95 -90.01 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.692 -1.594 . . . . 0.0 107.466 168.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.829 ' HB2' HG21 ' A' ' 124' ' ' VAL . 13.3 p-10 -91.11 -38.85 12.5 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.16 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.446 ' C ' ' HD2' ' A' ' 108' ' ' ARG . 2.7 m -49.3 -55.89 11.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.195 -172.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.537 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 5.3 mmm180 -120.48 34.77 5.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.134 0.493 . . . . 0.0 109.902 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.862 ' HB2' HD13 ' A' ' 138' ' ' ILE . 19.1 p -76.35 141.87 41.38 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -168.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 10.2 mm -120.94 84.16 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 121.87 0.843 . . . . 0.0 111.273 -176.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.651 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -74.2 102.63 4.35 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.26 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 3.2 mm -87.04 96.19 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.749 HG23 HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -103.29 144.58 13.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.689 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.796 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 31.2 t -105.31 120.28 41.17 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.6 ' HE3' ' HA3' ' A' ' 130' ' ' GLY . 23.9 tptp -123.45 110.41 15.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -174.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.07 17.29 7.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -168.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.796 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 2.8 t-20 73.98 35.53 0.78 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.913 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -104.82 101.33 10.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 164.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 15.6 mt-30 -67.2 120.99 14.68 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.34 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 5.7 t80 -120.21 143.41 48.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.819 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.3 p -87.14 95.42 9.95 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.396 1.093 . . . . 0.0 111.119 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.51 ' HD3' ' HB3' ' A' ' 126' ' ' GLU . 13.6 mmt180 -103.57 -157.48 0.61 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.569 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.883 ' HA2' HD12 ' A' ' 138' ' ' ILE . . . 162.28 -174.64 38.73 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 119.87 -1.157 . . . . 0.0 112.17 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 106' ' ' ASP . 2.1 t -56.62 122.72 6.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.134 -1.033 . . . . 0.0 109.639 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.505 ' HA ' ' CE ' ' A' ' 134' ' ' LYS . 7.7 m-20 75.29 35.16 0.59 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.969 1.366 . . . . 0.0 108.223 176.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HB3' ' HD3' ' A' ' 122' ' ' ARG . 4.8 mm-40 -133.8 144.88 49.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 111.985 -2.37 . . . . 0.0 106.81 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.571 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 34.7 mt-10 -103.34 132.56 49.5 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.196 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.628 HG21 HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -61.15 140.1 94.31 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.071 -176.271 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.709 ' O ' HD21 ' A' ' 95' ' ' LEU . 23.8 Cg_exo -64.77 142.67 77.39 Favored 'Trans proline' 0 C--O 1.223 -0.227 0 C-N-CA 123.094 2.529 . . . . 0.0 112.442 -167.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.6 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 97.06 -43.21 2.05 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.585 ' HB3' ' CE1' ' A' ' 147' ' ' TYR . 62.1 m-85 -114.11 170.13 8.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -96.43 46.44 1.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 170.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.688 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -85.81 97.52 10.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.571 ' CA ' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -81.81 104.61 12.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.715 -169.52 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 123' ' ' GLY . 70.8 mt -52.3 94.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.83 0.824 . . . . 0.0 110.106 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 145' ' ' LEU . 3.4 m -83.38 -3.78 7.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.517 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.827 ' HB3' ' HB ' ' A' ' 144' ' ' VAL . 3.6 t -168.71 117.4 0.7 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.905 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.883 HD12 ' HA2' ' A' ' 123' ' ' GLY . 7.1 tt -97.2 135.88 29.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.735 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.717 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 17.1 mmt180 -141.44 157.5 65.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 141' ' ' ASP . 60.2 Cg_exo -18.94 -82.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.013 1 C-N-CA 125.579 4.186 . . . . 0.0 115.05 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.465 ' C ' HD13 ' A' ' 97' ' ' LEU . 7.7 p-10 -133.21 40.19 3.21 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 123.471 1.605 . . . . 0.0 107.438 167.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.717 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -126.57 139.2 53.38 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 111.642 -2.526 . . . . 0.0 107.154 169.028 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.544 ' N ' ' HD3' ' A' ' 142' ' ' ARG . 1.1 t -137.07 160.33 36.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.133 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.954 HG22 HG12 ' A' ' 153' ' ' VAL . 13.9 t -120.33 117.16 52.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 165.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.843 HD11 HD12 ' A' ' 154' ' ' LEU . 2.2 pp -132.5 162.49 31.08 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.765 0.793 . . . . 0.0 111.956 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 1.7 tp-100 -109.97 108.91 19.33 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.65 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 131' ' ' TYR . 76.9 t80 -135.86 141.32 44.61 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.577 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.484 ' HB3' ' CD2' ' A' ' 147' ' ' TYR . 0.1 OUTLIER 59.11 22.38 10.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 169.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 98.6 -1.39 58.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.57 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.461 ' HG2' ' HG2' ' A' ' 148' ' ' GLN . 13.2 ptp180 -130.19 137.62 50.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.372 0.586 . . . . 0.0 111.875 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 16.5 p90 -114.7 108.22 16.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.391 1.091 . . . . 0.0 108.477 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.781 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 52.6 mt-10 -139.45 -170.42 2.9 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.443 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.954 HG12 HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -96.34 99.65 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 122.006 0.908 . . . . 0.0 110.208 -168.267 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.849 ' HG ' ' HB3' ' A' ' 91' ' ' SER . 0.4 OUTLIER -101.99 106.82 17.79 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.704 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -98.98 53.11 1.08 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 173.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.781 HD22 ' HB2' ' A' ' 95' ' ' LEU . 3.9 mt -32.36 115.22 0.17 Allowed 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.907 1.004 . . . . 0.0 110.69 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -133.59 160.85 36.26 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.3 m -48.37 104.51 0.06 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -149.62 18.68 0.92 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.726 0.774 . . . . 0.0 109.395 172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 161' ' ' ASP . 7.0 pt-20 -147.65 -34.45 0.24 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.41 ' N ' ' HG3' ' A' ' 160' ' ' GLU . 12.9 t0 -71.57 -36.03 70.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.997 172.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.2 t -144.32 146.8 32.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.092 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.25 118.26 2.92 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 38.6 m -128.16 173.82 9.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.937 0.368 . . . . 0.0 111.411 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -53.41 -51.34 62.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.033 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.91 12.3 14.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.061 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 84.4 t -115.76 115.69 41.3 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.96 145.88 28.75 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.977 2.452 . . . . 0.0 112.248 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -104.49 18.95 43.56 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.935 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.21 82.02 1.89 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.041 0.448 . . . . 0.0 110.395 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -120.17 -119.28 0.3 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.238 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 18.3 m -68.39 -19.66 24.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 166.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 . . . . . 0 C--O 1.248 1.02 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.451 170.932 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.2 m -128.53 89.58 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.344 0.592 . . . . 0.0 110.81 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -84.59 55.72 3.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.367 0.603 . . . . 0.0 110.173 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 71.5 mmm -82.75 68.82 9.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.036 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.03 -30.14 60.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.348 -175.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -67.88 -14.05 62.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.537 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 52.1 mtm -136.99 54.11 1.87 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.439 . . . . 0.0 110.524 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.72 -1.85 58.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.44 63.98 2.15 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.945 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -119.66 111.65 18.32 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.931 -0.158 . . . . 0.0 110.844 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.584 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 3.3 mm? 58.51 28.92 17.65 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.729 0.643 . . . . 0.0 111.435 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.584 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 27.0 t70 150.93 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -170.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.487 ' H ' ' CG ' ' A' ' 81' ' ' ASP . . . -91.98 -61.81 1.55 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.2 t -100.94 -65.17 0.99 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.713 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -101.33 -71.71 0.7 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -163.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.45 ' CA ' ' HB2' ' A' ' 81' ' ' ASP . 24.5 ptm -169.04 -35.39 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.5 m -153.5 49.05 0.68 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.093 -0.379 . . . . 0.0 111.54 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.9 m120 47.48 48.36 16.77 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.404 0.44 . . . . 0.0 111.719 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.676 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 49.8 tp -73.96 126.55 89.28 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.7 -176.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 88' ' ' LEU . 31.7 Cg_endo -97.1 90.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.893 3.062 . . . . 0.0 112.272 173.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.846 ' HG2' ' HB3' ' A' ' 152' ' ' GLU . 6.3 Cg_endo -90.42 -138.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.685 2.923 . . . . 0.0 112.118 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.635 ' HB2' HD13 ' A' ' 154' ' ' LEU . 70.5 m 56.83 -86.63 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.614 0.765 . . . . 0.0 112.179 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.577 HG23 HD21 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -160.97 -44.67 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.831 -0.543 . . . . 0.0 112.381 -176.331 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.945 ' H ' HD21 ' A' ' 154' ' ' LEU . 6.5 tt 51.54 112.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.708 ' H ' HD23 ' A' ' 156' ' ' LEU . 2.3 p-10 -167.48 -56.81 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.853 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -54.71 176.34 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 122.95 0.5 . . . . 0.0 111.154 176.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.665 ' HB2' ' OG ' ' A' ' 158' ' ' SER . 1.5 t -117.59 109.93 17.29 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.292 170.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.718 ' HA ' HG23 ' A' ' 113' ' ' ILE . 1.9 mp -73.23 115.95 13.19 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 170.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -35.7 26.14 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.51 169.83 31.55 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.745 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 111' ' ' ALA . 2.3 t -130.11 126.55 62.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.904 0.859 . . . . 0.0 110.889 -175.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.88 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 64.8 mtt -92.0 89.98 7.21 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.583 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.11 121.52 14.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.731 -175.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.579 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -114.04 100.37 1.03 Allowed Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -172.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.579 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 10.5 t70 74.4 -64.67 0.38 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -170.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 109' ' ' SER . 7.0 m-20 -169.37 -91.52 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.942 -1.935 . . . . 0.0 106.519 169.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.653 ' HA ' HG21 ' A' ' 124' ' ' VAL . 12.5 p-10 -91.87 -30.75 15.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.665 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 t -60.07 -57.18 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.464 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 4.4 mmm180 -111.58 28.9 8.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.367 0.603 . . . . 0.0 110.067 -170.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.809 ' HB2' HD13 ' A' ' 138' ' ' ILE . 22.5 p -73.02 135.8 44.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.685 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.88 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 6.4 mm -120.39 89.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.393 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.939 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -78.64 100.95 7.22 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.921 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.5 mm -86.3 93.18 3.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.939 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -106.86 159.93 6.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.235 -176.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 26.4 p -125.82 135.48 52.02 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-O 121.308 0.575 . . . . 0.0 109.54 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.9 tptp -119.21 108.39 14.59 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 59.25 20.43 8.54 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -167.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 66.7 t30 79.74 37.19 0.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 113.435 -1.711 . . . . 0.0 111.666 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 16.6 pt-20 -107.4 101.77 11.1 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.963 0.887 . . . . 0.0 109.626 166.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.709 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.2 mt-30 -67.24 135.89 54.11 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -142.81 146.15 33.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.737 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -88.07 103.11 15.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.924 0.869 . . . . 0.0 111.552 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.519 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 21.9 mmt180 -107.42 -159.62 0.7 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.682 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.691 ' HA2' HD12 ' A' ' 138' ' ' ILE . . . 174.94 173.64 40.93 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -175.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 106' ' ' ASP . 16.7 t -49.39 132.59 7.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 165.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.562 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 3.2 m-20 72.29 19.55 4.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.459 1.123 . . . . 0.0 109.574 175.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.519 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 0.4 OUTLIER -120.64 158.04 28.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.145 -1.843 . . . . 0.0 106.347 167.207 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.744 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 41.6 mt-10 -104.2 156.89 17.52 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 118.435 0.561 . . . . 0.0 110.116 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.742 HG22 ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -66.4 145.2 98.95 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.553 178.345 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.788 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 21.7 Cg_exo -52.98 130.69 39.1 Favored 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 122.847 2.364 . . . . 0.0 112.009 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.538 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 96.6 -59.06 1.29 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.633 176.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.468 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 27.0 m-85 -113.63 153.66 28.51 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 121.434 -0.106 . . . . 0.0 111.036 -174.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -74.81 44.76 0.23 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.673 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -83.06 90.4 7.03 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 170.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -80.49 120.83 24.99 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.472 -170.438 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.663 HG12 HG11 ' A' ' 143' ' ' VAL . 74.4 mt -68.62 94.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.412 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.742 HG22 ' HE2' ' A' ' 134' ' ' LYS . 1.5 t -88.59 -3.77 9.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.732 0.777 . . . . 0.0 108.965 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.474 ' HB3' HG23 ' A' ' 144' ' ' VAL . 1.7 t -162.38 115.32 1.71 Allowed 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.492 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.809 HD13 ' HB2' ' A' ' 109' ' ' SER . 3.5 tt -88.98 132.93 32.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.069 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 7.4 mmt180 -141.89 159.23 60.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -22.63 -78.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 125.093 3.862 . . . . 0.0 114.474 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.4 ' HA ' HD23 ' A' ' 97' ' ' LEU . 9.5 p-10 -128.33 39.53 3.81 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.398 1.094 . . . . 0.0 108.715 169.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.531 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 1.9 tpp180 -136.93 143.35 42.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.73 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.663 HG11 HG12 ' A' ' 135' ' ' ILE . 4.8 t -148.41 119.33 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.83 -176.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 1.076 HG22 HG13 ' A' ' 153' ' ' VAL . 7.1 t -79.04 65.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 1.9 pp -82.63 167.92 17.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.022 -175.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.619 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -112.57 124.39 52.43 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.577 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.559 ' HD2' ' HB2' ' A' ' 133' ' ' ALA . 0.3 OUTLIER -145.27 140.04 27.53 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.469 ' N ' ' HD1' ' A' ' 147' ' ' TYR . 0.0 OUTLIER 67.91 28.94 6.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.966 0.412 . . . . 0.0 109.942 176.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.15 8.43 87.44 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.605 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 0.3 OUTLIER -132.61 139.78 47.93 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 117.247 0.523 . . . . 0.0 110.905 -173.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.719 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 13.3 p90 -118.94 111.96 19.01 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.106 0.955 . . . . 0.0 109.392 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.846 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 34.6 mt-10 -134.94 -175.9 4.06 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.161 -177.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 1.076 HG13 HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -96.24 99.27 8.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 119.676 -0.809 . . . . 0.0 110.233 -165.17 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.945 HD21 ' H ' ' A' ' 93' ' ' LEU . 6.0 tp -103.66 119.55 39.14 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.384 -0.825 . . . . 0.0 113.163 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -104.29 54.86 0.62 Allowed Glycine 0 C--N 1.304 -1.204 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 168.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.708 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.5 mt -36.51 107.25 0.06 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.39 0.7 . . . . 0.0 110.101 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -134.24 121.7 21.7 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.665 ' OG ' ' HB2' ' A' ' 96' ' ' SER . 38.0 m -61.4 132.98 55.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.231 0.539 . . . . 0.0 111.399 -174.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -72.06 179.69 3.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.101 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -80.59 118.21 21.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.143 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -71.5 -18.93 62.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.516 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.8 p -82.29 -29.22 31.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.961 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -106.4 25.53 22.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.229 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.3 t -156.44 151.52 26.32 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.87 1.23 57.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.409 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 92.42 -21.26 39.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.942 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.24 130.72 23.71 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.73 109.19 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.312 2.008 . . . . 0.0 111.582 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 177.47 -178.28 48.33 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . 59.09 -158.59 0.31 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.911 0.418 . . . . 0.0 110.959 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 58.62 50.49 8.94 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.585 0.707 . . . . 0.0 110.496 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 20.6 t -91.02 -26.18 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 . . . . . 0 C--O 1.25 1.116 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.069 174.914 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.713 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 t -85.24 -1.35 56.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -86.66 -14.63 42.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 110.368 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 77.3 mtp -133.17 102.99 5.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.593 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.9 tp -72.2 105.64 4.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -94.01 117.09 29.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.221 0.534 . . . . 0.0 111.456 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -83.08 69.49 9.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.883 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.5 39.99 0.63 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.729 -176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.84 -171.78 41.8 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.019 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -163.73 -70.31 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.0 tp -124.39 93.51 3.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -103.54 131.17 50.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.161 -171.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.21 -12.8 61.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.734 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.6 m -64.4 -10.8 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.349 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -56.67 -40.8 76.16 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.058 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.446 ' CE ' ' HA ' ' A' ' 85' ' ' MET . 9.4 mmt 66.5 -163.54 0.23 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.625 0.578 . . . . 0.0 110.368 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.8 m 65.78 25.51 11.35 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.513 0.508 . . . . 0.0 111.334 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -92.41 69.13 5.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.768 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.638 ' HB3' ' HD3' ' A' ' 89' ' ' PRO . 8.8 tt -161.56 -56.5 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.305 -0.379 . . . . 0.0 111.786 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 88' ' ' LEU . 45.8 Cg_exo -56.74 114.28 1.85 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.548 2.165 . . . . 0.0 113.728 -173.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.759 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.6 Cg_exo -78.45 -133.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.712 2.941 . . . . 0.0 111.005 174.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.869 ' HB2' ' HB2' ' A' ' 152' ' ' GLU . 9.1 t 51.23 -137.98 1.11 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.211 0.205 . . . . 0.0 111.121 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.443 ' HB ' ' CD2' ' A' ' 147' ' ' TYR . 4.9 t -95.53 -37.85 10.69 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.677 ' HA ' HD11 ' A' ' 154' ' ' LEU . 31.7 tp 49.59 68.47 0.73 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.862 ' H ' HD23 ' A' ' 156' ' ' LEU . 15.7 t-20 -174.04 100.59 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.894 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER 164.44 -167.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 175.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.508 ' HB2' ' OG ' ' A' ' 114' ' ' SER . 49.9 m -132.01 103.75 6.45 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.606 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.926 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -83.25 74.14 10.05 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -37.72 -46.67 0.92 Allowed 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 140' ' ' PRO . . . 161.54 152.47 6.67 Favored Glycine 0 CA--C 1.486 -1.775 0 C-N-CA 119.121 -1.514 . . . . 0.0 112.358 172.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 111' ' ' ALA . 4.7 m -104.59 143.21 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 121.659 0.743 . . . . 0.0 110.021 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.863 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 87.1 mmm -90.86 86.33 6.27 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.754 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -65.61 119.69 11.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.945 -176.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -114.7 102.45 1.17 Allowed Glycine 0 CA--C 1.498 -1.022 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -171.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 2.6 m-20 72.22 -69.41 0.19 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -172.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -149.72 -111.89 0.06 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.092 170.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.495 ' OD2' HG11 ' A' ' 124' ' ' VAL . 5.8 m-20 -90.59 -13.13 35.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.739 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.3 t -64.44 -58.03 7.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.534 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -109.91 29.67 7.41 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.401 -173.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.754 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 2.6 t -85.52 141.65 29.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.247 0.546 . . . . 0.0 111.763 -170.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.863 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 10.7 mm -122.21 87.93 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.422 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.897 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -69.09 98.61 1.01 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.483 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.552 HG22 ' HG2' ' A' ' 119' ' ' GLN . 13.6 mm -87.33 90.03 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -101.79 132.84 46.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.759 -179.059 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.508 ' OG ' ' HB2' ' A' ' 96' ' ' SER . 2.7 p -99.41 135.21 41.16 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.04 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.776 ' HA ' HD21 ' A' ' 95' ' ' LEU . 24.3 tptp -122.69 110.87 16.04 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 61.71 21.51 12.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -166.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.3 t30 77.39 33.69 0.4 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.677 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 114' ' ' SER . 81.3 tt0 -101.6 96.78 7.34 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 170.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.552 ' HG2' HG22 ' A' ' 112' ' ' ILE . 3.8 mt-30 -67.5 108.62 2.9 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 5.2 t80 -110.13 141.99 42.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.927 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.9 p -90.19 95.12 10.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.807 0.813 . . . . 0.0 112.177 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.941 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 18.8 mmt180 -91.96 -160.07 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.492 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.638 ' N ' ' HG3' ' A' ' 126' ' ' GLU . . . 163.8 105.62 0.19 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.582 -168.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.752 HG22 ' HB ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -9.5 117.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 125.408 1.299 . . . . 0.0 113.23 -177.092 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.736 ' HB2' ' O ' ' A' ' 124' ' ' VAL . 5.9 m-20 88.59 27.48 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 124.999 1.437 . . . . 0.0 108.428 -167.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.941 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 5.1 mm-40 -124.75 147.49 48.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 112.833 -1.985 . . . . 0.0 107.891 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.565 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 50.9 mt-10 -105.41 140.25 38.81 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 156' ' ' LEU . 0.5 OUTLIER -57.18 154.77 19.59 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.23 -176.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 128' ' ' VAL . 15.5 Cg_exo -70.07 119.24 6.2 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.883 2.389 . . . . 0.0 112.279 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.583 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 99.21 -52.1 1.1 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.328 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.548 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 21.3 m-85 -104.34 132.57 50.44 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -79.27 52.57 1.35 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.571 1.078 . . . . 0.0 110.962 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.793 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -84.78 101.72 12.47 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -81.39 107.9 14.55 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.015 -171.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.1 mt -55.91 94.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 O-C-N 123.806 0.691 . . . . 0.0 109.834 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 151' ' ' TYR . 0.2 OUTLIER -88.19 -4.2 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.656 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -164.65 118.32 1.33 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.767 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.752 ' HB ' HG22 ' A' ' 124' ' ' VAL . 7.2 tt -92.88 128.79 44.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.552 0.691 . . . . 0.0 111.727 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.804 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 16.9 mmt180 -142.06 160.17 56.29 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.61 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 7.3 Cg_exo -25.49 -85.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 1 C-N-CA 126.14 4.56 . . . . 0.0 114.98 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.603 ' HA ' HD23 ' A' ' 97' ' ' LEU . 1.9 p30 -123.78 14.05 9.3 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.036 0.922 . . . . 0.0 109.08 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.804 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -115.25 142.72 46.3 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.704 169.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.533 ' N ' ' HG2' ' A' ' 142' ' ' ARG . 0.9 OUTLIER -137.89 170.48 17.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.851 177.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.811 HG22 HG12 ' A' ' 153' ' ' VAL . 40.7 t -122.1 97.98 5.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.793 HD13 ' HB1' ' A' ' 133' ' ' ALA . 1.2 pp -120.34 158.59 26.8 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.039 0.923 . . . . 0.0 112.847 -170.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 1.9 tp-100 -106.64 103.04 12.39 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.555 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.572 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 52.9 t80 -128.22 144.42 51.12 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.613 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 0.2 OUTLIER 59.38 29.31 18.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 171.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.24 5.24 89.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.133 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.657 ' HG2' ' HG2' ' A' ' 152' ' ' GLU . 66.5 ttt180 -133.32 138.47 46.39 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 117.071 0.435 . . . . 0.0 110.803 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 6.4 p90 -116.75 112.33 21.02 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.547 1.165 . . . . 0.0 108.812 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.869 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 76.5 mm-40 -128.87 -169.79 2.15 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.384 -174.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.811 HG12 HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -98.64 100.4 10.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.081 0.944 . . . . 0.0 108.475 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.677 HD11 ' HA ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -119.38 106.3 12.14 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.701 -172.224 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 142' ' ' ARG . . . -106.46 70.49 0.22 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.894 HD22 ' HB2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -37.06 124.14 0.91 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.604 0.762 . . . . 0.0 110.447 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -132.35 145.89 51.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -161.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.1 m -85.99 139.75 30.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.522 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 66.08 -156.65 0.26 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.957 170.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 70.05 -65.47 0.31 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.503 0.721 . . . . 0.0 111.098 -177.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.61 -14.05 57.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.577 0.703 . . . . 0.0 109.985 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.3 t -129.26 141.3 51.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.694 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -161.69 173.44 38.06 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.927 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 9.3 t -124.99 33.3 5.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.643 0.735 . . . . 0.0 110.021 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -97.36 25.73 5.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.369 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.43 15.84 13.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.175 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.03 122.22 84.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.605 0.24 . . . . 0.0 110.432 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.24 111.25 2.21 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.999 2.466 . . . . 0.0 112.716 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -116.86 172.45 14.24 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -84.77 12.41 7.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.014 0.435 . . . . 0.0 111.521 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -143.5 79.97 1.65 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.1 m -69.1 -28.14 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.824 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.53 -0.747 . . . . 0.0 110.73 179.393 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 m -74.1 -48.84 26.95 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -89.34 100.44 13.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.163 0.506 . . . . 0.0 112.088 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 69.7 mtm -126.07 81.31 1.98 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 2.7 pp -83.48 24.72 0.81 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.678 -171.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -66.31 -29.13 69.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.378 0.609 . . . . 0.0 109.902 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 28.7 mmt 65.36 43.13 3.59 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.881 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.64 -15.53 48.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.404 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.62 -136.36 13.16 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 54.64 49.69 17.55 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.721 0.408 . . . . 0.0 111.611 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.22 -93.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.931 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -146.58 14.92 1.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.763 0.316 . . . . 0.0 110.517 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.45 -38.25 68.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.238 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 p -93.61 -38.32 11.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.811 0.339 . . . . 0.0 111.535 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -73.82 -30.47 62.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 -176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.5 mtt 70.99 122.09 0.03 OUTLIER 'General case' 0 C--O 1.231 0.129 0 O-C-N 124.045 0.84 . . . . 0.0 110.557 -176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.6 t -72.22 -20.13 61.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.108 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 67.5 -168.58 0.2 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.984 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 pp -123.91 156.27 65.82 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.402 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.86 107.93 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.415 2.743 . . . . 0.0 114.031 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.54 ' O ' HD13 ' A' ' 154' ' ' LEU . 2.8 Cg_exo -77.53 -132.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.617 2.878 . . . . 0.0 111.364 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.518 ' HB2' HD13 ' A' ' 154' ' ' LEU . 58.5 m 56.38 -83.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.895 0.478 . . . . 0.0 112.006 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.683 ' HB ' HE22 ' A' ' 148' ' ' GLN . 1.6 t -161.07 -41.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.544 -0.722 . . . . 0.0 112.336 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.809 ' H ' HD21 ' A' ' 154' ' ' LEU . 48.8 tp 56.2 99.77 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.717 ' H ' HD23 ' A' ' 156' ' ' LEU . 3.1 p-10 -160.07 -61.09 0.06 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.842 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -57.28 -178.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.415 0.626 . . . . 0.0 111.75 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.819 ' HB2' ' HB3' ' A' ' 158' ' ' SER . 9.6 t -117.28 119.85 36.43 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.621 170.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.963 HD23 HG23 ' A' ' 113' ' ' ILE . 53.4 mt -76.74 131.34 38.68 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 165.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.459 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.2 OUTLIER -92.27 -32.48 15.01 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 175.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.934 ' HA2' ' HB3' ' A' ' 141' ' ' ASP . . . 154.71 168.19 17.67 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.97 161.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.718 HG11 HG23 ' A' ' 138' ' ' ILE . 2.7 t -114.4 132.01 64.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.781 0.801 . . . . 0.0 110.91 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.842 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 67.1 mtt -104.17 87.41 2.75 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.21 177.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.81 46.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.4 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.753 ' H ' ' HA ' ' A' ' 109' ' ' SER . . . -106.62 88.14 0.54 Allowed Glycine 0 CA--C 1.496 -1.156 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 25.1 t70 74.85 -54.65 0.66 Allowed 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -169.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.672 ' O ' ' HB3' ' A' ' 109' ' ' SER . 12.7 t70 -178.97 -124.07 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.902 -1.499 . . . . 0.0 106.994 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.74 ' HA ' HG21 ' A' ' 124' ' ' VAL . 2.3 p-10 -80.9 -6.59 58.85 Favored 'General case' 0 CA--C 1.522 -0.101 0 O-C-N 124.184 0.928 . . . . 0.0 109.939 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.1 t -60.46 -42.5 96.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.164 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 78.7 mtp180 -126.2 -65.61 0.97 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.421 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.753 ' HA ' ' H ' ' A' ' 103' ' ' GLY . 13.7 p 53.58 127.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 174.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.842 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 3.6 mm -116.9 129.92 72.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.329 174.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.927 ' HB2' HD11 ' A' ' 138' ' ' ILE . . . -120.69 98.42 6.01 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.802 0.335 . . . . 0.0 111.653 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.5 mm -80.33 94.54 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.963 HG23 HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -105.82 142.62 18.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.718 177.224 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.434 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 84.5 p -113.66 129.18 56.61 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.846 0.832 . . . . 0.0 109.353 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.842 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.6 tptp -124.81 101.46 7.1 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -171.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 55.07 22.16 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -164.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.8 t-20 78.24 40.67 0.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.697 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 15.5 pt-20 -108.71 90.75 3.39 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.276 1.036 . . . . 0.0 108.292 161.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 34.9 mt-30 -67.22 124.19 22.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.524 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -128.69 147.98 50.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.993 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -97.3 105.12 17.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.616 0.722 . . . . 0.0 111.532 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.982 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 28.1 mmt180 -95.2 -163.05 1.0 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.316 176.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.616 ' O ' ' HG2' ' A' ' 126' ' ' GLU . . . 164.74 110.88 0.24 Allowed Glycine 0 C--O 1.216 -1.001 0 C-N-CA 119.738 -1.22 . . . . 0.0 114.088 -171.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.74 HG21 ' HA ' ' A' ' 106' ' ' ASP . 28.1 t 4.85 115.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.152 1.381 . . . . 0.0 114.452 -175.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.705 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 4.7 m-20 80.8 35.48 0.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.313 -175.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.982 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 13.1 mm-40 -127.31 150.72 49.45 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.781 170.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 2.3 mp0 -101.39 150.84 22.6 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 118.571 0.623 . . . . 0.0 109.861 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.619 HG22 HG21 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -62.35 151.72 81.56 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.493 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.565 ' HD2' HG22 ' A' ' 128' ' ' VAL . 3.6 Cg_exo -62.94 127.52 20.62 Favored 'Trans proline' 0 C--N 1.332 -0.292 0 C-N-CA 122.953 2.435 . . . . 0.0 112.37 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.62 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 100.48 -64.1 0.59 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.353 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.51 ' HE2' HD12 ' A' ' 95' ' ' LEU . 4.3 m-85 -110.73 140.56 45.01 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -78.87 56.37 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.538 0.608 . . . . 0.0 111.831 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.727 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -79.88 96.97 6.51 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.705 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.5 OUTLIER -81.13 115.91 20.79 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.256 0.551 . . . . 0.0 110.911 -169.394 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.58 HG21 HG13 ' A' ' 138' ' ' ILE . 74.7 mt -67.47 94.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.401 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.634 HG22 ' HE2' ' A' ' 134' ' ' LYS . 1.3 t -86.62 -6.57 10.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.723 ' CB ' ' HB ' ' A' ' 144' ' ' VAL . 4.1 t -157.15 117.12 3.46 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.125 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.927 HD11 ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -91.55 125.99 44.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.991 0.9 . . . . 0.0 111.238 176.34 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.6 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 13.5 mmt85 -142.11 148.96 50.48 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.647 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.29 81.2 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.628 2.218 . . . . 0.0 113.67 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.934 ' HB3' ' HA2' ' A' ' 99' ' ' GLY 0.279 2.9 p30 75.62 27.0 1.05 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.868 1.667 . . . . 0.0 110.17 170.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.703 ' HD2' ' N ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -139.72 151.32 45.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 112.255 -2.248 . . . . 0.0 106.204 157.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.703 ' N ' ' HD2' ' A' ' 142' ' ' ARG . 7.2 t -141.21 164.89 19.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-O 121.526 0.679 . . . . 0.0 111.395 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 153' ' ' VAL . 59.1 t -122.12 100.45 8.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.727 HD13 ' HB1' ' A' ' 133' ' ' ALA . 2.0 pp -122.56 156.56 33.94 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 122.21 1.005 . . . . 0.0 113.223 -168.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -103.46 104.58 14.68 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 112.533 -2.121 . . . . 0.0 108.581 -174.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.505 ' CD2' HG21 ' A' ' 92' ' ' THR . 0.4 OUTLIER -136.54 135.5 38.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.711 175.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.683 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.8 mp0 67.93 34.34 4.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.46 175.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.55 12.81 70.56 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.729 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.472 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 29.2 ttp180 -130.95 137.43 49.28 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.792 -0.24 . . . . 0.0 110.362 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.715 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 22.3 p90 -118.58 108.8 15.4 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.704 1.24 . . . . 0.0 109.313 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.1 mm-40 -129.02 -170.72 2.32 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.483 -1.69 . . . . 0.0 109.179 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 144' ' ' VAL . 3.5 t -97.17 105.54 17.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.184 0.516 . . . . 0.0 109.903 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.809 HD21 ' H ' ' A' ' 93' ' ' LEU . 6.1 tp -108.17 121.2 44.36 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.488 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -108.14 59.26 0.37 Allowed Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 167.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.717 HD23 ' H ' ' A' ' 94' ' ' ASN . 1.5 mt -36.46 109.73 0.1 Allowed 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.269 0.629 . . . . 0.0 109.521 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -134.43 99.15 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -172.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.819 ' HB3' ' HB2' ' A' ' 96' ' ' SER . 8.6 t -115.35 142.27 46.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.085 0.469 . . . . 0.0 110.323 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.32 169.01 18.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.548 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.98 -76.63 0.59 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -109.52 -25.7 10.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.273 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.3 m 58.86 26.47 14.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.397 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.96 -62.1 4.25 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.998 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.3 m -148.33 104.49 3.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.969 0.414 . . . . 0.0 110.053 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -77.19 -21.93 53.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.105 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.96 -22.86 17.93 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.658 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.6 p -77.82 118.98 75.57 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.088 0.471 . . . . 0.0 110.246 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.28 130.75 5.53 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.519 2.146 . . . . 0.0 112.493 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -96.66 154.3 20.6 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.724 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.13 57.48 4.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.104 0.478 . . . . 0.0 110.877 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -84.39 93.36 8.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.938 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.98 135.23 60.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.657 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 173' ' ' ARG . 30.6 ptt180 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.973 -0.537 . . . . 0.0 110.333 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.6 m -83.62 95.52 8.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.23 0.538 . . . . 0.0 110.446 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -85.92 -47.95 9.17 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.459 ' HG2' ' HG ' ' A' ' 74' ' ' LEU . 27.1 ttt -174.49 127.35 0.33 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.96 175.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.459 ' HG ' ' HG2' ' A' ' 73' ' ' MET . 96.0 mt 69.91 115.37 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 O-C-N 124.069 0.856 . . . . 0.0 111.331 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -76.19 -2.3 30.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.309 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 47.1 ttm -57.77 -26.78 62.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.646 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.45 -20.39 65.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.074 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.94 80.2 0.7 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.95 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.11 97.47 7.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.9 0.381 . . . . 0.0 110.358 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.55 9.09 3.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.689 -173.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -104.05 -21.96 13.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.486 0.66 . . . . 0.0 109.647 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.86 3.36 51.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.505 0.669 . . . . 0.0 110.132 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.4 m -93.1 -26.84 17.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.568 -169.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -99.48 -42.1 7.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.585 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -152.38 134.03 14.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.057 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.5 t -174.41 171.39 3.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.509 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.6 m120 71.65 137.95 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.041 0.838 . . . . 0.0 112.923 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . 6.5 mp -125.24 123.44 25.24 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.675 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.78 ' HB3' HD22 ' A' ' 154' ' ' LEU . 53.8 Cg_exo -54.9 108.1 0.28 Allowed 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 123.583 2.855 . . . . 0.0 113.227 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 89' ' ' PRO . 2.7 Cg_exo -77.53 -31.74 3.23 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.667 2.911 . . . . 0.0 114.718 -172.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.657 ' HB3' HD23 ' A' ' 154' ' ' LEU . 46.5 t -61.63 -76.43 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.13 0.423 . . . . 0.0 111.624 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.841 ' H ' HD21 ' A' ' 154' ' ' LEU . 2.7 t -127.7 -45.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.835 ' H ' HD11 ' A' ' 154' ' ' LEU . 45.6 tp 59.06 86.07 0.09 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.308 0.575 . . . . 0.0 111.889 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.681 ' H ' HD23 ' A' ' 156' ' ' LEU . 5.9 t-20 -160.42 -149.5 0.19 Allowed 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.027 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.5 OUTLIER 51.71 177.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 172.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.434 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 40.8 m -137.23 115.55 11.81 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.221 166.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.938 HD23 HG23 ' A' ' 113' ' ' ILE . 12.0 mt -74.97 143.16 43.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 174.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -33.2 10.84 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 147.05 154.22 6.14 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 162.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 111' ' ' ALA . 13.6 m -103.69 144.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 122.654 1.216 . . . . 0.0 112.011 -173.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.748 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 65.3 mmm -97.73 89.5 4.65 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.374 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.791 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -64.74 134.64 54.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.788 0.327 . . . . 0.0 110.857 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -125.27 89.3 0.38 Allowed Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 28.9 t70 71.32 -57.81 0.59 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -166.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.63 ' O ' ' HB2' ' A' ' 109' ' ' SER . 20.8 t70 -173.88 -87.24 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.263 -1.789 . . . . 0.0 107.846 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.889 ' HA ' HG21 ' A' ' 124' ' ' VAL . 5.6 t70 -91.5 -46.6 7.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.492 -175.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.9 t -55.13 -40.64 70.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.41 -167.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -130.26 26.7 5.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.552 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.791 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 7.8 t -92.03 140.79 29.3 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.007 -172.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.748 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 8.0 mm -117.66 91.28 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.611 -174.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.974 ' HB2' HD11 ' A' ' 138' ' ' ILE . . . -72.75 96.8 2.09 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.267 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 4.5 mm -79.84 93.71 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.938 HG23 HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -101.86 154.12 5.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.87 175.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.474 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 14.5 p -121.09 126.13 49.02 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.709 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 24.5 tptp -117.24 105.21 11.96 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -171.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 58.43 24.7 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -163.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 15.3 t-20 68.9 40.25 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 112.002 -2.363 . . . . 0.0 112.161 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.709 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 12.4 pt-20 -102.26 103.09 13.55 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 162.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 4.8 mt-30 -68.17 131.48 45.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.489 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 7.9 t80 -135.96 144.3 45.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.448 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.6 p -88.9 94.78 10.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 122.057 0.932 . . . . 0.0 111.22 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.494 ' CB ' ' HB3' ' A' ' 111' ' ' ALA . 16.0 mmt180 -98.56 -159.53 0.74 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.049 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 126' ' ' GLU . . . 178.9 161.74 27.1 Favored Glycine 0 N--CA 1.408 -3.205 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.995 HG22 ' HB ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -57.12 128.04 17.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 165.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.668 ' HB2' ' O ' ' A' ' 124' ' ' VAL . 5.5 m-20 81.14 28.58 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.482 1.134 . . . . 0.0 109.057 -176.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 123' ' ' GLY . 1.2 mm-40 -132.65 153.29 51.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 112.596 -2.093 . . . . 0.0 107.664 170.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 41.4 mt-10 -104.83 145.61 30.15 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.716 HG21 HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -62.65 153.87 76.5 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.486 -174.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.633 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 23.7 Cg_exo -66.37 126.92 16.41 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.569 2.18 . . . . 0.0 111.787 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.676 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 103.91 -57.89 0.53 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.06 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 147' ' ' TYR . 34.1 m-85 -111.92 149.62 31.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.957 -0.121 . . . . 0.0 110.743 -176.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -75.97 53.77 0.79 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.089 0.471 . . . . 0.0 111.778 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.643 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -90.24 95.69 10.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.656 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.652 ' HE2' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -82.14 107.29 14.72 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.017 0.437 . . . . 0.0 110.846 -171.151 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.72 HG12 HG11 ' A' ' 143' ' ' VAL . 64.8 mt -54.07 94.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.357 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 144' ' ' VAL . 3.9 m -97.35 8.27 7.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.948 0.88 . . . . 0.0 108.815 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.775 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 5.7 m -165.41 114.81 1.04 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.079 176.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.995 ' HB ' HG22 ' A' ' 124' ' ' VAL . 1.1 tt -98.45 127.99 50.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.401 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 5.2 mmt180 -143.73 150.3 49.79 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -14.55 -74.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 1 C-N-CA 125.708 4.272 . . . . 0.0 114.974 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.44 ' C ' HD13 ' A' ' 97' ' ' LEU . 7.8 p-10 -138.98 47.73 1.91 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.247 1.022 . . . . 0.0 109.475 168.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.821 ' HD3' HG13 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -143.81 139.37 29.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.154 165.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.72 HG11 HG12 ' A' ' 135' ' ' ILE . 10.4 t -135.02 118.19 23.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.071 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 153' ' ' VAL . 9.2 t -80.48 62.23 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.136 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.705 HD11 ' HG ' ' A' ' 154' ' ' LEU . 1.7 pp -79.83 166.78 21.36 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -171.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -108.83 104.87 14.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 111.662 -2.517 . . . . 0.0 108.41 -177.035 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 131' ' ' TYR . 1.0 OUTLIER -139.3 133.48 31.27 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.458 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.573 ' OE1' ' HB ' ' A' ' 92' ' ' THR . 0.7 OUTLIER 70.39 32.83 2.66 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.471 0.482 . . . . 0.0 110.859 175.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.58 3.78 79.29 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.409 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.53 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 2.3 tpm_? -125.02 153.53 42.69 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.655 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 2.7 p90 -134.77 106.64 7.01 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.355 1.074 . . . . 0.0 108.229 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 81.0 mm-40 -134.62 -176.24 4.15 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.46 -169.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 144' ' ' VAL . 26.2 t -93.67 100.2 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.014 0.912 . . . . 0.0 108.724 -170.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.841 HD21 ' H ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -106.87 102.91 12.24 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 114.22 -1.354 . . . . 0.0 111.363 -175.78 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 142' ' ' ARG . . . -100.99 57.13 0.72 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.572 175.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 1.027 HD22 ' HB2' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -37.23 109.82 0.11 Allowed 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.385 0.697 . . . . 0.0 109.624 171.298 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -121.94 157.58 30.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 112.04 -164.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.434 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 18.1 m -86.22 106.78 17.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.354 175.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.593 ' HG3' ' HG3' ' A' ' 160' ' ' GLU . 9.7 pt20 -85.48 -57.1 3.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.133 -176.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.593 ' HG3' ' HG3' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -95.4 92.36 6.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.381 0.61 . . . . 0.0 111.108 177.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 162' ' ' SER . 4.2 p30 -89.91 18.22 5.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.377 177.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 169' ' ' GLY . 40.4 t 79.85 -29.98 0.13 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.222 1.009 . . . . 0.0 111.667 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.667 ' HA2' HG12 ' A' ' 167' ' ' VAL . . . 128.47 66.27 0.12 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.023 -1.084 . . . . 0.0 113.227 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.2 m -67.98 -40.09 83.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.937 0.399 . . . . 0.0 110.729 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -92.43 -12.46 32.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.02 0.438 . . . . 0.0 110.155 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 112.24 19.36 7.19 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.866 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.667 HG12 ' HA2' ' A' ' 163' ' ' GLY . 7.3 p -68.63 129.97 92.22 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.633 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 167' ' ' VAL . 23.4 Cg_exo -65.42 109.2 1.34 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.814 2.343 . . . . 0.0 112.378 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 162' ' ' SER . . . 166.16 57.39 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -116.83 -64.86 1.25 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.823 0.344 . . . . 0.0 111.221 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 171' ' ' GLN . 3.8 pp0? -82.47 -22.95 34.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.478 -176.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.1 m -99.5 -38.2 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.854 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 . . . . . 0 C--O 1.249 1.036 0 O-C-N 123.951 0.782 . . . . 0.0 110.526 -177.148 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 p -69.33 136.48 51.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.858 0.361 . . . . 0.0 110.233 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -88.79 64.22 7.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.256 0.55 . . . . 0.0 110.285 -175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 22.5 ptp -79.45 -22.91 43.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.357 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.8 mt 64.2 -78.96 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.993 0.808 . . . . 0.0 111.013 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -173.45 110.57 0.18 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.036 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 96.3 mmm -74.87 99.04 3.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.023 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.6 -35.78 10.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.022 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.39 163.38 36.63 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.867 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.38 132.01 35.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -77.08 -28.52 54.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.524 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 84' ' ' GLN . 30.8 m-20 -84.63 56.98 4.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.35 0.595 . . . . 0.0 110.355 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.22 -31.59 71.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.442 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 t -84.24 -15.39 46.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.262 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.564 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 35.4 tt0 -83.0 -28.9 29.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.839 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 70.6 mtm 63.25 45.32 5.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.124 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -62.42 99.45 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.537 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -126.29 133.21 51.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.21 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.748 HD23 ' H ' ' A' ' 88' ' ' LEU . 2.6 pt? -104.49 147.51 34.51 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.25 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 49.6 Cg_endo -70.71 113.49 3.55 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.66 2.24 . . . . 0.0 112.109 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.46 ' HB2' ' H ' ' A' ' 91' ' ' SER . 4.0 Cg_exo -75.84 -115.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.151 2.567 . . . . 0.0 111.518 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.797 ' HB2' HD13 ' A' ' 154' ' ' LEU . 22.1 m 54.74 -79.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.898 ' HB ' HE22 ' A' ' 148' ' ' GLN . 0.1 OUTLIER -163.72 -44.56 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.124 -0.36 . . . . 0.0 111.216 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.967 ' H ' HD21 ' A' ' 154' ' ' LEU . 1.0 OUTLIER 52.48 99.78 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.046 0.451 . . . . 0.0 111.434 -177.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.753 ' H ' HD23 ' A' ' 156' ' ' LEU . 40.1 t-20 -157.63 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.002 -172.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.868 HD21 ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -56.77 174.65 0.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.374 179.152 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.532 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 42.4 t -121.58 118.98 30.59 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.557 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.547 ' HA ' HG23 ' A' ' 113' ' ' ILE . 6.0 mp -79.02 124.36 28.19 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.72 -29.85 22.1 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.01 173.64 30.92 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 169.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.966 HG22 ' HA ' ' A' ' 111' ' ' ALA . 2.4 t -129.75 126.84 63.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.558 0.694 . . . . 0.0 110.397 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.878 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -89.42 89.38 7.84 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.047 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.695 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -65.91 132.24 48.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.224 -174.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 108' ' ' ARG . . . -117.47 92.16 0.55 Allowed Glycine 0 CA--C 1.5 -0.868 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 -173.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.5 t0 69.53 -59.55 0.49 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.935 0.874 . . . . 0.0 108.784 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -156.83 -146.81 0.17 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.313 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.67 ' HB3' HG21 ' A' ' 124' ' ' VAL . 7.2 m-20 -56.53 -33.34 65.98 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.49 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.8 t -46.84 -56.3 6.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.435 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 22.7 mtp180 -119.49 30.49 7.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.611 -167.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.695 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 8.4 t -86.96 145.64 26.44 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.733 0.777 . . . . 0.0 112.133 -172.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.878 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 12.6 mm -114.3 92.5 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.404 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.966 ' HA ' HG22 ' A' ' 100' ' ' VAL . . . -73.86 101.46 3.77 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.399 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 28.8 mm -86.47 93.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.901 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -104.5 150.08 7.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.647 -177.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 64.6 p -116.05 130.56 56.87 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.133 0.492 . . . . 0.0 109.724 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.868 ' HA ' HD21 ' A' ' 95' ' ' LEU . 19.0 tptp -110.43 102.48 11.1 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 59.89 27.13 16.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 66.8 t30 81.21 33.25 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 112.453 -2.158 . . . . 0.0 110.854 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -106.12 97.39 7.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.657 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 0.3 OUTLIER -66.61 135.89 54.79 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.594 -176.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 15.6 t80 -144.86 149.54 35.52 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.367 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.543 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 6.4 m -88.57 101.6 14.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.608 0.718 . . . . 0.0 111.169 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 122' ' ' ARG . 18.0 mmt180 -104.94 -160.13 0.74 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.828 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.458 ' HA2' HD12 ' A' ' 138' ' ' ILE . . . -179.31 169.47 40.66 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.115 -1.04 . . . . 0.0 111.461 -176.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.845 HG23 ' HB ' ' A' ' 138' ' ' ILE . 5.7 t -45.32 129.9 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 114.223 -0.988 . . . . 0.0 110.456 162.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.686 ' HA ' ' HD2' ' A' ' 134' ' ' LYS . 0.0 OUTLIER 69.09 14.75 8.76 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 124.749 1.281 . . . . 0.0 110.428 176.204 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -105.81 164.48 11.9 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 167.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.836 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 33.1 mt-10 -114.12 151.13 33.07 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 119.142 0.883 . . . . 0.0 110.018 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.614 HG22 HG21 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -59.13 143.42 84.54 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.048 0.451 . . . . 0.0 110.416 -176.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.625 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.1 Cg_exo -73.06 94.16 0.81 Allowed 'Trans proline' 0 C--O 1.222 -0.309 0 C-N-CA 123.244 2.63 . . . . 0.0 112.467 -170.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.474 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 132.76 -48.73 0.95 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.532 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 10.4 m-85 -112.65 137.7 50.53 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -73.91 46.75 0.24 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.897 0.772 . . . . 0.0 112.993 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.68 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -82.56 99.17 9.36 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 171.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.836 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -80.65 125.79 30.45 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-O 120.849 0.357 . . . . 0.0 110.939 -171.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.5 mt -77.23 89.93 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.601 HG22 ' HG3' ' A' ' 134' ' ' LYS . 1.3 t -85.11 -3.97 8.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 122.044 0.926 . . . . 0.0 108.641 -175.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.496 ' HB3' HG23 ' A' ' 144' ' ' VAL . 1.7 t -160.59 117.36 2.38 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.434 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.938 HD11 ' HB2' ' A' ' 111' ' ' ALA . 3.6 tt -94.92 133.51 35.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.495 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.574 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 17.0 mmt180 -141.79 162.85 44.21 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 170.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 139' ' ' ARG . 89.0 Cg_exo -25.22 -84.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.75 3.633 . . . . 0.0 114.635 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -116.64 29.81 7.71 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.154 0.978 . . . . 0.0 108.61 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.574 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 6.1 tpp85 -127.97 141.91 51.39 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.03 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.453 HG23 HD21 ' A' ' 97' ' ' LEU . 4.3 t -145.61 168.55 7.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.706 -175.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.956 HG22 HG23 ' A' ' 153' ' ' VAL . 19.5 t -129.84 62.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.798 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 1.5 pp -82.38 155.27 24.79 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -165.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 134' ' ' LYS . 5.0 tp-100 -99.91 104.42 16.06 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 111.937 -2.392 . . . . 0.0 108.586 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.859 ' HD2' HG21 ' A' ' 92' ' ' THR . 0.6 OUTLIER -141.83 132.95 26.21 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.487 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.898 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.8 mt-30 67.59 28.18 7.55 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.405 0.44 . . . . 0.0 110.774 175.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.32 -2.91 85.41 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 119.809 -1.186 . . . . 0.0 112.698 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.401 ' HD2' ' OE2' ' A' ' 152' ' ' GLU . 28.5 ptt180 -126.26 145.51 50.38 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.576 -0.367 . . . . 0.0 111.242 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.798 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 6.4 p90 -122.76 109.96 14.87 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 171.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.455 ' OE2' ' HB2' ' A' ' 90' ' ' PRO . 36.7 mt-10 -127.33 -175.47 3.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.956 HG23 HG22 ' A' ' 144' ' ' VAL . 6.0 p -95.99 98.72 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-O 122.835 1.302 . . . . 0.0 110.155 -165.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.967 HD21 ' H ' ' A' ' 93' ' ' LEU . 10.0 tp -106.81 116.22 31.55 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.36 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.567 ' O ' ' HD2' ' A' ' 157' ' ' TYR . . . -99.57 61.06 0.75 Allowed Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.952 167.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.753 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.7 mt -36.38 111.61 0.15 Allowed 'General case' 0 N--CA 1.485 1.306 0 O-C-N 124.325 0.662 . . . . 0.0 109.748 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.567 ' HD2' ' O ' ' A' ' 155' ' ' GLY . 51.3 p90 -134.09 149.07 51.09 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.19 0.45 . . . . 0.0 110.45 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.532 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 41.9 m -152.62 159.32 43.23 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 68.1 179.56 0.23 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.485 0.491 . . . . 0.0 111.262 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -126.06 112.62 16.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.543 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -74.25 -46.61 40.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.67 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.8 t 49.84 52.71 14.09 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.276 0.36 . . . . 0.0 111.175 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -169.05 -41.55 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.127 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.0 m -110.03 68.07 0.66 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.104 0.478 . . . . 0.0 110.964 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.468 ' HB2' HG22 ' A' ' 167' ' ' VAL . 8.6 p-10 -74.37 -53.49 9.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.651 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 58.54 34.18 74.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.433 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 165' ' ' ASP . 33.3 m -120.89 155.94 57.02 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.24 108.86 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.148 1.899 . . . . 0.0 111.435 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -78.39 123.41 6.26 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.049 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -94.26 77.27 3.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.375 0.607 . . . . 0.0 109.974 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -89.92 50.78 1.93 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.206 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.7 m -124.09 156.72 31.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.972 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.876 -179.288 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.849 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.9 m -84.27 74.35 10.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.815 0.34 . . . . 0.0 110.753 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 46.6 m170 58.46 56.71 4.2 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.805 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.42 51.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.691 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.9 tp -106.35 112.33 25.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.411 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 74.3 137.5 0.06 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.276 0.985 . . . . 0.0 112.617 171.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 42.4 tpp -75.4 -29.68 59.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.265 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.35 42.06 1.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.9 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.02 17.25 33.22 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.254 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.37 59.43 2.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.213 0.53 . . . . 0.0 110.587 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.574 ' HG ' ' H ' ' A' ' 81' ' ' ASP . 30.7 tp -153.66 176.06 12.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.337 -175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.574 ' H ' ' HG ' ' A' ' 80' ' ' LEU . 5.4 m-20 -64.8 -14.94 60.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.611 0.243 . . . . 0.0 111.583 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.92 -33.42 74.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.007 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.8 p -83.46 -19.26 36.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.655 0.264 . . . . 0.0 111.647 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -99.8 -51.28 3.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.258 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 70.1 mtm 47.97 34.39 4.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.189 0.518 . . . . 0.0 111.465 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.1 m -166.71 160.45 14.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.559 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -84.6 36.92 0.62 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.674 0.749 . . . . 0.0 109.537 175.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 89' ' ' PRO . 25.4 tp -88.02 130.1 47.65 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.722 -178.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 88' ' ' LEU . 56.3 Cg_exo -40.52 114.81 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.087 3.191 . . . . 0.0 113.682 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.6 ' O ' HD21 ' A' ' 154' ' ' LEU . 33.6 Cg_exo -63.75 -134.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.438 2.759 . . . . 0.0 111.99 172.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.671 ' HB2' ' HG ' ' A' ' 154' ' ' LEU . 60.0 m 53.46 -83.03 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.54 0.336 . . . . 0.0 110.992 -170.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.742 HG23 HD11 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -156.04 -49.51 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 119.491 -0.29 . . . . 0.0 111.037 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 156' ' ' LEU . 46.0 tp 54.17 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.504 0.502 . . . . 0.0 111.663 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.683 ' H ' HD23 ' A' ' 156' ' ' LEU . 26.5 t-20 -162.5 -60.21 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.024 0.44 . . . . 0.0 111.669 -175.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.847 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -56.34 175.96 0.1 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.124 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.8 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 21.7 t -114.98 108.5 16.79 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.028 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.836 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -73.22 117.33 14.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 171.341 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.491 HG21 ' OE1' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -91.18 -34.53 14.98 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -173.114 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 158.51 141.17 3.08 Favored Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.783 171.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.598 HG21 HG23 ' A' ' 138' ' ' ILE . 12.1 m -102.39 147.85 8.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.77 0.795 . . . . 0.0 109.689 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.866 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 67.5 mtt -104.03 90.69 3.68 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.024 176.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.59 120.95 9.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.777 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.598 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -110.98 97.96 1.01 Allowed Glycine 0 CA--C 1.492 -1.367 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -174.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.598 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 3.6 m-20 73.42 -66.03 0.33 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -173.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.539 ' O ' ' HB3' ' A' ' 109' ' ' SER . 8.3 m-20 -162.29 -102.64 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.692 -1.594 . . . . 0.0 107.594 167.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.693 ' HB2' HG21 ' A' ' 124' ' ' VAL . 6.5 p-10 -91.73 -20.2 21.8 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.35 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.45 ' C ' ' HD3' ' A' ' 108' ' ' ARG . 14.5 m -61.87 -47.01 86.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.077 -174.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.45 ' HD3' ' C ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -123.79 19.89 9.35 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.053 -168.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.66 ' HB2' HD12 ' A' ' 138' ' ' ILE . 2.8 p -66.77 147.29 53.45 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.324 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.866 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 5.5 mm -126.94 84.74 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-O 121.783 0.802 . . . . 0.0 110.862 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.865 ' HB3' ' HB2' ' A' ' 122' ' ' ARG . . . -72.93 96.92 2.18 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.404 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 9.9 mm -81.86 94.35 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.863 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -105.29 140.43 23.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.666 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.831 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 29.9 t -99.69 129.31 45.81 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.865 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.9 tptp -128.79 106.06 8.66 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.7 t70 62.52 18.57 10.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -169.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.831 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 64.8 t30 76.22 38.54 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.535 -175.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.506 ' HG2' ' CE1' ' A' ' 120' ' ' PHE . 31.1 tt0 -113.13 93.6 4.49 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.161 167.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 28.5 mt-30 -66.83 129.72 40.8 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.886 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.697 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 50.6 m-85 -119.88 150.34 40.63 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.306 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.499 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 6.2 m -94.23 99.16 11.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.712 0.768 . . . . 0.0 109.844 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.865 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 64.9 mmt-85 -89.61 -161.86 0.82 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.822 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.685 ' N ' ' HG2' ' A' ' 126' ' ' GLU . . . 161.11 95.59 0.11 Allowed Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.007 -1.092 . . . . 0.0 112.894 -163.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.693 HG21 ' HB2' ' A' ' 106' ' ' ASP . 2.2 t 4.55 123.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 126.563 1.978 . . . . 0.0 114.976 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.698 ' HA ' ' CE ' ' A' ' 134' ' ' LYS . 7.1 m-20 78.21 34.42 0.29 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.664 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.685 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 0.8 OUTLIER -124.04 167.08 14.67 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 112.669 -2.059 . . . . 0.0 107.844 168.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 1.9 mp0 -112.1 146.31 38.22 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.477 HG21 HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -61.66 153.72 69.52 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.479 ' O ' HD11 ' A' ' 95' ' ' LEU . 24.4 Cg_exo -66.04 127.84 18.45 Favored 'Trans proline' 0 C--N 1.333 -0.287 0 C-N-CA 122.424 2.083 . . . . 0.0 112.442 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.584 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 100.66 -59.78 0.67 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.209 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.622 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 10.9 m-85 -109.68 140.75 43.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.025 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -74.94 49.89 0.44 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.659 0.663 . . . . 0.0 111.789 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.705 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -80.64 96.68 6.94 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.752 ' HD2' ' C ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -80.49 108.96 14.55 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 121.044 0.45 . . . . 0.0 110.989 -168.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.652 HG12 HG11 ' A' ' 143' ' ' VAL . 50.5 mt -60.81 95.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.93 177.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.585 HG23 ' HA ' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -84.15 -8.63 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.081 179.09 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.683 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 39.4 m -157.49 116.18 3.22 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.435 -174.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.662 ' CD1' ' HB2' ' A' ' 111' ' ' ALA . 3.9 mt -92.61 127.91 44.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.598 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 28.0 mmt180 -141.2 151.62 62.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 173.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.411 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 78.0 Cg_exo -18.57 -75.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 1 C-N-CA 125.519 4.146 . . . . 0.0 114.776 -178.322 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.501 ' HA ' HD23 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -129.21 39.47 3.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.412 1.101 . . . . 0.0 108.797 168.093 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.593 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 8.2 tpp85 -136.06 143.56 44.73 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.835 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.729 HG23 HD21 ' A' ' 97' ' ' LEU . 3.4 t -141.67 169.25 14.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.534 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.85 HG22 HG12 ' A' ' 153' ' ' VAL . 18.3 t -133.58 61.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.786 HD11 HD12 ' A' ' 154' ' ' LEU . 1.9 pp -82.64 162.47 21.86 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -167.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.4 OUTLIER -105.73 105.49 15.56 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 112.556 -2.111 . . . . 0.0 108.232 -178.094 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.638 ' HD2' HG21 ' A' ' 92' ' ' THR . 0.7 OUTLIER -141.21 136.78 32.08 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.753 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.506 ' OE1' ' HB ' ' A' ' 92' ' ' THR . 4.7 mt-30 68.29 28.67 6.23 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.534 0.521 . . . . 0.0 110.998 173.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.35 3.25 78.79 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.71 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 20.4 ttt180 -133.31 144.69 49.84 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.78 -0.247 . . . . 0.0 111.065 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.709 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 11.0 p90 -115.88 107.84 15.53 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.438 1.113 . . . . 0.0 107.999 171.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.824 ' HG3' ' H ' ' A' ' 153' ' ' VAL . 10.2 tp10 -130.79 -173.18 3.01 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.546 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.85 HG12 HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -95.28 100.06 10.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.676 0.75 . . . . 0.0 111.015 -167.058 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.786 HD12 HD11 ' A' ' 145' ' ' LEU . 1.2 mt -101.35 109.44 21.29 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.672 176.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.437 ' O ' ' HD2' ' A' ' 157' ' ' TYR . . . -99.85 52.19 1.03 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.4 mt -35.77 117.68 0.45 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.673 0.866 . . . . 0.0 109.659 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.437 ' HD2' ' O ' ' A' ' 155' ' ' GLY . 45.6 p90 -135.84 153.08 51.61 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.8 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 2.3 t -99.61 168.33 10.02 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 173.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 68.79 -173.68 0.19 Allowed 'General case' 0 C--O 1.232 0.164 0 O-C-N 123.637 0.586 . . . . 0.0 110.221 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -99.05 124.87 44.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -72.16 -65.9 0.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.283 -172.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 47.2 p 46.13 49.33 12.51 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.216 0.607 . . . . 0.0 111.874 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.89 -163.79 10.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.625 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.3 m -112.49 135.8 52.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.055 0.455 . . . . 0.0 110.629 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -76.35 -27.99 56.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.229 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.32 3.64 27.46 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.885 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 66.6 t -86.03 112.0 42.29 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 167' ' ' VAL . 11.9 Cg_exo -70.53 110.94 2.84 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.071 2.514 . . . . 0.0 112.692 -176.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -86.27 -42.76 6.48 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . 57.96 -91.78 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.409 0.684 . . . . 0.0 111.607 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -81.76 69.09 8.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.84 0.352 . . . . 0.0 110.755 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.1 t -66.47 -38.16 81.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.568 ' HD3' ' C ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.822 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.176 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.844 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.4 m -84.22 123.36 30.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.706 0.288 . . . . 0.0 110.561 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -108.54 73.48 0.87 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 111.296 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 96.1 mmm -117.96 5.41 12.12 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.9 tp -77.5 75.11 4.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.109 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 54.42 65.28 1.55 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.076 175.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 19.8 ptm -84.0 78.4 9.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.418 0.628 . . . . 0.0 110.552 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.33 43.3 10.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.838 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.65 91.1 0.23 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.918 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 178.68 -36.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.588 0.355 . . . . 0.0 110.757 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.4 tp -64.33 96.5 0.16 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.435 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.5 t70 54.59 50.94 14.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.264 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -91.35 -64.39 1.13 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.298 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.429 ' HB3' HG11 ' A' ' 153' ' ' VAL . 14.9 m -88.99 -3.05 58.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.664 -176.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -76.15 -13.11 60.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.144 0.497 . . . . 0.0 110.255 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.1 mtt -78.26 -60.74 2.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.909 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.8 t 57.39 58.52 3.79 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.574 0.702 . . . . 0.0 109.84 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -99.32 -36.47 9.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.91 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.407 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 63.0 tp -139.2 108.65 7.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 2.4 Cg_endo -82.02 107.89 1.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.294 2.663 . . . . 0.0 111.596 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.718 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.9 Cg_exo -77.7 -133.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.297 2.665 . . . . 0.0 111.854 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.594 ' OG ' ' HB2' ' A' ' 152' ' ' GLU . 0.0 OUTLIER 47.91 -100.23 0.06 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.261 0.624 . . . . 0.0 112.049 -174.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.644 ' H ' HD11 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -138.45 -37.19 0.56 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.024 0.829 . . . . 0.0 112.541 -178.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.66 ' H ' ' CD1' ' A' ' 154' ' ' LEU . 1.3 tm? 66.57 -4.11 0.78 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.488 ' N ' HD23 ' A' ' 156' ' ' LEU . 4.0 t30 -103.96 97.61 7.57 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.623 -0.673 . . . . 0.0 112.572 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.746 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -179.97 179.01 0.57 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 177.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.537 ' H ' HD13 ' A' ' 95' ' ' LEU . 24.4 t -123.29 101.04 7.15 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 119.442 1.019 . . . . 0.0 110.345 173.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.894 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -81.23 75.46 8.19 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.133 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.586 HG21 ' OE1' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -40.31 -47.57 2.52 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 174.22 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 140' ' ' PRO . . . 160.33 153.45 6.94 Favored Glycine 0 CA--C 1.488 -1.595 0 C-N-CA 118.317 -1.897 . . . . 0.0 113.431 173.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.635 HG22 ' HA ' ' A' ' 140' ' ' PRO . 8.0 m -103.92 142.72 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-O 121.565 0.698 . . . . 0.0 109.64 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.846 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -98.48 87.42 3.84 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.81 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -56.18 135.21 53.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.878 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 105' ' ' ASP . . . -123.14 92.69 0.47 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.815 -176.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 t70 71.28 -40.57 0.48 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.239 1.015 . . . . 0.0 110.118 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 103' ' ' GLY . 4.3 t70 -178.88 -141.02 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.752 ' CB ' HG21 ' A' ' 124' ' ' VAL . 20.8 m-20 -67.07 -29.61 69.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.3 0.571 . . . . 0.0 109.605 167.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.5 t -52.86 -57.46 10.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.937 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.412 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 5.2 mmm180 -114.29 26.52 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.122 -173.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.81 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 1.6 t -76.47 152.29 36.19 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.781 0.324 . . . . 0.0 111.217 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.846 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 15.4 mm -123.69 85.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 122.059 0.933 . . . . 0.0 110.833 -176.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.883 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -70.85 99.52 1.76 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.95 -176.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 7.8 mm -88.29 91.72 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -100.8 137.74 27.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.904 -177.009 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 4.2 m -95.22 122.47 37.94 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.754 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.522 ' HE3' ' HA3' ' A' ' 130' ' ' GLY . 25.0 tptp -117.07 97.42 5.92 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 58.88 23.58 11.52 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -164.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 114' ' ' SER . 1.5 t30 75.98 38.8 0.33 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.912 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -99.26 92.88 5.65 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 161.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.586 ' OE1' HG21 ' A' ' 98' ' ' THR . 17.3 mt-30 -68.54 105.37 2.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.028 -173.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 6.7 t80 -106.67 133.82 50.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.863 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.6 p -85.31 98.89 10.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.307 1.051 . . . . 0.0 111.431 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.86 ' HB3' ' OE2' ' A' ' 126' ' ' GLU . 14.5 mmt180 -89.45 -161.89 0.82 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.392 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.588 ' N ' ' HG2' ' A' ' 126' ' ' GLU . . . 158.93 94.13 0.1 OUTLIER Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.586 -165.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.752 HG21 ' CB ' ' A' ' 106' ' ' ASP . 21.5 t 7.74 120.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.478 1.911 . . . . 0.0 115.71 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.676 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 5.4 m-20 83.04 40.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 123.05 1.405 . . . . 0.0 109.165 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.86 ' OE2' ' HB3' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -135.83 158.26 44.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 111.917 -2.401 . . . . 0.0 108.115 171.245 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 52.9 mt-10 -105.49 142.75 34.7 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.223 0.535 . . . . 0.0 110.981 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.836 HG22 ' HD2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -56.65 143.51 68.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.723 -174.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.836 ' HD2' HG22 ' A' ' 128' ' ' VAL . 2.2 Cg_endo -57.22 116.91 3.55 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.761 2.307 . . . . 0.0 112.924 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.522 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 113.98 -63.05 0.31 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.524 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.468 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 18.2 m-85 -107.79 147.36 30.95 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -78.58 58.37 2.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.983 0.81 . . . . 0.0 111.674 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.705 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -91.9 97.71 11.14 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.244 175.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.676 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER -80.23 106.92 12.61 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 120.69 0.281 . . . . 0.0 110.653 -171.652 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.744 ' HB ' ' OE1' ' A' ' 126' ' ' GLU . 75.6 mt -56.5 96.33 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 122.097 0.951 . . . . 0.0 110.174 176.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.715 HG23 ' HA ' ' A' ' 145' ' ' LEU . 1.6 t -88.09 -2.74 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.379 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -165.89 117.61 1.07 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.332 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.629 HG21 ' OG ' ' A' ' 109' ' ' SER . 1.9 mt -92.79 125.13 45.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.043 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 8.4 mmt180 -129.9 153.21 80.91 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.635 ' HA ' HG22 ' A' ' 100' ' ' VAL . 32.4 Cg_exo -22.82 -68.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 1 C-N-CA 125.388 4.059 . . . . 0.0 114.605 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.505 ' HA ' HD23 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -137.31 39.07 2.49 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.642 1.21 . . . . 0.0 109.111 172.585 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 2.3 tpp85 -142.05 142.81 32.89 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.208 -1.814 . . . . 0.0 108.393 176.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.61 HG11 HG12 ' A' ' 135' ' ' ILE . 2.1 t -139.87 166.91 19.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.499 0.666 . . . . 0.0 110.996 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 153' ' ' VAL . 40.9 t -130.04 95.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.878 HD11 HD12 ' A' ' 154' ' ' LEU . 2.6 pp -121.12 158.4 28.02 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -164.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.7 OUTLIER -92.27 110.41 21.8 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.168 -1.833 . . . . 0.0 109.468 -176.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.476 ' CD2' HG21 ' A' ' 92' ' ' THR . 0.5 OUTLIER -151.14 133.38 15.33 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.265 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 74.14 34.83 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.65 0.593 . . . . 0.0 110.423 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.0 13.74 82.89 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.794 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 32.5 ptt180 -142.59 170.47 15.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.689 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 26.1 p90 -136.03 111.08 8.88 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.314 1.054 . . . . 0.0 108.409 171.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.718 ' HG3' ' HB2' ' A' ' 90' ' ' PRO . 76.7 mm-40 -119.76 -170.19 1.91 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.126 -173.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.677 HG12 HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -103.03 107.13 21.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.637 0.732 . . . . 0.0 110.407 -172.26 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.878 HD12 HD11 ' A' ' 145' ' ' LEU . 1.4 mt -113.44 114.16 26.18 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.47 -175.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.468 ' O ' ' HD1' ' A' ' 157' ' ' TYR . . . -110.11 50.84 0.74 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 168.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.746 HD22 ' HB2' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -36.04 113.25 0.21 Allowed 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.803 0.943 . . . . 0.0 109.608 178.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.468 ' HD1' ' O ' ' A' ' 155' ' ' GLY . 51.3 p90 -134.12 144.03 48.32 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.75 -0.594 . . . . 0.0 109.784 -172.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.505 ' HB3' ' HB2' ' A' ' 96' ' ' SER . 23.2 t -152.45 107.79 3.28 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -97.9 -66.7 0.89 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.705 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -127.03 179.77 5.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.779 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.44 -68.53 0.61 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -176.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.7 t 49.77 40.65 20.74 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.977 0.417 . . . . 0.0 111.006 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.89 -49.39 7.09 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.055 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.6 t 69.82 -68.73 0.19 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.337 0.655 . . . . 0.0 111.269 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.49 -14.88 36.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.343 0.592 . . . . 0.0 110.351 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.41 -21.17 22.17 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.36 139.4 32.83 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.07 124.71 16.25 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.805 2.337 . . . . 0.0 111.818 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -92.08 38.52 3.17 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.415 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -88.37 43.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.206 0.527 . . . . 0.0 110.37 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -111.56 92.71 4.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.38 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 27.4 m -84.32 40.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.323 0.583 . . . . 0.0 111.571 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.608 -0.71 . . . . 0.0 109.872 -179.687 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.449 ' HB2' HD11 ' A' ' 74' ' ' LEU . 4.7 p -102.39 88.44 3.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.138 0.494 . . . . 0.0 110.646 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -113.42 -37.48 4.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.354 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.4 tpp -97.55 75.18 2.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.653 0.739 . . . . 0.0 110.779 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 71' ' ' SER . 97.1 mt -113.54 11.66 18.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.32 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -89.17 8.21 31.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.45 -173.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.3 ttt -156.81 -81.62 0.07 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 47.02 74.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.029 0.831 . . . . 0.0 112.906 174.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.79 63.91 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.898 -1.144 . . . . 0.0 113.021 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -143.51 110.89 5.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.558 0.218 . . . . 0.0 110.983 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.2 mt 57.79 33.11 22.83 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.393 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.93 4.66 7.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.282 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 86' ' ' SER . . . -76.95 -30.04 55.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.046 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.1 m -69.92 -11.14 60.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.733 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -63.15 -64.16 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.553 -174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 37.3 tpp -120.85 -19.18 7.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.841 0.353 . . . . 0.0 111.446 -176.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 13.1 m -80.73 132.27 35.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.877 0.37 . . . . 0.0 110.481 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -116.31 -36.05 4.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.657 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 89' ' ' PRO . 33.1 tp -74.87 124.78 89.77 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.921 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.829 ' HB3' HD12 ' A' ' 154' ' ' LEU . 76.3 Cg_exo -51.09 108.97 0.26 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.724 2.949 . . . . 0.0 112.796 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.668 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 9.1 Cg_exo -73.45 -33.87 6.44 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.856 3.038 . . . . 0.0 115.434 -169.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.677 ' HB2' HD13 ' A' ' 154' ' ' LEU . 67.9 m -56.0 -71.29 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.502 0.592 . . . . 0.0 111.142 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.635 HG23 HD21 ' A' ' 154' ' ' LEU . 1.7 t -160.36 -48.45 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.046 ' H ' HD21 ' A' ' 154' ' ' LEU . 53.8 tp 60.99 118.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.581 ' H ' HD23 ' A' ' 156' ' ' LEU . 24.7 t-20 -176.54 -63.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.834 0.35 . . . . 0.0 111.901 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.835 HD21 ' HD2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -55.64 169.31 0.34 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.798 -178.329 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 158' ' ' SER . 16.5 m -114.55 110.74 20.28 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.713 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.694 ' HA ' HG23 ' A' ' 113' ' ' ILE . 3.3 mp -76.21 123.06 25.27 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 114' ' ' SER . 0.2 OUTLIER -87.58 -36.54 17.48 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -175.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.555 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 159.49 146.75 4.66 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.654 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.75 HG22 ' HA ' ' A' ' 111' ' ' ALA . 5.2 t -103.97 131.05 53.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.054 0.454 . . . . 0.0 110.689 -174.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.864 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -97.46 88.02 4.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.805 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -67.95 126.74 30.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -174.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -128.52 110.48 1.13 Allowed Glycine 0 CA--C 1.5 -0.871 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.93 -171.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 23.9 t70 70.11 -65.18 0.33 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.692 ' O ' ' HB2' ' A' ' 109' ' ' SER . 20.2 t70 -167.72 -91.34 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.26 161.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.767 ' HA ' HG21 ' A' ' 124' ' ' VAL . 6.1 p-10 -91.97 -21.21 20.67 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.812 0.695 . . . . 0.0 111.078 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.447 ' HB2' ' HG2' ' A' ' 108' ' ' ARG . 3.9 m -60.03 -38.0 81.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.385 -172.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 107' ' ' SER . 0.1 OUTLIER -141.94 32.44 1.58 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.674 -172.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.805 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 1.5 t -85.99 135.84 33.49 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.034 0.445 . . . . 0.0 110.24 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.864 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 13.0 mm -116.91 88.49 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.341 -173.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.959 ' HB2' HD11 ' A' ' 138' ' ' ILE . . . -73.88 98.06 2.91 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.47 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 17.1 mm -82.87 94.73 3.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.807 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.3 OUTLIER -106.28 148.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.644 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.526 ' HB3' ' OG1' ' A' ' 98' ' ' THR . 1.3 p -118.37 132.71 56.26 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.473 0.654 . . . . 0.0 109.611 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.835 ' HD2' HD21 ' A' ' 95' ' ' LEU . 17.8 tptm -108.68 100.65 9.87 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.2 t70 52.92 33.32 14.28 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -165.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 63.9 t30 79.85 29.81 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 112.537 -2.119 . . . . 0.0 111.393 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 8.6 tp10 -96.88 92.77 6.28 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 170.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 11.5 mt-30 -73.85 132.58 42.68 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -138.29 152.29 48.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.58 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.2 p -95.39 105.79 17.79 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.316 0.579 . . . . 0.0 111.503 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 1.093 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 30.1 mmt180 -96.83 -163.75 1.08 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.805 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.628 ' N ' ' HG3' ' A' ' 126' ' ' GLU . . . 173.05 93.41 0.09 OUTLIER Glycine 0 C--O 1.222 -0.596 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.456 -164.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 1.016 HG22 ' HB ' ' A' ' 138' ' ' ILE . 1.3 t 4.64 45.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 127.426 2.29 . . . . 0.0 115.84 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.48 ' C ' ' HD3' ' A' ' 134' ' ' LYS . 2.1 t30 166.96 39.3 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -174.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 1.093 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 11.4 mm-40 -144.58 135.05 24.52 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 111.777 -2.465 . . . . 0.0 108.071 -170.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 58.4 mt-10 -91.84 142.62 27.38 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.695 HG22 HG21 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -60.0 152.12 62.08 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.15 -177.283 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.659 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 24.0 Cg_exo -66.23 129.44 21.64 Favored 'Trans proline' 0 C--N 1.329 -0.454 0 C-N-CA 122.667 2.245 . . . . 0.0 111.46 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.448 ' HA3' ' CE ' ' A' ' 115' ' ' LYS . . . 93.82 -38.31 3.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.942 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.402 ' HB3' ' HE2' ' A' ' 147' ' ' TYR . 44.1 m-85 -124.67 133.18 53.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.607 -174.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -76.92 52.98 0.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.399 0.619 . . . . 0.0 111.084 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.678 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -93.22 99.01 11.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 172.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.754 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 1.4 tmmm? -81.09 121.92 26.7 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-O 121.005 0.431 . . . . 0.0 110.827 -170.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.796 HG12 HG11 ' A' ' 143' ' ' VAL . 95.4 mt -67.14 94.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.648 HG22 ' HE2' ' A' ' 134' ' ' LYS . 2.8 t -86.58 -9.88 11.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.508 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -158.12 116.8 3.11 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.982 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 1.016 ' HB ' HG22 ' A' ' 124' ' ' VAL . 0.2 OUTLIER -86.64 133.51 29.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.064 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.668 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 19.2 mmt180 -141.88 154.56 65.59 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 172.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 100' ' ' VAL . 52.6 Cg_exo -22.79 -78.19 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 125.138 3.892 . . . . 0.0 114.777 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.492 ' HA ' HD23 ' A' ' 97' ' ' LEU . 3.4 p-10 -127.43 39.85 3.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.494 1.14 . . . . 0.0 109.086 168.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.668 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 7.1 tpp85 -134.95 139.98 45.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.689 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.796 HG11 HG12 ' A' ' 135' ' ' ILE . 3.5 t -143.59 123.38 8.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.747 0.784 . . . . 0.0 112.429 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 HG12 ' A' ' 153' ' ' VAL . 22.0 t -80.55 101.66 5.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 169.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.969 HD11 HD22 ' A' ' 154' ' ' LEU . 1.1 pp -122.77 158.41 30.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -168.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.6 OUTLIER -95.27 103.1 14.95 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.449 -175.473 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.563 ' HD1' ' N ' ' A' ' 148' ' ' GLN . 0.3 OUTLIER -139.93 135.62 33.01 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.563 ' N ' ' HD1' ' A' ' 147' ' ' TYR . 0.0 OUTLIER 72.96 31.94 1.43 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.635 0.584 . . . . 0.0 110.57 173.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.04 16.49 74.94 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.062 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.805 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 6.0 tpp180 -132.28 157.13 45.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.814 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 25.4 p90 -134.67 107.11 7.29 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.805 ' HG2' ' HG3' ' A' ' 150' ' ' ARG . 43.1 mm-40 -124.03 -171.69 2.38 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.523 -174.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.902 HG12 HG22 ' A' ' 144' ' ' VAL . 3.1 m -100.4 99.95 9.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.838 0.828 . . . . 0.0 110.489 -172.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 1.046 HD21 ' H ' ' A' ' 93' ' ' LEU . 3.5 tp -107.27 109.75 21.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.854 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 142' ' ' ARG . . . -97.11 53.51 1.36 Allowed Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.312 172.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.599 ' HA ' HD12 ' A' ' 93' ' ' LEU . 2.2 mt -37.09 115.49 0.39 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.447 0.734 . . . . 0.0 109.358 176.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -133.21 160.7 36.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.533 0.606 . . . . 0.0 109.946 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.444 ' HA ' ' OG ' ' A' ' 96' ' ' SER . 19.9 m -53.33 123.61 12.41 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.349 0.406 . . . . 0.0 110.819 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' A' ' 162' ' ' SER . 11.9 pt20 -112.99 166.61 11.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 110.976 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -142.52 -36.57 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.475 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.75 -28.87 68.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.186 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.473 ' HA ' ' OE1' ' A' ' 159' ' ' GLN . 22.7 t 65.85 20.97 11.45 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.85 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.02 -3.25 87.56 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.586 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -91.03 -160.74 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.08 -12.31 61.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.107 0.479 . . . . 0.0 111.358 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.97 -2.95 27.15 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.268 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 p -92.99 127.97 45.3 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.37 109.52 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.669 2.246 . . . . 0.0 112.126 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 159.75 29.56 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.926 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.04 80.2 8.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.151 0.501 . . . . 0.0 110.209 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -83.4 -36.57 24.18 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 46.9 t -117.13 -60.71 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.421 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.715 -0.659 . . . . 0.0 109.67 178.097 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.492 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.8 Cg_exo . . . . . 0 CA--C 1.532 0.404 0 N-CA-C 111.711 -0.15 . . . . 0.0 111.711 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.545 ' OG ' ' HB2' ' A' ' 152' ' ' GLU . 52.7 m 54.16 -99.58 0.09 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.514 0.326 . . . . 0.0 111.077 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.583 HG23 HD21 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -139.2 -42.3 0.46 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -176.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.903 ' H ' HD21 ' A' ' 154' ' ' LEU . 50.9 tp 60.38 109.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.496 0.665 . . . . 0.0 111.934 -174.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.589 ' H ' HD23 ' A' ' 156' ' ' LEU . 2.9 p-10 -174.55 -157.88 0.08 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.748 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER 44.37 -175.41 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 176.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.2 t -127.31 111.8 14.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.219 163.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.93 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -82.43 72.82 9.49 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.563 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -34.3 -42.62 0.14 Allowed 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 178.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 157.78 150.71 5.81 Favored Glycine 0 CA--C 1.484 -1.903 0 C-N-CA 119.16 -1.495 . . . . 0.0 112.676 171.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.755 HG21 HG23 ' A' ' 138' ' ' ILE . 19.0 m -104.13 160.44 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 122.432 1.111 . . . . 0.0 110.69 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.842 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 23.4 mmt -119.34 89.41 3.12 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 112.89 -1.959 . . . . 0.0 107.698 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.82 132.91 55.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.85 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 108' ' ' ARG . . . -117.34 90.85 0.52 Allowed Glycine 0 CA--C 1.496 -1.142 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.252 -173.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 107' ' ' SER . 31.0 t0 73.86 -53.33 0.69 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -172.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.755 ' O ' ' HB3' ' A' ' 109' ' ' SER . 38.6 t70 179.24 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.45 -1.704 . . . . 0.0 106.935 170.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.713 ' HB2' HG11 ' A' ' 124' ' ' VAL . 9.9 p-10 -90.37 -9.74 46.54 Favored 'General case' 0 C--N 1.334 -0.103 0 O-C-N 124.248 0.968 . . . . 0.0 109.885 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.696 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 24.9 m -69.02 11.39 0.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.771 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.696 ' HG3' ' O ' ' A' ' 107' ' ' SER . 30.2 mtt85 178.59 -79.87 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -171.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.957 ' HB2' HD12 ' A' ' 138' ' ' ILE . 13.2 p 48.51 110.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 174.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.842 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 3.9 mm -94.41 134.25 32.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.76 174.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 1.032 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -124.06 108.42 12.33 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.745 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.654 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 13.8 mm -94.55 92.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 1.032 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.5 OUTLIER -105.87 143.16 17.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.047 -174.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.839 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 31.4 t -103.61 126.36 50.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.703 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.772 ' HB2' ' HB2' ' A' ' 129' ' ' PRO . 26.3 tptp -118.55 98.77 6.41 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 52.3 26.77 4.25 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -166.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.839 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 3.4 t-20 79.01 39.72 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.851 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 12.6 pt-20 -111.94 92.47 4.04 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.965 0.888 . . . . 0.0 108.934 161.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.673 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 63.0 mt-30 -66.4 126.63 29.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.585 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.654 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.5 m-85 -118.8 161.65 19.78 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.543 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.0 p -102.98 99.16 9.04 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 122.086 0.946 . . . . 0.0 110.922 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.542 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 22.8 mmt180 -107.74 -159.24 0.68 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.531 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.619 ' HA2' ' CD1' ' A' ' 138' ' ' ILE . . . 165.33 179.94 39.43 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.857 -174.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.713 HG11 ' HB2' ' A' ' 106' ' ' ASP . 25.4 t -52.53 121.83 2.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 114.183 -1.009 . . . . 0.0 109.924 168.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.798 ' HA ' ' HE3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 78.52 21.55 0.78 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.546 1.165 . . . . 0.0 109.747 178.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 123' ' ' GLY . 3.6 mm-40 -117.06 158.93 23.33 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.96 -1.927 . . . . 0.0 106.42 167.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.876 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 40.1 mt-10 -113.22 148.91 34.54 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 118.17 0.441 . . . . 0.0 110.38 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.757 HG22 ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -58.74 147.77 70.32 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.755 -177.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.772 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 6.0 Cg_exo -58.79 130.95 39.32 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.811 2.341 . . . . 0.0 112.188 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.542 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 94.99 -63.5 1.48 Allowed Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 116.086 -0.507 . . . . 0.0 112.765 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.42 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 14.6 m-85 -109.31 148.07 31.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.15 49.83 0.58 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -175.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.676 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -84.58 97.56 9.66 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.876 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . 5.7 tptm -79.8 123.04 27.36 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-O 121.324 0.583 . . . . 0.0 111.373 -171.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.621 HG12 HG11 ' A' ' 143' ' ' VAL . 71.2 mt -75.68 93.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.603 HG22 ' HG3' ' A' ' 134' ' ' LYS . 2.1 t -87.97 -10.53 10.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.585 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.2 OUTLIER -157.08 117.35 3.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.984 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.957 HD12 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -87.45 131.42 35.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.139 178.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 13.1 mmt180 -141.45 151.15 60.11 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -19.41 -77.68 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 125.261 3.974 . . . . 0.0 114.767 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.553 ' HA ' HD23 ' A' ' 97' ' ' LEU . 4.4 p-10 -125.05 36.86 4.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.467 1.127 . . . . 0.0 109.034 168.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.824 ' HD2' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -131.45 138.15 48.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.006 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.67 HG23 HD21 ' A' ' 97' ' ' LEU . 3.2 t -144.74 121.71 4.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 122.044 0.925 . . . . 0.0 112.131 -176.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.806 HG22 HG22 ' A' ' 153' ' ' VAL . 37.4 t -79.21 102.18 5.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.876 HD11 HD22 ' A' ' 154' ' ' LEU . 1.8 pp -120.12 152.0 38.25 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.103 0.954 . . . . 0.0 113.294 -169.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.565 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 4.0 tp60 -100.23 102.86 14.26 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.716 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.504 ' HD2' ' HB2' ' A' ' 133' ' ' ALA . 0.4 OUTLIER -136.78 135.16 37.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.15 -1.386 . . . . 0.0 107.529 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.466 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.7 mp0 70.39 32.19 2.83 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.673 0.389 . . . . 0.0 111.274 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.441 ' N ' HE22 ' A' ' 146' ' ' GLN . . . 79.84 1.96 87.84 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.027 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.775 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 20.1 tpp180 -130.31 143.49 50.81 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 34.6 p90 -119.84 108.94 14.98 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 122.278 1.037 . . . . 0.0 108.523 175.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.775 ' HG2' ' HG3' ' A' ' 150' ' ' ARG . 51.1 mm-40 -125.79 -170.41 2.18 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.646 -173.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.824 HG13 ' HD2' ' A' ' 142' ' ' ARG . 2.9 t -102.25 101.84 12.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.843 0.83 . . . . 0.0 109.985 -169.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.903 HD21 ' H ' ' A' ' 93' ' ' LEU . 4.7 tp -112.23 118.19 34.63 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.54 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.448 ' HA3' ' NH1' ' A' ' 142' ' ' ARG . . . -102.96 58.27 0.56 Allowed Glycine 0 C--N 1.308 -0.98 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.553 169.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.836 HD12 HD13 ' A' ' 97' ' ' LEU . 2.3 mt -37.67 104.74 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.687 0 O-C-N 124.52 0.777 . . . . 0.0 110.214 174.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 91.2 t80 . . . . . 0 C--N 1.329 -0.312 0 O-C-N 121.524 -0.735 . . . . 0.0 109.544 -178.117 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.781 ' HG2' ' HB3' ' A' ' 152' ' ' GLU . 73.4 Cg_endo . . . . . 0 CA--C 1.532 0.39 0 CA-C-O 119.554 -0.269 . . . . 0.0 111.675 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.849 ' HB3' ' HG ' ' A' ' 154' ' ' LEU . 22.8 t 53.21 -101.8 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 117.878 0.308 . . . . 0.0 110.677 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.791 HG23 HD11 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -127.94 -34.67 2.13 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.475 0.58 . . . . 0.0 112.46 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.65 ' H ' HD11 ' A' ' 154' ' ' LEU . 47.2 tp 59.68 107.48 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.335 0.588 . . . . 0.0 111.993 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.463 ' H ' HD23 ' A' ' 156' ' ' LEU . 2.4 p-10 -176.54 -157.05 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.781 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.4 OUTLIER 55.23 174.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 173.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.1 t -126.67 117.31 22.48 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.749 163.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.749 HD23 HG23 ' A' ' 113' ' ' ILE . 11.5 mt -77.23 125.51 29.44 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.608 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -91.53 -33.8 15.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.21 154.43 6.17 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.088 162.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.633 ' HB ' HD11 ' A' ' 138' ' ' ILE . 3.4 m -104.17 146.8 11.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 122.303 1.049 . . . . 0.0 110.799 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.632 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 65.6 mtt -105.75 91.58 3.81 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.176 -1.829 . . . . 0.0 108.782 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.31 129.59 42.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.55 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -114.6 94.85 0.7 Allowed Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 1.3 m-20 73.92 -53.81 0.69 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -169.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.766 ' O ' ' HB3' ' A' ' 109' ' ' SER . 25.8 t70 178.95 -90.01 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.692 -1.594 . . . . 0.0 107.466 168.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.829 ' HB2' HG21 ' A' ' 124' ' ' VAL . 13.3 p-10 -91.11 -38.85 12.5 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.16 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.446 ' C ' ' HD2' ' A' ' 108' ' ' ARG . 2.7 m -49.3 -55.89 11.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.195 -172.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.537 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 5.3 mmm180 -120.48 34.77 5.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.134 0.493 . . . . 0.0 109.902 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.862 ' HB2' HD13 ' A' ' 138' ' ' ILE . 19.1 p -76.35 141.87 41.38 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -168.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 10.2 mm -120.94 84.16 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 121.87 0.843 . . . . 0.0 111.273 -176.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.651 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -74.2 102.63 4.35 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.26 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 3.2 mm -87.04 96.19 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.749 HG23 HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -103.29 144.58 13.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.689 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.796 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 31.2 t -105.31 120.28 41.17 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.6 ' HE3' ' HA3' ' A' ' 130' ' ' GLY . 23.9 tptp -123.45 110.41 15.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -174.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.07 17.29 7.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -168.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.796 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 2.8 t-20 73.98 35.53 0.78 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.913 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -104.82 101.33 10.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 164.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.608 ' NE2' HG21 ' A' ' 98' ' ' THR . 36.3 mt-30 -67.2 120.99 14.68 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.34 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 5.7 t80 -120.21 143.41 48.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.819 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.3 p -87.14 95.42 9.95 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.396 1.093 . . . . 0.0 111.119 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.51 ' HD3' ' HB3' ' A' ' 126' ' ' GLU . 13.6 mmt180 -103.57 -157.48 0.61 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.569 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.883 ' HA2' HD12 ' A' ' 138' ' ' ILE . . . 162.28 -174.64 38.73 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 119.87 -1.157 . . . . 0.0 112.17 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 106' ' ' ASP . 2.1 t -56.62 122.72 6.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.134 -1.033 . . . . 0.0 109.639 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.536 HD22 ' N ' ' A' ' 125' ' ' ASN . 0.9 OUTLIER 75.29 35.16 0.59 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.969 1.366 . . . . 0.0 108.223 176.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HB3' ' HD3' ' A' ' 122' ' ' ARG . 4.8 mm-40 -133.8 144.88 49.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 111.985 -2.37 . . . . 0.0 106.81 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.571 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 34.7 mt-10 -103.34 132.56 49.5 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.196 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.628 HG21 HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -61.15 140.1 94.31 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.071 -176.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.709 ' O ' HD21 ' A' ' 95' ' ' LEU . 23.8 Cg_exo -64.77 142.67 77.39 Favored 'Trans proline' 0 C--O 1.223 -0.227 0 C-N-CA 123.094 2.529 . . . . 0.0 112.442 -167.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.6 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 97.06 -43.21 2.05 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.585 ' HB3' ' CE1' ' A' ' 147' ' ' TYR . 62.1 m-85 -114.11 170.13 8.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -96.43 46.44 1.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 170.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.688 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -85.81 97.52 10.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.571 ' CA ' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -81.81 104.61 12.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.715 -169.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 123' ' ' GLY . 70.8 mt -52.3 94.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.83 0.824 . . . . 0.0 110.106 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 145' ' ' LEU . 3.4 m -83.38 -3.78 7.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.517 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.827 ' HB3' ' HB ' ' A' ' 144' ' ' VAL . 3.6 t -168.71 117.4 0.7 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.905 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.883 HD12 ' HA2' ' A' ' 123' ' ' GLY . 7.1 tt -97.2 135.88 29.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.735 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.717 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 17.1 mmt180 -141.44 157.5 65.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 141' ' ' ASP . 60.2 Cg_exo -18.94 -82.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.013 1 C-N-CA 125.579 4.186 . . . . 0.0 115.05 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.465 ' C ' HD13 ' A' ' 97' ' ' LEU . 7.7 p-10 -133.21 40.19 3.21 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 123.471 1.605 . . . . 0.0 107.438 167.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.717 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -126.57 139.2 53.38 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 111.642 -2.526 . . . . 0.0 107.154 169.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.544 ' N ' ' HD3' ' A' ' 142' ' ' ARG . 1.1 t -137.07 160.33 36.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.133 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.954 HG22 HG12 ' A' ' 153' ' ' VAL . 13.9 t -120.33 117.16 52.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 165.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.843 HD11 HD12 ' A' ' 154' ' ' LEU . 2.2 pp -132.5 162.49 31.08 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.765 0.793 . . . . 0.0 111.956 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.489 HE22 ' H ' ' A' ' 149' ' ' GLY . 4.2 tp60 -109.97 108.91 19.33 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.65 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 131' ' ' TYR . 76.9 t80 -135.86 141.32 44.61 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.577 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.566 ' NE2' ' HD2' ' A' ' 147' ' ' TYR . 0.0 OUTLIER 59.11 22.38 10.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 169.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.489 ' H ' HE22 ' A' ' 146' ' ' GLN . . . 98.6 -1.39 58.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.57 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.461 ' HG2' ' HG2' ' A' ' 148' ' ' GLN . 13.2 ptp180 -130.19 137.62 50.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.372 0.586 . . . . 0.0 111.875 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 16.5 p90 -114.7 108.22 16.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.391 1.091 . . . . 0.0 108.477 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.781 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 52.6 mt-10 -139.45 -170.42 2.9 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.443 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.954 HG12 HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -96.34 99.65 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 122.006 0.908 . . . . 0.0 110.208 -168.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.849 ' HG ' ' HB3' ' A' ' 91' ' ' SER . 0.4 OUTLIER -101.99 106.82 17.79 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.704 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -98.98 53.11 1.08 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 173.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.781 HD22 ' HB2' ' A' ' 95' ' ' LEU . 3.9 mt -32.36 115.22 0.17 Allowed 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.907 1.004 . . . . 0.0 110.69 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.4 p90 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -172.168 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.846 ' HG2' ' HB3' ' A' ' 152' ' ' GLU . 6.3 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 CA-C-O 119.773 -0.178 . . . . 0.0 112.118 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.635 ' HB2' HD13 ' A' ' 154' ' ' LEU . 70.5 m 56.83 -86.63 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.614 0.765 . . . . 0.0 112.179 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.577 HG23 HD21 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -160.97 -44.67 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.831 -0.543 . . . . 0.0 112.381 -176.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.945 ' H ' HD21 ' A' ' 154' ' ' LEU . 6.5 tt 51.54 112.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.708 ' H ' HD23 ' A' ' 156' ' ' LEU . 2.3 p-10 -167.48 -56.81 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.853 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -54.71 176.34 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 122.95 0.5 . . . . 0.0 111.154 176.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.492 ' HB3' ' OG ' ' A' ' 114' ' ' SER . 1.5 t -117.59 109.93 17.29 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.292 170.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.718 ' HA ' HG23 ' A' ' 113' ' ' ILE . 1.9 mp -73.23 115.95 13.19 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 170.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.448 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -82.83 -35.7 26.14 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -176.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.51 169.83 31.55 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.745 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 111' ' ' ALA . 2.3 t -130.11 126.55 62.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.904 0.859 . . . . 0.0 110.889 -175.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.88 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 64.8 mtt -92.0 89.98 7.21 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.583 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.11 121.52 14.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.731 -175.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.579 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -114.04 100.37 1.03 Allowed Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -172.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.579 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 10.5 t70 74.4 -64.67 0.38 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -170.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 109' ' ' SER . 7.0 m-20 -169.37 -91.52 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.942 -1.935 . . . . 0.0 106.519 169.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.653 ' HA ' HG21 ' A' ' 124' ' ' VAL . 12.5 p-10 -91.87 -30.75 15.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.665 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 t -60.07 -57.18 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.464 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 4.4 mmm180 -111.58 28.9 8.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.367 0.603 . . . . 0.0 110.067 -170.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.809 ' HB2' HD13 ' A' ' 138' ' ' ILE . 22.5 p -73.02 135.8 44.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.685 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.88 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 6.4 mm -120.39 89.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.393 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.939 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -78.64 100.95 7.22 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.921 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.5 mm -86.3 93.18 3.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.939 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -106.86 159.93 6.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.235 -176.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 26.4 p -125.82 135.48 52.02 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-O 121.308 0.575 . . . . 0.0 109.54 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.9 tptp -119.21 108.39 14.59 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 59.25 20.43 8.54 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -167.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.1 t-20 79.74 37.19 0.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 113.435 -1.711 . . . . 0.0 111.666 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 16.6 pt-20 -107.4 101.77 11.1 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.963 0.887 . . . . 0.0 109.626 166.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.709 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 2.8 mt-30 -67.24 135.89 54.11 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -142.81 146.15 33.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.737 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -88.07 103.11 15.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.924 0.869 . . . . 0.0 111.552 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.519 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 21.9 mmt180 -107.42 -159.62 0.7 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.682 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.691 ' HA2' HD12 ' A' ' 138' ' ' ILE . . . 174.94 173.64 40.93 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -175.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 106' ' ' ASP . 16.7 t -49.39 132.59 7.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 165.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.562 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 72.29 19.55 4.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.459 1.123 . . . . 0.0 109.574 175.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.519 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 0.4 OUTLIER -120.64 158.04 28.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.145 -1.843 . . . . 0.0 106.347 167.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.744 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 41.6 mt-10 -104.2 156.89 17.52 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 118.435 0.561 . . . . 0.0 110.116 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.742 HG22 ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -66.4 145.2 98.95 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.553 178.345 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.788 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 21.7 Cg_exo -52.98 130.69 39.1 Favored 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 122.847 2.364 . . . . 0.0 112.009 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.538 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 96.6 -59.06 1.29 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.633 176.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.468 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 27.0 m-85 -113.63 153.66 28.51 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 121.434 -0.106 . . . . 0.0 111.036 -174.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -74.81 44.76 0.23 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.673 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -83.06 90.4 7.03 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 170.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -80.49 120.83 24.99 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.472 -170.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.663 HG12 HG11 ' A' ' 143' ' ' VAL . 74.4 mt -68.62 94.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.412 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.742 HG22 ' HE2' ' A' ' 134' ' ' LYS . 1.5 t -88.59 -3.77 9.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.732 0.777 . . . . 0.0 108.965 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.474 ' HB3' HG23 ' A' ' 144' ' ' VAL . 1.7 t -162.38 115.32 1.71 Allowed 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.492 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.809 HD13 ' HB2' ' A' ' 109' ' ' SER . 3.5 tt -88.98 132.93 32.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.069 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 7.4 mmt180 -141.89 159.23 60.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -22.63 -78.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 125.093 3.862 . . . . 0.0 114.474 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.4 ' HA ' HD23 ' A' ' 97' ' ' LEU . 9.5 p-10 -128.33 39.53 3.81 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.398 1.094 . . . . 0.0 108.715 169.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.531 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 1.9 tpp180 -136.93 143.35 42.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.73 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.663 HG11 HG12 ' A' ' 135' ' ' ILE . 4.8 t -148.41 119.33 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.83 -176.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 1.076 HG22 HG13 ' A' ' 153' ' ' VAL . 7.1 t -79.04 65.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 1.9 pp -82.63 167.92 17.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.022 -175.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.619 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -112.57 124.39 52.43 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.577 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.559 ' HD2' ' HB2' ' A' ' 133' ' ' ALA . 0.3 OUTLIER -145.27 140.04 27.53 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.492 HE22 ' HB ' ' A' ' 92' ' ' THR . 2.2 mp0 67.91 28.94 6.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.966 0.412 . . . . 0.0 109.942 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.15 8.43 87.44 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.605 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 0.3 OUTLIER -132.61 139.78 47.93 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 117.247 0.523 . . . . 0.0 110.905 -173.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.719 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 13.3 p90 -118.94 111.96 19.01 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.106 0.955 . . . . 0.0 109.392 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.846 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 34.6 mt-10 -134.94 -175.9 4.06 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.161 -177.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 1.076 HG13 HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -96.24 99.27 8.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 119.676 -0.809 . . . . 0.0 110.233 -165.17 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.945 HD21 ' H ' ' A' ' 93' ' ' LEU . 6.0 tp -103.66 119.55 39.14 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.384 -0.825 . . . . 0.0 113.163 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -104.29 54.86 0.62 Allowed Glycine 0 C--N 1.304 -1.204 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 168.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.708 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.5 mt -36.51 107.25 0.06 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.39 0.7 . . . . 0.0 110.101 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 19.7 t80 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.746 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.759 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.6 Cg_exo . . . . . 0 CA--C 1.534 0.496 0 N-CA-C 111.005 -0.421 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.869 ' HB2' ' HB2' ' A' ' 152' ' ' GLU . 9.1 t 51.23 -137.98 1.11 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.211 0.205 . . . . 0.0 111.121 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.443 ' HB ' ' CD2' ' A' ' 147' ' ' TYR . 4.9 t -95.53 -37.85 10.69 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.677 ' HA ' HD11 ' A' ' 154' ' ' LEU . 31.7 tp 49.59 68.47 0.73 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.862 ' H ' HD23 ' A' ' 156' ' ' LEU . 5.3 t30 -174.04 100.59 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.894 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER 164.44 -167.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 175.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.508 ' HB2' ' OG ' ' A' ' 114' ' ' SER . 49.9 m -132.01 103.75 6.45 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.606 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.926 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -83.25 74.14 10.05 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -37.72 -46.67 0.92 Allowed 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 140' ' ' PRO . . . 161.54 152.47 6.67 Favored Glycine 0 CA--C 1.486 -1.775 0 C-N-CA 119.121 -1.514 . . . . 0.0 112.358 172.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 111' ' ' ALA . 4.7 m -104.59 143.21 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 121.659 0.743 . . . . 0.0 110.021 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.863 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 87.1 mmm -90.86 86.33 6.27 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.754 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -65.61 119.69 11.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.945 -176.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -114.7 102.45 1.17 Allowed Glycine 0 CA--C 1.498 -1.022 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -171.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 2.6 m-20 72.22 -69.41 0.19 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -172.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -149.72 -111.89 0.06 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.092 170.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.495 ' OD2' HG11 ' A' ' 124' ' ' VAL . 5.8 m-20 -90.59 -13.13 35.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.739 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.3 t -64.44 -58.03 7.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.534 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -109.91 29.67 7.41 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.401 -173.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.754 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 2.6 t -85.52 141.65 29.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.247 0.546 . . . . 0.0 111.763 -170.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.863 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 10.7 mm -122.21 87.93 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.422 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.897 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -69.09 98.61 1.01 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.483 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.552 HG22 ' HG2' ' A' ' 119' ' ' GLN . 13.6 mm -87.33 90.03 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -101.79 132.84 46.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.759 -179.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.508 ' OG ' ' HB2' ' A' ' 96' ' ' SER . 2.7 p -99.41 135.21 41.16 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.04 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.776 ' HA ' HD21 ' A' ' 95' ' ' LEU . 24.3 tptp -122.69 110.87 16.04 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 61.71 21.51 12.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -166.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 117' ' ' ASN . 3.4 t-20 77.39 33.69 0.4 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.677 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 114' ' ' SER . 81.3 tt0 -101.6 96.78 7.34 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 170.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.552 ' HG2' HG22 ' A' ' 112' ' ' ILE . 3.8 mt-30 -67.5 108.62 2.9 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 5.2 t80 -110.13 141.99 42.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.927 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.9 p -90.19 95.12 10.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.807 0.813 . . . . 0.0 112.177 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.941 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 18.8 mmt180 -91.96 -160.07 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.492 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.638 ' N ' ' HG3' ' A' ' 126' ' ' GLU . . . 163.8 105.62 0.19 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.582 -168.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.752 HG22 ' HB ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -9.5 117.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 125.408 1.299 . . . . 0.0 113.23 -177.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.736 ' HB2' ' O ' ' A' ' 124' ' ' VAL . 0.9 OUTLIER 88.59 27.48 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 124.999 1.437 . . . . 0.0 108.428 -167.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.941 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 5.1 mm-40 -124.75 147.49 48.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 112.833 -1.985 . . . . 0.0 107.891 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.565 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 50.9 mt-10 -105.41 140.25 38.81 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 156' ' ' LEU . 0.5 OUTLIER -57.18 154.77 19.59 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.23 -176.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 128' ' ' VAL . 15.5 Cg_exo -70.07 119.24 6.2 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.883 2.389 . . . . 0.0 112.279 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.583 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 99.21 -52.1 1.1 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.328 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.548 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 21.3 m-85 -104.34 132.57 50.44 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -79.27 52.57 1.35 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.571 1.078 . . . . 0.0 110.962 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.793 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -84.78 101.72 12.47 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -81.39 107.9 14.55 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.015 -171.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.1 mt -55.91 94.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 O-C-N 123.806 0.691 . . . . 0.0 109.834 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 151' ' ' TYR . 0.2 OUTLIER -88.19 -4.2 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.656 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -164.65 118.32 1.33 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.767 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.752 ' HB ' HG22 ' A' ' 124' ' ' VAL . 7.2 tt -92.88 128.79 44.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.552 0.691 . . . . 0.0 111.727 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.804 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 16.9 mmt180 -142.06 160.17 56.29 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.61 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 7.3 Cg_exo -25.49 -85.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 1 C-N-CA 126.14 4.56 . . . . 0.0 114.98 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.603 ' HA ' HD23 ' A' ' 97' ' ' LEU . 1.9 p30 -123.78 14.05 9.3 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.036 0.922 . . . . 0.0 109.08 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.804 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -115.25 142.72 46.3 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.704 169.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.533 ' N ' ' HG2' ' A' ' 142' ' ' ARG . 0.9 OUTLIER -137.89 170.48 17.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.851 177.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.811 HG22 HG12 ' A' ' 153' ' ' VAL . 40.7 t -122.1 97.98 5.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.793 HD13 ' HB1' ' A' ' 133' ' ' ALA . 1.2 pp -120.34 158.59 26.8 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.039 0.923 . . . . 0.0 112.847 -170.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.512 HE22 ' N ' ' A' ' 149' ' ' GLY . 4.6 tp60 -106.64 103.04 12.39 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.555 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.572 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 52.9 t80 -128.22 144.42 51.12 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.613 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 0.0 OUTLIER 59.38 29.31 18.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 171.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.512 ' N ' HE22 ' A' ' 146' ' ' GLN . . . 83.24 5.24 89.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.133 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.657 ' HG2' ' HG2' ' A' ' 152' ' ' GLU . 66.5 ttt180 -133.32 138.47 46.39 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 117.071 0.435 . . . . 0.0 110.803 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 6.4 p90 -116.75 112.33 21.02 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.547 1.165 . . . . 0.0 108.812 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.869 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 76.5 mm-40 -128.87 -169.79 2.15 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.384 -174.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.811 HG12 HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -98.64 100.4 10.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.081 0.944 . . . . 0.0 108.475 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.677 HD11 ' HA ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -119.38 106.3 12.14 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.701 -172.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 142' ' ' ARG . . . -106.46 70.49 0.22 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.894 HD22 ' HB2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -37.06 124.14 0.91 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.604 0.762 . . . . 0.0 110.447 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.2 t80 . . . . . 0 C--N 1.331 -0.23 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -161.859 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.54 ' O ' HD13 ' A' ' 154' ' ' LEU . 2.8 Cg_exo . . . . . 0 CA--C 1.531 0.35 0 N-CA-C 111.364 -0.283 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.518 ' HB2' HD13 ' A' ' 154' ' ' LEU . 58.5 m 56.38 -83.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.895 0.478 . . . . 0.0 112.006 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.683 ' HB ' HE22 ' A' ' 148' ' ' GLN . 1.6 t -161.07 -41.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.544 -0.722 . . . . 0.0 112.336 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.809 ' H ' HD21 ' A' ' 154' ' ' LEU . 48.8 tp 56.2 99.77 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.717 ' H ' HD23 ' A' ' 156' ' ' LEU . 3.1 p-10 -160.07 -61.09 0.06 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.842 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -57.28 -178.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.415 0.626 . . . . 0.0 111.75 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.434 ' HB3' ' OG ' ' A' ' 114' ' ' SER . 9.6 t -117.28 119.85 36.43 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.621 170.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.963 HD23 HG23 ' A' ' 113' ' ' ILE . 53.4 mt -76.74 131.34 38.68 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 165.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.459 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.2 OUTLIER -92.27 -32.48 15.01 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 175.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.934 ' HA2' ' HB3' ' A' ' 141' ' ' ASP . . . 154.71 168.19 17.67 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.97 161.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.718 HG11 HG23 ' A' ' 138' ' ' ILE . 2.7 t -114.4 132.01 64.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.781 0.801 . . . . 0.0 110.91 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.842 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 67.1 mtt -104.17 87.41 2.75 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.21 177.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.81 46.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.4 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.753 ' H ' ' HA ' ' A' ' 109' ' ' SER . . . -106.62 88.14 0.54 Allowed Glycine 0 CA--C 1.496 -1.156 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 25.1 t70 74.85 -54.65 0.66 Allowed 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -169.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.672 ' O ' ' HB3' ' A' ' 109' ' ' SER . 12.7 t70 -178.97 -124.07 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.902 -1.499 . . . . 0.0 106.994 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.74 ' HA ' HG21 ' A' ' 124' ' ' VAL . 2.3 p-10 -80.9 -6.59 58.85 Favored 'General case' 0 CA--C 1.522 -0.101 0 O-C-N 124.184 0.928 . . . . 0.0 109.939 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.1 t -60.46 -42.5 96.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.164 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 78.7 mtp180 -126.2 -65.61 0.97 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.421 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.753 ' HA ' ' H ' ' A' ' 103' ' ' GLY . 13.7 p 53.58 127.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 174.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.842 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 3.6 mm -116.9 129.92 72.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.329 174.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.927 ' HB2' HD11 ' A' ' 138' ' ' ILE . . . -120.69 98.42 6.01 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.802 0.335 . . . . 0.0 111.653 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.5 mm -80.33 94.54 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.963 HG23 HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -105.82 142.62 18.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.718 177.224 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.434 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 84.5 p -113.66 129.18 56.61 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.846 0.832 . . . . 0.0 109.353 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.842 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.6 tptp -124.81 101.46 7.1 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -171.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 55.07 22.16 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -164.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.8 t-20 78.24 40.67 0.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.697 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 15.5 pt-20 -108.71 90.75 3.39 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.276 1.036 . . . . 0.0 108.292 161.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 34.9 mt-30 -67.22 124.19 22.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.524 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -128.69 147.98 50.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.993 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -97.3 105.12 17.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.616 0.722 . . . . 0.0 111.532 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.982 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 28.1 mmt180 -95.2 -163.05 1.0 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.316 176.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.616 ' O ' ' HG2' ' A' ' 126' ' ' GLU . . . 164.74 110.88 0.24 Allowed Glycine 0 C--O 1.216 -1.001 0 C-N-CA 119.738 -1.22 . . . . 0.0 114.088 -171.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.74 HG21 ' HA ' ' A' ' 106' ' ' ASP . 28.1 t 4.85 115.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.152 1.381 . . . . 0.0 114.452 -175.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.705 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 80.8 35.48 0.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.313 -175.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.982 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 13.1 mm-40 -127.31 150.72 49.45 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.781 170.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 2.3 mp0 -101.39 150.84 22.6 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 118.571 0.623 . . . . 0.0 109.861 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.619 HG22 HG21 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -62.35 151.72 81.56 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.493 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.565 ' HD2' HG22 ' A' ' 128' ' ' VAL . 3.6 Cg_exo -62.94 127.52 20.62 Favored 'Trans proline' 0 C--N 1.332 -0.292 0 C-N-CA 122.953 2.435 . . . . 0.0 112.37 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.62 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 100.48 -64.1 0.59 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.353 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.51 ' HE2' HD12 ' A' ' 95' ' ' LEU . 4.3 m-85 -110.73 140.56 45.01 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -78.87 56.37 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.538 0.608 . . . . 0.0 111.831 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.727 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -79.88 96.97 6.51 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.705 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.5 OUTLIER -81.13 115.91 20.79 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.256 0.551 . . . . 0.0 110.911 -169.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.58 HG21 HG13 ' A' ' 138' ' ' ILE . 74.7 mt -67.47 94.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.401 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.634 HG22 ' HE2' ' A' ' 134' ' ' LYS . 1.3 t -86.62 -6.57 10.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.723 ' CB ' ' HB ' ' A' ' 144' ' ' VAL . 4.1 t -157.15 117.12 3.46 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.125 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.927 HD11 ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -91.55 125.99 44.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.991 0.9 . . . . 0.0 111.238 176.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.6 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 13.5 mmt85 -142.11 148.96 50.48 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.647 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.29 81.2 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.628 2.218 . . . . 0.0 113.67 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.934 ' HB3' ' HA2' ' A' ' 99' ' ' GLY 0.279 2.9 p30 75.62 27.0 1.05 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.868 1.667 . . . . 0.0 110.17 170.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.703 ' HD2' ' N ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -139.72 151.32 45.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 112.255 -2.248 . . . . 0.0 106.204 157.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.703 ' N ' ' HD2' ' A' ' 142' ' ' ARG . 7.2 t -141.21 164.89 19.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-O 121.526 0.679 . . . . 0.0 111.395 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 153' ' ' VAL . 59.1 t -122.12 100.45 8.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.727 HD13 ' HB1' ' A' ' 133' ' ' ALA . 2.0 pp -122.56 156.56 33.94 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 122.21 1.005 . . . . 0.0 113.223 -168.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.52 HE22 ' N ' ' A' ' 149' ' ' GLY . 2.2 tp60 -103.46 104.58 14.68 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 112.533 -2.121 . . . . 0.0 108.581 -174.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.505 ' CD2' HG21 ' A' ' 92' ' ' THR . 0.4 OUTLIER -136.54 135.5 38.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.711 175.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.683 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.8 mp0 67.93 34.34 4.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.46 175.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.52 ' N ' HE22 ' A' ' 146' ' ' GLN . . . 70.55 12.81 70.56 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.729 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.472 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 29.2 ttp180 -130.95 137.43 49.28 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.792 -0.24 . . . . 0.0 110.362 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.715 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 22.3 p90 -118.58 108.8 15.4 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.704 1.24 . . . . 0.0 109.313 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.1 mm-40 -129.02 -170.72 2.32 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.483 -1.69 . . . . 0.0 109.179 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 144' ' ' VAL . 3.5 t -97.17 105.54 17.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.184 0.516 . . . . 0.0 109.903 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.809 HD21 ' H ' ' A' ' 93' ' ' LEU . 6.1 tp -108.17 121.2 44.36 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.488 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -108.14 59.26 0.37 Allowed Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 167.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.717 HD23 ' H ' ' A' ' 94' ' ' ASN . 1.5 mt -36.46 109.73 0.1 Allowed 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.269 0.629 . . . . 0.0 109.521 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.4 t80 . . . . . 0 C--N 1.329 -0.299 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -172.269 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 CA--C 1.534 0.493 0 N-CA-C 114.718 1.007 . . . . 0.0 114.718 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.657 ' HB3' HD23 ' A' ' 154' ' ' LEU . 46.5 t -61.63 -76.43 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.13 0.423 . . . . 0.0 111.624 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.88 ' HB ' HE22 ' A' ' 148' ' ' GLN . 2.7 t -127.7 -45.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.835 ' H ' HD11 ' A' ' 154' ' ' LEU . 45.6 tp 59.06 86.07 0.09 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.308 0.575 . . . . 0.0 111.889 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.727 ' ND2' ' H ' ' A' ' 95' ' ' LEU . 9.5 t30 -160.42 -149.5 0.19 Allowed 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.027 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.5 OUTLIER 51.71 177.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 172.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 40.8 m -137.23 115.55 11.81 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.221 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.938 HD23 HG23 ' A' ' 113' ' ' ILE . 12.0 mt -74.97 143.16 43.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 174.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -33.2 10.84 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 147.05 154.22 6.14 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 162.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 111' ' ' ALA . 13.6 m -103.69 144.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 122.654 1.216 . . . . 0.0 112.011 -173.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.748 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 65.3 mmm -97.73 89.5 4.65 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.374 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.791 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -64.74 134.64 54.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.788 0.327 . . . . 0.0 110.857 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -125.27 89.3 0.38 Allowed Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 28.9 t70 71.32 -57.81 0.59 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -166.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.63 ' O ' ' HB2' ' A' ' 109' ' ' SER . 20.8 t70 -173.88 -87.24 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.263 -1.789 . . . . 0.0 107.846 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.889 ' HA ' HG21 ' A' ' 124' ' ' VAL . 5.6 t70 -91.5 -46.6 7.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.492 -175.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.9 t -55.13 -40.64 70.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.41 -167.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -130.26 26.7 5.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.552 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.791 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 7.8 t -92.03 140.79 29.3 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.007 -172.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.748 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 8.0 mm -117.66 91.28 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.611 -174.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.974 ' HB2' HD11 ' A' ' 138' ' ' ILE . . . -72.75 96.8 2.09 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.267 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 4.5 mm -79.84 93.71 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.938 HG23 HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -101.86 154.12 5.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.87 175.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.474 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 14.5 p -121.09 126.13 49.02 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.709 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 24.5 tptp -117.24 105.21 11.96 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -171.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 58.43 24.7 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -163.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 15.3 t-20 68.9 40.25 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 112.002 -2.363 . . . . 0.0 112.161 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.709 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 12.4 pt-20 -102.26 103.09 13.55 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 162.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 4.8 mt-30 -68.17 131.48 45.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.489 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 7.9 t80 -135.96 144.3 45.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.448 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.6 p -88.9 94.78 10.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 122.057 0.932 . . . . 0.0 111.22 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.494 ' CB ' ' HB3' ' A' ' 111' ' ' ALA . 16.0 mmt180 -98.56 -159.53 0.74 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.049 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 126' ' ' GLU . . . 178.9 161.74 27.1 Favored Glycine 0 N--CA 1.408 -3.205 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.995 HG22 ' HB ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -57.12 128.04 17.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 165.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.668 ' HB2' ' O ' ' A' ' 124' ' ' VAL . 0.9 OUTLIER 81.14 28.58 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.482 1.134 . . . . 0.0 109.057 -176.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 123' ' ' GLY . 1.2 mm-40 -132.65 153.29 51.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 112.596 -2.093 . . . . 0.0 107.664 170.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 41.4 mt-10 -104.83 145.61 30.15 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.716 HG21 HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -62.65 153.87 76.5 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.486 -174.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.633 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 23.7 Cg_exo -66.37 126.92 16.41 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.569 2.18 . . . . 0.0 111.787 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.676 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 103.91 -57.89 0.53 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.06 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 147' ' ' TYR . 34.1 m-85 -111.92 149.62 31.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.957 -0.121 . . . . 0.0 110.743 -176.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.97 53.77 0.79 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.089 0.471 . . . . 0.0 111.778 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.643 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -90.24 95.69 10.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.656 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.652 ' HE2' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -82.14 107.29 14.72 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.017 0.437 . . . . 0.0 110.846 -171.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.72 HG12 HG11 ' A' ' 143' ' ' VAL . 64.8 mt -54.07 94.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.357 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 144' ' ' VAL . 3.9 m -97.35 8.27 7.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.948 0.88 . . . . 0.0 108.815 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.775 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 5.7 m -165.41 114.81 1.04 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.079 176.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.995 ' HB ' HG22 ' A' ' 124' ' ' VAL . 1.1 tt -98.45 127.99 50.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.401 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 5.2 mmt180 -143.73 150.3 49.79 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -14.55 -74.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 1 C-N-CA 125.708 4.272 . . . . 0.0 114.974 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.44 ' C ' HD13 ' A' ' 97' ' ' LEU . 7.8 p-10 -138.98 47.73 1.91 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.247 1.022 . . . . 0.0 109.475 168.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.821 ' HD3' HG13 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -143.81 139.37 29.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.154 165.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.72 HG11 HG12 ' A' ' 135' ' ' ILE . 10.4 t -135.02 118.19 23.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.071 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 153' ' ' VAL . 9.2 t -80.48 62.23 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.136 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.705 HD11 ' HG ' ' A' ' 154' ' ' LEU . 1.7 pp -79.83 166.78 21.36 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -171.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 2.1 tp60 -108.83 104.87 14.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 111.662 -2.517 . . . . 0.0 108.41 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 131' ' ' TYR . 1.0 OUTLIER -139.3 133.48 31.27 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.88 HE22 ' HB ' ' A' ' 92' ' ' THR . 3.1 mt-30 70.39 32.83 2.66 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.471 0.482 . . . . 0.0 110.859 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.405 ' CA ' HE22 ' A' ' 146' ' ' GLN . . . 76.58 3.78 79.29 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.409 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.53 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 2.3 tpm_? -125.02 153.53 42.69 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.655 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 2.7 p90 -134.77 106.64 7.01 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.355 1.074 . . . . 0.0 108.229 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 81.0 mm-40 -134.62 -176.24 4.15 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.46 -169.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 144' ' ' VAL . 26.2 t -93.67 100.2 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.014 0.912 . . . . 0.0 108.724 -170.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.841 HD21 ' H ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -106.87 102.91 12.24 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 114.22 -1.354 . . . . 0.0 111.363 -175.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 142' ' ' ARG . . . -100.99 57.13 0.72 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.572 175.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 1.027 HD22 ' HB2' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -37.23 109.82 0.11 Allowed 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.385 0.697 . . . . 0.0 109.624 171.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 33.9 p90 . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 112.04 -164.892 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.46 ' HB2' ' H ' ' A' ' 91' ' ' SER . 4.0 Cg_exo . . . . . 0 N--CA 1.461 -0.395 0 CA-C-O 119.243 -0.399 . . . . 0.0 111.518 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.797 ' HB2' HD13 ' A' ' 154' ' ' LEU . 22.1 m 54.74 -79.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.898 ' HB ' HE22 ' A' ' 148' ' ' GLN . 0.1 OUTLIER -163.72 -44.56 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.124 -0.36 . . . . 0.0 111.216 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.967 ' H ' HD21 ' A' ' 154' ' ' LEU . 1.0 OUTLIER 52.48 99.78 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.046 0.451 . . . . 0.0 111.434 -177.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.753 ' H ' HD23 ' A' ' 156' ' ' LEU . 0.1 OUTLIER -157.63 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.002 -172.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.868 HD21 ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -56.77 174.65 0.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.374 179.152 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.4 t -121.58 118.98 30.59 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.557 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.547 ' HA ' HG23 ' A' ' 113' ' ' ILE . 6.0 mp -79.02 124.36 28.19 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.416 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -86.72 -29.85 22.1 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.01 173.64 30.92 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 169.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.966 HG22 ' HA ' ' A' ' 111' ' ' ALA . 2.4 t -129.75 126.84 63.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.558 0.694 . . . . 0.0 110.397 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.878 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -89.42 89.38 7.84 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.047 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.695 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -65.91 132.24 48.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.224 -174.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 108' ' ' ARG . . . -117.47 92.16 0.55 Allowed Glycine 0 CA--C 1.5 -0.868 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 -173.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.5 t0 69.53 -59.55 0.49 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.935 0.874 . . . . 0.0 108.784 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -156.83 -146.81 0.17 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.313 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.67 ' HB3' HG21 ' A' ' 124' ' ' VAL . 7.2 m-20 -56.53 -33.34 65.98 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.49 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.8 t -46.84 -56.3 6.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.435 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 22.7 mtp180 -119.49 30.49 7.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.611 -167.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.695 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 8.4 t -86.96 145.64 26.44 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.733 0.777 . . . . 0.0 112.133 -172.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.878 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 12.6 mm -114.3 92.5 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.404 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.966 ' HA ' HG22 ' A' ' 100' ' ' VAL . . . -73.86 101.46 3.77 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.399 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 28.8 mm -86.47 93.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.901 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -104.5 150.08 7.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.647 -177.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 64.6 p -116.05 130.56 56.87 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.133 0.492 . . . . 0.0 109.724 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.868 ' HA ' HD21 ' A' ' 95' ' ' LEU . 19.0 tptp -110.43 102.48 11.1 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 59.89 27.13 16.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.3 t-20 81.21 33.25 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 112.453 -2.158 . . . . 0.0 110.854 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -106.12 97.39 7.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.657 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.7 mt-30 -66.61 135.89 54.79 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.594 -176.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 15.6 t80 -144.86 149.54 35.52 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.367 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.543 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 6.4 m -88.57 101.6 14.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.608 0.718 . . . . 0.0 111.169 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 122' ' ' ARG . 18.0 mmt180 -104.94 -160.13 0.74 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.828 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.458 ' HA2' HD12 ' A' ' 138' ' ' ILE . . . -179.31 169.47 40.66 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.115 -1.04 . . . . 0.0 111.461 -176.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.845 HG23 ' HB ' ' A' ' 138' ' ' ILE . 5.7 t -45.32 129.9 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 114.223 -0.988 . . . . 0.0 110.456 162.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.686 ' HA ' ' HD2' ' A' ' 134' ' ' LYS . 0.0 OUTLIER 69.09 14.75 8.76 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 124.749 1.281 . . . . 0.0 110.428 176.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -105.81 164.48 11.9 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 167.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.836 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 33.1 mt-10 -114.12 151.13 33.07 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 119.142 0.883 . . . . 0.0 110.018 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.614 HG22 HG21 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -59.13 143.42 84.54 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.048 0.451 . . . . 0.0 110.416 -176.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.625 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.1 Cg_exo -73.06 94.16 0.81 Allowed 'Trans proline' 0 C--O 1.222 -0.309 0 C-N-CA 123.244 2.63 . . . . 0.0 112.467 -170.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.474 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 132.76 -48.73 0.95 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.532 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 10.4 m-85 -112.65 137.7 50.53 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -73.91 46.75 0.24 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.897 0.772 . . . . 0.0 112.993 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.68 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -82.56 99.17 9.36 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 171.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.836 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -80.65 125.79 30.45 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-O 120.849 0.357 . . . . 0.0 110.939 -171.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.5 mt -77.23 89.93 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.601 HG22 ' HG3' ' A' ' 134' ' ' LYS . 1.3 t -85.11 -3.97 8.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 122.044 0.926 . . . . 0.0 108.641 -175.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.496 ' HB3' HG23 ' A' ' 144' ' ' VAL . 1.7 t -160.59 117.36 2.38 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.434 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.938 HD11 ' HB2' ' A' ' 111' ' ' ALA . 3.6 tt -94.92 133.51 35.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.495 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.574 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 17.0 mmt180 -141.79 162.85 44.21 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 170.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 139' ' ' ARG . 89.0 Cg_exo -25.22 -84.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.75 3.633 . . . . 0.0 114.635 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -116.64 29.81 7.71 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.154 0.978 . . . . 0.0 108.61 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.574 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 6.1 tpp85 -127.97 141.91 51.39 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.03 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.453 HG23 HD21 ' A' ' 97' ' ' LEU . 4.3 t -145.61 168.55 7.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.706 -175.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.956 HG22 HG23 ' A' ' 153' ' ' VAL . 19.5 t -129.84 62.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.798 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 1.5 pp -82.38 155.27 24.79 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -165.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.484 HE22 ' N ' ' A' ' 150' ' ' ARG . 11.4 tp60 -99.91 104.42 16.06 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 111.937 -2.392 . . . . 0.0 108.586 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.859 ' HD2' HG21 ' A' ' 92' ' ' THR . 0.6 OUTLIER -141.83 132.95 26.21 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.898 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.8 mt-30 67.59 28.18 7.55 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.405 0.44 . . . . 0.0 110.774 175.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.4 ' C ' HE22 ' A' ' 146' ' ' GLN . . . 88.32 -2.91 85.41 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 119.809 -1.186 . . . . 0.0 112.698 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.484 ' N ' HE22 ' A' ' 146' ' ' GLN . 28.5 ptt180 -126.26 145.51 50.38 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.576 -0.367 . . . . 0.0 111.242 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.798 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 6.4 p90 -122.76 109.96 14.87 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 171.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.455 ' OE2' ' HB2' ' A' ' 90' ' ' PRO . 36.7 mt-10 -127.33 -175.47 3.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.956 HG23 HG22 ' A' ' 144' ' ' VAL . 6.0 p -95.99 98.72 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-O 122.835 1.302 . . . . 0.0 110.155 -165.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.967 HD21 ' H ' ' A' ' 93' ' ' LEU . 10.0 tp -106.81 116.22 31.55 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.36 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.567 ' O ' ' HD2' ' A' ' 157' ' ' TYR . . . -99.57 61.06 0.75 Allowed Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.952 167.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.753 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.7 mt -36.38 111.61 0.15 Allowed 'General case' 0 N--CA 1.485 1.306 0 O-C-N 124.325 0.662 . . . . 0.0 109.748 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.567 ' HD2' ' O ' ' A' ' 155' ' ' GLY . 51.3 p90 . . . . . 0 C--O 1.234 0.248 0 CA-C-N 118.19 0.45 . . . . 0.0 110.45 -172.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.6 ' O ' HD21 ' A' ' 154' ' ' LEU . 33.6 Cg_exo . . . . . 0 CA--C 1.536 0.597 0 CA-C-O 119.556 -0.269 . . . . 0.0 111.99 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.671 ' HB2' ' HG ' ' A' ' 154' ' ' LEU . 60.0 m 53.46 -83.03 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.54 0.336 . . . . 0.0 110.992 -170.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 1.033 ' HB ' HE22 ' A' ' 148' ' ' GLN . 0.0 OUTLIER -156.04 -49.51 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 119.491 -0.29 . . . . 0.0 111.037 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 156' ' ' LEU . 46.0 tp 54.17 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.504 0.502 . . . . 0.0 111.663 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.683 ' H ' HD23 ' A' ' 156' ' ' LEU . 5.8 t30 -162.5 -60.21 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.024 0.44 . . . . 0.0 111.669 -175.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.847 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -56.34 175.96 0.1 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.124 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.7 t -114.98 108.5 16.79 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.028 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.836 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -73.22 117.33 14.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 171.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.641 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -91.18 -34.53 14.98 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -173.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 158.51 141.17 3.08 Favored Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.783 171.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.598 HG21 HG23 ' A' ' 138' ' ' ILE . 12.1 m -102.39 147.85 8.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.77 0.795 . . . . 0.0 109.689 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.866 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 67.5 mtt -104.03 90.69 3.68 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.024 176.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.59 120.95 9.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.777 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.598 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -110.98 97.96 1.01 Allowed Glycine 0 CA--C 1.492 -1.367 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -174.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.598 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 3.6 m-20 73.42 -66.03 0.33 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -173.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.539 ' O ' ' HB3' ' A' ' 109' ' ' SER . 8.3 m-20 -162.29 -102.64 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.692 -1.594 . . . . 0.0 107.594 167.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.693 ' HB2' HG21 ' A' ' 124' ' ' VAL . 6.5 p-10 -91.73 -20.2 21.8 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.35 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.45 ' C ' ' HD3' ' A' ' 108' ' ' ARG . 14.5 m -61.87 -47.01 86.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.077 -174.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.45 ' HD3' ' C ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -123.79 19.89 9.35 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.053 -168.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.66 ' HB2' HD12 ' A' ' 138' ' ' ILE . 2.8 p -66.77 147.29 53.45 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.324 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.866 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 5.5 mm -126.94 84.74 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-O 121.783 0.802 . . . . 0.0 110.862 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.865 ' HB3' ' HB2' ' A' ' 122' ' ' ARG . . . -72.93 96.92 2.18 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.404 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 9.9 mm -81.86 94.35 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.863 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -105.29 140.43 23.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.666 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.831 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 29.9 t -99.69 129.31 45.81 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.865 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.9 tptp -128.79 106.06 8.66 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.7 t70 62.52 18.57 10.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -169.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.831 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 2.6 t-20 76.22 38.54 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.535 -175.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.506 ' HG2' ' CE1' ' A' ' 120' ' ' PHE . 31.1 tt0 -113.13 93.6 4.49 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.161 167.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.641 ' NE2' HG21 ' A' ' 98' ' ' THR . 74.2 mt-30 -66.83 129.72 40.8 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.886 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.697 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 50.6 m-85 -119.88 150.34 40.63 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.306 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.499 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 6.2 m -94.23 99.16 11.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.712 0.768 . . . . 0.0 109.844 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.865 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 64.9 mmt-85 -89.61 -161.86 0.82 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.822 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.685 ' N ' ' HG2' ' A' ' 126' ' ' GLU . . . 161.11 95.59 0.11 Allowed Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.007 -1.092 . . . . 0.0 112.894 -163.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.693 HG21 ' HB2' ' A' ' 106' ' ' ASP . 2.2 t 4.55 123.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 126.563 1.978 . . . . 0.0 114.976 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.698 ' HA ' ' CE ' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 78.21 34.42 0.29 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.664 -177.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.685 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 0.8 OUTLIER -124.04 167.08 14.67 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 112.669 -2.059 . . . . 0.0 107.844 168.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 1.9 mp0 -112.1 146.31 38.22 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.477 HG21 HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -61.66 153.72 69.52 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.479 ' O ' HD11 ' A' ' 95' ' ' LEU . 24.4 Cg_exo -66.04 127.84 18.45 Favored 'Trans proline' 0 C--N 1.333 -0.287 0 C-N-CA 122.424 2.083 . . . . 0.0 112.442 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.584 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 100.66 -59.78 0.67 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.209 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.622 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 10.9 m-85 -109.68 140.75 43.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.025 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -74.94 49.89 0.44 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.659 0.663 . . . . 0.0 111.789 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.705 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -80.64 96.68 6.94 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.752 ' HD2' ' C ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -80.49 108.96 14.55 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 121.044 0.45 . . . . 0.0 110.989 -168.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.652 HG12 HG11 ' A' ' 143' ' ' VAL . 50.5 mt -60.81 95.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.93 177.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.585 HG23 ' HA ' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -84.15 -8.63 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.081 179.09 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.683 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 39.4 m -157.49 116.18 3.22 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.435 -174.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.662 ' CD1' ' HB2' ' A' ' 111' ' ' ALA . 3.9 mt -92.61 127.91 44.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.598 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 28.0 mmt180 -141.2 151.62 62.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 173.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.411 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 78.0 Cg_exo -18.57 -75.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 1 C-N-CA 125.519 4.146 . . . . 0.0 114.776 -178.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.501 ' HA ' HD23 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -129.21 39.47 3.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.412 1.101 . . . . 0.0 108.797 168.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.593 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 8.2 tpp85 -136.06 143.56 44.73 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.835 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.729 HG23 HD21 ' A' ' 97' ' ' LEU . 3.4 t -141.67 169.25 14.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.534 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.85 HG22 HG12 ' A' ' 153' ' ' VAL . 18.3 t -133.58 61.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.786 HD11 HD12 ' A' ' 154' ' ' LEU . 1.9 pp -82.64 162.47 21.86 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -167.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 1.8 tp60 -105.73 105.49 15.56 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 112.556 -2.111 . . . . 0.0 108.232 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.638 ' HD2' HG21 ' A' ' 92' ' ' THR . 0.7 OUTLIER -141.21 136.78 32.08 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.753 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 1.033 HE22 ' HB ' ' A' ' 92' ' ' THR . 11.8 mt-30 68.29 28.67 6.23 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.534 0.521 . . . . 0.0 110.998 173.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.35 3.25 78.79 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.71 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 20.4 ttt180 -133.31 144.69 49.84 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.78 -0.247 . . . . 0.0 111.065 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.709 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 11.0 p90 -115.88 107.84 15.53 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.438 1.113 . . . . 0.0 107.999 171.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.824 ' HG3' ' H ' ' A' ' 153' ' ' VAL . 10.2 tp10 -130.79 -173.18 3.01 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.546 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.85 HG12 HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -95.28 100.06 10.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.676 0.75 . . . . 0.0 111.015 -167.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.786 HD12 HD11 ' A' ' 145' ' ' LEU . 1.2 mt -101.35 109.44 21.29 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.672 176.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.437 ' O ' ' HD2' ' A' ' 157' ' ' TYR . . . -99.85 52.19 1.03 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.4 mt -35.77 117.68 0.45 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.673 0.866 . . . . 0.0 109.659 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.437 ' HD2' ' O ' ' A' ' 155' ' ' GLY . 45.6 p90 . . . . . 0 C--N 1.321 -0.661 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.718 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.9 Cg_exo . . . . . 0 CA--C 1.531 0.347 0 N-CA-C 111.854 -0.095 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.594 ' OG ' ' HB2' ' A' ' 152' ' ' GLU . 0.0 OUTLIER 47.91 -100.23 0.06 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.261 0.624 . . . . 0.0 112.049 -174.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.644 ' H ' HD11 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -138.45 -37.19 0.56 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.024 0.829 . . . . 0.0 112.541 -178.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.66 ' H ' ' CD1' ' A' ' 154' ' ' LEU . 1.3 tm? 66.57 -4.11 0.78 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.488 ' N ' HD23 ' A' ' 156' ' ' LEU . 4.0 t30 -103.96 97.61 7.57 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.623 -0.673 . . . . 0.0 112.572 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.746 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -179.97 179.01 0.57 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 177.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.537 ' H ' HD13 ' A' ' 95' ' ' LEU . 24.4 t -123.29 101.04 7.15 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 119.442 1.019 . . . . 0.0 110.345 173.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.894 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -81.23 75.46 8.19 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.736 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -40.31 -47.57 2.52 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 174.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 140' ' ' PRO . . . 160.33 153.45 6.94 Favored Glycine 0 CA--C 1.488 -1.595 0 C-N-CA 118.317 -1.897 . . . . 0.0 113.431 173.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.635 HG22 ' HA ' ' A' ' 140' ' ' PRO . 8.0 m -103.92 142.72 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-O 121.565 0.698 . . . . 0.0 109.64 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.846 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -98.48 87.42 3.84 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.81 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -56.18 135.21 53.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.878 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 105' ' ' ASP . . . -123.14 92.69 0.47 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.815 -176.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 t70 71.28 -40.57 0.48 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.239 1.015 . . . . 0.0 110.118 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 103' ' ' GLY . 4.3 t70 -178.88 -141.02 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.752 ' CB ' HG21 ' A' ' 124' ' ' VAL . 20.8 m-20 -67.07 -29.61 69.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.3 0.571 . . . . 0.0 109.605 167.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.5 t -52.86 -57.46 10.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.937 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.412 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 5.2 mmm180 -114.29 26.52 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.122 -173.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.81 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 1.6 t -76.47 152.29 36.19 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.781 0.324 . . . . 0.0 111.217 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.846 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 15.4 mm -123.69 85.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 122.059 0.933 . . . . 0.0 110.833 -176.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.883 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -70.85 99.52 1.76 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.95 -176.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 7.8 mm -88.29 91.72 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -100.8 137.74 27.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.904 -177.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 4.2 m -95.22 122.47 37.94 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.754 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.522 ' HE3' ' HA3' ' A' ' 130' ' ' GLY . 25.0 tptp -117.07 97.42 5.92 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 58.88 23.58 11.52 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -164.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 114' ' ' SER . 1.5 t30 75.98 38.8 0.33 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.912 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -99.26 92.88 5.65 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 161.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.736 ' NE2' HG21 ' A' ' 98' ' ' THR . 61.6 mt-30 -68.54 105.37 2.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.028 -173.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 6.7 t80 -106.67 133.82 50.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.863 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.6 p -85.31 98.89 10.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.307 1.051 . . . . 0.0 111.431 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.86 ' HB3' ' OE2' ' A' ' 126' ' ' GLU . 14.5 mmt180 -89.45 -161.89 0.82 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.392 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.588 ' N ' ' HG2' ' A' ' 126' ' ' GLU . . . 158.93 94.13 0.1 OUTLIER Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.586 -165.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.752 HG21 ' CB ' ' A' ' 106' ' ' ASP . 21.5 t 7.74 120.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.478 1.911 . . . . 0.0 115.71 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.676 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 83.04 40.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 123.05 1.405 . . . . 0.0 109.165 -178.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.86 ' OE2' ' HB3' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -135.83 158.26 44.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 111.917 -2.401 . . . . 0.0 108.115 171.245 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 52.9 mt-10 -105.49 142.75 34.7 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.223 0.535 . . . . 0.0 110.981 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.836 HG22 ' HD2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -56.65 143.51 68.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.723 -174.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.836 ' HD2' HG22 ' A' ' 128' ' ' VAL . 2.2 Cg_endo -57.22 116.91 3.55 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.761 2.307 . . . . 0.0 112.924 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.522 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 113.98 -63.05 0.31 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.524 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.468 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 18.2 m-85 -107.79 147.36 30.95 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -78.58 58.37 2.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.983 0.81 . . . . 0.0 111.674 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.705 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -91.9 97.71 11.14 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.244 175.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.676 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER -80.23 106.92 12.61 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 120.69 0.281 . . . . 0.0 110.653 -171.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.744 ' HB ' ' OE1' ' A' ' 126' ' ' GLU . 75.6 mt -56.5 96.33 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 122.097 0.951 . . . . 0.0 110.174 176.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.715 HG23 ' HA ' ' A' ' 145' ' ' LEU . 1.6 t -88.09 -2.74 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.379 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -165.89 117.61 1.07 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.332 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.629 HG21 ' OG ' ' A' ' 109' ' ' SER . 1.9 mt -92.79 125.13 45.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.043 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 8.4 mmt180 -129.9 153.21 80.91 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.635 ' HA ' HG22 ' A' ' 100' ' ' VAL . 32.4 Cg_exo -22.82 -68.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 1 C-N-CA 125.388 4.059 . . . . 0.0 114.605 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.505 ' HA ' HD23 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -137.31 39.07 2.49 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.642 1.21 . . . . 0.0 109.111 172.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 2.3 tpp85 -142.05 142.81 32.89 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.208 -1.814 . . . . 0.0 108.393 176.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.61 HG11 HG12 ' A' ' 135' ' ' ILE . 2.1 t -139.87 166.91 19.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.499 0.666 . . . . 0.0 110.996 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 153' ' ' VAL . 40.9 t -130.04 95.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.878 HD11 HD12 ' A' ' 154' ' ' LEU . 2.6 pp -121.12 158.4 28.02 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -164.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.7 OUTLIER -92.27 110.41 21.8 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.168 -1.833 . . . . 0.0 109.468 -176.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.476 ' CD2' HG21 ' A' ' 92' ' ' THR . 0.5 OUTLIER -151.14 133.38 15.33 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 74.14 34.83 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.65 0.593 . . . . 0.0 110.423 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.0 13.74 82.89 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.794 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 32.5 ptt180 -142.59 170.47 15.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.689 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 26.1 p90 -136.03 111.08 8.88 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.314 1.054 . . . . 0.0 108.409 171.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.718 ' HG3' ' HB2' ' A' ' 90' ' ' PRO . 76.7 mm-40 -119.76 -170.19 1.91 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.126 -173.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.677 HG12 HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -103.03 107.13 21.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.637 0.732 . . . . 0.0 110.407 -172.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.878 HD12 HD11 ' A' ' 145' ' ' LEU . 1.4 mt -113.44 114.16 26.18 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.47 -175.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.468 ' O ' ' HD1' ' A' ' 157' ' ' TYR . . . -110.11 50.84 0.74 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 168.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.746 HD22 ' HB2' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -36.04 113.25 0.21 Allowed 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.803 0.943 . . . . 0.0 109.608 178.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.468 ' HD1' ' O ' ' A' ' 155' ' ' GLY . 51.3 p90 . . . . . 0 N--CA 1.45 -0.448 0 O-C-N 121.75 -0.594 . . . . 0.0 109.784 -172.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.668 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 9.1 Cg_exo . . . . . 0 CA--C 1.538 0.687 0 N-CA-C 115.434 1.282 . . . . 0.0 115.434 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.677 ' HB2' HD13 ' A' ' 154' ' ' LEU . 67.9 m -56.0 -71.29 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.502 0.592 . . . . 0.0 111.142 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.635 HG23 HD21 ' A' ' 154' ' ' LEU . 1.7 t -160.36 -48.45 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.046 ' H ' HD21 ' A' ' 154' ' ' LEU . 53.8 tp 60.99 118.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.581 ' H ' HD23 ' A' ' 156' ' ' LEU . 4.5 t30 -176.54 -63.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.834 0.35 . . . . 0.0 111.901 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.835 HD21 ' HD2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -55.64 169.31 0.34 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.798 -178.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.5 m -114.55 110.74 20.28 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.713 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.694 ' HA ' HG23 ' A' ' 113' ' ' ILE . 3.3 mp -76.21 123.06 25.27 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 114' ' ' SER . 0.2 OUTLIER -87.58 -36.54 17.48 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -175.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.555 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 159.49 146.75 4.66 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.654 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.75 HG22 ' HA ' ' A' ' 111' ' ' ALA . 5.2 t -103.97 131.05 53.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.054 0.454 . . . . 0.0 110.689 -174.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.864 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -97.46 88.02 4.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.805 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -67.95 126.74 30.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -174.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -128.52 110.48 1.13 Allowed Glycine 0 CA--C 1.5 -0.871 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.93 -171.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 23.9 t70 70.11 -65.18 0.33 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.692 ' O ' ' HB2' ' A' ' 109' ' ' SER . 20.2 t70 -167.72 -91.34 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.26 161.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.767 ' HA ' HG21 ' A' ' 124' ' ' VAL . 6.1 p-10 -91.97 -21.21 20.67 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.812 0.695 . . . . 0.0 111.078 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.447 ' HB2' ' HG2' ' A' ' 108' ' ' ARG . 3.9 m -60.03 -38.0 81.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.385 -172.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 107' ' ' SER . 0.1 OUTLIER -141.94 32.44 1.58 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.674 -172.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.805 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 1.5 t -85.99 135.84 33.49 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.034 0.445 . . . . 0.0 110.24 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.864 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 13.0 mm -116.91 88.49 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.341 -173.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.959 ' HB2' HD11 ' A' ' 138' ' ' ILE . . . -73.88 98.06 2.91 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.47 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 17.1 mm -82.87 94.73 3.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.807 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.3 OUTLIER -106.28 148.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.644 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.526 ' HB3' ' OG1' ' A' ' 98' ' ' THR . 1.3 p -118.37 132.71 56.26 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.473 0.654 . . . . 0.0 109.611 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.835 ' HD2' HD21 ' A' ' 95' ' ' LEU . 17.8 tptm -108.68 100.65 9.87 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.2 t70 52.92 33.32 14.28 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -165.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.2 t-20 79.85 29.81 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 112.537 -2.119 . . . . 0.0 111.393 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 8.6 tp10 -96.88 92.77 6.28 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 170.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 29.3 mt-30 -73.85 132.58 42.68 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -138.29 152.29 48.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.58 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.2 p -95.39 105.79 17.79 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.316 0.579 . . . . 0.0 111.503 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 1.093 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 30.1 mmt180 -96.83 -163.75 1.08 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.805 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.628 ' N ' ' HG3' ' A' ' 126' ' ' GLU . . . 173.05 93.41 0.09 OUTLIER Glycine 0 C--O 1.222 -0.596 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.456 -164.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 1.016 HG22 ' HB ' ' A' ' 138' ' ' ILE . 1.3 t 4.64 45.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 127.426 2.29 . . . . 0.0 115.84 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.48 ' C ' ' HD3' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 166.96 39.3 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -174.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 1.093 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 11.4 mm-40 -144.58 135.05 24.52 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 111.777 -2.465 . . . . 0.0 108.071 -170.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 58.4 mt-10 -91.84 142.62 27.38 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.695 HG22 HG21 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -60.0 152.12 62.08 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.15 -177.283 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.659 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 24.0 Cg_exo -66.23 129.44 21.64 Favored 'Trans proline' 0 C--N 1.329 -0.454 0 C-N-CA 122.667 2.245 . . . . 0.0 111.46 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.448 ' HA3' ' CE ' ' A' ' 115' ' ' LYS . . . 93.82 -38.31 3.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.942 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.402 ' HB3' ' HE2' ' A' ' 147' ' ' TYR . 44.1 m-85 -124.67 133.18 53.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.607 -174.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -76.92 52.98 0.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.399 0.619 . . . . 0.0 111.084 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.678 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -93.22 99.01 11.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 172.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.754 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 1.4 tmmm? -81.09 121.92 26.7 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-O 121.005 0.431 . . . . 0.0 110.827 -170.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.796 HG12 HG11 ' A' ' 143' ' ' VAL . 95.4 mt -67.14 94.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.648 HG22 ' HE2' ' A' ' 134' ' ' LYS . 2.8 t -86.58 -9.88 11.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.508 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -158.12 116.8 3.11 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.982 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 1.016 ' HB ' HG22 ' A' ' 124' ' ' VAL . 0.2 OUTLIER -86.64 133.51 29.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.064 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.668 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 19.2 mmt180 -141.88 154.56 65.59 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 172.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 100' ' ' VAL . 52.6 Cg_exo -22.79 -78.19 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 125.138 3.892 . . . . 0.0 114.777 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.492 ' HA ' HD23 ' A' ' 97' ' ' LEU . 3.4 p-10 -127.43 39.85 3.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.494 1.14 . . . . 0.0 109.086 168.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.668 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 7.1 tpp85 -134.95 139.98 45.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.689 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.796 HG11 HG12 ' A' ' 135' ' ' ILE . 3.5 t -143.59 123.38 8.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.747 0.784 . . . . 0.0 112.429 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 HG12 ' A' ' 153' ' ' VAL . 22.0 t -80.55 101.66 5.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 169.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.969 HD11 HD22 ' A' ' 154' ' ' LEU . 1.1 pp -122.77 158.41 30.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -168.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -95.27 103.1 14.95 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.449 -175.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.563 ' HD1' ' N ' ' A' ' 148' ' ' GLN . 0.3 OUTLIER -139.93 135.62 33.01 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.563 ' N ' ' HD1' ' A' ' 147' ' ' TYR . 1.9 mp0 72.96 31.94 1.43 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.635 0.584 . . . . 0.0 110.57 173.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.04 16.49 74.94 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.062 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.805 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 6.0 tpp180 -132.28 157.13 45.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.814 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 25.4 p90 -134.67 107.11 7.29 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.805 ' HG2' ' HG3' ' A' ' 150' ' ' ARG . 43.1 mm-40 -124.03 -171.69 2.38 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.523 -174.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.902 HG12 HG22 ' A' ' 144' ' ' VAL . 3.1 m -100.4 99.95 9.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.838 0.828 . . . . 0.0 110.489 -172.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 1.046 HD21 ' H ' ' A' ' 93' ' ' LEU . 3.5 tp -107.27 109.75 21.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.854 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 142' ' ' ARG . . . -97.11 53.51 1.36 Allowed Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.312 172.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.599 ' HA ' HD12 ' A' ' 93' ' ' LEU . 2.2 mt -37.09 115.49 0.39 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.447 0.734 . . . . 0.0 109.358 176.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 53.4 p90 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 118.533 0.606 . . . . 0.0 109.946 -175.816 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 111.999 -0.44 . . . . 0.0 111.999 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.7 p -114.33 -18.09 11.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.098 0.475 . . . . 0.0 110.859 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -88.47 -11.44 45.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.967 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 54.8 ttp -119.06 111.18 17.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.727 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.0 tt -98.11 104.43 16.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -96.13 -74.7 0.55 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.138 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 24.4 mmt 55.99 72.56 0.48 Allowed 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.714 0.634 . . . . 0.0 110.565 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.34 45.92 1.32 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.931 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 81.09 -115.89 4.11 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.51 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -175.94 -35.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.135 0.493 . . . . 0.0 109.907 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -154.67 163.03 40.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.459 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -77.33 81.99 3.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.405 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.03 -33.72 72.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.888 0.375 . . . . 0.0 111.312 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.622 ' HA ' ' HB2' ' A' ' 86' ' ' SER . 20.0 m -68.54 -16.23 63.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.436 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -60.56 -34.4 74.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.935 0.398 . . . . 0.0 110.424 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.6 ttt -102.03 7.79 41.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.413 0.625 . . . . 0.0 110.26 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.622 ' HB2' ' HA ' ' A' ' 83' ' ' SER . 8.0 t -80.78 81.76 6.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.522 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -98.16 -15.42 19.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.287 0.565 . . . . 0.0 109.747 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.2 118.23 57.43 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.427 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -62.11 110.13 0.96 Allowed 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.858 2.372 . . . . 0.0 112.745 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.492 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.8 Cg_exo -77.16 -137.29 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.505 2.803 . . . . 0.0 111.711 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.545 ' OG ' ' HB2' ' A' ' 152' ' ' GLU . 52.7 m 54.16 -99.58 0.09 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.514 0.326 . . . . 0.0 111.077 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.583 HG23 HD21 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -139.2 -42.3 0.46 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -176.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.903 ' H ' HD21 ' A' ' 154' ' ' LEU . 50.9 tp 60.38 109.72 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.496 0.665 . . . . 0.0 111.934 -174.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.589 ' H ' HD23 ' A' ' 156' ' ' LEU . 2.9 p-10 -174.55 -157.88 0.08 Allowed 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.748 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER 44.37 -175.41 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 176.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 10.2 t -127.31 111.8 14.32 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.219 163.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.93 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.9 OUTLIER -82.43 72.82 9.49 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 175.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.563 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -34.3 -42.62 0.14 Allowed 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 178.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 157.78 150.71 5.81 Favored Glycine 0 CA--C 1.484 -1.903 0 C-N-CA 119.16 -1.495 . . . . 0.0 112.676 171.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.755 HG21 HG23 ' A' ' 138' ' ' ILE . 19.0 m -104.13 160.44 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 122.432 1.111 . . . . 0.0 110.69 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.842 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 23.4 mmt -119.34 89.41 3.12 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 112.89 -1.959 . . . . 0.0 107.698 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.82 132.91 55.39 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.85 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 108' ' ' ARG . . . -117.34 90.85 0.52 Allowed Glycine 0 CA--C 1.496 -1.142 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.252 -173.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 107' ' ' SER . 31.0 t0 73.86 -53.33 0.69 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -172.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.755 ' O ' ' HB3' ' A' ' 109' ' ' SER . 38.6 t70 179.24 -106.85 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.45 -1.704 . . . . 0.0 106.935 170.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.713 ' HB2' HG11 ' A' ' 124' ' ' VAL . 9.9 p-10 -90.37 -9.74 46.54 Favored 'General case' 0 C--N 1.334 -0.103 0 O-C-N 124.248 0.968 . . . . 0.0 109.885 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.696 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 24.9 m -69.02 11.39 0.21 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.771 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.696 ' HG3' ' O ' ' A' ' 107' ' ' SER . 30.2 mtt85 178.59 -79.87 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -171.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.957 ' HB2' HD12 ' A' ' 138' ' ' ILE . 13.2 p 48.51 110.9 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 174.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.842 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 3.9 mm -94.41 134.25 32.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.76 174.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 1.032 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -124.06 108.42 12.33 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.745 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.654 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 13.8 mm -94.55 92.41 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 1.032 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.5 OUTLIER -105.87 143.16 17.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.047 -174.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.839 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 31.4 t -103.61 126.36 50.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.703 -177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.772 ' HB2' ' HB2' ' A' ' 129' ' ' PRO . 26.3 tptp -118.55 98.77 6.41 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.836 ' HA ' ' HB2' ' A' ' 161' ' ' ASP . 3.6 m-20 52.3 26.77 4.25 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -166.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.839 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 3.4 t-20 79.01 39.72 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.851 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 12.6 pt-20 -111.94 92.47 4.04 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.965 0.888 . . . . 0.0 108.934 161.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.673 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 63.0 mt-30 -66.4 126.63 29.43 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.585 -176.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.654 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 26.5 m-85 -118.8 161.65 19.78 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.543 177.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.0 p -102.98 99.16 9.04 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 122.086 0.946 . . . . 0.0 110.922 175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.542 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 22.8 mmt180 -107.74 -159.24 0.68 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.531 -177.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.619 ' HA2' ' CD1' ' A' ' 138' ' ' ILE . . . 165.33 179.94 39.43 Favored Glycine 0 N--CA 1.419 -2.457 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.857 -174.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.713 HG11 ' HB2' ' A' ' 106' ' ' ASP . 25.4 t -52.53 121.83 2.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 114.183 -1.009 . . . . 0.0 109.924 168.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.798 ' HA ' ' HE3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 78.52 21.55 0.78 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 122.546 1.165 . . . . 0.0 109.747 178.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 123' ' ' GLY . 3.6 mm-40 -117.06 158.93 23.33 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.96 -1.927 . . . . 0.0 106.42 167.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.876 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 40.1 mt-10 -113.22 148.91 34.54 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 118.17 0.441 . . . . 0.0 110.38 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.757 HG22 ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -58.74 147.77 70.32 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.755 -177.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.772 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 6.0 Cg_exo -58.79 130.95 39.32 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.811 2.341 . . . . 0.0 112.188 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.542 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 94.99 -63.5 1.48 Allowed Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 116.086 -0.507 . . . . 0.0 112.765 176.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.42 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 14.6 m-85 -109.31 148.07 31.63 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.15 49.83 0.58 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -175.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.676 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -84.58 97.56 9.66 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.876 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . 5.7 tptm -79.8 123.04 27.36 Favored 'General case' 0 C--O 1.211 -0.953 0 CA-C-O 121.324 0.583 . . . . 0.0 111.373 -171.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.621 HG12 HG11 ' A' ' 143' ' ' VAL . 71.2 mt -75.68 93.97 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.603 HG22 ' HG3' ' A' ' 134' ' ' LYS . 2.1 t -87.97 -10.53 10.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.585 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.2 OUTLIER -157.08 117.35 3.53 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.984 -179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.957 HD12 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -87.45 131.42 35.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.139 178.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 13.1 mmt180 -141.45 151.15 60.11 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -19.41 -77.68 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 125.261 3.974 . . . . 0.0 114.767 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.553 ' HA ' HD23 ' A' ' 97' ' ' LEU . 4.4 p-10 -125.05 36.86 4.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 122.467 1.127 . . . . 0.0 109.034 168.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.824 ' HD2' HG13 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -131.45 138.15 48.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.006 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.67 HG23 HD21 ' A' ' 97' ' ' LEU . 3.2 t -144.74 121.71 4.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 122.044 0.925 . . . . 0.0 112.131 -176.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.806 HG22 HG22 ' A' ' 153' ' ' VAL . 37.4 t -79.21 102.18 5.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.876 HD11 HD22 ' A' ' 154' ' ' LEU . 1.8 pp -120.12 152.0 38.25 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.103 0.954 . . . . 0.0 113.294 -169.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.565 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 4.0 tp60 -100.23 102.86 14.26 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.716 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.504 ' HD2' ' HB2' ' A' ' 133' ' ' ALA . 0.4 OUTLIER -136.78 135.16 37.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.15 -1.386 . . . . 0.0 107.529 176.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.466 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.7 mp0 70.39 32.19 2.83 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.673 0.389 . . . . 0.0 111.274 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.441 ' N ' HE22 ' A' ' 146' ' ' GLN . . . 79.84 1.96 87.84 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.027 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.775 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 20.1 tpp180 -130.31 143.49 50.81 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.739 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 34.6 p90 -119.84 108.94 14.98 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 122.278 1.037 . . . . 0.0 108.523 175.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.775 ' HG2' ' HG3' ' A' ' 150' ' ' ARG . 51.1 mm-40 -125.79 -170.41 2.18 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.646 -173.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.824 HG13 ' HD2' ' A' ' 142' ' ' ARG . 2.9 t -102.25 101.84 12.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 121.843 0.83 . . . . 0.0 109.985 -169.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.903 HD21 ' H ' ' A' ' 93' ' ' LEU . 4.7 tp -112.23 118.19 34.63 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.54 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.448 ' HA3' ' NH1' ' A' ' 142' ' ' ARG . . . -102.96 58.27 0.56 Allowed Glycine 0 C--N 1.308 -0.98 0 C-N-CA 120.099 -1.048 . . . . 0.0 110.553 169.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.836 HD12 HD13 ' A' ' 97' ' ' LEU . 2.3 mt -37.67 104.74 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.687 0 O-C-N 124.52 0.777 . . . . 0.0 110.214 174.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -136.62 133.8 36.67 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 121.524 -0.735 . . . . 0.0 109.544 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 75.3 m -154.51 162.04 41.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.268 0.556 . . . . 0.0 111.059 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -132.75 -6.09 3.19 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -77.25 -17.37 58.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.127 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.836 ' HB2' ' HA ' ' A' ' 116' ' ' ASP . 14.9 p-10 -80.35 -43.91 20.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.723 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.553 ' HA ' ' HB2' ' A' ' 117' ' ' ASN . 20.2 m -71.11 -34.17 70.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.406 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -90.66 59.15 3.32 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.382 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 66.9 p -162.66 146.9 11.71 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -98.98 -9.58 23.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.516 0.674 . . . . 0.0 110.14 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 97.67 11.12 51.73 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.434 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.2 100.09 53.19 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.3 109.52 2.44 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.579 2.186 . . . . 0.0 111.757 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -162.4 -167.45 22.84 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.518 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.31 -43.61 7.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.909 0.385 . . . . 0.0 110.722 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -122.54 83.31 2.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.256 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.32 -35.26 22.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.898 175.027 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.1 p -100.95 35.29 2.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.306 0.574 . . . . 0.0 111.377 -176.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -92.49 97.63 10.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 172.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -68.35 134.48 50.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.491 0.662 . . . . 0.0 111.677 -174.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 pp -104.02 17.49 24.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.896 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -68.29 139.29 55.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.8 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 14.8 ptm -94.25 40.05 1.08 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.366 -174.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.46 -152.78 0.39 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.611 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.32 -27.65 24.74 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.985 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 68.88 14.65 8.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.238 0.615 . . . . 0.0 110.643 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -163.18 27.1 0.09 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.54 -25.55 64.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.086 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 87' ' ' ASN . . . -58.14 -36.43 72.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.331 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 m -77.14 -13.66 59.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.726 0.298 . . . . 0.0 111.297 -175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.573 ' HG2' ' HG3' ' A' ' 85' ' ' MET . 58.8 tt0 -85.64 -33.58 21.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.757 0.313 . . . . 0.0 111.201 -175.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.573 ' HG3' ' HG2' ' A' ' 84' ' ' GLN . 65.3 mtt -146.13 -86.8 0.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.137 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.7 t -148.43 -55.06 0.2 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 82' ' ' ALA . 4.8 t-20 59.7 89.86 0.06 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.81 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.6 mp -70.64 119.38 72.42 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HG2' HD22 ' A' ' 93' ' ' LEU . 14.7 Cg_endo -57.02 110.31 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.405 2.737 . . . . 0.0 113.138 -175.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.781 ' HG2' ' HB3' ' A' ' 152' ' ' GLU . 73.4 Cg_endo -78.03 -139.81 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.144 2.563 . . . . 0.0 111.675 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.849 ' HB3' ' HG ' ' A' ' 154' ' ' LEU . 22.8 t 53.21 -101.8 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 117.878 0.308 . . . . 0.0 110.677 -177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.791 HG23 HD11 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -127.94 -34.67 2.13 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.475 0.58 . . . . 0.0 112.46 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.65 ' H ' HD11 ' A' ' 154' ' ' LEU . 47.2 tp 59.68 107.48 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.335 0.588 . . . . 0.0 111.993 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' HA ' HE21 ' A' ' 159' ' ' GLN . 2.4 p-10 -176.54 -157.05 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -175.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.781 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.4 OUTLIER 55.23 174.7 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 173.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.1 t -126.67 117.31 22.48 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.749 163.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.749 HD23 HG23 ' A' ' 113' ' ' ILE . 11.5 mt -77.23 125.51 29.44 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 171.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.608 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -91.53 -33.8 15.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.21 154.43 6.17 Favored Glycine 0 N--CA 1.432 -1.602 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.088 162.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.633 ' HB ' HD11 ' A' ' 138' ' ' ILE . 3.4 m -104.17 146.8 11.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 122.303 1.049 . . . . 0.0 110.799 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.632 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 65.6 mtt -105.75 91.58 3.81 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 113.176 -1.829 . . . . 0.0 108.782 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.31 129.59 42.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.55 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -114.6 94.85 0.7 Allowed Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 1.3 m-20 73.92 -53.81 0.69 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -169.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.766 ' O ' ' HB3' ' A' ' 109' ' ' SER . 25.8 t70 178.95 -90.01 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.692 -1.594 . . . . 0.0 107.466 168.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.829 ' HB2' HG21 ' A' ' 124' ' ' VAL . 13.3 p-10 -91.11 -38.85 12.5 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.16 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.446 ' C ' ' HD2' ' A' ' 108' ' ' ARG . 2.7 m -49.3 -55.89 11.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.171 -0.922 . . . . 0.0 113.195 -172.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.537 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 5.3 mmm180 -120.48 34.77 5.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.134 0.493 . . . . 0.0 109.902 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.862 ' HB2' HD13 ' A' ' 138' ' ' ILE . 19.1 p -76.35 141.87 41.38 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -168.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.632 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 10.2 mm -120.94 84.16 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 121.87 0.843 . . . . 0.0 111.273 -176.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.651 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -74.2 102.63 4.35 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.26 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 3.2 mm -87.04 96.19 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.749 HG23 HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -103.29 144.58 13.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.689 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.796 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 31.2 t -105.31 120.28 41.17 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.6 ' HE3' ' HA3' ' A' ' 130' ' ' GLY . 23.9 tptp -123.45 110.41 15.07 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -174.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 34.3 t70 61.07 17.29 7.88 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -168.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.796 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 2.8 t-20 73.98 35.53 0.78 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.913 -175.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -104.82 101.33 10.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 164.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.608 ' NE2' HG21 ' A' ' 98' ' ' THR . 36.3 mt-30 -67.2 120.99 14.68 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.34 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 5.7 t80 -120.21 143.41 48.27 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.819 -176.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.3 p -87.14 95.42 9.95 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 122.396 1.093 . . . . 0.0 111.119 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.51 ' HD3' ' HB3' ' A' ' 126' ' ' GLU . 13.6 mmt180 -103.57 -157.48 0.61 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.569 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.883 ' HA2' HD12 ' A' ' 138' ' ' ILE . . . 162.28 -174.64 38.73 Favored Glycine 0 N--CA 1.421 -2.355 0 C-N-CA 119.87 -1.157 . . . . 0.0 112.17 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.829 HG21 ' HB2' ' A' ' 106' ' ' ASP . 2.1 t -56.62 122.72 6.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-N 114.134 -1.033 . . . . 0.0 109.639 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.536 HD22 ' N ' ' A' ' 125' ' ' ASN . 0.9 OUTLIER 75.29 35.16 0.59 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.969 1.366 . . . . 0.0 108.223 176.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.51 ' HB3' ' HD3' ' A' ' 122' ' ' ARG . 4.8 mm-40 -133.8 144.88 49.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 111.985 -2.37 . . . . 0.0 106.81 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.571 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 34.7 mt-10 -103.34 132.56 49.5 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.196 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.628 HG21 HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -61.15 140.1 94.31 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.071 -176.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.709 ' O ' HD21 ' A' ' 95' ' ' LEU . 23.8 Cg_exo -64.77 142.67 77.39 Favored 'Trans proline' 0 C--O 1.223 -0.227 0 C-N-CA 123.094 2.529 . . . . 0.0 112.442 -167.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.6 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 97.06 -43.21 2.05 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.585 ' HB3' ' CE1' ' A' ' 147' ' ' TYR . 62.1 m-85 -114.11 170.13 8.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -96.43 46.44 1.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 170.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.688 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -85.81 97.52 10.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.571 ' CA ' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -81.81 104.61 12.31 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.715 -169.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 123' ' ' GLY . 70.8 mt -52.3 94.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.83 0.824 . . . . 0.0 110.106 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 145' ' ' LEU . 3.4 m -83.38 -3.78 7.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.517 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.827 ' HB3' ' HB ' ' A' ' 144' ' ' VAL . 3.6 t -168.71 117.4 0.7 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.905 -174.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.883 HD12 ' HA2' ' A' ' 123' ' ' GLY . 7.1 tt -97.2 135.88 29.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.735 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.717 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 17.1 mmt180 -141.44 157.5 65.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 172.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 141' ' ' ASP . 60.2 Cg_exo -18.94 -82.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.013 1 C-N-CA 125.579 4.186 . . . . 0.0 115.05 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.465 ' C ' HD13 ' A' ' 97' ' ' LEU . 7.7 p-10 -133.21 40.19 3.21 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 123.471 1.605 . . . . 0.0 107.438 167.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.717 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -126.57 139.2 53.38 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 111.642 -2.526 . . . . 0.0 107.154 169.028 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.544 ' N ' ' HD3' ' A' ' 142' ' ' ARG . 1.1 t -137.07 160.33 36.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.133 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.954 HG22 HG12 ' A' ' 153' ' ' VAL . 13.9 t -120.33 117.16 52.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 165.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.843 HD11 HD12 ' A' ' 154' ' ' LEU . 2.2 pp -132.5 162.49 31.08 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.765 0.793 . . . . 0.0 111.956 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.489 HE22 ' H ' ' A' ' 149' ' ' GLY . 4.2 tp60 -109.97 108.91 19.33 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.65 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 131' ' ' TYR . 76.9 t80 -135.86 141.32 44.61 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.577 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.566 ' NE2' ' HD2' ' A' ' 147' ' ' TYR . 0.0 OUTLIER 59.11 22.38 10.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 169.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.489 ' H ' HE22 ' A' ' 146' ' ' GLN . . . 98.6 -1.39 58.4 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.57 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.461 ' HG2' ' HG2' ' A' ' 148' ' ' GLN . 13.2 ptp180 -130.19 137.62 50.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.372 0.586 . . . . 0.0 111.875 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 16.5 p90 -114.7 108.22 16.5 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.391 1.091 . . . . 0.0 108.477 175.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.781 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 52.6 mt-10 -139.45 -170.42 2.9 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.443 -176.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.954 HG12 HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -96.34 99.65 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 122.006 0.908 . . . . 0.0 110.208 -168.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.849 ' HG ' ' HB3' ' A' ' 91' ' ' SER . 0.4 OUTLIER -101.99 106.82 17.79 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.704 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -98.98 53.11 1.08 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 173.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.781 HD22 ' HB2' ' A' ' 95' ' ' LEU . 3.9 mt -32.36 115.22 0.17 Allowed 'General case' 0 N--CA 1.47 0.544 0 O-C-N 124.907 1.004 . . . . 0.0 110.69 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -133.59 160.85 36.26 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -172.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.3 m -48.37 104.51 0.06 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.52 HE21 ' HA ' ' A' ' 94' ' ' ASN . 13.7 pt20 -149.62 18.68 0.92 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.726 0.774 . . . . 0.0 109.395 172.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 161' ' ' ASP . 7.0 pt-20 -147.65 -34.45 0.24 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 175.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.41 ' N ' ' HG3' ' A' ' 160' ' ' GLU . 12.9 t0 -71.57 -36.03 70.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.997 172.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.2 t -144.32 146.8 32.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.092 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.25 118.26 2.92 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 38.6 m -128.16 173.82 9.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.937 0.368 . . . . 0.0 111.411 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -53.41 -51.34 62.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.033 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.91 12.3 14.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.061 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 84.4 t -115.76 115.69 41.3 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.96 145.88 28.75 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.977 2.452 . . . . 0.0 112.248 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -104.49 18.95 43.56 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.935 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -138.21 82.02 1.89 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.041 0.448 . . . . 0.0 110.395 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -120.17 -119.28 0.3 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.238 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 18.3 m -68.39 -19.66 24.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 166.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 . . . . . 0 C--O 1.248 1.02 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.451 170.932 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.2 m -128.53 89.58 2.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.344 0.592 . . . . 0.0 110.81 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -84.59 55.72 3.53 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.367 0.603 . . . . 0.0 110.173 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 71.5 mmm -82.75 68.82 9.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.036 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.03 -30.14 60.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.348 -175.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -67.88 -14.05 62.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.537 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 52.1 mtm -136.99 54.11 1.87 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.021 0.439 . . . . 0.0 110.524 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.72 -1.85 58.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.44 63.98 2.15 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.945 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -119.66 111.65 18.32 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.931 -0.158 . . . . 0.0 110.844 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.584 ' O ' ' HB2' ' A' ' 81' ' ' ASP . 3.3 mm? 58.51 28.92 17.65 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.729 0.643 . . . . 0.0 111.435 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.584 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 27.0 t70 150.93 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -170.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.487 ' H ' ' CG ' ' A' ' 81' ' ' ASP . . . -91.98 -61.81 1.55 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 167.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.2 t -100.94 -65.17 0.99 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.713 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -101.33 -71.71 0.7 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -163.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.45 ' CA ' ' HB2' ' A' ' 81' ' ' ASP . 24.5 ptm -169.04 -35.39 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.5 m -153.5 49.05 0.68 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.093 -0.379 . . . . 0.0 111.54 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.9 m120 47.48 48.36 16.77 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 123.404 0.44 . . . . 0.0 111.719 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.676 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 49.8 tp -73.96 126.55 89.28 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.7 -176.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 88' ' ' LEU . 31.7 Cg_endo -97.1 90.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.893 3.062 . . . . 0.0 112.272 173.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.846 ' HG2' ' HB3' ' A' ' 152' ' ' GLU . 6.3 Cg_endo -90.42 -138.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.685 2.923 . . . . 0.0 112.118 -178.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.635 ' HB2' HD13 ' A' ' 154' ' ' LEU . 70.5 m 56.83 -86.63 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.614 0.765 . . . . 0.0 112.179 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.577 HG23 HD21 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -160.97 -44.67 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.831 -0.543 . . . . 0.0 112.381 -176.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.945 ' H ' HD21 ' A' ' 154' ' ' LEU . 6.5 tt 51.54 112.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.708 ' H ' HD23 ' A' ' 156' ' ' LEU . 2.3 p-10 -167.48 -56.81 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.853 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -54.71 176.34 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 122.95 0.5 . . . . 0.0 111.154 176.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.665 ' HB2' ' OG ' ' A' ' 158' ' ' SER . 1.5 t -117.59 109.93 17.29 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.292 170.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.718 ' HA ' HG23 ' A' ' 113' ' ' ILE . 1.9 mp -73.23 115.95 13.19 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 170.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.448 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -82.83 -35.7 26.14 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -176.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.51 169.83 31.55 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.745 170.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 111' ' ' ALA . 2.3 t -130.11 126.55 62.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 CA-C-O 121.904 0.859 . . . . 0.0 110.889 -175.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.88 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 64.8 mtt -92.0 89.98 7.21 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.308 -1.314 . . . . 0.0 108.583 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.11 121.52 14.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.731 -175.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.579 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -114.04 100.37 1.03 Allowed Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -172.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.579 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 10.5 t70 74.4 -64.67 0.38 Allowed 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -170.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 109' ' ' SER . 7.0 m-20 -169.37 -91.52 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 112.942 -1.935 . . . . 0.0 106.519 169.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.653 ' HA ' HG21 ' A' ' 124' ' ' VAL . 12.5 p-10 -91.87 -30.75 15.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.665 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.8 t -60.07 -57.18 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.464 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 4.4 mmm180 -111.58 28.9 8.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.367 0.603 . . . . 0.0 110.067 -170.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.809 ' HB2' HD13 ' A' ' 138' ' ' ILE . 22.5 p -73.02 135.8 44.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.685 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.88 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 6.4 mm -120.39 89.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.393 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.939 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -78.64 100.95 7.22 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.921 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.5 mm -86.3 93.18 3.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.939 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -106.86 159.93 6.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.235 -176.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.492 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 26.4 p -125.82 135.48 52.02 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-O 121.308 0.575 . . . . 0.0 109.54 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.853 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.9 tptp -119.21 108.39 14.59 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 59.25 20.43 8.54 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -167.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.1 t-20 79.74 37.19 0.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 113.435 -1.711 . . . . 0.0 111.666 -176.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 16.6 pt-20 -107.4 101.77 11.1 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.963 0.887 . . . . 0.0 109.626 166.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.709 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 2.8 mt-30 -67.24 135.89 54.11 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -142.81 146.15 33.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.737 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.8 p -88.07 103.11 15.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.924 0.869 . . . . 0.0 111.552 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.519 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 21.9 mmt180 -107.42 -159.62 0.7 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.27 -1.332 . . . . 0.0 110.682 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.691 ' HA2' HD12 ' A' ' 138' ' ' ILE . . . 174.94 173.64 40.93 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -175.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.653 HG21 ' HA ' ' A' ' 106' ' ' ASP . 16.7 t -49.39 132.59 7.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 165.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.562 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 72.29 19.55 4.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.459 1.123 . . . . 0.0 109.574 175.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.519 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 0.4 OUTLIER -120.64 158.04 28.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.145 -1.843 . . . . 0.0 106.347 167.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.744 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 41.6 mt-10 -104.2 156.89 17.52 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 118.435 0.561 . . . . 0.0 110.116 178.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.742 HG22 ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -66.4 145.2 98.95 Favored Pre-proline 0 N--CA 1.442 -0.85 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.553 178.345 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.788 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 21.7 Cg_exo -52.98 130.69 39.1 Favored 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 122.847 2.364 . . . . 0.0 112.009 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.538 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 96.6 -59.06 1.29 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.633 176.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.468 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 27.0 m-85 -113.63 153.66 28.51 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 121.434 -0.106 . . . . 0.0 111.036 -174.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -74.81 44.76 0.23 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.673 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -83.06 90.4 7.03 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 170.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.744 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 0.7 OUTLIER -80.49 120.83 24.99 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.472 -170.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.663 HG12 HG11 ' A' ' 143' ' ' VAL . 74.4 mt -68.62 94.67 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.412 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.742 HG22 ' HE2' ' A' ' 134' ' ' LYS . 1.5 t -88.59 -3.77 9.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.732 0.777 . . . . 0.0 108.965 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.474 ' HB3' HG23 ' A' ' 144' ' ' VAL . 1.7 t -162.38 115.32 1.71 Allowed 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.492 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.809 HD13 ' HB2' ' A' ' 109' ' ' SER . 3.5 tt -88.98 132.93 32.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.069 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 7.4 mmt180 -141.89 159.23 60.16 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -22.63 -78.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 125.093 3.862 . . . . 0.0 114.474 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.4 ' HA ' HD23 ' A' ' 97' ' ' LEU . 9.5 p-10 -128.33 39.53 3.81 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.398 1.094 . . . . 0.0 108.715 169.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.531 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 1.9 tpp180 -136.93 143.35 42.85 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 113.385 -1.734 . . . . 0.0 109.73 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.663 HG11 HG12 ' A' ' 135' ' ' ILE . 4.8 t -148.41 119.33 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.83 -176.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 1.076 HG22 HG13 ' A' ' 153' ' ' VAL . 7.1 t -79.04 65.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.719 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 1.9 pp -82.63 167.92 17.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 114.952 -1.022 . . . . 0.0 113.022 -175.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.619 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -112.57 124.39 52.43 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.577 179.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.559 ' HD2' ' HB2' ' A' ' 133' ' ' ALA . 0.3 OUTLIER -145.27 140.04 27.53 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.492 HE22 ' HB ' ' A' ' 92' ' ' THR . 2.2 mp0 67.91 28.94 6.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.966 0.412 . . . . 0.0 109.942 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.15 8.43 87.44 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.925 -0.579 . . . . 0.0 113.605 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.619 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 0.3 OUTLIER -132.61 139.78 47.93 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 117.247 0.523 . . . . 0.0 110.905 -173.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.719 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 13.3 p90 -118.94 111.96 19.01 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.106 0.955 . . . . 0.0 109.392 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.846 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 34.6 mt-10 -134.94 -175.9 4.06 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.161 -177.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 1.076 HG13 HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -96.24 99.27 8.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 C-N-CA 119.676 -0.809 . . . . 0.0 110.233 -165.17 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.945 HD21 ' H ' ' A' ' 93' ' ' LEU . 6.0 tp -103.66 119.55 39.14 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.384 -0.825 . . . . 0.0 113.163 -176.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -104.29 54.86 0.62 Allowed Glycine 0 C--N 1.304 -1.204 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 168.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.708 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.5 mt -36.51 107.25 0.06 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.39 0.7 . . . . 0.0 110.101 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -134.24 121.7 21.7 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.665 ' OG ' ' HB2' ' A' ' 96' ' ' SER . 38.0 m -61.4 132.98 55.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.231 0.539 . . . . 0.0 111.399 -174.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -72.06 179.69 3.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.101 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -80.59 118.21 21.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.143 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -71.5 -18.93 62.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.516 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.8 p -82.29 -29.22 31.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.961 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -106.4 25.53 22.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.229 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.3 t -156.44 151.52 26.32 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.87 1.23 57.15 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.409 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 92.42 -21.26 39.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.942 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.24 130.72 23.71 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.73 109.19 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.312 2.008 . . . . 0.0 111.582 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 177.47 -178.28 48.33 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . 59.09 -158.59 0.31 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.911 0.418 . . . . 0.0 110.959 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 58.62 50.49 8.94 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.585 0.707 . . . . 0.0 110.496 176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 20.6 t -91.02 -26.18 5.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 . . . . . 0 C--O 1.25 1.116 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.069 174.914 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.713 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.5 t -85.24 -1.35 56.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.063 0.459 . . . . 0.0 110.764 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -86.66 -14.63 42.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 110.368 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 77.3 mtp -133.17 102.99 5.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.593 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.9 tp -72.2 105.64 4.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -94.01 117.09 29.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.221 0.534 . . . . 0.0 111.456 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -83.08 69.49 9.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.883 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.5 39.99 0.63 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.729 -176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.84 -171.78 41.8 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.019 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -163.73 -70.31 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.0 tp -124.39 93.51 3.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 172.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -103.54 131.17 50.9 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.161 -171.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.21 -12.8 61.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.734 -178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.6 m -64.4 -10.8 27.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.349 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -56.67 -40.8 76.16 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.058 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.446 ' HA ' ' CE ' ' A' ' 85' ' ' MET . 9.4 mmt 66.5 -163.54 0.23 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.625 0.578 . . . . 0.0 110.368 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.8 m 65.78 25.51 11.35 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 123.513 0.508 . . . . 0.0 111.334 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -92.41 69.13 5.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.768 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.638 ' HB3' ' HD3' ' A' ' 89' ' ' PRO . 8.8 tt -161.56 -56.5 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.305 -0.379 . . . . 0.0 111.786 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 88' ' ' LEU . 45.8 Cg_exo -56.74 114.28 1.85 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.548 2.165 . . . . 0.0 113.728 -173.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.759 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.6 Cg_exo -78.45 -133.66 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.712 2.941 . . . . 0.0 111.005 174.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.869 ' HB2' ' HB2' ' A' ' 152' ' ' GLU . 9.1 t 51.23 -137.98 1.11 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 122.211 0.205 . . . . 0.0 111.121 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.443 ' HB ' ' CD2' ' A' ' 147' ' ' TYR . 4.9 t -95.53 -37.85 10.69 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -175.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.677 ' HA ' HD11 ' A' ' 154' ' ' LEU . 31.7 tp 49.59 68.47 0.73 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.862 ' H ' HD23 ' A' ' 156' ' ' LEU . 5.3 t30 -174.04 100.59 0.1 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.894 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.0 OUTLIER 164.44 -167.63 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 175.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.508 ' HB2' ' OG ' ' A' ' 114' ' ' SER . 49.9 m -132.01 103.75 6.45 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.606 173.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.926 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -83.25 74.14 10.05 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -37.72 -46.67 0.92 Allowed 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 140' ' ' PRO . . . 161.54 152.47 6.67 Favored Glycine 0 CA--C 1.486 -1.775 0 C-N-CA 119.121 -1.514 . . . . 0.0 112.358 172.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 111' ' ' ALA . 4.7 m -104.59 143.21 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-O 121.659 0.743 . . . . 0.0 110.021 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.863 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 87.1 mmm -90.86 86.33 6.27 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 173.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.754 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -65.61 119.69 11.57 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.945 -176.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -114.7 102.45 1.17 Allowed Glycine 0 CA--C 1.498 -1.022 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -171.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 2.6 m-20 72.22 -69.41 0.19 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -172.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -149.72 -111.89 0.06 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.092 170.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.495 ' OD2' HG11 ' A' ' 124' ' ' VAL . 5.8 m-20 -90.59 -13.13 35.05 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.739 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.3 t -64.44 -58.03 7.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.534 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -109.91 29.67 7.41 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.401 -173.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.754 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 2.6 t -85.52 141.65 29.73 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.247 0.546 . . . . 0.0 111.763 -170.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.863 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 10.7 mm -122.21 87.93 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.422 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.897 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -69.09 98.61 1.01 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.43 -1.259 . . . . 0.0 111.483 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.552 HG22 ' HG2' ' A' ' 119' ' ' GLN . 13.6 mm -87.33 90.03 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.926 HG23 ' HA ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -101.79 132.84 46.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.759 -179.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.508 ' OG ' ' HB2' ' A' ' 96' ' ' SER . 2.7 p -99.41 135.21 41.16 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.04 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.776 ' HA ' HD21 ' A' ' 95' ' ' LEU . 24.3 tptp -122.69 110.87 16.04 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 61.71 21.51 12.24 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -166.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 117' ' ' ASN . 3.4 t-20 77.39 33.69 0.4 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.677 -178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 114' ' ' SER . 81.3 tt0 -101.6 96.78 7.34 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 170.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.552 ' HG2' HG22 ' A' ' 112' ' ' ILE . 3.8 mt-30 -67.5 108.62 2.9 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 5.2 t80 -110.13 141.99 42.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.927 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.9 p -90.19 95.12 10.05 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.807 0.813 . . . . 0.0 112.177 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.941 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 18.8 mmt180 -91.96 -160.07 0.7 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.492 176.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.638 ' N ' ' HG3' ' A' ' 126' ' ' GLU . . . 163.8 105.62 0.19 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.582 -168.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.752 HG22 ' HB ' ' A' ' 138' ' ' ILE . 0.0 OUTLIER -9.5 117.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 125.408 1.299 . . . . 0.0 113.23 -177.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.736 ' HB2' ' O ' ' A' ' 124' ' ' VAL . 0.9 OUTLIER 88.59 27.48 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.474 0 O-C-N 124.999 1.437 . . . . 0.0 108.428 -167.601 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.941 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 5.1 mm-40 -124.75 147.49 48.63 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 112.833 -1.985 . . . . 0.0 107.891 172.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.565 ' HG2' ' CA ' ' A' ' 134' ' ' LYS . 50.9 mt-10 -105.41 140.25 38.81 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 156' ' ' LEU . 0.5 OUTLIER -57.18 154.77 19.59 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.23 -176.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 128' ' ' VAL . 15.5 Cg_exo -70.07 119.24 6.2 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.883 2.389 . . . . 0.0 112.279 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.583 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 99.21 -52.1 1.1 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.328 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.548 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 21.3 m-85 -104.34 132.57 50.44 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -79.27 52.57 1.35 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.571 1.078 . . . . 0.0 110.962 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.793 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -84.78 101.72 12.47 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -81.39 107.9 14.55 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.015 -171.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 81.1 mt -55.91 94.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 O-C-N 123.806 0.691 . . . . 0.0 109.834 175.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.527 HG21 ' HB2' ' A' ' 151' ' ' TYR . 0.2 OUTLIER -88.19 -4.2 9.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.656 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -164.65 118.32 1.33 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.767 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.752 ' HB ' HG22 ' A' ' 124' ' ' VAL . 7.2 tt -92.88 128.79 44.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.552 0.691 . . . . 0.0 111.727 -174.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.804 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 16.9 mmt180 -142.06 160.17 56.29 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.61 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 7.3 Cg_exo -25.49 -85.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 1 C-N-CA 126.14 4.56 . . . . 0.0 114.98 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.603 ' HA ' HD23 ' A' ' 97' ' ' LEU . 1.9 p30 -123.78 14.05 9.3 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 122.036 0.922 . . . . 0.0 109.08 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.804 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -115.25 142.72 46.3 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.704 169.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.533 ' N ' ' HG2' ' A' ' 142' ' ' ARG . 0.9 OUTLIER -137.89 170.48 17.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.851 177.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.811 HG22 HG12 ' A' ' 153' ' ' VAL . 40.7 t -122.1 97.98 5.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.793 HD13 ' HB1' ' A' ' 133' ' ' ALA . 1.2 pp -120.34 158.59 26.8 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.039 0.923 . . . . 0.0 112.847 -170.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.512 HE22 ' N ' ' A' ' 149' ' ' GLY . 4.6 tp60 -106.64 103.04 12.39 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.555 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.572 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 52.9 t80 -128.22 144.42 51.12 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.128 -1.396 . . . . 0.0 107.613 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.572 ' HG2' ' O ' ' A' ' 147' ' ' TYR . 0.0 OUTLIER 59.38 29.31 18.86 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 171.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.512 ' N ' HE22 ' A' ' 146' ' ' GLN . . . 83.24 5.24 89.11 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.133 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.657 ' HG2' ' HG2' ' A' ' 152' ' ' GLU . 66.5 ttt180 -133.32 138.47 46.39 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 117.071 0.435 . . . . 0.0 110.803 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 6.4 p90 -116.75 112.33 21.02 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 122.547 1.165 . . . . 0.0 108.812 177.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.869 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 76.5 mm-40 -128.87 -169.79 2.15 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.384 -174.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.811 HG12 HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -98.64 100.4 10.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 122.081 0.944 . . . . 0.0 108.475 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.677 HD11 ' HA ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -119.38 106.3 12.14 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.701 -172.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 142' ' ' ARG . . . -106.46 70.49 0.22 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.894 HD22 ' HB2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -37.06 124.14 0.91 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.604 0.762 . . . . 0.0 110.447 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -132.35 145.89 51.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -161.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.1 m -85.99 139.75 30.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.522 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 66.08 -156.65 0.26 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.957 170.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 70.05 -65.47 0.31 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.503 0.721 . . . . 0.0 111.098 -177.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -81.61 -14.05 57.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.577 0.703 . . . . 0.0 109.985 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.3 t -129.26 141.3 51.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.694 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -161.69 173.44 38.06 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.927 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 9.3 t -124.99 33.3 5.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.643 0.735 . . . . 0.0 110.021 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -97.36 25.73 5.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.369 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 108.43 15.84 13.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.175 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 59.7 t -79.03 122.22 84.21 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.605 0.24 . . . . 0.0 110.432 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.24 111.25 2.21 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.999 2.466 . . . . 0.0 112.716 -178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -116.86 172.45 14.24 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -84.77 12.41 7.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.014 0.435 . . . . 0.0 111.521 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -143.5 79.97 1.65 Allowed 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.1 m -69.1 -28.14 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.824 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.53 -0.747 . . . . 0.0 110.73 179.393 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.313 -0.315 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 m -74.1 -48.84 26.95 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -89.34 100.44 13.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.163 0.506 . . . . 0.0 112.088 -176.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 69.7 mtm -126.07 81.31 1.98 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 170.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 2.7 pp -83.48 24.72 0.81 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.678 -171.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -66.31 -29.13 69.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.378 0.609 . . . . 0.0 109.902 175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 28.7 mmt 65.36 43.13 3.59 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.881 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.64 -15.53 48.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.404 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.62 -136.36 13.16 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 54.64 49.69 17.55 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.721 0.408 . . . . 0.0 111.611 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.22 -93.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.931 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -146.58 14.92 1.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.763 0.316 . . . . 0.0 110.517 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.45 -38.25 68.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.238 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.1 p -93.61 -38.32 11.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.811 0.339 . . . . 0.0 111.535 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -73.82 -30.47 62.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 -176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 66.5 mtt 70.99 122.09 0.03 OUTLIER 'General case' 0 C--O 1.231 0.129 0 O-C-N 124.045 0.84 . . . . 0.0 110.557 -176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.6 t -72.22 -20.13 61.6 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.108 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 67.5 -168.58 0.2 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.984 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 pp -123.91 156.27 65.82 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.402 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.86 107.93 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.415 2.743 . . . . 0.0 114.031 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.54 ' O ' HD13 ' A' ' 154' ' ' LEU . 2.8 Cg_exo -77.53 -132.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.617 2.878 . . . . 0.0 111.364 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.518 ' HB2' HD13 ' A' ' 154' ' ' LEU . 58.5 m 56.38 -83.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.895 0.478 . . . . 0.0 112.006 -176.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.683 ' HB ' HE22 ' A' ' 148' ' ' GLN . 1.6 t -161.07 -41.09 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.544 -0.722 . . . . 0.0 112.336 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.809 ' H ' HD21 ' A' ' 154' ' ' LEU . 48.8 tp 56.2 99.77 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.717 ' H ' HD23 ' A' ' 156' ' ' LEU . 3.1 p-10 -160.07 -61.09 0.06 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.842 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -57.28 -178.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.415 0.626 . . . . 0.0 111.75 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.819 ' HB2' ' HB3' ' A' ' 158' ' ' SER . 9.6 t -117.28 119.85 36.43 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.621 170.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.963 HD23 HG23 ' A' ' 113' ' ' ILE . 53.4 mt -76.74 131.34 38.68 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 165.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.459 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.2 OUTLIER -92.27 -32.48 15.01 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 175.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.934 ' HA2' ' HB3' ' A' ' 141' ' ' ASP . . . 154.71 168.19 17.67 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.97 161.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.718 HG11 HG23 ' A' ' 138' ' ' ILE . 2.7 t -114.4 132.01 64.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.781 0.801 . . . . 0.0 110.91 -174.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.842 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 67.1 mtt -104.17 87.41 2.75 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.21 177.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.81 46.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.4 -175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.753 ' H ' ' HA ' ' A' ' 109' ' ' SER . . . -106.62 88.14 0.54 Allowed Glycine 0 CA--C 1.496 -1.156 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 25.1 t70 74.85 -54.65 0.66 Allowed 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -169.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.672 ' O ' ' HB3' ' A' ' 109' ' ' SER . 12.7 t70 -178.97 -124.07 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.902 -1.499 . . . . 0.0 106.994 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.74 ' HA ' HG21 ' A' ' 124' ' ' VAL . 2.3 p-10 -80.9 -6.59 58.85 Favored 'General case' 0 CA--C 1.522 -0.101 0 O-C-N 124.184 0.928 . . . . 0.0 109.939 172.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.1 t -60.46 -42.5 96.33 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.164 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 78.7 mtp180 -126.2 -65.61 0.97 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.421 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.753 ' HA ' ' H ' ' A' ' 103' ' ' GLY . 13.7 p 53.58 127.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 174.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.842 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 3.6 mm -116.9 129.92 72.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.329 174.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.927 ' HB2' HD11 ' A' ' 138' ' ' ILE . . . -120.69 98.42 6.01 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.802 0.335 . . . . 0.0 111.653 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.5 mm -80.33 94.54 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.963 HG23 HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -105.82 142.62 18.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.718 177.224 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.434 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 84.5 p -113.66 129.18 56.61 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.846 0.832 . . . . 0.0 109.353 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.842 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.6 tptp -124.81 101.46 7.1 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -171.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 55.07 22.16 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -164.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.401 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.8 t-20 78.24 40.67 0.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.697 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 15.5 pt-20 -108.71 90.75 3.39 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.276 1.036 . . . . 0.0 108.292 161.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 34.9 mt-30 -67.22 124.19 22.41 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.524 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -128.69 147.98 50.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.993 -177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.4 p -97.3 105.12 17.2 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.616 0.722 . . . . 0.0 111.532 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.982 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 28.1 mmt180 -95.2 -163.05 1.0 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.316 176.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.616 ' O ' ' HG2' ' A' ' 126' ' ' GLU . . . 164.74 110.88 0.24 Allowed Glycine 0 C--O 1.216 -1.001 0 C-N-CA 119.738 -1.22 . . . . 0.0 114.088 -171.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.74 HG21 ' HA ' ' A' ' 106' ' ' ASP . 28.1 t 4.85 115.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.152 1.381 . . . . 0.0 114.452 -175.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.705 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 80.8 35.48 0.11 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.313 -175.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.982 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 13.1 mm-40 -127.31 150.72 49.45 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.781 170.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 2.3 mp0 -101.39 150.84 22.6 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 118.571 0.623 . . . . 0.0 109.861 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.619 HG22 HG21 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -62.35 151.72 81.56 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.493 -179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.565 ' HD2' HG22 ' A' ' 128' ' ' VAL . 3.6 Cg_exo -62.94 127.52 20.62 Favored 'Trans proline' 0 C--N 1.332 -0.292 0 C-N-CA 122.953 2.435 . . . . 0.0 112.37 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.62 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 100.48 -64.1 0.59 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.353 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.51 ' HE2' HD12 ' A' ' 95' ' ' LEU . 4.3 m-85 -110.73 140.56 45.01 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -78.87 56.37 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 118.538 0.608 . . . . 0.0 111.831 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.727 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -79.88 96.97 6.51 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.705 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.5 OUTLIER -81.13 115.91 20.79 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.256 0.551 . . . . 0.0 110.911 -169.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.58 HG21 HG13 ' A' ' 138' ' ' ILE . 74.7 mt -67.47 94.31 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.401 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.634 HG22 ' HE2' ' A' ' 134' ' ' LYS . 1.3 t -86.62 -6.57 10.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.723 ' CB ' ' HB ' ' A' ' 144' ' ' VAL . 4.1 t -157.15 117.12 3.46 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.125 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.927 HD11 ' HB2' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -91.55 125.99 44.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.991 0.9 . . . . 0.0 111.238 176.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.6 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 13.5 mmt85 -142.11 148.96 50.48 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.292 -1.322 . . . . 0.0 107.647 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.29 81.2 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.628 2.218 . . . . 0.0 113.67 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.934 ' HB3' ' HA2' ' A' ' 99' ' ' GLY 0.279 2.9 p30 75.62 27.0 1.05 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.868 1.667 . . . . 0.0 110.17 170.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.703 ' HD2' ' N ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -139.72 151.32 45.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 112.255 -2.248 . . . . 0.0 106.204 157.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.703 ' N ' ' HD2' ' A' ' 142' ' ' ARG . 7.2 t -141.21 164.89 19.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-O 121.526 0.679 . . . . 0.0 111.395 -173.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 153' ' ' VAL . 59.1 t -122.12 100.45 8.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.727 HD13 ' HB1' ' A' ' 133' ' ' ALA . 2.0 pp -122.56 156.56 33.94 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 122.21 1.005 . . . . 0.0 113.223 -168.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.52 HE22 ' N ' ' A' ' 149' ' ' GLY . 2.2 tp60 -103.46 104.58 14.68 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 112.533 -2.121 . . . . 0.0 108.581 -174.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.505 ' CD2' HG21 ' A' ' 92' ' ' THR . 0.4 OUTLIER -136.54 135.5 38.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.711 175.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.683 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.8 mp0 67.93 34.34 4.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 110.46 175.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.52 ' N ' HE22 ' A' ' 146' ' ' GLN . . . 70.55 12.81 70.56 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.729 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.472 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 29.2 ttp180 -130.95 137.43 49.28 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.792 -0.24 . . . . 0.0 110.362 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.715 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 22.3 p90 -118.58 108.8 15.4 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.704 1.24 . . . . 0.0 109.313 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 6.1 mm-40 -129.02 -170.72 2.32 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 113.483 -1.69 . . . . 0.0 109.179 -175.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 144' ' ' VAL . 3.5 t -97.17 105.54 17.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.184 0.516 . . . . 0.0 109.903 -173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.809 HD21 ' H ' ' A' ' 93' ' ' LEU . 6.1 tp -108.17 121.2 44.36 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.488 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -108.14 59.26 0.37 Allowed Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 167.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.717 HD23 ' H ' ' A' ' 94' ' ' ASN . 1.5 mt -36.46 109.73 0.1 Allowed 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.269 0.629 . . . . 0.0 109.521 173.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -134.43 99.15 4.28 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -172.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.819 ' HB3' ' HB2' ' A' ' 96' ' ' SER . 8.6 t -115.35 142.27 46.92 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.085 0.469 . . . . 0.0 110.323 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.32 169.01 18.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.548 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.98 -76.63 0.59 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -109.52 -25.7 10.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.273 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.3 m 58.86 26.47 14.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.397 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.96 -62.1 4.25 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.095 -0.574 . . . . 0.0 111.998 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.3 m -148.33 104.49 3.53 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.969 0.414 . . . . 0.0 110.053 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -77.19 -21.93 53.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.105 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.96 -22.86 17.93 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.658 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.6 p -77.82 118.98 75.57 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 121.088 0.471 . . . . 0.0 110.246 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.28 130.75 5.53 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.519 2.146 . . . . 0.0 112.493 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -96.66 154.3 20.6 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.724 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.13 57.48 4.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.104 0.478 . . . . 0.0 110.877 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -84.39 93.36 8.25 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.938 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.98 135.23 60.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.657 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 173' ' ' ARG . 30.6 ptt180 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.973 -0.537 . . . . 0.0 110.333 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.6 m -83.62 95.52 8.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.23 0.538 . . . . 0.0 110.446 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -85.92 -47.95 9.17 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.459 ' HG2' ' HG ' ' A' ' 74' ' ' LEU . 27.1 ttt -174.49 127.35 0.33 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.96 175.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.459 ' HG ' ' HG2' ' A' ' 73' ' ' MET . 96.0 mt 69.91 115.37 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 O-C-N 124.069 0.856 . . . . 0.0 111.331 -177.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -76.19 -2.3 30.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.309 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 47.1 ttm -57.77 -26.78 62.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.646 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.45 -20.39 65.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.074 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -96.94 80.2 0.7 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.95 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.11 97.47 7.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.9 0.381 . . . . 0.0 110.358 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.55 9.09 3.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.689 -173.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -104.05 -21.96 13.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.486 0.66 . . . . 0.0 109.647 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.86 3.36 51.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.505 0.669 . . . . 0.0 110.132 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.4 m -93.1 -26.84 17.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.568 -169.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -99.48 -42.1 7.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.585 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -152.38 134.03 14.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.057 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.5 t -174.41 171.39 3.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.509 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.6 m120 71.65 137.95 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.041 0.838 . . . . 0.0 112.923 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . 6.5 mp -125.24 123.44 25.24 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.675 175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.78 ' HB3' HD22 ' A' ' 154' ' ' LEU . 53.8 Cg_exo -54.9 108.1 0.28 Allowed 'Trans proline' 0 N--CA 1.476 0.464 0 C-N-CA 123.583 2.855 . . . . 0.0 113.227 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 89' ' ' PRO . 2.7 Cg_exo -77.53 -31.74 3.23 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 123.667 2.911 . . . . 0.0 114.718 -172.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.657 ' HB3' HD23 ' A' ' 154' ' ' LEU . 46.5 t -61.63 -76.43 0.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.13 0.423 . . . . 0.0 111.624 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.88 ' HB ' HE22 ' A' ' 148' ' ' GLN . 2.7 t -127.7 -45.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.835 ' H ' HD11 ' A' ' 154' ' ' LEU . 45.6 tp 59.06 86.07 0.09 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.308 0.575 . . . . 0.0 111.889 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.727 ' ND2' ' H ' ' A' ' 95' ' ' LEU . 9.5 t30 -160.42 -149.5 0.19 Allowed 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.027 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.5 OUTLIER 51.71 177.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 172.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.434 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 40.8 m -137.23 115.55 11.81 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.221 166.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.938 HD23 HG23 ' A' ' 113' ' ' ILE . 12.0 mt -74.97 143.16 43.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 174.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.25 -33.2 10.84 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 171.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 147.05 154.22 6.14 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 162.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.647 HG12 ' HA ' ' A' ' 111' ' ' ALA . 13.6 m -103.69 144.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-O 122.654 1.216 . . . . 0.0 112.011 -173.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.748 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 65.3 mmm -97.73 89.5 4.65 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.374 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.791 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -64.74 134.64 54.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.788 0.327 . . . . 0.0 110.857 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -125.27 89.3 0.38 Allowed Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 28.9 t70 71.32 -57.81 0.59 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -166.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.63 ' O ' ' HB2' ' A' ' 109' ' ' SER . 20.8 t70 -173.88 -87.24 0.01 OUTLIER 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.263 -1.789 . . . . 0.0 107.846 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.889 ' HA ' HG21 ' A' ' 124' ' ' VAL . 5.6 t70 -91.5 -46.6 7.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.492 -175.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.9 t -55.13 -40.64 70.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.41 -167.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -130.26 26.7 5.13 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.552 -168.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.791 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 7.8 t -92.03 140.79 29.3 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.007 -172.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.748 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 8.0 mm -117.66 91.28 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.611 -174.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.974 ' HB2' HD11 ' A' ' 138' ' ' ILE . . . -72.75 96.8 2.09 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.267 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 4.5 mm -79.84 93.71 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.938 HG23 HD23 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -101.86 154.12 5.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.87 175.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.474 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 14.5 p -121.09 126.13 49.02 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.709 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 24.5 tptp -117.24 105.21 11.96 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -171.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 58.43 24.7 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -163.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 15.3 t-20 68.9 40.25 1.71 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 112.002 -2.363 . . . . 0.0 112.161 -177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.709 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 12.4 pt-20 -102.26 103.09 13.55 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 162.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 4.8 mt-30 -68.17 131.48 45.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.489 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 7.9 t80 -135.96 144.3 45.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.448 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.6 p -88.9 94.78 10.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 122.057 0.932 . . . . 0.0 111.22 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.494 ' CB ' ' HB3' ' A' ' 111' ' ' ALA . 16.0 mmt180 -98.56 -159.53 0.74 Allowed 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.049 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 126' ' ' GLU . . . 178.9 161.74 27.1 Favored Glycine 0 N--CA 1.408 -3.205 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -171.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.995 HG22 ' HB ' ' A' ' 138' ' ' ILE . 0.2 OUTLIER -57.12 128.04 17.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 165.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.668 ' HB2' ' O ' ' A' ' 124' ' ' VAL . 0.9 OUTLIER 81.14 28.58 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.482 1.134 . . . . 0.0 109.057 -176.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 123' ' ' GLY . 1.2 mm-40 -132.65 153.29 51.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 112.596 -2.093 . . . . 0.0 107.664 170.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 41.4 mt-10 -104.83 145.61 30.15 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.716 HG21 HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -62.65 153.87 76.5 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.486 -174.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.633 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 23.7 Cg_exo -66.37 126.92 16.41 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.569 2.18 . . . . 0.0 111.787 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.676 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 103.91 -57.89 0.53 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.06 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 147' ' ' TYR . 34.1 m-85 -111.92 149.62 31.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.957 -0.121 . . . . 0.0 110.743 -176.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.97 53.77 0.79 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.089 0.471 . . . . 0.0 111.778 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.643 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -90.24 95.69 10.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.656 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.652 ' HE2' HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -82.14 107.29 14.72 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.017 0.437 . . . . 0.0 110.846 -171.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.72 HG12 HG11 ' A' ' 143' ' ' VAL . 64.8 mt -54.07 94.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.357 176.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 144' ' ' VAL . 3.9 m -97.35 8.27 7.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.948 0.88 . . . . 0.0 108.815 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.775 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 5.7 m -165.41 114.81 1.04 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.079 176.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.995 ' HB ' HG22 ' A' ' 124' ' ' VAL . 1.1 tt -98.45 127.99 50.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.401 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.614 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 5.2 mmt180 -143.73 150.3 49.79 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -14.55 -74.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.837 1 C-N-CA 125.708 4.272 . . . . 0.0 114.974 -174.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.44 ' C ' HD13 ' A' ' 97' ' ' LEU . 7.8 p-10 -138.98 47.73 1.91 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.247 1.022 . . . . 0.0 109.475 168.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.821 ' HD3' HG13 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -143.81 139.37 29.3 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.154 165.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.72 HG11 HG12 ' A' ' 135' ' ' ILE . 10.4 t -135.02 118.19 23.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.071 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 153' ' ' VAL . 9.2 t -80.48 62.23 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.136 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.705 HD11 ' HG ' ' A' ' 154' ' ' LEU . 1.7 pp -79.83 166.78 21.36 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -171.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 2.1 tp60 -108.83 104.87 14.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 111.662 -2.517 . . . . 0.0 108.41 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 131' ' ' TYR . 1.0 OUTLIER -139.3 133.48 31.27 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.88 HE22 ' HB ' ' A' ' 92' ' ' THR . 3.1 mt-30 70.39 32.83 2.66 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 123.471 0.482 . . . . 0.0 110.859 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.405 ' CA ' HE22 ' A' ' 146' ' ' GLN . . . 76.58 3.78 79.29 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.409 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.53 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 2.3 tpm_? -125.02 153.53 42.69 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.655 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 2.7 p90 -134.77 106.64 7.01 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.355 1.074 . . . . 0.0 108.229 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 144' ' ' VAL . 81.0 mm-40 -134.62 -176.24 4.15 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.46 -169.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 144' ' ' VAL . 26.2 t -93.67 100.2 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.014 0.912 . . . . 0.0 108.724 -170.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.841 HD21 ' H ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -106.87 102.91 12.24 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 114.22 -1.354 . . . . 0.0 111.363 -175.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 142' ' ' ARG . . . -100.99 57.13 0.72 Allowed Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.572 175.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 1.027 HD22 ' HB2' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -37.23 109.82 0.11 Allowed 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.385 0.697 . . . . 0.0 109.624 171.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -121.94 157.58 30.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.215 0.531 . . . . 0.0 112.04 -164.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.434 ' OG ' ' HB3' ' A' ' 96' ' ' SER . 18.1 m -86.22 106.78 17.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.354 175.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.593 ' HG3' ' HG3' ' A' ' 160' ' ' GLU . 9.7 pt20 -85.48 -57.1 3.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.133 -176.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.593 ' HG3' ' HG3' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -95.4 92.36 6.66 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.381 0.61 . . . . 0.0 111.108 177.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 162' ' ' SER . 4.2 p30 -89.91 18.22 5.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.377 177.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 169' ' ' GLY . 40.4 t 79.85 -29.98 0.13 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.222 1.009 . . . . 0.0 111.667 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.667 ' HA2' HG12 ' A' ' 167' ' ' VAL . . . 128.47 66.27 0.12 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.023 -1.084 . . . . 0.0 113.227 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.2 m -67.98 -40.09 83.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.937 0.399 . . . . 0.0 110.729 176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -92.43 -12.46 32.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.02 0.438 . . . . 0.0 110.155 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 112.24 19.36 7.19 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.729 -0.668 . . . . 0.0 112.866 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.667 HG12 ' HA2' ' A' ' 163' ' ' GLY . 7.3 p -68.63 129.97 92.22 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.633 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 167' ' ' VAL . 23.4 Cg_exo -65.42 109.2 1.34 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.814 2.343 . . . . 0.0 112.378 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 162' ' ' SER . . . 166.16 57.39 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -116.83 -64.86 1.25 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.823 0.344 . . . . 0.0 111.221 -175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' A' ' 171' ' ' GLN . 3.8 pp0? -82.47 -22.95 34.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.478 -176.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.1 m -99.5 -38.2 6.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.854 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 . . . . . 0 C--O 1.249 1.036 0 O-C-N 123.951 0.782 . . . . 0.0 110.526 -177.148 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.856 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 p -69.33 136.48 51.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.858 0.361 . . . . 0.0 110.233 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -88.79 64.22 7.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.256 0.55 . . . . 0.0 110.285 -175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 22.5 ptp -79.45 -22.91 43.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.357 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 75.8 mt 64.2 -78.96 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.993 0.808 . . . . 0.0 111.013 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -173.45 110.57 0.18 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.036 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 96.3 mmm -74.87 99.04 3.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.023 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.6 -35.78 10.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.022 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.39 163.38 36.63 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.867 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.38 132.01 35.22 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.7 tp -77.08 -28.52 54.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.524 -177.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 84' ' ' GLN . 30.8 m-20 -84.63 56.98 4.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.35 0.595 . . . . 0.0 110.355 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.22 -31.59 71.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.442 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.4 t -84.24 -15.39 46.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.136 0.493 . . . . 0.0 110.262 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.564 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 35.4 tt0 -83.0 -28.9 29.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.839 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 70.6 mtm 63.25 45.32 5.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.124 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -62.42 99.45 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.537 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' A' ' 87' ' ' ASN . 8.6 m120 -126.29 133.21 51.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.21 175.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.748 ' H ' HD23 ' A' ' 88' ' ' LEU . 2.6 pt? -104.49 147.51 34.51 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.25 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 49.6 Cg_endo -70.71 113.49 3.55 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.66 2.24 . . . . 0.0 112.109 177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.46 ' HB2' ' H ' ' A' ' 91' ' ' SER . 4.0 Cg_exo -75.84 -115.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.151 2.567 . . . . 0.0 111.518 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.797 ' HB2' HD13 ' A' ' 154' ' ' LEU . 22.1 m 54.74 -79.61 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.898 ' HB ' HE22 ' A' ' 148' ' ' GLN . 0.1 OUTLIER -163.72 -44.56 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.124 -0.36 . . . . 0.0 111.216 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.967 ' H ' HD21 ' A' ' 154' ' ' LEU . 1.0 OUTLIER 52.48 99.78 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 CA-C-O 121.046 0.451 . . . . 0.0 111.434 -177.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.753 ' H ' HD23 ' A' ' 156' ' ' LEU . 0.1 OUTLIER -157.63 -73.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.002 -172.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.868 HD21 ' HA ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -56.77 174.65 0.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.374 179.152 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.532 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 42.4 t -121.58 118.98 30.59 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.557 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.547 ' HA ' HG23 ' A' ' 113' ' ' ILE . 6.0 mp -79.02 124.36 28.19 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.416 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -86.72 -29.85 22.1 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.01 173.64 30.92 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 169.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.966 HG22 ' HA ' ' A' ' 111' ' ' ALA . 2.4 t -129.75 126.84 63.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-O 121.558 0.694 . . . . 0.0 110.397 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.878 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -89.42 89.38 7.84 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.047 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.695 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -65.91 132.24 48.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.224 -174.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 108' ' ' ARG . . . -117.47 92.16 0.55 Allowed Glycine 0 CA--C 1.5 -0.868 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 -173.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.5 t0 69.53 -59.55 0.49 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.935 0.874 . . . . 0.0 108.784 -173.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -156.83 -146.81 0.17 Allowed 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.313 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.67 ' HB3' HG21 ' A' ' 124' ' ' VAL . 7.2 m-20 -56.53 -33.34 65.98 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.49 173.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.8 t -46.84 -56.3 6.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.435 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 22.7 mtp180 -119.49 30.49 7.06 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.611 -167.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.695 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 8.4 t -86.96 145.64 26.44 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.733 0.777 . . . . 0.0 112.133 -172.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.878 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 12.6 mm -114.3 92.5 2.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.404 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.966 ' HA ' HG22 ' A' ' 100' ' ' VAL . . . -73.86 101.46 3.77 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.399 -177.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 28.8 mm -86.47 93.05 3.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.901 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -104.5 150.08 7.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.647 -177.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 117' ' ' ASN . 64.6 p -116.05 130.56 56.87 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.133 0.492 . . . . 0.0 109.724 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.868 ' HA ' HD21 ' A' ' 95' ' ' LEU . 19.0 tptp -110.43 102.48 11.1 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 59.89 27.13 16.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -169.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.3 t-20 81.21 33.25 0.12 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 112.453 -2.158 . . . . 0.0 110.854 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -106.12 97.39 7.21 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.657 171.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 1.7 mt-30 -66.61 135.89 54.79 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.594 -176.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 15.6 t80 -144.86 149.54 35.52 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.367 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.543 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 6.4 m -88.57 101.6 14.11 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.608 0.718 . . . . 0.0 111.169 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 122' ' ' ARG . 18.0 mmt180 -104.94 -160.13 0.74 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.828 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.458 ' HA2' HD12 ' A' ' 138' ' ' ILE . . . -179.31 169.47 40.66 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.115 -1.04 . . . . 0.0 111.461 -176.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.845 HG23 ' HB ' ' A' ' 138' ' ' ILE . 5.7 t -45.32 129.9 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 114.223 -0.988 . . . . 0.0 110.456 162.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.686 ' HA ' ' HD2' ' A' ' 134' ' ' LYS . 0.0 OUTLIER 69.09 14.75 8.76 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 124.749 1.281 . . . . 0.0 110.428 176.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -105.81 164.48 11.9 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 167.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.836 ' HG2' ' HB2' ' A' ' 134' ' ' LYS . 33.1 mt-10 -114.12 151.13 33.07 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 119.142 0.883 . . . . 0.0 110.018 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.614 HG22 HG21 ' A' ' 113' ' ' ILE . 0.7 OUTLIER -59.13 143.42 84.54 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.048 0.451 . . . . 0.0 110.416 -176.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.625 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.1 Cg_exo -73.06 94.16 0.81 Allowed 'Trans proline' 0 C--O 1.222 -0.309 0 C-N-CA 123.244 2.63 . . . . 0.0 112.467 -170.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.474 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 132.76 -48.73 0.95 Allowed Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.532 ' CZ ' ' HE2' ' A' ' 115' ' ' LYS . 10.4 m-85 -112.65 137.7 50.53 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -73.91 46.75 0.24 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.897 0.772 . . . . 0.0 112.993 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.68 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -82.56 99.17 9.36 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 171.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.836 ' HB2' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -80.65 125.79 30.45 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-O 120.849 0.357 . . . . 0.0 110.939 -171.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.5 mt -77.23 89.93 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.601 HG22 ' HG3' ' A' ' 134' ' ' LYS . 1.3 t -85.11 -3.97 8.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 122.044 0.926 . . . . 0.0 108.641 -175.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.496 ' HB3' HG23 ' A' ' 144' ' ' VAL . 1.7 t -160.59 117.36 2.38 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.434 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.938 HD11 ' HB2' ' A' ' 111' ' ' ALA . 3.6 tt -94.92 133.51 35.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.495 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.574 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 17.0 mmt180 -141.79 162.85 44.21 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 170.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 139' ' ' ARG . 89.0 Cg_exo -25.22 -84.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.75 3.633 . . . . 0.0 114.635 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -116.64 29.81 7.71 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.154 0.978 . . . . 0.0 108.61 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.574 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 6.1 tpp85 -127.97 141.91 51.39 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.03 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.453 HG23 HD21 ' A' ' 97' ' ' LEU . 4.3 t -145.61 168.55 7.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.706 -175.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.956 HG22 HG23 ' A' ' 153' ' ' VAL . 19.5 t -129.84 62.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.798 ' O ' ' HA ' ' A' ' 151' ' ' TYR . 1.5 pp -82.38 155.27 24.79 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 -165.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.484 HE22 ' N ' ' A' ' 150' ' ' ARG . 11.4 tp60 -99.91 104.42 16.06 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 111.937 -2.392 . . . . 0.0 108.586 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.859 ' HD2' HG21 ' A' ' 92' ' ' THR . 0.6 OUTLIER -141.83 132.95 26.21 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.898 HE22 ' HB ' ' A' ' 92' ' ' THR . 1.8 mt-30 67.59 28.18 7.55 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.405 0.44 . . . . 0.0 110.774 175.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.4 ' C ' HE22 ' A' ' 146' ' ' GLN . . . 88.32 -2.91 85.41 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 119.809 -1.186 . . . . 0.0 112.698 177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.484 ' N ' HE22 ' A' ' 146' ' ' GLN . 28.5 ptt180 -126.26 145.51 50.38 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.576 -0.367 . . . . 0.0 111.242 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.798 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 6.4 p90 -122.76 109.96 14.87 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 171.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.455 ' OE2' ' HB2' ' A' ' 90' ' ' PRO . 36.7 mt-10 -127.33 -175.47 3.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.956 HG23 HG22 ' A' ' 144' ' ' VAL . 6.0 p -95.99 98.72 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 CA-C-O 122.835 1.302 . . . . 0.0 110.155 -165.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.967 HD21 ' H ' ' A' ' 93' ' ' LEU . 10.0 tp -106.81 116.22 31.55 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.426 -1.261 . . . . 0.0 112.36 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.567 ' O ' ' HD2' ' A' ' 157' ' ' TYR . . . -99.57 61.06 0.75 Allowed Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.924 -1.132 . . . . 0.0 110.952 167.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.753 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.7 mt -36.38 111.61 0.15 Allowed 'General case' 0 N--CA 1.485 1.306 0 O-C-N 124.325 0.662 . . . . 0.0 109.748 177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.567 ' HD2' ' O ' ' A' ' 155' ' ' GLY . 51.3 p90 -134.09 149.07 51.09 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.19 0.45 . . . . 0.0 110.45 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.532 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 41.9 m -152.62 159.32 43.23 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 172.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 68.1 179.56 0.23 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.485 0.491 . . . . 0.0 111.262 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -126.06 112.62 16.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.543 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -74.25 -46.61 40.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.67 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.8 t 49.84 52.71 14.09 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.276 0.36 . . . . 0.0 111.175 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -169.05 -41.55 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.127 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 24.0 m -110.03 68.07 0.66 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.104 0.478 . . . . 0.0 110.964 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.468 ' HB2' HG22 ' A' ' 167' ' ' VAL . 8.6 p-10 -74.37 -53.49 9.52 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.651 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 58.54 34.18 74.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.433 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 165' ' ' ASP . 33.3 m -120.89 155.94 57.02 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.24 108.86 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.148 1.899 . . . . 0.0 111.435 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -78.39 123.41 6.26 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.049 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -94.26 77.27 3.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.375 0.607 . . . . 0.0 109.974 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -89.92 50.78 1.93 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.206 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 28.7 m -124.09 156.72 31.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.972 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.876 -179.288 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.849 0 N-CA-C 112.038 -0.425 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.9 m -84.27 74.35 10.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.815 0.34 . . . . 0.0 110.753 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 46.6 m170 58.46 56.71 4.2 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.805 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.42 51.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.691 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.9 tp -106.35 112.33 25.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.411 -174.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 74.3 137.5 0.06 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 124.276 0.985 . . . . 0.0 112.617 171.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 42.4 tpp -75.4 -29.68 59.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.265 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.35 42.06 1.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.9 175.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.02 17.25 33.22 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.254 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.37 59.43 2.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.213 0.53 . . . . 0.0 110.587 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.574 ' HG ' ' H ' ' A' ' 81' ' ' ASP . 30.7 tp -153.66 176.06 12.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.337 -175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.574 ' H ' ' HG ' ' A' ' 80' ' ' LEU . 5.4 m-20 -64.8 -14.94 60.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.611 0.243 . . . . 0.0 111.583 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.92 -33.42 74.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.007 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.8 p -83.46 -19.26 36.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.655 0.264 . . . . 0.0 111.647 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -99.8 -51.28 3.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.258 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 70.1 mtm 47.97 34.39 4.09 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.189 0.518 . . . . 0.0 111.465 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.1 m -166.71 160.45 14.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.559 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -84.6 36.92 0.62 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.674 0.749 . . . . 0.0 109.537 175.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 89' ' ' PRO . 25.4 tp -88.02 130.1 47.65 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.722 -178.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 88' ' ' LEU . 56.3 Cg_exo -40.52 114.81 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.087 3.191 . . . . 0.0 113.682 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.6 ' O ' HD21 ' A' ' 154' ' ' LEU . 33.6 Cg_exo -63.75 -134.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.438 2.759 . . . . 0.0 111.99 172.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.671 ' HB2' ' HG ' ' A' ' 154' ' ' LEU . 60.0 m 53.46 -83.03 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.54 0.336 . . . . 0.0 110.992 -170.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 1.033 ' HB ' HE22 ' A' ' 148' ' ' GLN . 0.0 OUTLIER -156.04 -49.51 0.08 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 119.491 -0.29 . . . . 0.0 111.037 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 156' ' ' LEU . 46.0 tp 54.17 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.504 0.502 . . . . 0.0 111.663 -175.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.683 ' H ' HD23 ' A' ' 156' ' ' LEU . 5.8 t30 -162.5 -60.21 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.024 0.44 . . . . 0.0 111.669 -175.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.847 HD11 ' HD3' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -56.34 175.96 0.1 Allowed 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.124 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.8 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 21.7 t -114.98 108.5 16.79 Favored 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.028 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.836 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -73.22 117.33 14.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 171.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.641 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -91.18 -34.53 14.98 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -173.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 158.51 141.17 3.08 Favored Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.783 171.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.598 HG21 HG23 ' A' ' 138' ' ' ILE . 12.1 m -102.39 147.85 8.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.77 0.795 . . . . 0.0 109.689 -177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.866 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 67.5 mtt -104.03 90.69 3.68 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.288 -1.324 . . . . 0.0 108.024 176.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.59 120.95 9.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.777 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.598 ' O ' ' HB2' ' A' ' 104' ' ' ASP . . . -110.98 97.96 1.01 Allowed Glycine 0 CA--C 1.492 -1.367 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -174.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.598 ' HB2' ' O ' ' A' ' 103' ' ' GLY . 3.6 m-20 73.42 -66.03 0.33 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -173.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.539 ' O ' ' HB3' ' A' ' 109' ' ' SER . 8.3 m-20 -162.29 -102.64 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 113.692 -1.594 . . . . 0.0 107.594 167.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.693 ' HB2' HG21 ' A' ' 124' ' ' VAL . 6.5 p-10 -91.73 -20.2 21.8 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.35 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.45 ' C ' ' HD3' ' A' ' 108' ' ' ARG . 14.5 m -61.87 -47.01 86.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.077 -174.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.45 ' HD3' ' C ' ' A' ' 107' ' ' SER . 0.0 OUTLIER -123.79 19.89 9.35 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.053 -168.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.66 ' HB2' HD12 ' A' ' 138' ' ' ILE . 2.8 p -66.77 147.29 53.45 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.185 -0.916 . . . . 0.0 113.324 -170.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.866 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 5.5 mm -126.94 84.74 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 CA-C-O 121.783 0.802 . . . . 0.0 110.862 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.865 ' HB3' ' HB2' ' A' ' 122' ' ' ARG . . . -72.93 96.92 2.18 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.404 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 9.9 mm -81.86 94.35 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.863 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -105.29 140.43 23.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.666 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.831 ' OG ' ' HA ' ' A' ' 117' ' ' ASN . 29.9 t -99.69 129.31 45.81 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.865 -178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.847 ' HD3' HD11 ' A' ' 95' ' ' LEU . 24.9 tptp -128.79 106.06 8.66 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.7 t70 62.52 18.57 10.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 -169.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.831 ' HA ' ' OG ' ' A' ' 114' ' ' SER . 2.6 t-20 76.22 38.54 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.535 -175.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.506 ' HG2' ' CE1' ' A' ' 120' ' ' PHE . 31.1 tt0 -113.13 93.6 4.49 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.161 167.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.641 ' NE2' HG21 ' A' ' 98' ' ' THR . 74.2 mt-30 -66.83 129.72 40.8 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.886 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.697 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 50.6 m-85 -119.88 150.34 40.63 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.306 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.499 ' HB3' ' CG2' ' A' ' 110' ' ' ILE . 6.2 m -94.23 99.16 11.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.712 0.768 . . . . 0.0 109.844 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.865 ' HB2' ' HB3' ' A' ' 111' ' ' ALA . 64.9 mmt-85 -89.61 -161.86 0.82 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.822 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.685 ' N ' ' HG2' ' A' ' 126' ' ' GLU . . . 161.11 95.59 0.11 Allowed Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.007 -1.092 . . . . 0.0 112.894 -163.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.693 HG21 ' HB2' ' A' ' 106' ' ' ASP . 2.2 t 4.55 123.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 O-C-N 126.563 1.978 . . . . 0.0 114.976 -177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.698 ' HA ' ' CE ' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 78.21 34.42 0.29 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.664 -177.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.685 ' HG2' ' N ' ' A' ' 123' ' ' GLY . 0.8 OUTLIER -124.04 167.08 14.67 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 112.669 -2.059 . . . . 0.0 107.844 168.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 1.9 mp0 -112.1 146.31 38.22 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.477 HG21 HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -61.66 153.72 69.52 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.479 ' O ' HD11 ' A' ' 95' ' ' LEU . 24.4 Cg_exo -66.04 127.84 18.45 Favored 'Trans proline' 0 C--N 1.333 -0.287 0 C-N-CA 122.424 2.083 . . . . 0.0 112.442 -175.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.584 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 100.66 -59.78 0.67 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.209 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.622 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 10.9 m-85 -109.68 140.75 43.17 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.025 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -74.94 49.89 0.44 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.659 0.663 . . . . 0.0 111.789 -178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.705 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -80.64 96.68 6.94 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.752 ' HD2' ' C ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -80.49 108.96 14.55 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 121.044 0.45 . . . . 0.0 110.989 -168.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.652 HG12 HG11 ' A' ' 143' ' ' VAL . 50.5 mt -60.81 95.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.93 177.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.585 HG23 ' HA ' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -84.15 -8.63 11.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.081 179.09 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.683 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 39.4 m -157.49 116.18 3.22 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.435 -174.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.662 ' CD1' ' HB2' ' A' ' 111' ' ' ALA . 3.9 mt -92.61 127.91 44.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.598 176.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.593 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 28.0 mmt180 -141.2 151.62 62.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 173.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.411 ' O ' ' HA2' ' A' ' 99' ' ' GLY . 78.0 Cg_exo -18.57 -75.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 1 C-N-CA 125.519 4.146 . . . . 0.0 114.776 -178.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.501 ' HA ' HD23 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -129.21 39.47 3.76 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.412 1.101 . . . . 0.0 108.797 168.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.593 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 8.2 tpp85 -136.06 143.56 44.73 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.835 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.729 HG23 HD21 ' A' ' 97' ' ' LEU . 3.4 t -141.67 169.25 14.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.534 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.85 HG22 HG12 ' A' ' 153' ' ' VAL . 18.3 t -133.58 61.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.786 HD11 HD12 ' A' ' 154' ' ' LEU . 1.9 pp -82.64 162.47 21.86 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -167.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 1.8 tp60 -105.73 105.49 15.56 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 112.556 -2.111 . . . . 0.0 108.232 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.638 ' HD2' HG21 ' A' ' 92' ' ' THR . 0.7 OUTLIER -141.21 136.78 32.08 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.753 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 1.033 HE22 ' HB ' ' A' ' 92' ' ' THR . 11.8 mt-30 68.29 28.67 6.23 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.534 0.521 . . . . 0.0 110.998 173.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.35 3.25 78.79 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.71 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 20.4 ttt180 -133.31 144.69 49.84 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 122.78 -0.247 . . . . 0.0 111.065 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.709 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 11.0 p90 -115.88 107.84 15.53 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.438 1.113 . . . . 0.0 107.999 171.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.824 ' HG3' ' H ' ' A' ' 153' ' ' VAL . 10.2 tp10 -130.79 -173.18 3.01 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.546 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.85 HG12 HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -95.28 100.06 10.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.676 0.75 . . . . 0.0 111.015 -167.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.786 HD12 HD11 ' A' ' 145' ' ' LEU . 1.2 mt -101.35 109.44 21.29 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.672 176.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.437 ' O ' ' HD2' ' A' ' 157' ' ' TYR . . . -99.85 52.19 1.03 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 166.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 94' ' ' ASN . 2.4 mt -35.77 117.68 0.45 Allowed 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.673 0.866 . . . . 0.0 109.659 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.437 ' HD2' ' O ' ' A' ' 155' ' ' GLY . 45.6 p90 -135.84 153.08 51.61 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.8 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 2.3 t -99.61 168.33 10.02 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 173.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 68.79 -173.68 0.19 Allowed 'General case' 0 C--O 1.232 0.164 0 O-C-N 123.637 0.586 . . . . 0.0 110.221 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -99.05 124.87 44.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -72.16 -65.9 0.72 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.283 -172.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 47.2 p 46.13 49.33 12.51 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.216 0.607 . . . . 0.0 111.874 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.89 -163.79 10.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.625 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 43.3 m -112.49 135.8 52.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.055 0.455 . . . . 0.0 110.629 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -76.35 -27.99 56.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.229 -176.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.32 3.64 27.46 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.885 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 66.6 t -86.03 112.0 42.29 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 167' ' ' VAL . 11.9 Cg_exo -70.53 110.94 2.84 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.071 2.514 . . . . 0.0 112.692 -176.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -86.27 -42.76 6.48 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . 57.96 -91.78 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.409 0.684 . . . . 0.0 111.607 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -81.76 69.09 8.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.84 0.352 . . . . 0.0 110.755 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.1 t -66.47 -38.16 81.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.568 ' HD3' ' C ' ' A' ' 173' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.822 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.176 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.844 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.4 m -84.22 123.36 30.04 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.706 0.288 . . . . 0.0 110.561 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -108.54 73.48 0.87 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 111.296 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 96.1 mmm -117.96 5.41 12.12 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 50.9 tp -77.5 75.11 4.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.109 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 54.42 65.28 1.55 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.076 175.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 19.8 ptm -84.0 78.4 9.75 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.418 0.628 . . . . 0.0 110.552 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.33 43.3 10.81 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.838 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.65 91.1 0.23 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.918 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 178.68 -36.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 122.588 0.355 . . . . 0.0 110.757 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.4 tp -64.33 96.5 0.16 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.435 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.5 t70 54.59 50.94 14.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.264 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -91.35 -64.39 1.13 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.298 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.429 ' HB3' HG11 ' A' ' 153' ' ' VAL . 14.9 m -88.99 -3.05 58.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.664 -176.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -76.15 -13.11 60.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.144 0.497 . . . . 0.0 110.255 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 65.1 mtt -78.26 -60.74 2.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.909 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.8 t 57.39 58.52 3.79 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.574 0.702 . . . . 0.0 109.84 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -99.32 -36.47 9.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.91 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.407 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 63.0 tp -139.2 108.65 7.46 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.228 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 2.4 Cg_endo -82.02 107.89 1.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.294 2.663 . . . . 0.0 111.596 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.718 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 2.9 Cg_exo -77.7 -133.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.297 2.665 . . . . 0.0 111.854 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.594 ' OG ' ' HB2' ' A' ' 152' ' ' GLU . 0.0 OUTLIER 47.91 -100.23 0.06 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.261 0.624 . . . . 0.0 112.049 -174.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.644 ' H ' HD11 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -138.45 -37.19 0.56 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.024 0.829 . . . . 0.0 112.541 -178.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.66 ' H ' ' CD1' ' A' ' 154' ' ' LEU . 1.3 tm? 66.57 -4.11 0.78 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.488 ' N ' HD23 ' A' ' 156' ' ' LEU . 4.0 t30 -103.96 97.61 7.57 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.623 -0.673 . . . . 0.0 112.572 -173.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.746 ' HB2' HD22 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -179.97 179.01 0.57 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 177.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.537 ' H ' HD13 ' A' ' 95' ' ' LEU . 24.4 t -123.29 101.04 7.15 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 119.442 1.019 . . . . 0.0 110.345 173.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.894 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.6 OUTLIER -81.23 75.46 8.19 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.736 HG21 ' NE2' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -40.31 -47.57 2.52 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 174.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 140' ' ' PRO . . . 160.33 153.45 6.94 Favored Glycine 0 CA--C 1.488 -1.595 0 C-N-CA 118.317 -1.897 . . . . 0.0 113.431 173.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.635 HG22 ' HA ' ' A' ' 140' ' ' PRO . 8.0 m -103.92 142.72 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-O 121.565 0.698 . . . . 0.0 109.64 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.846 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -98.48 87.42 3.84 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.81 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -56.18 135.21 53.31 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.878 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 105' ' ' ASP . . . -123.14 92.69 0.47 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.815 -176.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 t70 71.28 -40.57 0.48 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.239 1.015 . . . . 0.0 110.118 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 103' ' ' GLY . 4.3 t70 -178.88 -141.02 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -174.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.752 ' CB ' HG21 ' A' ' 124' ' ' VAL . 20.8 m-20 -67.07 -29.61 69.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.3 0.571 . . . . 0.0 109.605 167.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.5 t -52.86 -57.46 10.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.937 -169.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.412 ' O ' ' HA3' ' A' ' 103' ' ' GLY . 5.2 mmm180 -114.29 26.52 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.122 -173.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.81 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 1.6 t -76.47 152.29 36.19 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.781 0.324 . . . . 0.0 111.217 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.846 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 15.4 mm -123.69 85.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 122.059 0.933 . . . . 0.0 110.833 -176.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.883 ' HB1' HD11 ' A' ' 113' ' ' ILE . . . -70.85 99.52 1.76 Allowed 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.2 -1.364 . . . . 0.0 111.95 -176.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 120' ' ' PHE . 7.8 mm -88.29 91.72 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -100.8 137.74 27.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.904 -177.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 4.2 m -95.22 122.47 37.94 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.156 -1.384 . . . . 0.0 110.754 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.522 ' HE3' ' HA3' ' A' ' 130' ' ' GLY . 25.0 tptp -117.07 97.42 5.92 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 58.88 23.58 11.52 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -164.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 114' ' ' SER . 1.5 t30 75.98 38.8 0.33 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.912 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -99.26 92.88 5.65 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 161.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.736 ' NE2' HG21 ' A' ' 98' ' ' THR . 61.6 mt-30 -68.54 105.37 2.21 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.028 -173.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 112' ' ' ILE . 6.7 t80 -106.67 133.82 50.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.863 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.6 p -85.31 98.89 10.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.307 1.051 . . . . 0.0 111.431 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.86 ' HB3' ' OE2' ' A' ' 126' ' ' GLU . 14.5 mmt180 -89.45 -161.89 0.82 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.392 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.588 ' N ' ' HG2' ' A' ' 126' ' ' GLU . . . 158.93 94.13 0.1 OUTLIER Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.586 -165.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.752 HG21 ' CB ' ' A' ' 106' ' ' ASP . 21.5 t 7.74 120.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.478 1.911 . . . . 0.0 115.71 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.676 ' HA ' ' HD3' ' A' ' 134' ' ' LYS . 0.9 OUTLIER 83.04 40.51 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 123.05 1.405 . . . . 0.0 109.165 -178.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.86 ' OE2' ' HB3' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -135.83 158.26 44.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 111.917 -2.401 . . . . 0.0 108.115 171.245 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 52.9 mt-10 -105.49 142.75 34.7 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.223 0.535 . . . . 0.0 110.981 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.836 HG22 ' HD2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -56.65 143.51 68.1 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.723 -174.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.836 ' HD2' HG22 ' A' ' 128' ' ' VAL . 2.2 Cg_endo -57.22 116.91 3.55 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 122.761 2.307 . . . . 0.0 112.924 -176.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.522 ' HA3' ' HE3' ' A' ' 115' ' ' LYS . . . 113.98 -63.05 0.31 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.524 176.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.468 ' HB3' ' CE2' ' A' ' 147' ' ' TYR . 18.2 m-85 -107.79 147.36 30.95 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -78.58 58.37 2.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.983 0.81 . . . . 0.0 111.674 -173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.705 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -91.9 97.71 11.14 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.244 175.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.676 ' HD3' ' HA ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER -80.23 106.92 12.61 Favored 'General case' 0 C--O 1.212 -0.907 0 CA-C-O 120.69 0.281 . . . . 0.0 110.653 -171.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.744 ' HB ' ' OE1' ' A' ' 126' ' ' GLU . 75.6 mt -56.5 96.33 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 122.097 0.951 . . . . 0.0 110.174 176.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.715 HG23 ' HA ' ' A' ' 145' ' ' LEU . 1.6 t -88.09 -2.74 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.379 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -165.89 117.61 1.07 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.332 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.629 HG21 ' OG ' ' A' ' 109' ' ' SER . 1.9 mt -92.79 125.13 45.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.043 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 8.4 mmt180 -129.9 153.21 80.91 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.635 ' HA ' HG22 ' A' ' 100' ' ' VAL . 32.4 Cg_exo -22.82 -68.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.645 1 C-N-CA 125.388 4.059 . . . . 0.0 114.605 -179.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.505 ' HA ' HD23 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -137.31 39.07 2.49 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.642 1.21 . . . . 0.0 109.111 172.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 2.3 tpp85 -142.05 142.81 32.89 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 113.208 -1.814 . . . . 0.0 108.393 176.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.61 HG11 HG12 ' A' ' 135' ' ' ILE . 2.1 t -139.87 166.91 19.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.499 0.666 . . . . 0.0 110.996 -176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 153' ' ' VAL . 40.9 t -130.04 95.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.878 HD11 HD12 ' A' ' 154' ' ' LEU . 2.6 pp -121.12 158.4 28.02 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -164.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.7 OUTLIER -92.27 110.41 21.8 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.168 -1.833 . . . . 0.0 109.468 -176.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.476 ' CD2' HG21 ' A' ' 92' ' ' THR . 0.5 OUTLIER -151.14 133.38 15.33 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 175.265 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 74.14 34.83 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.65 0.593 . . . . 0.0 110.423 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.0 13.74 82.89 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.794 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 146' ' ' GLN . 32.5 ptt180 -142.59 170.47 15.64 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.689 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 26.1 p90 -136.03 111.08 8.88 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.314 1.054 . . . . 0.0 108.409 171.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.718 ' HG3' ' HB2' ' A' ' 90' ' ' PRO . 76.7 mm-40 -119.76 -170.19 1.91 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.126 -173.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.677 HG12 HG22 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -103.03 107.13 21.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.637 0.732 . . . . 0.0 110.407 -172.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.878 HD12 HD11 ' A' ' 145' ' ' LEU . 1.4 mt -113.44 114.16 26.18 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.47 -175.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.468 ' O ' ' HD1' ' A' ' 157' ' ' TYR . . . -110.11 50.84 0.74 Allowed Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 168.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.746 HD22 ' HB2' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -36.04 113.25 0.21 Allowed 'General case' 0 N--CA 1.475 0.803 0 O-C-N 124.803 0.943 . . . . 0.0 109.608 178.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.468 ' HD1' ' O ' ' A' ' 155' ' ' GLY . 51.3 p90 -134.12 144.03 48.32 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.75 -0.594 . . . . 0.0 109.784 -172.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.505 ' HB3' ' HB2' ' A' ' 96' ' ' SER . 23.2 t -152.45 107.79 3.28 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -97.9 -66.7 0.89 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.705 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -127.03 179.77 5.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.779 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.44 -68.53 0.61 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -176.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.7 t 49.77 40.65 20.74 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.977 0.417 . . . . 0.0 111.006 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.89 -49.39 7.09 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.055 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.6 t 69.82 -68.73 0.19 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.337 0.655 . . . . 0.0 111.269 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.49 -14.88 36.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.343 0.592 . . . . 0.0 110.351 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.41 -21.17 22.17 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -174.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.36 139.4 32.83 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.07 124.71 16.25 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.805 2.337 . . . . 0.0 111.818 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -92.08 38.52 3.17 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.415 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -88.37 43.86 1.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.206 0.527 . . . . 0.0 110.37 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -111.56 92.71 4.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.38 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 27.4 m -84.32 40.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.323 0.583 . . . . 0.0 111.571 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.608 -0.71 . . . . 0.0 109.872 -179.687 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.449 ' HB2' HD11 ' A' ' 74' ' ' LEU . 4.7 p -102.39 88.44 3.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.138 0.494 . . . . 0.0 110.646 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -113.42 -37.48 4.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.354 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 40.4 tpp -97.55 75.18 2.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.653 0.739 . . . . 0.0 110.779 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 71' ' ' SER . 97.1 mt -113.54 11.66 18.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.32 175.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -89.17 8.21 31.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.45 -173.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 23.3 ttt -156.81 -81.62 0.07 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 47.02 74.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.029 0.831 . . . . 0.0 112.906 174.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.79 63.91 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.898 -1.144 . . . . 0.0 113.021 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -143.51 110.89 5.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.558 0.218 . . . . 0.0 110.983 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.2 mt 57.79 33.11 22.83 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.393 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.93 4.66 7.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.282 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 86' ' ' SER . . . -76.95 -30.04 55.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.046 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.1 m -69.92 -11.14 60.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.733 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -63.15 -64.16 0.99 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.553 -174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 37.3 tpp -120.85 -19.18 7.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.841 0.353 . . . . 0.0 111.446 -176.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 13.1 m -80.73 132.27 35.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.877 0.37 . . . . 0.0 110.481 -178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -116.31 -36.05 4.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.657 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 89' ' ' PRO . 33.1 tp -74.87 124.78 89.77 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.921 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.829 ' HB3' HD12 ' A' ' 154' ' ' LEU . 76.3 Cg_exo -51.09 108.97 0.26 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.724 2.949 . . . . 0.0 112.796 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.668 ' HB2' ' HG3' ' A' ' 152' ' ' GLU . 9.1 Cg_exo -73.45 -33.87 6.44 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.856 3.038 . . . . 0.0 115.434 -169.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.677 ' HB2' HD13 ' A' ' 154' ' ' LEU . 67.9 m -56.0 -71.29 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.502 0.592 . . . . 0.0 111.142 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.635 HG23 HD21 ' A' ' 154' ' ' LEU . 1.7 t -160.36 -48.45 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.046 ' H ' HD21 ' A' ' 154' ' ' LEU . 53.8 tp 60.99 118.89 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.581 ' H ' HD23 ' A' ' 156' ' ' LEU . 4.5 t30 -176.54 -63.92 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.834 0.35 . . . . 0.0 111.901 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.835 HD21 ' HD2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -55.64 169.31 0.34 Allowed 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.798 -178.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 158' ' ' SER . 16.5 m -114.55 110.74 20.28 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.713 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.694 ' HA ' HG23 ' A' ' 113' ' ' ILE . 3.3 mp -76.21 123.06 25.27 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 114' ' ' SER . 0.2 OUTLIER -87.58 -36.54 17.48 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -175.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.555 ' O ' ' HB ' ' A' ' 112' ' ' ILE . . . 159.49 146.75 4.66 Favored Glycine 0 N--CA 1.43 -1.754 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.654 170.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.75 HG22 ' HA ' ' A' ' 111' ' ' ALA . 5.2 t -103.97 131.05 53.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.054 0.454 . . . . 0.0 110.689 -174.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.864 ' HB2' ' HB ' ' A' ' 110' ' ' ILE . 26.2 mmt -97.46 88.02 4.28 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.805 ' HA ' ' OG ' ' A' ' 109' ' ' SER . . . -67.95 126.74 30.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -174.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 104' ' ' ASP . . . -128.52 110.48 1.13 Allowed Glycine 0 CA--C 1.5 -0.871 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.93 -171.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 103' ' ' GLY . 23.9 t70 70.11 -65.18 0.33 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.692 ' O ' ' HB2' ' A' ' 109' ' ' SER . 20.2 t70 -167.72 -91.34 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.086 -1.87 . . . . 0.0 107.26 161.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.767 ' HA ' HG21 ' A' ' 124' ' ' VAL . 6.1 p-10 -91.97 -21.21 20.67 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.812 0.695 . . . . 0.0 111.078 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.447 ' HB2' ' HG2' ' A' ' 108' ' ' ARG . 3.9 m -60.03 -38.0 81.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.385 -172.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 107' ' ' SER . 0.1 OUTLIER -141.94 32.44 1.58 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.674 -172.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.805 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 1.5 t -85.99 135.84 33.49 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.034 0.445 . . . . 0.0 110.24 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.864 ' HB ' ' HB2' ' A' ' 101' ' ' MET . 13.0 mm -116.91 88.49 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.341 -173.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.959 ' HB2' HD11 ' A' ' 138' ' ' ILE . . . -73.88 98.06 2.91 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.47 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' A' ' 99' ' ' GLY . 17.1 mm -82.87 94.73 3.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.807 HD11 ' HB1' ' A' ' 111' ' ' ALA . 0.3 OUTLIER -106.28 148.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.644 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.526 ' HB3' ' OG1' ' A' ' 98' ' ' THR . 1.3 p -118.37 132.71 56.26 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.473 0.654 . . . . 0.0 109.611 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.835 ' HD2' HD21 ' A' ' 95' ' ' LEU . 17.8 tptm -108.68 100.65 9.87 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.2 t70 52.92 33.32 14.28 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -165.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 3.2 t-20 79.85 29.81 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 112.537 -2.119 . . . . 0.0 111.393 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 8.6 tp10 -96.88 92.77 6.28 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 170.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.655 ' HA ' ' O ' ' A' ' 113' ' ' ILE . 29.3 mt-30 -73.85 132.58 42.68 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -138.29 152.29 48.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.58 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.2 p -95.39 105.79 17.79 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.316 0.579 . . . . 0.0 111.503 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 1.093 ' HD2' ' HB3' ' A' ' 126' ' ' GLU . 30.1 mmt180 -96.83 -163.75 1.08 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.805 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.628 ' N ' ' HG3' ' A' ' 126' ' ' GLU . . . 173.05 93.41 0.09 OUTLIER Glycine 0 C--O 1.222 -0.596 0 C-N-CA 119.792 -1.194 . . . . 0.0 114.456 -164.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 1.016 HG22 ' HB ' ' A' ' 138' ' ' ILE . 1.3 t 4.64 45.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 127.426 2.29 . . . . 0.0 115.84 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.48 ' C ' ' HD3' ' A' ' 134' ' ' LYS . 0.2 OUTLIER 166.96 39.3 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -174.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 1.093 ' HB3' ' HD2' ' A' ' 122' ' ' ARG . 11.4 mm-40 -144.58 135.05 24.52 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 111.777 -2.465 . . . . 0.0 108.071 -170.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.754 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 58.4 mt-10 -91.84 142.62 27.38 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.695 HG22 HG21 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -60.0 152.12 62.08 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.15 -177.283 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.659 ' HB2' ' HB2' ' A' ' 115' ' ' LYS . 24.0 Cg_exo -66.23 129.44 21.64 Favored 'Trans proline' 0 C--N 1.329 -0.454 0 C-N-CA 122.667 2.245 . . . . 0.0 111.46 -176.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.448 ' HA3' ' CE ' ' A' ' 115' ' ' LYS . . . 93.82 -38.31 3.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.942 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.402 ' HB3' ' HE2' ' A' ' 147' ' ' TYR . 44.1 m-85 -124.67 133.18 53.3 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.607 -174.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -76.92 52.98 0.9 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.399 0.619 . . . . 0.0 111.084 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.678 ' HB1' HD13 ' A' ' 145' ' ' LEU . . . -93.22 99.01 11.65 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 172.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.754 ' HA ' ' HA ' ' A' ' 127' ' ' GLU . 1.4 tmmm? -81.09 121.92 26.7 Favored 'General case' 0 C--O 1.211 -0.944 0 CA-C-O 121.005 0.431 . . . . 0.0 110.827 -170.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.796 HG12 HG11 ' A' ' 143' ' ' VAL . 95.4 mt -67.14 94.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.648 HG22 ' HE2' ' A' ' 134' ' ' LYS . 2.8 t -86.58 -9.88 11.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.508 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -158.12 116.8 3.11 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.982 -178.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 1.016 ' HB ' HG22 ' A' ' 124' ' ' VAL . 0.2 OUTLIER -86.64 133.51 29.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.064 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.668 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 19.2 mmt180 -141.88 154.56 65.59 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 172.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 100' ' ' VAL . 52.6 Cg_exo -22.79 -78.19 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 125.138 3.892 . . . . 0.0 114.777 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.492 ' HA ' HD23 ' A' ' 97' ' ' LEU . 3.4 p-10 -127.43 39.85 3.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.494 1.14 . . . . 0.0 109.086 168.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.668 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 7.1 tpp85 -134.95 139.98 45.36 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.374 -1.739 . . . . 0.0 109.689 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.796 HG11 HG12 ' A' ' 135' ' ' ILE . 3.5 t -143.59 123.38 8.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.747 0.784 . . . . 0.0 112.429 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.902 HG22 HG12 ' A' ' 153' ' ' VAL . 22.0 t -80.55 101.66 5.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 169.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.969 HD11 HD22 ' A' ' 154' ' ' LEU . 1.1 pp -122.77 158.41 30.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -168.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.659 ' HA ' ' O ' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -95.27 103.1 14.95 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 112.754 -2.021 . . . . 0.0 109.449 -175.473 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.563 ' HD1' ' N ' ' A' ' 148' ' ' GLN . 0.3 OUTLIER -139.93 135.62 33.01 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.563 ' N ' ' HD1' ' A' ' 147' ' ' TYR . 1.9 mp0 72.96 31.94 1.43 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.635 0.584 . . . . 0.0 110.57 173.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.04 16.49 74.94 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.062 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.805 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 6.0 tpp180 -132.28 157.13 45.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.814 ' HA ' ' O ' ' A' ' 145' ' ' LEU . 25.4 p90 -134.67 107.11 7.29 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.805 ' HG2' ' HG3' ' A' ' 150' ' ' ARG . 43.1 mm-40 -124.03 -171.69 2.38 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.523 -174.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.902 HG12 HG22 ' A' ' 144' ' ' VAL . 3.1 m -100.4 99.95 9.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.838 0.828 . . . . 0.0 110.489 -172.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 1.046 HD21 ' H ' ' A' ' 93' ' ' LEU . 3.5 tp -107.27 109.75 21.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.854 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 142' ' ' ARG . . . -97.11 53.51 1.36 Allowed Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.312 172.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.599 ' HA ' HD12 ' A' ' 93' ' ' LEU . 2.2 mt -37.09 115.49 0.39 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.447 0.734 . . . . 0.0 109.358 176.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -133.21 160.7 36.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.533 0.606 . . . . 0.0 109.946 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.444 ' HA ' ' OG ' ' A' ' 96' ' ' SER . 19.9 m -53.33 123.61 12.41 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.349 0.406 . . . . 0.0 110.819 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' A' ' 162' ' ' SER . 11.9 pt20 -112.99 166.61 11.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 110.976 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -142.52 -36.57 0.4 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.475 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -66.75 -28.87 68.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.186 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.473 ' HA ' ' OE1' ' A' ' 159' ' ' GLN . 22.7 t 65.85 20.97 11.45 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.85 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.02 -3.25 87.56 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.586 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -91.03 -160.74 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -71.08 -12.31 61.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.107 0.479 . . . . 0.0 111.358 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 111.97 -2.95 27.15 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.268 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.1 p -92.99 127.97 45.3 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.37 109.52 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.669 2.246 . . . . 0.0 112.126 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 159.75 29.56 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.926 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -86.04 80.2 8.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.151 0.501 . . . . 0.0 110.209 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -83.4 -36.57 24.18 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 46.9 t -117.13 -60.71 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.421 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.715 -0.659 . . . . 0.0 109.67 178.097 . . . . . . . . 0 0 . 1 stop_ save_